Part 3 / PARTE 3: TABLA DE CLASIFICACIÓN Y ETIQUETADO ARMONIZADOS
Tabla 3
Lista de clasificación y etiquetado armonizados de sustancias peligrosas
|
N.o Índice |
►M18 Nombre químico ◄ |
N.o CE |
N.o CAS |
Clasificación |
Etiquetado |
►M18 Límites de concentración específicos, factores M y ETA (*1) ◄ |
Notas |
|||
|
Códigos de clase y categoría de peligro |
Códigos de indicaciones de peligro |
Códigos de pictogramas y palabras de advertencia |
Códigos de indicaciones de peligro |
Códigos de indicaciones de peligro suplementarias |
||||||
|
001-001-00-9 |
Hidrógeno |
215-605-7 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
001-002-00-4 |
Hidruro de litio y aluminio |
240-877-9 |
Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
|
|
|
|
|
001-003-00-X |
Hidruro de sodio |
231-587-3 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
|
|
|
001-004-00-5 |
Hidruro de calcio |
232-189-2 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
|
|
|
003-001-00-4 |
Litio |
231-102-5 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
|
003-002-00-X |
n-Hexil-litio |
404-950-0 |
Water-react. 1 Pyr. Sol. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Dgr |
H260 H250 H314 |
EUH014 |
|
|
|
|
003-003-00-5 |
(2-Metilpropil)litio; isobutil-litio |
440-620-2 |
Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H314 H336 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H260 H250 H314 H336 H410 |
EUH014 |
|
|
|
|
004-001-00-7 |
Berilio |
231-150-7 |
Carc. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372** H319 H335 H315 H317 |
GHS06 GHS08 Dgr |
H350i H330 H301 H372** H319 H335 H315 H317 |
|
|
|
|
|
004-002-00-2 |
Compuestos de berilio, excepto los silicatos de aluminio y berilio y los especificados en otras partes del presente anexo |
— |
— |
Carc. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H350i H330 H301 H372** H319 H335 H315 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H350i H330 H301 H372** H319 H335 H315 H317 H411 |
|
|
A |
|
004-003-00-8 |
Óxido de berilio |
215-133-1 |
Carc. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372** H319 H335 H315 H317 |
GHS06 GHS08 Dgr |
H350i H330 H301 H372** H319 H335 H315 H317 |
|
|
|
|
|
005-001-00-X |
Trifluoruro de boro |
231-569-5 |
Press. Gas Acute Tox. 2* Skin Corr. 1A |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
EUH014 |
|
U |
|
|
005-002-00-5 |
Tricloruro de boro |
233-658-4 |
Press. Gas Acute Tox. 2* Acute Tox. 2* Skin Corr. 1B |
H330 H300 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H300 H314 |
EUH014 |
|
U |
|
|
005-003-00-0 |
Tribromuro de boro |
233-657-9 |
Acute Tox. 2* Acute Tox. 2* Skin Corr. 1A |
H330 H300 H314 |
GHS06 GHS05 Dgr |
H330 H300 H314 |
EUH014 |
|
|
|
|
005-004-00-6 |
Trialquilboranos, sólidos |
— |
— |
Pyr. Sol. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Dgr |
H250 H314 |
|
|
A |
|
005-004-01-3 |
Trialquilboranos, líquidos |
— |
— |
Pyr. Liq. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Dgr |
H250 H314 |
|
|
A |
|
005-005-00-1 |
Borato de trimetilo |
204-468-9 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4* |
H226 H360FD H312 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H312 |
|
|
11 |
|
|
005-006-00-7 |
Hidrogenoborato de dibutilestaño |
401-040-5 |
Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4* Acute Tox. 4* Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H341 H372** H312 H302 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H360FD H341 H372** H312 H302 H318 H317 H410 |
|
|
|
|
|
005-007-00-2 |
Ácido bórico; [1] Ácido bórico [2] |
233-139-2 [1] 234-343-4 [2] |
10043-35-3 [1] 11113-50-1 [2] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
11 |
|
005-008-00-8 |
Trióxido de diboro |
215-125-8 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
11 |
|
|
005-009-00-3 |
Butiltrifenilborato de tetrabutilamonio |
418-080-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
005-010-00-9 |
N, N-dimetilanilinio tetrakis(pentafluorofenil)borato |
422-050-6 |
Carc. 2 Acute Tox. 4* Skin Irrit. 2 Eye Dam. 1 |
H351 H302 H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H351 H302 H315 H318 |
|
|
|
|
|
005-011-00-4 |
heptaóxido de tetraboro y disodio, hidratado; [1] tetraborato de disodio, anhidro; [2] ácido ortobórico, sal de sodio; [3] Tetraborato de disodio, decahidratado [4] tetraborato de disodio pentahidratado [5] |
235-541-3 [1] 215-540-4 [2] 237-560-2 [3] 215-540-4 [4] 215-540-4 [5] |
12267-73-1 [1] 1330-43-4 [2] 13840-56-7 [3] 1303-96-4 [4] 12179-04-3 [5] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
11 |
|
005-012-00-X |
Butiltrifenilborato de dietil{4-[1,5,5-tris(4-dietilaminofenil)penta-2,4-dieniliden]ciclohexa-2,5-dieniliden}amonio |
418-070-1 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
005-013-00-5 |
Dietilmetoxiborano |
425-380-9 |
Pyr. Liq. 1 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT RE 2* Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H250 H332 H312 H302 H373** H314 H317 H413 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H250 H332 H312 H302 H373** H314 H317 H413 |
|
|
|
|
|
005-014-00-0 |
Ácido 4-formilfenilborónico |
438-670-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
005-015-00-6 |
Bis(tetrafluoroborato) de 1-clorometil-4-fluoro-1,4-diazoniabiciclo[2.2.2]octano |
414-380-4 |
Acute Tox. 4* Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
|
|
005-016-00-1 |
Tris(4-terc-butilfenil)borato de tetrabutilamonio y butilo |
431-370-5 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
▼M36 ————— |
||||||||||
|
005-020-00-3 |
octaborato de disodio anhidro; [1] octaborato de disodio tetrahidratado [2] |
234-541-0 [1] 234-541-0 [2] |
12008-41-2 [1] 12280-03-4 [2] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
005-022-00-4 |
Ácido perbórico, sal de sodio; [1] ácido perbórico, sal de sodio, monohidratada; [2] ácido perbórico (HBO(O2)), sal de sodio, monohidratada; [3] peroxoborato de sodio; [4] perborato de sodio; [5] |
234-390-0 [1] 234-390-0 [2] - [3] - [4] 239-172-9 [5] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] - [4] 15120-21-5 [5] |
Ox. Sol. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Dam. 1 |
H272 H360FD H331 H302 H335 H318 |
GHS03 GHS08 GHS06 GHS05 Dgr |
H272 H360FD H331 H302 H335 H318 |
|
Por inhalación: ETA = 0,75 mg/l (polvos o nieblas) Por vía oral: ETA = 890 mg/kg pc Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
11 |
|
005-023-00-X |
Ácido perbórico (H3BO2(O2)), sal de monosodio trihidratada [1] ácido perbórico, sal de sodio, tetrahidratada [2] ácido perbórico (HBO(O2)), sal de sodio, tetrahidratada [3] peroxoborato de sodio, hexahidratado [4] |
239-172-9 [1] 234-390-0 [2] - [3] - [4] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] - [4] |
Repr. 1B Acute Tox. 4 STOT SE 3 Eye Dam. 1 |
H360FD H332 H335 H318 |
GHS08 GHS05 GHS07 Dgr |
H360FD H332 H335 H318 |
|
Por inhalación: ETA = 1,2 mg/l (polvos o nieblas) Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |
11 |
|
005-024-00-5 |
Peroxometaborato de sodio |
231-556-4 |
Ox. Sol. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Dam. 1 |
H272 H360FD H331 H302 H335 H318 |
GHS03 GHS08 GHS06 GHS05 Dgr |
H272 H360FD H331 H302 H335 H318 |
|
Por inhalación: ETA = 0,62 mg/l (polvos o nieblas) Por vía oral: ETA = 730 mg/kg pc Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
11 |
|
|
006-001-00-2 |
Monóxido de carbono |
211-128-3 |
Flam. Gas 1 Press. Gas Repr. 1A Acute Tox. 3* STOT RE 1 |
H220 H360D*** H331 H372** |
GHS02 GHS04 GHS06 GHS08 Dgr |
H220 H360D*** H331 H372** |
|
|
U |
|
|
006-002-00-8 |
Fosgeno; cloruro de carbonilo |
200-870-3 |
Press. Gas Acute Tox. 2* Skin Corr. 1B |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
|
|
U |
|
|
006-003-00-3 |
Disulfuro de carbono |
200-843-6 |
Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H361fd H372** H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H361fd H372** H319 H315 |
|
Repr. 2; H361fd: C ≥ 1 % STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
|
|
|
006-004-00-9 |
Carburo de calcio |
200-848-3 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
T |
|
|
006-005-00-4 |
Tiram (ISO); disulfuro de tetrametiltiuram |
205-286-2 |
Acute Tox. 4* Acute Tox. 4* STOT RE 2* Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H373** H319 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H332 H302 H373** H319 H315 H317 H410 |
|
M = 10 |
|
|
|
006-006-00-X |
Cianuro de hidrógeno; ácido cianhídrico |
200-821-6 |
Flam. Liq. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H224 H330 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H224 H330 H410 |
|
|
|
|
|
006-006-01-7 |
Cianuro de hidrógeno … %; ácido cianhídrico … % |
200-821-6 |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
|
B |
|
|
006-007-00-5 |
sales del ácido cianhídrico, excepto los cianuros complejos, tales como los ferrocianuros y ferricianuros y oxicianuro de mercurio y aquellos especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
EUH032 |
|
A |
|
006-008-00-0 |
Antu (ISO); 1-(1-naftil)-2-tiourea |
201-706-3 |
Acute Tox. 2* Carc. 2 |
H300 H351 |
GHS06 GHS08 Dgr |
H300 H351 |
|
|
|
|
|
006-009-00-6 |
Dimetilcarbamato de 1-isopropil-3-metilpirazol-5-ilo; isolán |
204-318-2 |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
006-010-00-1 |
Dimetilcarbamato de 5,5-dimetil-3-oxociclohex-1-enilo; dimetilcarbamato de 5,5- dimetil-dihidro-resorcinol; dimetán |
204-525-8 |
Acute Tox. 3* |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
|
006-011-00-7 |
Carbarilo (ISO); metilcarbamato de 1-naftilo |
200-555-0 |
Carc. 2 Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 |
H351 H332 H302 H400 |
GHS08 GHS07 GHS09 Wng |
H351 H332 H302 H400 |
|
M=100 |
|
|
|
006-012-00-2 |
Ziram (ISO); bisdimetilditiocarbamato de cinc |
205-288-3 |
Acute Tox. 2* Acute Tox. 4* STOT RE 2* STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H373** H335 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H302 H373** H335 H318 H317 H410 |
|
M = 100 |
|
|
|
006-013-00-8 |
Metam-sodio (ISO); metilditiocarbamato de sodio |
205-293-0 |
Acute Tox. 4* Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
EUH031 |
|
|
|
|
006-014-00-3 |
Nabam (ISO); etilen-bis(N, N'-ditiocarbamato) de disodio |
205-547-0 |
Acute Tox. 4* STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H317 H410 |
GHS07 GHS09 Wng |
H302 H335 H317 H410 |
|
|
|
|
|
006-015-00-9 |
Diurón (ISO); 3-(3,4-diclorofenil)-1,1-dimetilurea |
206-354-4 |
Carc. 1B STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H373 (sistema sanguíneo) H400 H410 |
GHS08 GHS09 Dgr |
H350 H373 (sistema sanguíneo) H410 |
|
M = 100 M = 100 |
|
|
|
006-016-00-4 |
Propoxur (ISO); N-metilcarbamato de 2-isopropiloxifenilo; metilcarbamato de 2-isopropoxifenilo |
204-043-8 |
Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-017-00-X |
Aldicarb (ISO); 2-metil-2-(metiltio)propanal-O-(N-metilcarbamoil)oxima |
204-123-2 |
Acute Tox. 2* Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
|
|
|
|
006-018-00-5 |
Aminocarb (ISO); metilcarbamato de 4-dimetilamino-3-tolilo |
217-990-7 |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
006-019-00-0 |
Dialato (ISO); N,N-Diisopropiltiocarbamato de S-(2,3-dicloroalilo) |
218-961-1 |
Carc. 2 Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
|
006-020-00-6 |
Barbán (ISO); N-(3-clorofenil)carbamato de 4-clorobut-2-inilo |
202-930-4 |
Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
|
006-021-00-1 |
Linurón (ISO); 3-(3,4-diclorofenil)-1-metoxi-1-metilurea |
206-356-5 |
Repr. 1B Carc. 2 Acute Tox. 4* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H351 H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H351 H302 H373** H410 |
|
|
|
|
|
006-022-00-7 |
Decarbofurán (ISO); metilcarbamato de 2,3-dihidro-2-metilbenzofuran-7-ilo |
— |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
006-023-00-2 |
Mercaptodimetur (ISO); metiocarb (ISO); N-metilcarbamato de 3,5-dimetil-4-metiltiofenilo |
217-991-2 |
Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-024-00-8 |
Proxán-sodio (ISO); O-isopropilditiocarbonato de sodio |
205-443-5 |
Acute Tox. 4* Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Wng |
H302 H315 H411 |
|
|
|
|
|
006-025-00-3 |
Aletrina; (1RS,3RS;1RS,3SR)-2,2- dimetil-3-(2-metilprop-1-enil)ciclopropanocarboxilato de (RS)-3-alil-2-metil-4- oxociclopent-2-enilo; bioaletrina; (1RS,3R)-2,2- dimetil-3-(2-metilprop-1-enil)ciclopropanocarboxilato de (RS)-3-alil-2-metil-4-oxociclopent-2-enilo; [1] S-bioaletrina; [3] (1R,3R)-2,2- dimetil-3-(2-metilprop-1-enil)ciclopropanocarboxilato de (S)-3-alil-2-metil-4-oxociclopent-2-enilo; [2] esbiotrina; (1R,3R)-2,2- dimetil-3-(2-metilprop-1-enil)ciclopropanocarboxilato de (RS)-3-alil-2-metil-4-oxociclopent-2-enilo [3] |
209-542-4 [1] 249-013-5 [2]-[3] |
584-79-2 [1] 28434-00-6 [2] 84030-86-4 [3] |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
|
C |
|
006-026-00-9 |
Carbofurán (ISO); N-metilcarbamato de 2,3-dihidro-2,2-dimetilbenzofuran-7-ilo |
216-353-0 |
Acute Tox. 2* Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H410 |
|
|
|
|
|
006-028-00-X |
Dinobutón (ISO); carbonato de 2-(1-metilpropil)-4,6-dinitrofenilo e isopropilo |
213-546-1 |
Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-029-00-5 |
Dioxacarb (ISO); N-metilcarbamato de 2-(1,3-dioxolan-2-il)fenilo |
230-253-4 |
Acute Tox. 3* Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
|
|
006-030-00-0 |
EPTC (ISO); dipropiltiocarbamato de S-etilo |
212-073-8 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-031-00-6 |
Formetanato (ISO); metilcarbamato de 3-[(EZ)-dimetilaminometilenamino]fenilo |
244-879-0 |
Acute Tox. 2* Acute Tox. 2* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H317 H410 |
|
|
|
|
|
006-032-00-1 |
Monolinurón (ISO); 3-(4-clorofenil)-1-metoxi-1-metilurea |
217-129-5 |
Acute Tox. 4* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H410 |
|
|
|
|
|
006-033-00-7 |
Metoxurón (ISO); 3-(3-cloro-4-metoxifenil)-1,1-dimetilurea |
243-433-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
006-034-00-2 |
Pebulato (ISO); tiocarbamato de N-butil-N-etil-S-propilo |
214-215-4 |
Acute Tox. 4* Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-035-00-8 |
pirimicarb (ISO); 2-(dimetilamino)-5,6-dimetilpirimidin-4-il dimetilcarbamato |
245-430-1 |
Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H301 H317 H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H351 H331 H301 H317 H410 |
|
M = 10 M = 100 |
|
|
|
006-036-00-3 |
Benztiazurón (ISO); 1-benzotiazol-2-il-3-metilurea |
217-685-9 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-037-00-9 |
Promecarb (ISO); N-metilcarbamato de 3-isopropil-5-metilfenilo |
220-113-0 |
Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-038-00-4 |
Sulfalato (ISO); N, N-dimetilditiocarbamato de 2-cloroalilo |
202-388-9 |
Carc. 1B Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
|
006-039-00-X |
Trialato (ISO); diisopropiltiocarbamato de S-2,3,3-tricloroalilo |
218-962-7 |
Acute Tox. 4* STOT RE 2* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H317 H410 |
|
|
|
|
|
006-040-00-5 |
Dimetilcarbamato de 3-metilpirazol-5-ilo; monometilán |
— |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
006-041-00-0 |
Cloruro de dimetilcarbamoílo |
201-208-6 |
Carc. 1B Acute Tox. 3* Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H331 H302 H319 H335 H315 |
GHS06 GHS08 Dgr |
H350 H331 H302 H319 H335 H315 |
|
Carc. 1B; H350: C ≥ 0,001 % |
|
|
|
006-042-00-6 |
Monurón (ISO); 3-(4-clorofenil)-1,1-dimetilurea |
205-766-1 |
Carc. 2 Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
|
006-043-00-1 |
Tricloroacetato de 3-(4-clorofenil)-1,1-dimetiluronio; monurón-TCA |
— |
Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H319 H315 H410 |
|
|
|
|
|
006-044-00-7 |
Isoproturón (ISO); 3-(4-isopropilfenil)-1,1-dimetilurea |
251-835-4 |
Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H373 (sangre) H400 H410 |
GHS08 GHS09 Wng |
H351 H373 (sangre) H410 |
|
M = 10 M = 10 |
|
|
|
006-045-00-2 |
Metomilo (ISO); N-metilcarbamato de 1-(metiltio)-etilidenamino |
240-815-0 |
Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H410 |
|
M=100 |
|
|
|
006-046-00-8 |
Bendiocarb (ISO); N-metilcarbamato de 2,2-dimetil-1,3-benzodioxol-4-ilo; metilcarbamato de 2,2-dimetil-1,3-benzodioxol-4-ilo |
245-216-8 |
Acute Tox. 3 Acute Tox. 3 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H300 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H300 H410 |
|
M = 10 M = 100 |
|
|
|
006-047-00-3 |
Bufencarb (ISO); masa de reacción de N-metilcarbamato de 3-(1-metilbutil)fenilo y N- metilcarbamato de 3-(1-etilpropil)fenilo |
— |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
006-048-00-9 |
Etiofencarb (ISO); N-metilcarbamato de 2-(etiltiometil)fenilo |
249-981-9 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-049-00-4 |
Dixantógeno; ditiobis(tioformiato) de O, O-dietilo |
207-944-4 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-050-00-X |
Tricloroacetato de 1,1-dimetil-3-feniluronio; fenurón-TCA |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
006-051-00-5 |
Ferbam (ISO); tris(dimetilditiocarbamato) de hierro |
238-484-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
|
|
|
|
006-052-00-0 |
Clorhidrato de formetanato; N-metilcarbamato de 3-(N, N-dimetilaminometilenamino)fenilo |
245-656-0 |
Acute Tox. 2* Acute Tox. 2* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H317 H410 |
|
|
|
|
|
006-053-00-6 |
Isoprocarb (ISO); N-metilcarbamato de 2-isopropilfenilo |
220-114-6 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-054-00-1 |
Mexacarbato (ISO); N-metilcarbamato de 3,5-dimetil-4-dimetilaminofenilo |
206-249-3 |
Acute Tox. 2* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
|
006-055-00-7 |
Xililcarb (ISO); N-metilcarbamato de 3,4-dimetilfenilo; metilcarbamato de 3,4-xililo; MPMC |
219-364-9 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-056-00-2 |
Metolcarb (ISO); metilcarbamato de m-tolilo; MTMC |
214-446-0 |
Acute Tox. 4* Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-057-00-8 |
Nitrapirina (ISO); 2-cloro-6-triclorometilpiridina |
217-682-2 |
Acute Tox. 4* Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-058-00-3 |
Norurón (ISO); 1,1-dimetil-3-(perhidro-4,7-metanoinden-5-il)urea |
— |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-059-00-9 |
Oxamilo (ISO); N-metilcarbamato de N',N'-dimetilcarbamoil(metiltio)metilenamina |
245-445-3 |
Acute Tox. 2* Acute Tox. 2* Acute Tox. 4* Aquatic Chronic 2 |
H330 H300 H312 H411 |
GHS06 GHS09 Dgr |
H330 H300 H312 H411 |
|
|
|
|
|
006-060-00-4 |
Oxicarboxina (ISO) 2,3-dihidro-6-metil-5-(N-fenilcarbamoil)-1,4-oxotiina-4,4-dióxido |
226-066-2 |
Acute Tox. 4* Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
006-061-00-X |
Clorhidrato de N-(dimetilaminopropil)tiocarbamato de S-etilo; clorhidrato de protiocarb |
243-193-9 |
Acute Tox. 4* Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-062-00-5 |
3,4-Diclorofenilcarbanilato de metilo; SWEP |
— |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-063-00-0 |
Tiobencarb (ISO); dietiltiocarbamato de S-4-clorobencilo |
248-924-5 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-064-00-6 |
Tiofanox (ISO); 3,3-dimetil-1-(metiltio)butanona-O-(N-metilcarbamoil)oxima |
254-346-4 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
006-065-00-1 |
3-Cloro-6-ciano-biciclo(2,2,1)heptan-2-ona-O-(N-metilcarbamoil)oxima; triamid |
— |
Acute Tox. 2* Acute Tox. 3* Aquatic Chronic 2 |
H300 H311 H411 |
GHS06 GHS09 Dgr |
H300 H311 H411 |
|
|
|
|
|
006-066-00-7 |
Vernolato (ISO); dipropiltiocarbamato de S-propilo |
217-681-7 |
Acute Tox. 4* Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-067-00-2 |
XMC; metilcarbamato de 3,5-xililo |
— |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-068-00-8 |
Diazometano |
206-382-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
006-069-00-3 |
Tiofanato-metilo (ISO); (1,2-fenilendicarbamotioil)biscarbamato de dimetilo; 4,4′-(o-fenilen)bis(3-tioalofanato) de dimetilo |
245-740-7 |
Carc. 2 Muta. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H341 H332 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H341 H332 H317 H410 |
|
Por inhalación: ETA = 1,7 mg/l (polvos y nieblas) M = 10 M = 10 |
|
|
|
006-070-00-9 |
Furmeciclox (ISO); N-ciclohexil-N-metoxi-2,5-dimetil-3-furamida |
262-302-0 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
|
|
006-071-00-4 |
Carbonato de ciclo-oct-4-en-1-il-metilo |
401-620-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
006-072-00-X |
Prosulfocarb (ISO); N, N-dipropiltiocarbamato de S-bencilo |
401-730-6 |
Acute Tox. 4* Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
006-073-00-5 |
3-(Dimetilamino)propilurea |
401-950-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
006-074-00-0 |
Isocianato de 2-(3-(prop-1-en-2-il)fenil)prop-2-ilo |
402-440-2 |
Acute Tox. 2* Skin Corr. 1B STOT RE 2* Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H314 H373** H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H314 H373** H334 H317 H410 |
|
|
|
|
|
006-076-00-1 |
Mancoceb (ISO); complejo de etilen-bis(ditiocarbamato) (polimérico) de manganeso con sales de cinc |
- |
Carc. 2 Repr. 1B STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360D H373 (tiroides, sistema nervioso) H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D H373 (tiroides, sistema nervioso) H317 H410 |
|
M = 10 M = 10 |
|
|
|
006-077-00-7 |
Maneb (ISO); etilen-bis(ditiocarbamato) (polimérico) de manganeso |
235-654-8 |
Repr. 2 Acute Tox. 4* Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H332 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d*** H332 H319 H317 H410 |
|
M=10 |
|
|
|
006-078-00-2 |
Zineb (ISO); etilen-bis(ditiocarbamato) de cinc (polímero) |
235-180-1 |
STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Wng |
H335 H317 |
|
|
|
|
|
006-079-00-8 |
Disulfiram; disulfuro de tetraetiltiuram |
202-607-8 |
Acute Tox. 4* STOT RE 2* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H317 H410 |
|
|
|
|
|
006-080-00-3 |
Monosulfuro de tetrametiltiuram |
202-605-7 |
Acute Tox. 4* Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
006-081-00-9 |
Bis(dibutilditiocarbamato) de cinc |
205-232-8 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H410 |
|
|
|
|
|
006-082-00-4 |
Bis(dietilditiocarbamato) de cinc |
238-270-9 |
Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H317 H410 |
|
|
|
|
|
006-083-00-X |
Butocarboxim (ISO); 3-(metiltio)-2-butanona-O-[(metilamino)carbonil]oxima |
252-139-3 |
Flam. Liq. 3 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H331 H311 H301 H319 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H226 H331 H311 H301 H319 H410 |
|
|
|
|
|
006-084-00-5 |
Carbosulfano (ISO); [(dibutilamino)tio]metilcarbamato de 2,3-dihidro-2,2-dimetil-7-benzofurilo |
259-565-9 |
Acute Tox. 2* Acute Tox. 3* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H317 H410 |
|
|
|
|
|
006-085-00-0 |
Fenobucarb (ISO); metilcarbamato de 2-butilfenilo |
223-188-8 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-086-00-6 |
Fenoxicarb (ISO); [2-(4-fenoxifenoxi)etil]carbamato de etilo |
276-696-7 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 1 M = 10 000 |
|
|
|
006-087-00-1 |
Furatiocarb (ISO); 2,4-dimetil-6-oxa-5-oxo-3-tia-2,4-diazadecanoato de 2,3-dihidro-2,2-dimetil-7-benzofurilo |
265-974-3 |
Acute Tox. 2* Acute Tox. 3* STOT RE 2* Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H373** H319 H315 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H301 H373** H319 H315 H317 H410 |
|
M = 100 |
|
|
|
006-088-00-7 |
Benfuracarb (ISO); N-[2,3-dihidro-2,2-dimetilbenzofuran-7-il-oxicarbonil(metil)aminotio]-N-isopropil-β-alaninato de etilo |
— |
Repr. 2 Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H331 H302 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361f*** H331 H302 H410 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
006-090-00-8 |
Fenilcarbamato de 2-(3-yodoprop-2-in-1-iloxi)etilo |
408-010-0 |
Acute Tox. 4* Eye Dam. 1 Aquatic Chronic 3 |
H332 H318 H412 |
GHS05 GHS07 Dgr |
H332 H318 H412 |
|
|
|
|
|
006-091-00-3 |
Propineb (ISO); propileno-bis(ditiocarbamato) de cinc polimérico |
— |
Acute Tox. 4* STOT RE 2* Skin Sens. 1 Aquatic Acute 1 |
H332 H373** H317 H400 |
GHS08 GHS07 GHS09 Wng |
H332 H373** H317 H400 |
|
|
|
|
|
006-092-00-9 |
(1S)-N-[1-((2S)-2-Oxiranil)-2-feniletil]carbamato de terc-butilo |
425-420-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
006-093-00-4 |
2,2'-Ditio-di(etilamonio)-bis(dibencilditiocarbamato) |
427-180-7 |
— |
Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
006-094-00-X |
Tiocarbamato de O-isobutilo y N-etoxicarbonilo |
434-350-4 |
Flam. Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4* STOT RE 2* Skin Sens. 1 Aquatic Chronic 2 |
H226 H350 H340 H302 H373** H317 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H350 H340 H302 H373** H317 H411 |
|
|
|
|
|
006-095-00-5 |
Fosetilo-aluminio (ISO); trifosfonato de aluminio y trietilo |
254-320-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
006-096-00-0 |
Clorprofam (ISO); 3-clorocarbanilato de isopropilo |
202-925-7 |
Carc. 2 STOT RE 2* Aquatic Chronic 2 |
H351 H373** H411 |
GHS08 GHS09 Wng |
H351 H373** H411 |
|
|
|
|
|
006-097-00-6 |
1-Fenil-3-(p-toluenosulfonil)urea |
424-620-1 |
Acute Tox. 4* STOT RE 2* Aquatic Chronic 3 |
H302 H373** H412 |
GHS08 GHS07 Wng |
H302 H373** H412 |
|
|
|
|
|
006-098-00-1 |
(1R,5S)-3-Azabiciclo[3.1.0]hex-6-ilcarbamato de terc-butilo |
429-170-8 |
Acute Tox. 4* STOT RE 2* Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H317 |
|
|
|
|
|
006-099-00-7 |
N-(p-Toluenosulfonil)-N'-(3-(p-toluenosulfoniloxi)fenil)urea; 4-metilbencenosulfonato de 3-{[(4-metilfenil)sulfonil]-carbamoil}amino)fenilo |
520-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
006-101-00-6 |
Masa de reacción de: N, N"-(metilen-di-4,1-fenilen)bis[N'-fenilurea]; N-(4-[[4-[[(fenilamino)carbonil]amino]fenilmetil]fenil] -N'-ciclohexilurea; N, N"-(metilen-di-4,1-fenilen)bis[N'-ciclohexilurea] |
423-070-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
006-102-00-1 |
Tiocarbamato de O-hexilo y N-etoxicarbonilo |
432-750-3 |
— |
Carc. 1B Muta. 1B Acute Tox. 4* STOT RE 2* Skin Sens. 1 Aquatic Chronic 2 |
H350 H340 H302 H373** H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H302 H373** H317 H411 |
|
|
|
|
006-103-00-7 |
N, N''-(Metilen-di-4,1-fenilen)bis[N'-octil]urea |
445-760-8 |
— |
Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H318 H334 H410 |
|
M=100 |
|
|
006-104-00-2 |
Tubos de carbono de pared múltiple (grafito sintético en forma tubular) con un diámetro del tubo geométrico que oscila entre ≥ 30 nm y < 3 μm, una longitud de ≥ 5 μm y una relación de aspecto > 3:1, incluidos los nanotubos de carbono de pared múltiple, MWC(N)T |
— |
— |
Carc. 1B STOT RE 1 |
H350i H372 (pulmón) (inhalación) |
GHS08 Dgr |
H350i H372 (pulmón) (inhalación) |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % |
|
|
007-001-00-5 |
Amoniaco anhidro |
231-635-3 |
Flam. Gas 2 Press. Gas Acute Tox. 3* Skin Corr. 1B Aquatic Acute 1 |
H221 H331 H314 H400 |
GHS04 GHS06 GHS05 GHS09 Dgr |
H221 H331 H314 H400 |
|
|
U |
|
|
007-001-01-2 |
Amoniaco al … % |
215-647-6 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
STOT SE 3; H335: C ≥ 5 % |
B |
|
|
007-002-00-0 |
Dióxido de nitrógeno; [1] tetraóxido de dinitrógeno [2] |
233-272-6 [1] 234-126-4 [2] |
10102-44-0 [1] 10544-72-6 [2] |
Press. Gas Ox. Gas 1 Acute Tox. 2* Skin Corr. 1B |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Dgr |
H270 H330 H314 |
|
* STOT SE 3; H335: C ≥0,5 % |
5 |
|
007-003-00-6 |
Cloruro de clormecuat (ISO); Cloruro de 2-cloroetiltrimetilamonio |
213-666-4 |
Acute Tox. 4* Acute Tox. 4* |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
007-004-00-1 |
Ácido nítrico...% [C > 70 %] |
231-714-2 |
Ox. Liq. 2 Acute Tox. 1 Skin Corr. 1A |
H272 H330 H314 |
GHS03 GHS06 GHS05 Dgr |
H272 H330 H314 |
EUH071 |
Ox. Liq. 2; H272: C ≥ 99 % Ox. Liq. 3; H272: 70 % ≤ C < 99 % |
B |
|
|
007-006-00-2 |
Nitrito de etilo |
203-722-6 |
Flam. Gas 1 Press. Gas Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* |
H220 H332 H312 H302 |
GHS02 GHS04 GHS07 Dgr |
H220 H332 H312 H302 |
|
|
U |
|
|
007-007-00-8 |
Nitrato de etilo |
210-903-3 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
|
007-008-00-3 |
Hidrazina |
206-114-9 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H350 H331 H311 H301 H314 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H226 H350 H331 H311 H301 H314 H317 H410 |
|
Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 3 % ≤ C < 10 % |
|
|
|
007-009-00-9 |
Nitrito de diciclohexilamonio |
221-515-9 |
Acute Tox. 4* Acute Tox. 4* |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
|
|
|
007-010-00-4 |
Nitrito de sodio |
231-555-9 |
Ox. Sol. 3 Acute Tox. 3* Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Dgr |
H272 H301 H400 |
|
* |
|
|
|
007-011-00-X |
Nitrito de potasio |
231-832-4 |
Ox. Sol. 2 Acute Tox. 3* Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Dgr |
H272 H301 H400 |
|
* |
|
|
|
007-012-00-5 |
N,N-Dimetilhidrazina |
200-316-0 |
Flam. Liq. 2 Carc. 1B Acute Tox. 3* Acute Tox. 3* Skin Corr. 1B Aquatic Chronic 2 |
H225 H350 H331 H301 H314 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H350 H331 H301 H314 H411 |
|
|
|
|
|
007-013-00-0 |
1,2-Dimetilhidrazina |
— |
Carc. 1B Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Aquatic Chronic 2 |
H350 H331 H311 H301 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H411 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
|
007-014-00-6 |
Sales de hidrazina |
— |
— |
Carc. 1B Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H311 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H317 H410 |
|
|
A |
|
007-015-00-1 |
O-Etilhidroxilamina |
402-030-3 |
Flam. Liq. 2 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT RE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H225 H331 H311 H301 H372** H319 H317 H400 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H331 H311 H301 H372** H319 H317 H400 |
|
|
|
|
|
007-016-00-7 |
Nitrito de butilo |
208-862-1 |
Flam. Liq. 2 Acute Tox. 3* Acute Tox. 3* |
H225 H331 H301 |
GHS02 GHS06 Dgr |
H225 H331 H301 |
|
|
|
|
|
007-017-00-2 |
Nitrito de isobutilo |
208-819-7 |
Flam. Liq. 2 Carc. 1B Muta. 2 Acute Tox. 4* Acute Tox. 4* |
H225 H350 H341 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H341 H332 H302 |
|
|
|
|
|
007-018-00-8 |
Nitrito de sec-butilo |
213-104-8 |
Flam. Liq. 2 Acute Tox. 4* Acute Tox. 4* |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
|
007-019-00-3 |
Nitrito de terc-butilo |
208-757-0 |
Flam. Liq. 2 Acute Tox. 4* Acute Tox. 4* |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
|
007-020-00-9 |
Nitrito de pentilo; [1] «nitrito de amilo», mezcla de isómeros [2] |
207-332-7 [1] 203-770-8 [2] |
463-04-7 [1] 110-46-3 [2] |
Flam. Liq. 2 Acute Tox. 4* Acute Tox. 4* |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
007-021-00-4 |
Hidrazobenceno; 1,2-difenilhidrazina |
204-563-5 |
Carc. 1B Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
|
007-022-00-X |
Bis(3-carboxi-4-hidroxibencenosulfonato) de hidrazina |
405-030-1 |
— |
Carc. 1B Acute Tox. 4* Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H350 H302 H314 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H350 H302 H314 H317 H412 |
|
|
|
|
007-023-00-5 |
3,5-Bis(3-(2,4-di-terc-pentilfenoxi)propilcarbamoil)bencenosulfonato de sodio |
405-510-0 |
— |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
007-024-00-0 |
Cloruro de 2-(deciltio)etilamonio |
405-640-8 |
STOT RE 2* Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H373** H315 H318 H410 |
|
|
|
|
|
007-025-00-6 |
Clorhidrato de (4-hidracinofenil)-N-metilmetansulfonamida |
406-090-1 |
Muta. 2 Acute Tox. 3* STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H301 H372** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H301 H372** H317 H410 |
|
|
|
|
|
007-026-00-1 |
Oxo-((2,2,6,6-tetrametilpiperidin-4-il)amino)carbonilacetohidrazida |
413-230-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
007-027-00-7 |
1,6-Bis(3,3-bis((1-metilpentilidenimino)propil)ureido)hexano |
420-190-2 |
Acute Tox. 4* Acute Tox. 4* STOT RE 2* Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373** H314 H317 H410 |
|
|
|
|
|
007-028-00-2 |
Nitrato de hidroxilamonio |
236-691-2 |
Expl. 1.1**** Carc. 2 Acute Tox. 3* Acute Tox. 4* STOT RE 2* Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
|
|
|
|
|
007-029-00-8 |
Hidróxido de dietildimetilamonio |
419-400-5 |
Acute Tox. 4* Acute Tox. 4* Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
|
007-030-00-3 |
Ácido nítrico...% [C ≤ 70 %] |
231-714-2 |
Ox. Liq. 3 Acute Tox. 3 Skin Corr. 1A |
H272 H331 H314 |
GHS03 GHS06 GHS05 Dgr |
H272 H331 H314 |
EUH071 |
Ox. Liq. 3; H272: C ≥ 65 % Por inhalación: ETA = 2,65 mg/l (vapores) Skin Corr. 1A; H314: C ≥ 20 % Skin Corr. 1B; H314: 5 % ≤ C < 20 % |
B |
|
|
008-001-00-8 |
Oxigeno |
231-956-9 |
Ox. Gas 1 Press. Gas |
H270 |
GHS03 GHS04 Dgr |
H270 |
|
|
U |
|
|
008-003-00-9 |
Solución de peróxido de hidrógeno al … % |
231-765-0 |
Ox. Liq. 1 Acute Tox. 4* Acute Tox. 4* Skin Corr. 1A |
H271 H332 H302 H314 |
GHS03 GHS05 GHS07 Dgr |
H271 H332 H302 H314 |
|
Ox. Liq. 1; H271: C ≥70 %**** Ox. Liq. 2; H272: 50 % ≤ C < 70 %**** * Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % Skin Irrit. 2; H315: 35 % ≤ C < 50 % Eye Dam. 1; H318: 8 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 % |
B |
|
|
009-001-00-0 |
Flúor |
231-954-8 |
Press. Gas Ox. Gas 1 Acute Tox. 2* Skin Corr. 1A |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Dgr |
H270 H330 H314 |
|
|
|
|
|
009-002-00-6 |
Fluoruro de hidrógeno |
231-634-8 |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
|
|
|
|
009-003-00-1 |
Ácido fluorhídrico al … % |
231-634-8 |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C< 7 % Eye Irrit. 2; H319: 0,1 % ≤C < 1 % |
B |
|
|
009-004-00-7 |
Fluoruro de sodio |
231-667-8 |
Acute Tox. 3* Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Dgr |
H301 H319 H315 |
EUH032 |
|
|
|
|
009-005-00-2 |
Fluoruro de potasio |
232-151-5 |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
009-006-00-8 |
Fluoruro de amonio |
235-185-9 |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
009-007-00-3 |
Bifluoruro de sodio; difluoruro de hidrógeno y sodio |
215-608-3 |
Acute Tox. 3* Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
*Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
|
|
009-008-00-9 |
Bifluoruro de potasio; difluoruro de hidrógeno y potasio |
232-156-2 |
Acute Tox. 3* Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
|
|
009-009-00-4 |
Bifluoruro de amonio; difluoruro de hidrógeno y amonio |
215-676-4 |
Acute Tox. 3* Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
|
|
009-010-00-X |
Ácido fluorobórico al … % |
240-898-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
|
|
009-011-00-5 |
Ácido fluorosilícico al … % |
241-034-8 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
B |
|
|
009-012-00-0 |
Fluorosilicatos alcalinos (Na); [1] fluorosilicatos alcalinos (K); [2] fluorosilicatos alcalinos (NH4) [3] |
240-934-8 [1] 240-896-2 [2] 240-968-3 [3] |
16893-85-9 [1] 16871-90-2 [2] 16919-19-0 [3] |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
* |
A |
|
009-013-00-6 |
Fluorosilicatos, excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
* |
A |
|
009-014-00-1 |
Hexafluorisilicato de plomo |
247-278-1 |
Repr. 1A Acute Tox. 4* Acute Tox. 4* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H332 H302 H373** H410 |
|
|
1 |
|
|
009-015-00-7 |
Difluoruro de sulfurilo |
220-281-5 |
Press. Gas Acute Tox. 3* STOT RE 2* Aquatic Acute 1 |
H331 H373** H400 |
GHS04 GHS06 GHS08 GHS09 Dgr |
H331 H373** H400 |
|
|
U |
|
|
009-016-00-2 |
Hexafluoroaluminato de trisodio [1] hexafluoroaluminato de trisodio (criolita) [2] |
237-410-6 [1] 239-148-8 [2] |
13775-53-6 [1] 15096-52-3 [2] |
STOT RE 1 Acute Tox. 4 Aquatic Chronic 2 |
H372 H332 H411 |
GHS07 GHS08 GHS09 Dgr |
H372 H332 H411 |
|
|
|
|
009-017-00-8 |
μ-Fluoro-bis(trietil-aluminio) de potasio |
400-040-2 |
Flam. Sol. 1 Water-react. 1 Skin Corr. 1A Acute Tox. 4* |
H228 H270 H314 H332 |
GHS02 GHS05 GHS07 Dgr |
H228 H270 H314 H332 |
EUH014 |
|
T |
|
|
009-018-00-3 |
Hexafluorosilicato de magnesio |
241-022-2 |
Acute Tox. 3* |
H301 |
GHS06 Dgr |
H301 |
|
* |
|
|
|
011-001-00-0 |
Sodio |
231-132-9 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
|
011-002-00-6 |
Hidróxido de sodio; sosa cáustica |
215-185-5 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit.2; H319: 0,5 % ≤ C < 2 % |
|
|
|
011-003-00-1 |
Peróxido de sodio |
215-209-4 |
Ox. Sol. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Dgr |
H271 H314 |
|
|
|
|
|
011-004-00-7 |
Azida de sodio |
247-852-1 |
Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H400 H410 |
EUH032 |
|
|
|
|
011-005-00-2 |
Carbonato de sodio |
207-838-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
011-006-00-8 |
Cianato de sodio |
213-030-6 |
Acute Tox. 4* Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
011-007-00-3 |
Propoxicarbazona-sodio |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 10 |
|
|
|
012-001-00-3 |
Magnesio en polvo (pirofórico) |
231-104-6 |
Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Dgr |
H260 H250 |
|
|
T |
|
|
012-002-00-9 |
Magnesio en polvo o virutas |
231-104-6 |
— |
Flam. Sol. 1 Water-react. 2 Self-heat. 1 |
H228 H261 H252 |
GHS02 Dgr |
H228 H261 H252 |
|
|
T |
|
012-003-00-4 |
Alquilos de magnesio |
— |
— |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Dgr |
H250 H260 H314 |
EUH014 |
|
A |
|
012-004-00-X |
carbonato-hidróxido-perclorato de aluminio y magnesio hidratado |
422-150-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
013-001-00-6 |
Aluminio en polvo (pirofórico) |
231-072-3 |
Water-react. 2 Pyr. Sol. 1 |
H261 H250 |
GHS02 Dgr |
H261 H250 |
|
|
T |
|
|
013-002-00-1 |
Aluminio en polvo (estabilizado) |
231-072-3 |
Water-react. 2 Flam. Sol. 1 |
H261 H228 |
GHS02 Dgr |
H261 H228 |
|
|
T |
|
|
013-003-00-7 |
Cloruro de aluminio, anhidro |
231-208-1 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
013-004-00-2 |
Alquilos de aluminio |
— |
— |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Dgr |
H250 H260 H314 |
EUH014 |
|
A |
|
013-005-00-8 |
Dietil(etildimetilsilanolato) de aluminio |
401-160-8 |
Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Dgr |
H260 H250 H314 |
EUH014 |
|
|
|
|
013-006-00-3 |
(Etil-3-oxobutanoato- O'1,O'3)(2-dimetilaminoetanolato)(1-metoxipropan-2-olato) de aluminio(III), dimerizado |
402-370-2 |
— |
Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Dgr |
H226 H318 |
|
|
|
|
013-007-00-9 |
Poli(oxo(2-butoxietil-3-oxobutanoato-O'1,O'3) de aluminio) |
403-430-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
013-008-00-4 |
Yoduro de di-n-octilaluminio |
408-190-0 |
Pyr. Liq. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H314 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H250 H314 H410 |
EUH014 |
|
|
|
|
013-009-00-X |
(n-Butil)x(etil)y-1,5-dihidro)aluminato de sodio x = 0,5 y = 1,5 |
418-720-2 |
— |
Flam. Sol. 1 Water-react. 1 Pyr. Sol. 1 Acute Tox. 4* Skin Corr. 1A |
H228 H260 H250 H332 H314 |
GHS02 GHS05 GHS07 Dgr |
H228 H260 H250 H332 H314 |
EUH014 |
|
T |
|
013-010-00-5 |
Bis(2,4,8,10-tetra-terc-butil-6- hidroxi-12H- dibenzo[d, g][1.3.2]dioxafosfocin-6-óxido) de hidroxialuminio |
430-650-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
014-001-00-9 |
Triclorosilano |
233-042-5 |
Flam. Liq. 1 Water-react. 1 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Eye Dam. 1 |
H224 H260 H331 H302 H314 H318 |
GHS02 GHS06 GHS05 Dgr |
H224 H260 H331 H302 H314 |
EUH014 EUH029 EUH071 |
Por inhalación: ETA = 7,6 mg/l (vapores) Por vía oral: ETA = 1 000 mg/kg pc |
|
|
|
014-002-00-4 |
Tetracloruro de silicio |
233-054-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
EUH014 |
|
|
|
|
014-003-00-X |
Dimetildiclorosilano |
200-901-0 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
|
|
|
|
|
014-004-00-5 |
Tricloro(metil)silano; metiltriclorosilano |
200-902-6 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
EUH014 |
Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
|
|
014-005-00-0 |
Silicato de tetraetilo; silicato de etilo |
201-083-8 |
Flam. Liq. 3 Acute Tox. 4* Eye Irrit. 2 STOT SE 3 |
H226 H332 H319 H335 |
GHS02 GHS07 Wng |
H226 H332 H319 H335 |
|
|
|
|
|
014-006-00-6 |
Clorhidrato de bis(4-fluorofenil)-metil-(1,2,4-triazol-4-ilmetil)silano |
401-380-4 |
— |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
014-007-00-1 |
Trietoxiisobutilsilano |
402-810-3 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
|
014-008-00-7 |
(Clorometil)bis(4-fluorofenil)metilsilano |
401-200-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
014-009-00-2 |
Isobutilisopropildimetoxisilano |
402-580-4 |
Flam. Liq. 3 Acute Tox. 4* Skin Irrit. 2 |
H226 H332 H315 |
GHS02 GHS07 Wng |
H226 H332 H315 |
|
|
|
|
|
014-010-00-8 |
Metasilicato de disodio |
229-912-9 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
|
|
|
|
014-011-00-3 |
Ciclohexildimetoximetilsilano |
402-140-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
014-012-00-9 |
Bis(3-(trimetoxisilil)propil)amina |
403-480-3 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
014-013-00-4 |
α-Hidroxipoli(metil-(3-(2,2,6,6-tetrametilpiperidin-4-iloxi)propil)siloxano) |
404-920-7 |
— |
Acute Tox. 4* Acute Tox. 4* Skin Corr. 1B Aquatic Chronic 2 |
H312 H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H411 |
|
|
|
|
014-014-00-X |
Etacelasilo (ISO); 6-(2-cloroetil)-6-(2-metoxietoxi)-2,5,7,10-tetraoxa-6-silaundecano |
253-704-7 |
Repr. 1B Acute Tox. 4* STOT RE 2* |
H360D*** H302 H373** |
GHS08 GHS07 Dgr |
H360D*** H302 H373** |
|
|
|
|
|
014-015-00-5 |
α-Trimetilsilanil-ω-trimetilsiloxipoli[oxi(metil-3-(2-(2-metoxipropoxi)propoxi)propilsilanodiil]-co-oxi(dimetilsilano)) |
406-420-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
014-016-00-0 |
Masa de reacción de: 1,3-dihex-5-en-1-il-1,1,3,3-tetrametildisiloxano; 1,3-dihex-n-en-1-il-1,1,3,3-tetrametildisiloxano |
406-490-6 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-017-00-6 |
Flusilazol (ISO); bis(4-fluorofenil)(metil)-(1H-1,2,4-triazol-1-ilmetil)silano |
— |
Carc. 2 Repr. 1B Acute Tox. 4* Aquatic Chronic 2 |
H351 H360D*** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D*** H302 H411 |
|
|
|
|
|
014-018-00-1 |
Octametilciclotetrasiloxano; [D4] |
209-136-7 |
Repr. 2 Aquatic Chronic 1 |
H361f *** H410 |
GHS08 GHS09 Wng |
H361f *** H410 |
|
M = 10 |
|
|
|
014-019-00-7 |
Masa de reacción de: 4-[[bis(4-fluorofenil)metilsilil]metil]-4H-1,2,4-triazol; 1-[[bis(4-fluorofenil)metilsilil]metil]-1H-1,2,4-triazol |
403-250-2 |
— |
Carc. 2 Repr. 1B Acute Tox. 4* Aquatic Chronic 2 |
H351 H360D*** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D*** H302 H411 |
|
|
|
|
014-020-00-2 |
Bis(1,1-dimetil-2-propiniloxi)dimetilsilano |
414-960-7 |
Acute Tox. 4* |
H332 |
GHS07 Wng |
H332 |
|
|
|
|
|
014-021-00-8 |
Tris(isopropeniloxi)fenilsilano |
411-340-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H400 H410 |
|
|
|
|
|
014-022-00-3 |
Producto de reacción de: (2-hidroxi-4-(3-propenoxi)benzofenona y trietoxisilano) con (producto de la hidrólisis de sílice y metiltrimetoxisilano) |
401-530-9 |
— |
Flam. Sol. 1 STOT SE 1 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* |
H228 H370** H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H228 H370** H332 H312 H302 |
|
|
T |
|
014-023-00-9 |
α, ω-Dihidroxipoli(hex-5-en-1-ilmetilsiloxano)oxisilano con (producto de la hidrólisis de sílice y metiltrimetoxisilano)diazol |
408-160-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
014-024-00-4 |
1-((3-(3-Cloro-4-fluorofenil)propil)dimetilsilanil)-4-etoxibenceno |
412-620-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
014-025-00-X |
4- [3-(Dietoximetilsililpropoxi)-2,2,6,6-tetrametil]piperidina |
411-400-3 |
Acute Tox. 4* STOT RE 2* Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H302 H373** H315 H318 H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H373** H315 H318 H412 |
|
|
|
|
|
014-026-00-5 |
Dicloro-(3-(3-cloro-4-fluorofenil)propil)metilsilano |
407-180-3 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
014-027-00-0 |
Cloro(3-(3-cloro-4-fluorofenil)propil)dimetilsilano |
410-270-5 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
014-028-00-6 |
α-[3-(1-Oxoprop-2-enil)-1-oxipropil]dimetoxisililoxi-ω- [3(1-oxoprop-2-enil)-1-oxipropil]dimetoxisilil-poli(dimetilsiloxano) |
415-290-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
014-029-00-1 |
O, O′-(Etenilmetilsilileno)di[(4-metilpentan-2-ona)oxima] |
421-870-1 |
Repr. 2 Acute Tox. 4* STOT RE 2* |
H361f*** H302 H373** |
GHS08 GHS07 Wng |
H361f*** H302 H373** |
|
|
|
|
|
014-030-00-7 |
[(Dimetilsilileno)bis((1,2,3,3a,7a-η)-1H-inden-1-ilideno)dimetil]hafnio |
422-060-0 |
Acute Tox. 2* |
H300 |
GHS06 Dgr |
H300 |
|
|
|
|
|
014-031-00-2 |
Bis(1-metiletil)dimetoxisilano |
421-540-7 |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H226 H315 H317 H412 |
GHS02 GHS07 Wng |
H226 H315 H317 H412 |
|
|
|
|
|
014-032-00-8 |
Diciclopentildimetoxisilano |
404-370-8 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
|
014-033-00-3 |
Producto de hidrólisis de 2-propenoato de 2-metil-3-(trimetoxisilil)propilo con sílice |
419-030-4 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
|
|
|
|
|
014-034-00-9 |
3-Hexilheptametiltrisiloxano |
428-700-5 |
Acute Tox. 4* Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
|
014-035-00-4 |
2-(3,4-Epoxiciclohexil)etiltrietoxisilano |
425-050-4 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
014-036-00-X |
(4-Etoxifenil)(3-(4-fluoro-3-fenoxifenil)propil)dimetilsilano |
405-020-7 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360F*** H400 H410 |
GHS08 GHS09 Dgr |
H360F*** H410 |
|
M=1000 |
|
|
|
014-037-00-5 |
2-Butanona-O, O',O''-(fenilsililidin)trioxima |
433-360-6 |
STOT RE 2* Skin Sens. 1 Aquatic Chronic 3 |
H373** H317 H412 |
GHS08 GHS07 Wng |
H373** H317 H412 |
|
|
|
|
|
014-038-00-0 |
Octanotioato de S-(3-(trietoxisilil)propilo |
436-690-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
014-039-00-6 |
(2,3-Dimetilbut-2-il)trimetoxisilano |
439-360-2 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
|
014-041-00-7 |
N, N-bis(trimetilsilil)aminopropilmetildietoxisilano |
445-890-5 |
Acute Tox. 4* Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
|
014-042-00-2 |
Masa de reacción de: O,O',O'',O'''- silanotetrailtetrakis(oxima de 4-metil-2-pentanona) (3 estereoisómeros) |
423-010-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
014-043-00-8 |
Producto de reacción de sílice amorfa (50-85 %), butil (1-metilpropil)magnesio (3-15 %), ortosilicato de tetraetilo (5-15 %) y tetracloruro de titanio (5-20 %) |
432-200-2 |
— |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H335 H315 H318 H412 |
GHS05 GHS07 Dgr |
H335 H315 H318 H412 |
|
|
|
|
014-044-00-3 |
3-[(4'-Acetoxi-3'-metoxifenil)propil]trimetoxisilano |
433-050-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-045-00-9 |
Fluoruro-silicato de magnesio y sodio |
442-650-1 |
— |
STOT RE 2* |
H373** |
GHS08 Wng |
H373** |
|
|
|
|
014-046-00-4 |
microfibras de vidrio E de composición representativa: [fibras de calcio-aluminio-silicio con orientación aleatoria con la siguiente composición representativa (% en peso): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %; procesos de fabricación: producidos habitualmente por estirado a la llama y procesos de rotación (pueden estar presentes otros elementos en niveles bajos; la lista de los procesos no excluye la innovación).] |
— |
— |
Carc. 1B |
H350i |
GHS08 Dgr |
H350i |
|
|
A |
|
014-047-00-X |
microfibras de vidrio de composición representativa: [fibras de calcio-aluminio-silicio con orientación aleatoria con la siguiente composición (% en peso): SiO2 55,0-60,0 %, Al2O3 4,0-7,0 %, B2O3 8,0-11,0 %, ZrO2 0,0-4,0 %, Na2O 9,5-13,5 %, K2O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe2O3 < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F2 < 1,0 %; procesos de fabricación: producidos habitualmente por estirado a la llama y procesos de rotación (pueden estar presentes otros elementos en niveles bajos; la lista de los procesos no excluye la innovación).] |
— |
— |
Carc. 2 |
H351 (inhalación) |
GHS08 Wng |
H351 (inhalación) |
|
|
A |
|
014-048-00-5 |
Fibras de carburo de silicio (con un diámetro < 3 μm, una longitud > 5 μm y una relación de aspecto ≥ 3:1) |
206-991-8 |
Carc. 1B |
H350i |
GHS08 Dgr |
H350i |
|
|
|
|
|
014-049-00-0 |
Trimetoxivinilsilano; trimetoxi(vinil)silano |
220-449-8 |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
014-050-00-6 |
Tris(2-metoxietoxi)vinilsilano; 6-(2-metoxietoxi)-6-vinil-2,5,7,10-tetraoxa-6-silaundecano |
213-934-0 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
014-052-00-7 |
Silanamina, 1,1,1-trimetil-N-(trimetilsilil)-, productos de hidrólisis con sílice; pirogénicos, sintéticos amorfos, nano, dióxido de silicio con tratamiento superficial |
272-697-1 |
STOT RE 2 |
H373 (pulmones) (inhalación) |
GHS08 Wng |
H373 (pulmones) (inhalación) |
EUH066 |
|
|
|
|
015-001-00-1 |
Fósforo blanco |
231-768-7 |
Pyr. Sol. 1 Acute Tox. 2* Acute Tox. 2* Skin Corr. 1A Aquatic Acute 1 |
H250 H330 H300 H314 H400 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H250 H330 H300 H314 H400 |
|
|
|
|
|
015-002-00-7 |
Fósforo rojo |
231-768-7 |
Flam. Sol. 1 Aquatic Chronic 3 |
H228 H412 |
GHS02 Dgr |
H228 H412 |
|
|
|
|
|
015-003-00-2 |
fosfuro de calcio; difosfuro de tricalcio |
215-142-0 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Eye Dam. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H318 H400 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H260 H300 H311 H330 H318 H400 |
EUH029 EUH032 |
M = 100 |
|
|
|
015-004-00-8 |
Fosfuro de aluminio |
244-088-0 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H311 H330 H400 |
EUH029 EUH032 |
M = 100 |
|
|
|
015-005-00-3 |
Fosfuro de magnesio; difosfuro de trimagnesio |
235-023-7 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H311 H330 H400 |
EUH029 EUH032 |
M = 100 |
|
|
|
015-006-00-9 |
Difosfuro de tricinc; fosfuro de cinc |
215-244-5 |
Water-react. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H260 H300 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H410 |
EUH029 EUH032 |
M=100 |
T |
|
|
015-007-00-4 |
Tricloruro de fósforo |
231-749-3 |
Acute Tox. 2* Acute Tox. 2* STOT RE 2* Skin Corr. 1A |
H330 H300 H373** H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H300 H373** H314 |
EUH014 EUH029 |
|
|
|
|
015-008-00-X |
Pentacloruro de fósforo |
233-060-3 |
Acute Tox. 2* Acute Tox. 4* STOT RE 2* Skin Corr. 1B |
H330 H302 H373** H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H302 H373** H314 |
EUH014 EUH029 |
|
|
|
|
015-009-00-5 |
Tricloruro de fosforilo |
233-046-7 |
Acute Tox. 2* STOT RE 1 Acute Tox. 4* Skin Corr. 1A |
H330 H372** H302 H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H372** H302 H314 |
EUH014 EUH029 |
|
|
|
|
015-010-00-0 |
Pentóxido de fósforo |
215-236-1 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
015-011-00-6 |
Ácido fosfórico al … %; ácido ortofosfórico al … % |
231-633-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
|
|
015-012-00-1 |
Trisulfuro de tetrafósforo; sesquisulfuro de fósforo |
215-245-0 |
Flam. Sol. 2 Water-react. 1 Acute Tox. 4* Aquatic Acute 1 |
H228 H260 H302 H400 |
GHS02 GHS07 GHS09 Dgr |
H228 H260 H302 H400 |
|
|
T |
|
|
015-013-00-7 |
Fosfato de trietilo |
201-114-5 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
015-014-00-2 |
Fosfato de tributilo |
204-800-2 |
Carc. 2 Acute Tox. 4* Skin Irrit. 2 |
H351 H302 H315 |
GHS08 GHS07 Wng |
H351 H302 H315 |
|
|
|
|
|
015-015-00-8 |
Fosfato de tricresilo (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); fosfato de tritolilo (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-) |
201-103-5 |
STOT SE 1 Aquatic Chronic 2 |
H370** H411 |
GHS08 GHS09 Dgr |
H370** H411 |
|
STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2 % ≤ C < 1 % |
C |
|
|
015-016-00-3 |
Fosfato de tricresilo (m-m-m-, m-m-p-, m-p-p-, p-p-p-); fosfato de tritolilo (m-m-m-, m-m-p-, m-p-p-, p-p-p-) |
201-105-6 |
Acute Tox. 4* Acute Tox. 4* Aquatic Chronic 2 |
H312 H302 H411 |
GHS07 GHS09 Wng |
H312 H302 H411 |
|
* |
C |
|
|
015-019-00-X |
Diclorvós (ISO); fosfato de 2,2-diclorovinilo y dimetilo |
200-547-7 |
Acute Tox. 2* Acute Tox. 3* Acute Tox. 3* Skin Sens. 1 Aquatic Acute 1 |
H330 H311 H301 H317 H400 |
GHS06 GHS09 Dgr |
H330 H311 H301 H317 H400 |
|
M=1000 |
|
|
|
015-020-00-5 |
Mevinfós (ISO); fosfato de 2-metoxicarbonil-1-metilvinilo y dimetilo |
232-095-1 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 10000 |
|
|
|
015-021-00-0 |
Triclorfón (ISO); 2,2,2-tricloro-1-hidroxietilfosfonato de dimetilo |
200-149-3 |
Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H400 H410 |
|
M = 1000 |
|
|
|
015-022-00-6 |
Fosfamidón (ISO); fosfato de 2-cloro-2-dietilcarbamoil-1-metilvinilo y dimetilo |
236-116-5 |
Muta. 2 Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H341 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H300 H311 H410 |
|
|
|
|
|
015-023-00-1 |
Pirazoxón; fosfato de 3-metilpirazol-5-ilo y dietilo |
— |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
|
015-024-00-7 |
Triamifós (ISO); diamida del ácido 5-amino-3-fenil-1,2,4-triazol-1-il-N, N,N',N'-tetrametilfosfónico |
— |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-025-00-2 |
TEPP (ISO); pirofosfato de tetraetilo |
203-495-3 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
|
015-026-00-8 |
Escradán (ISO); octametilpirofosforamida |
205-801-0 |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-027-00-3 |
Sulfotep (ISO); ditiopirofosfato de O, O,O, O-tetraetilo |
222-995-2 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
|
015-028-00-9 |
Demetón-O (ISO); fosforotioato de O,O-dietilo y O-2-etiltioetilo |
206-053-8 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
|
015-029-00-4 |
Demetón-S (ISO); fosforotioato de dietilo y S-2-etiltioetilo |
204-801-8 |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-030-00-X |
Demetón-O-metilo (ISO); fosforotioato de O-2-etiltioetilo y O,O-dimetilo |
212-758-1 |
Acute Tox. 3* |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
|
015-031-00-5 |
Demetón-S-metilo (ISO); fosforotioato de S-2-etiltioetilo y dimetilo |
213-052-6 |
Acute Tox. 3* Acute Tox. 3* Aquatic Chronic 2 |
H311 H301 H411 |
GHS06 GHS09 Dgr |
H311 H301 H411 |
|
|
|
|
|
015-032-00-0 |
Protoato (ISO); fosforoditioato de O, O-dietilo e isopropilcarbamoilmetilo |
218-893-2 |
Acute Tox. 1 Acute Tox. 2* Aquatic Chronic 3 |
H310 H300 H412 |
GHS06 Dgr |
H310 H300 H412 |
|
|
|
|
|
015-033-00-6 |
Forato (ISO); fosforoditioato de O, O-dietilo y etiltiometilo |
206-052-2 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
|
015-034-00-1 |
Paratión (ISO); fosforotioato de O,O-dietilo y O-4-nitrofenilo |
200-271-7 |
Acute Tox. 2* Acute Tox. 2* Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H311 H372** H410 |
|
M = 100 |
|
|
|
015-035-00-7 |
Paratión-metilo (ISO); fosforotioato de O,O-dimetilo y O-4-nitrofenilo |
206-050-1 |
Flam. Liq. 3 Acute Tox. 2* Acute Tox. 2* Acute Tox. 3* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H226 H330 H300 H311 H373** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H330 H300 H311 H373** H410 |
|
M = 100 |
|
|
|
015-036-00-2 |
Fenilfosfonotioato de O-etilo y O-4-nitrofenilo; EPN |
218-276-8 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-037-00-8 |
Fenkaptón (ISO); fosforoditioato de S-(2,5-diclorofeniltiometilo) y O, O-dietilo |
218-892-7 |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
|
015-038-00-3 |
Cumafós (ISO); fosforotioato de O-3-cloro-4-metilcumarin-7-ilo y O, O-dietilo |
200-285-3 |
Acute Tox. 2* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
|
015-039-00-9 |
Azinfós-metilo (ISO); ditiofosfato de O, O-dimetilo y 4-oxobenzotriazin-3-ilmetilo |
201-676-1 |
Acute Tox. 2* Acute Tox. 2* Acute Tox. 3* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H317 H410 |
|
|
|
|
|
015-040-00-4 |
Diazinón (ISO); fosforotioato de O,O-dietilo y O-2-isopropil-6-metilpirimidin-4-ilo |
206-373-8 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
|
015-041-00-X |
Malatión (ISO); fosforoditioato de 1,2-bis(etoxicarbonil)etilo y O, O-dimetilo; [con ≤ 0,03 % de isomalatión] |
204-497-7 |
Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=1000 |
|
|
|
015-042-00-5 |
Clortión; fosforotioato de O-(3-cloro-4-nitrofenilo) y O, O-dimetilo |
207-902-5 |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M = 100 |
|
|
|
015-043-00-0 |
Fosniclor (ISO); fosforotioato de O-4-cloro-3-nitrofenilo y O, O-dimetilo |
— |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
|
|
|
015-044-00-6 |
Carbofenotión (ISO); fosforoditioato de 4-clorofeniltiometilo y O, O-dietilo |
212-324-1 |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
015-045-00-1 |
Mecarbam (ISO); fosforoditioato de N-etoxicarbonil-N-metilcarbamoilmetilo y O, O-dietilo |
219-993-9 |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H400 H410 |
|
|
|
|
|
015-046-00-7 |
Oxidemetón-metilo; fosforotioato de S-2-(etilsulfinil)etilo y O, O-dimetilo |
206-110-7 |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 |
H311 H301 H400 |
GHS06 GHS09 Dgr |
H311 H301 H400 |
|
|
|
|
|
015-047-00-2 |
Etión (ISO); S, S'-metilendi(fosforoditioato) de O, O,O',O'-tetraetilo; dietión |
209-242-3 |
Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
M = 10000 |
|
|
|
015-048-00-8 |
Fentión (ISO); fosforotioato de O, O-dimetilo y O-(4-metiltio-m-tolilo) |
200-231-9 |
Muta. 2 Acute Tox. 3* Acute Tox. 4* Acute Tox. 4* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H331 H312 H302 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H331 H312 H302 H372** H410 |
|
M=100 |
|
|
|
015-049-00-3 |
Endotión (ISO); fosforotioato de S-5-metoxi-4-oxopiran-2-ilmetilo y dimetilo |
220-472-3 |
Acute Tox. 3* Acute Tox. 3* |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
|
|
015-050-00-9 |
Tiometón (ISO); fosforoditioato de S-2-etiltioetilo y O,O-dimetilo |
211-362-6 |
Acute Tox. 3* Acute Tox. 4* |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
|
|
015-051-00-4 |
Dimetoato (ISO); fosforoditioato de O, O-dimetilo y S-metilcarbamoilmetilo |
200-480-3 |
Acute Tox. 4* Acute Tox. 4* |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
015-052-00-X |
Fenclorfós (ISO); fosforotioato de O, O-dimetilo y O-2,4,5-triclorofenilo |
206-082-6 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
015-053-00-5 |
Menazón (ISO); fosforoditioato de S-[(4,6-diamino-1,3,5-triazin-2-il)metilo] y O, O-dimetilo |
201-123-4 |
Acute Tox. 4* Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
015-054-00-0 |
Fenitrotión (ISO); fosforotioato de O, O-dimetilo y O-4-nitro-m-tolilo |
204-524-2 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
015-055-00-6 |
Naled (ISO); fosfato de 1,2-dibromo-2,2-dicloroetilo y dimetilo |
206-098-3 |
Acute Tox. 4* Acute Tox. 4* Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 |
H312 H302 H319 H315 H400 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H400 |
|
M = 1000 |
|
|
|
015-056-00-1 |
Azinfós-etilo (ISO); fosforoditioato de O,O-dietilo y 4-oxobenzotriazin-3-ilmetilo |
220-147-6 |
Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M=100 |
|
|
|
015-057-00-7 |
Formotión (ISO); fosforoditioato de N-formil-N-metilcarbamoilmetilo y O, O-dimetilo |
219-818-6 |
Acute Tox. 4* Acute Tox. 4* |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
015-058-00-2 |
Morfotión (ISO); fosforoditioato de O, O-dimetilo y S-(morfolinocarbonilmetilo) |
205-628-0 |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
|
015-059-00-8 |
Vamidotión (ISO); fosforotioato de O, O-dimetilo y S-2- (1-metilcarbamoiletilotio)etilo |
218-894-8 |
Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Dgr |
H301 H312 H400 |
|
|
|
|
|
015-060-00-3 |
Disulfotón (ISO); fosforoditioato de O,O-dietilo y 2-etiltioetilo |
206-054-3 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-061-00-9 |
Dimefox (ISO); fluoruro tetrametilfosforodiamídico |
204-076-8 |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-062-00-4 |
Mipafox (ISO); fluoruro N, N'-di-isopropilfosforodiamídico |
206-742-3 |
STOT SE 1 |
H370** |
GHS08 Dgr |
H370** |
|
|
|
|
|
015-063-00-X |
Dioxatión (ISO); di(fosforoditioato) de 1,4-dioxano-2,3-diilo y O,O,O',O'- tetraetilo |
201-107-7 |
Acute Tox. 2* Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
M = 1000 |
|
|
|
015-064-00-5 |
Bromofós-etilo (ISO); fosforotioato de O-4-bromo-2,5-diclorofenilo y O, O-dietilo |
225-399-0 |
Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
|
|
015-065-00-0 |
Fosforoditioato de S[2-(etilsulfinil)etilo] y O,O-dimetilo |
— |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Aquatic Chronic 2 |
H330 H310 H300 H411 |
GHS06 GHS09 Dgr |
H330 H310 H300 H411 |
|
|
|
|
|
015-066-00-6 |
Ometoato (ISO); fosforotioato de O, O-dimetilo y S-metilcarbamoilmetilo |
214-197-8 |
Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Dgr |
H301 H312 H400 |
|
|
|
|
|
015-067-00-1 |
Fosalona (ISO); fosforoditioato de S-(6-cloro-2-oxobenzoxazolin-3-il)metilo y O, O-dietilo |
218-996-2 |
Acute Tox. 3* Acute Tox. 4* Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H301 H332 H312 H317 H410 |
|
M=1000 |
|
|
|
015-068-00-7 |
Diclofentión (ISO); fosforotioato de O-2,4-diclorofenilo y O, O-dietilo |
202-564-5 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
|
015-069-00-2 |
Metidatión (ISO); fosforoditioato de 2,3-dihidro-5-metoxi-2-oxo-1,3,4-tiadiazol-3-ilmetilo y O,O-dimetilo |
213-449-4 |
Acute Tox. 2* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
|
015-070-00-8 |
Ciantoato (ISO); fosforotioato de S-(N-(1-ciano-1-metiletil)carbamoilmetilo) y O,O-dietilo |
223-099-4 |
Acute Tox. 2* Acute Tox. 3* |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
|
015-071-00-3 |
Clorfenvinfós (ISO); fosfato de 2-cloro-1-(2,4-diclorofenil)vinilo y dietilo |
207-432-0 |
Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
|
015-072-00-9 |
Monocrotofós (ISO); fosfato de dimetilo y 1-metil-2-(metilcarbamoil)vinilo |
230-042-7 |
Muta. 2 Acute Tox. 2* Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H341 H330 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H330 H300 H311 H410 |
|
|
|
|
|
015-073-00-4 |
Dicrotofós (ISO); fosfato de (Z)-2-dimetilcarbamoil-1-metilvinilo y dimetilo |
205-494-3 |
Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
|
015-074-00-X |
Crufomato (ISO); metilfosforamidato de 4-terc-butil-2-clorofenilo y metilo |
206-083-1 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
015-075-00-5 |
Fosforotioato de S[2-(isopropilsulfinil)etilo] y O,O-dimetilo |
— |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
015-076-00-0 |
Potasán; fosforotioato de O, O-dietilo y O-(4-metilcumarin-7-ilo) |
— |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
M = 1000 |
|
|
|
015-077-00-6 |
Fosfato de 2,2-diclorovinilo, 2-etilsulfiniletilo y metilo |
— |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
015-078-00-1 |
Demetón-S-metilsulfón (ISO); fosforotioato de S-2-etilsulfoniletilo y dimetilo |
241-109-5 |
Acute Tox. 3* Acute Tox. 4* Aquatic Chronic 2 |
H301 H312 H411 |
GHS06 GHS09 Dgr |
H301 H312 H411 |
|
|
|
|
|
015-079-00-7 |
Acefato (ISO); acetilfosforamidotioato de O,S-dimetilo |
250-241-2 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
015-080-00-2 |
Amiditión (ISO); fosforoditioato de 2-metoxietilcarbamoilmetilo y O,O-dimetilo |
— |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
015-081-00-8 |
Ditiopirofosfato de O,O,O',O'-tetrapropilo |
221-817-0 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
015-082-00-3 |
Azotoato (ISO); fosforotioato de O-4-(4-clorofenilazo)fenilo y O,O-dimetilo |
227-419-3 |
Acute Tox. 4* Acute Tox. 4* |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
|
|
015-083-00-9 |
Bensulida (ISO); fosforoditioato de O, O-diisopropilo y 2-fenilsulfonilaminoetilo |
212-010-4 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
015-084-00-4 |
Clorpirifós (ISO); fosforotioato de O,O-dietilo y O-3,5,6-tricloro-2-piridilo |
220-864-4 |
Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H400 H410 |
|
M = 10000 |
|
|
|
015-085-00-X |
Cloruro de clorfonio (ISO); cloruro de tributil(2,4-diclorobencil)-fosfonio |
204-105-4 |
Acute Tox. 3* Acute Tox. 4* Eye Irrit. 2 Skin Irrit. 2 |
H301 H312 H319 H315 |
GHS06 Dgr |
H301 H312 H319 H315 |
|
|
|
|
|
015-086-00-5 |
Cumitoato (ISO); fosforotioato de O, O-dietilo y O-7,8,9,10- tetrahidro-6-oxo-benzo(c)cromen-3-ilo |
— |
Acute Tox. 3* |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
|
015-087-00-0 |
Cianofós (ISO); fosforotioato de O-4-cianofenilo y O,O-dimetilo |
220-130-3 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
015-088-00-6 |
Dialifós (ISO); fosforoditioato de 2-cloro-1-ftalimidoetilo y O,O-dietilo |
233-689-3 |
Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H400 H410 |
|
|
|
|
|
015-089-00-1 |
Etoato-metilo (ISO); fosforoditioato de etilcarbamoilmetilo y O,O-dimetilo |
204-121-1 |
Acute Tox. 4* Acute Tox. 4* |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
015-090-00-7 |
Fensulfotión (ISO); fosforotioato de O, O-dietilo y O-4-metilsulfinilfenilo |
204-114-3 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-091-00-2 |
Fonofós (ISO); etilfosfonoditioato de O-etilo y fenilo |
213-408-0 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-092-00-8 |
Fosacetim (ISO); N-acetimidoilfosforamidotioato de O,O-bis(4-clorofenilo) |
223-874-7 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-093-00-3 |
Leptofós (ISO); fenilfosforotioato de O-4-bromo-2,5-diclorofenilo y O-metilo |
244-472-8 |
Acute Tox. 3* STOT SE 1 Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H370** H312 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H370** H312 H410 |
|
|
|
|
|
015-094-00-9 |
Mefosfolan (ISO); 4-metil-1,3-ditiolan-2-ilidenfosforamidato de dietilo |
213-447-3 |
Acute Tox. 1 Acute Tox. 2* Aquatic Chronic 2 |
H310 H300 H411 |
GHS06 GHS09 Dgr |
H310 H300 H411 |
|
|
|
|
|
015-095-00-4 |
Metamidofós (ISO); fosforamidotioato de O, S-dimetilo |
233-606-0 |
Acute Tox. 2* Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 |
H330 H300 H311 H400 |
GHS06 GHS09 Dgr |
H330 H300 H311 H400 |
|
|
|
|
|
015-096-00-X |
Oxidisulfotón (ISO); fosforoditioato de O, O-dietilo y S-2-etilsulfiniletilo |
219-679-1 |
Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M = 10 |
|
|
|
015-097-00-5 |
Fentoato (ISO); 2-(dimetoxifosfinotioiltio)-2-fenilacetato de etilo |
219-997-0 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
M = 100 |
|
|
|
015-098-00-0 |
Tricloronato (ISO); etilfosfonotioato de O-etilo y O-2,4,5-triclorofenilo |
206-326-1 |
Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
|
015-099-00-6 |
Pirimifós-etilo (ISO); fosforotioato de O, O-dietilo y O-2-dietilamino-6-metilpirimidin-4-ilo |
245-704-0 |
Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
|
|
015-100-00-X |
Foxim (ISO); α-(dietoxifosfinotioilimino)fenilacetonitrilo |
238-887-3 |
Repr. 2 Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f*** H302 H317 H410 |
|
M=1000 |
|
|
|
015-101-00-5 |
Fosmet (ISO); fosforoditioato de S-[(1,3-dioxo-1,3-dihidro-2H-isoindol-2-il)metilo] y O,O-dimetilo; fosforoditioato de O,O-dimetilo y S-ftalimidometilo |
211-987-4 |
Repr. 2 Acute Tox. 4 Acute Tox. 3 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H332 H301 H370 (sistema nervioso) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H361f H332 H301 H370 (sistema nervioso) H410 |
|
M = 100 M = 100 |
|
|
|
015-102-00-0 |
Fosfato de tris(2-cloroetilo) |
204-118-5 |
Carc. 2 Repr. 1B Acute Tox. 4* Aquatic Chronic 2 |
H351 H360F*** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360F*** H302 H411 |
|
|
|
|
|
015-103-00-6 |
Tribromuro de fósforo |
232-178-2 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
|
015-104-00-1 |
Pentasulfuro de difósforo; pentasulfuro de fósforo |
215-242-4 |
Flam. Sol. 1 Water-react. 1 Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 |
H228 H260 H332 H302 H400 |
GHS02 GHS07 GHS09 Dgr |
H228 H260 H332 H302 H400 |
EUH029 |
|
T |
|
|
015-105-00-7 |
Fosfito de trifenilo |
202-908-4 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % |
|
|
|
015-106-00-2 |
Hexametiltriamida fosfórica; hexametilfosforamida |
211-653-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
|
015-107-00-8 |
Etoprofós (ISO); fosforoditioato de etilo y S,S-dipropilo |
236-152-1 |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 3* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H301 H317 H410 |
|
|
|
|
|
015-108-00-3 |
Bromofós (ISO); fosforotioato de O-4-bromo-2,5-diclorofenilo y O, O-dimetilo |
218-277-3 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 100 |
|
|
|
015-109-00-9 |
Crotoxifós (ISO); 3-(dimetoxifosfiniloxi)isocrotonato de 1-feniletilo |
231-720-5 |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 10 |
|
|
|
015-110-00-4 |
Cianofenfós (ISO); fenilfosfonotioato de O-4-cianofenilo y O-etilo |
— |
Acute Tox. 3* STOT SE 1 Acute Tox. 4* Eye Irrit. 2 Aquatic Chronic 2 |
H301 H370** H312 H319 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H370** H312 H319 H411 |
|
|
|
|
|
015-111-00-X |
Fosfolán (ISO); 1,3-ditiolan-2-ilidenfosforamidato de dietilo |
213-423-2 |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-112-00-5 |
Tionazina (ISO); fosforotioato de O,O-dietilo y O-pirazin-2-ilo |
206-049-6 |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-113-00-0 |
Tolclofós-metilo (ISO); tiofosfato de O-(2,6-dicloro-p-tolilo) y O,O-dimetilo |
260-515-3 |
Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M = 1 M = 1 |
|
|
|
015-114-00-6 |
Clormefós (ISO); fosforoditioato de S-clorometilo y O,O-dietilo |
246-538-1 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 10 |
|
|
|
015-115-00-1 |
Clortiofós (ISO); [masa de reacción isomérica en la que predomina el fosforotioato de O-2,5-diclorofenil-4-metiltiofenilo y O, O-dietilo] |
244-663-6 |
Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M = 1000 |
|
|
|
015-116-00-7 |
Demefión-O (ISO); fosforotioato de O, O-dimetilo y O-2-metiltioetilo |
211-666-9 |
Acute Tox. 2* Acute Tox. 3* |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
|
015-117-00-2 |
Demefión-S (ISO); fosforotioato de O, O-dimetilo y S-2-metil-tioetilo |
219-971-9 |
Acute Tox. 2* Acute Tox. 3* |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
|
015-118-00-8 |
Demetón |
— |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
|
015-119-00-3 |
Fosfato de dimetilo y 4-(metiltio)fenilo |
— |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-120-00-9 |
Ditalimfós (ISO); ftalimidofosfonotioato de O, O-dietilo |
225-875-8 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
|
015-121-00-4 |
Edifenfós (ISO); fosforoditioato de O-etilo y S, S-difenilo |
241-178-1 |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H317 H410 |
|
|
|
|
|
015-122-00-X |
Etrimfós (ISO); fosforotioato de O-6-etoxi-2-etilpirimidin-4-ilo y O, O-dimetilo |
253-855-9 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 10 |
|
|
|
015-123-00-5 |
Fenamifós (ISO); isopropilfosforamidato de etilo y 4-metiltio-m-tolilo |
244-848-1 |
Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H300 H310 H330 H319 H400 H410 |
GHS06 GHS09 Dgr |
H300 H310 H330 H319 H410 |
|
M = 100 M = 100 |
|
|
|
015-124-00-0 |
Fostietán (ISO); 1,3-ditietan-2-ilidenfosforamidato de dietilo |
244-437-7 |
Acute Tox. 1 Acute Tox. 2* |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-125-00-6 |
Glifosina (ISO); N,N-bis(fosfonometil)glicina |
219-468-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
015-126-00-1 |
Heptenofós (ISO); fosfato de 7-clorobiciclo(3.2.0)hepta-2,6-dien-6-ilo y dimetilo |
245-737-0 |
Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
M = 100 |
|
|
|
015-127-00-7 |
Iprobenfós (ISO); fosforotioato de S-bencilo y diisopropilo |
247-449-0 |
Acute Tox. 4* Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
015-128-00-2 |
IPSP; fosforoditioato de S-etilsulfinilmetilo y O,O-diisopropilo |
— |
Acute Tox. 1 Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H301 H400 H410 |
GHS06 GHS09 Dgr |
H310 H301 H410 |
|
M = 100 |
|
|
|
015-129-00-8 |
Isofenfós (ISO); isopropilfosforamidotioato de O-etilo y O-2-isopropoxicarbonilfenilo |
246-814-1 |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 100 |
|
|
|
015-130-00-3 |
Isotioato (ISO); fosforoditioato de S-2-isopropiltioetilo y O,O-dimetilo |
— |
Acute Tox. 3* Acute Tox. 3* |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
|
|
015-131-00-9 |
Isoxatión (ISO); fosforotioato de O,O-dietilo y O-5-fenilisoxazol-3-ilo |
242-624-8 |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
015-132-00-4 |
Fosforoditioato de S-(clorofeniltiometilo) y O,O-dimetilo; metilcarbofenotiona |
— |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 1000 |
|
|
|
015-133-00-X |
Piperofós (ISO); fosforoditioato de S-2-metilpiperidinocarbonilmetilo y O, O-dipropilo |
— |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 10 |
|
|
|
015-134-00-5 |
Pirimifós-metilo (ISO); O,O-dimetil-fosforotioato de O-[2-(dietilamino)-6-metilpirimidin-4-ilo] |
249-528-5 |
Acute Tox. 4 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H372 (sistema nervioso) H400 H410 |
GHS07 GHS08 GHS09 Dgr |
H302 H372 (sistema nervioso) H410 |
|
Por vía oral: ETA = 1 414 mg/kg pc M = 1 000 M = 1 000 |
|
|
|
015-135-00-0 |
Profenofós (ISO); fosforotioato de O-(4-bromo-2-clorofenilo), O-etilo y S-propilo |
255-255-2 |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M = 1000 |
|
|
|
015-136-00-6 |
3-[[(Etilamino)metoxifosfinotioil]oxi]crotonato de trans-isopropilo; 3-[[(etilamino)metoxifosfinotioil]oxi]isocrotonato de isopropilo; propetamfós (ISO) |
250-517-2 |
Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
M = 100 |
|
|
|
015-137-00-1 |
Pirazofós(ISO); fosforotioato de O, O-dietilo y O-(6-etoxicarbonil-5-metilpirazolo[2,3-a]pirimidin-2-ilo) |
236-656-1 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
|
|
|
|
015-138-00-7 |
Quinalfós (ISO); fosforotioato de O, O-dietilo y O-quinoxalin-2-ilo |
237-031-6 |
Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
M = 1000 |
|
|
|
015-139-00-2 |
Terbufós (ISO); fosforoditioato de S-terc-butiltiometilo y O, O-dietilo |
235-963-8 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
|
015-140-00-8 |
Triazofós (ISO); fosforotioato de O, O-dietilo y O-1-fenil-1H-1,2,4-triazol-3-ilo |
245-986-5 |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H410 |
|
M=100 |
|
|
|
015-141-00-3 |
Mezcla de isómeros de fosforoditioato de etilenodiamonio y O, O- bis(octilo) |
400-520-1 |
— |
Skin Corr. 1B Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H314 H302 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H410 |
|
|
|
|
015-142-00-9 |
Fosfato de butilo, (dialquiloxi(dibutoxifosforiloxi))titanio y (trialquiloxi)titanio |
401-100-0 |
— |
Flam. Liq. 2 Eye Irrit. 2 Aquatic Chronic 2 |
H225 H319 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H319 H411 |
|
|
T |
|
015-143-00-4 |
Masa de reacción de 2-cloroetilfosfonato de 2-cloroetilo y cloropropilo, masa de reacción de isómeros y 2-cloropropilfosfonato de 2-cloroetilo y cloropropilo, masa de reacción de isómeros |
401-740-0 |
— |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
015-144-00-X |
Masa de reacción de metilfosfinato de pentilo y metilfosfinato de 2-metilbutilo |
402-090-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
015-145-00-5 |
Masa de reacción de fosforoditioato de cobre(I) y O, O-diisopropilo, fosforoditioato de cobre(I), O-isopropilo y O-(4-metilpent-2-ilo) y fosforoditioato de cobre(I) y O, O-bis(4-metilpent-2-ilo) |
401-520-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
015-146-00-0 |
Fosforoditioato de S-(triciclo(5.2.1.02,6)deca-3-en-8(o 9)-ilo, O-(isopropilo o isobutilo o 2-etilhexilo) y O-(isopropilo o isobutilo o 2-etilhexilo) |
401-850-9 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
015-147-00-6 |
Masa de reacción de fosforotioato de C12-14-terc-alquilamonio y difenilo, y sulfuro (o disulfuro) de dinonilo |
400-930-0 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
015-148-00-1 |
Ácido 2-(difosfonometil)succínico |
403-070-4 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
|
015-149-00-7 |
Masa de reacción de: óxido de hexildioctilfosfina; óxido de dihexiloctilfosfina; óxido de trioctilfosfina |
403-470-9 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
015-150-00-2 |
Bromuro de (2-(1,3-dioxolan-2-il)etil)trifenilfosfonio |
404-940-6 |
Acute Tox. 4* Eye Dam. 1 STOT RE 2* Aquatic Chronic 3 |
H302 H318 H373** H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H318 H373** H412 |
|
|
|
|
|
015-151-00-8 |
Fosfato de tris(isopropil/terc-butilfenilo) |
405-010-2 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
015-152-00-3 |
Dioxabenzofós (ISO); 2-metoxi-4H-1,3,2-benzodioxafosforina-2-sulfuro |
223-292-3 |
Acute Tox. 3* Acute Tox. 3* STOT SE 1 Aquatic Chronic 2 |
H311 H301 H370** H411 |
GHS06 GHS08 GHS09 Dgr |
H311 H301 H370** H411 |
|
|
|
|
|
015-153-00-9 |
Isazofós (ISO); fosforotioato de O-(5-cloro-1-isopropil-1,2,4-triazol-3-ilo) y O, O-dietilo |
255-863-8 |
Acute Tox. 2* Acute Tox. 3* Acute Tox. 3* STOT RE 2* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H301 H373** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H311 H301 H373** H317 H410 |
|
|
|
|
|
015-154-00-4 |
Etefón; ácido 2-cloroetilfosfónico |
240-718-3 |
Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2 |
H311 H332 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H332 H302 H314 H411 |
EUH071 |
|
|
|
|
015-155-00-X |
Glufosinato de amonio (ISO); 2-amino-4-(hidroximetilfosfinil)butirato de amonio |
278-636-5 |
Repr. 1B Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT RE 2* |
H360Fd H332 H312 H302 H373** |
GHS08 GHS07 Dgr |
H360Fd H332 H312 H302 H373** |
|
|
|
|
|
015-156-00-5 |
3-[(Dimetoxifosfinotioil)oxi]metacrilato de metilo; [1] metacrifós (ISO); (E)-3-[(dimetoxifosfinotioil)oxi]metacrilato de metilo [2] |
250-366-9 [1]-[2] |
30864-28-9 [1] 62610-77-9 [2] |
Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
015-157-00-0 |
Ácido fosfónico; [1] ácido fosforoso [2] |
237-066-7 [1] 233-663-1 [2] |
13598-36-2 [1] 10294-56-1 [2] |
Acute Tox. 4* Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
015-158-00-6 |
Hexafluorofosfato(1-) de (η-ciclopentadienil)-(η-cumenil)-hierro(1+) |
402-340-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
015-159-00-1 |
Ácido hidroxifosfonoacético |
405-710-8 |
Acute Tox. 4* STOT RE 2* Skin Corr. 1B Skin Sens. 1 |
H302 H373** H314 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H373** H314 H317 |
|
|
|
|
|
015-160-00-7 |
Pirofosfato de vanadilo |
406-260-5 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
|
015-161-00-2 |
Pirofosfato de divanadilo |
407-130-0 |
Acute Tox. 4* Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
|
015-162-00-8 |
Hidrogenofosfato de óxido de vanadio(IV) hemihidratado, dopado con litio, cinc, molibdeno, hierro y cloro |
407-350-7 |
— |
Acute Tox. 4* STOT RE 2* Eye Dam. 1 Aquatic Chronic 2 |
H332 H373** H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H332 H373** H318 H411 |
|
|
|
|
015-163-00-3 |
Óxido de bis(2,6-dimetoxibenzoil)-2,4,4-trimetilpentilfosfina |
412-010-6 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
015-164-00-9 |
P, P'-(1-Hidroxietilen)bisfosfonato de hidrógeno y calcio (dihidratado) |
400-480-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
015-165-00-4 |
Masa de reacción de: bishexafluorofosfato de tiobis(4,1-fenilen)-S, S,S',S'-tetrafenildisulfonio; hexafluorofosfato de difenil(4-feniltiofenil)sulfonio |
404-986-7 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
015-166-00-X |
3,9-Bis(2,6-di-terc-butil-4-metilfenoxi)-2,4,8,10-tetraoxa-3,9-difosfaespiro[5.5]undecano |
410-290-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
015-167-00-5 |
Ácido 3-(hidroxifenilfosfinil)propanoico |
411-200-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
015-168-00-0 |
Fostiazato (ISO); 2-oxo-1,3-tiazolidin-3-ilfosfonotioato de (RS)-S-sec-butilo y O-etilo |
— |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H317 H410 |
EUH070 |
|
|
|
|
015-169-00-6 |
Tetrafluoroborato de tributiltetradecilfosfonio |
413-520-1 |
— |
Acute Tox. 4* STOT RE 2* Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373** H314 H317 H410 |
|
|
|
|
015-170-00-1 |
Masa de reacción de: fosfato de di-(1-octano-N, N,N-trimetilamonio) y octilo; fosfato de 1-octano-N, N,N-trimetilamonio y di-octilo; fosfato de 1-octano-N, N,N-trimetilamonio y octilo |
407-490-9 |
— |
Acute Tox. 4* Acute Tox. 4* Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
015-171-00-7 |
Fosforotioato de O, O,O-tris(2(o 4)-C9-10-isoalquilfenilo) |
406-940-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
015-172-00-2 |
Masa de reacción de: fosfato de bis(isotridecilamonio) y mono(di-(4-metilpent-2-il-oxi)tiofosforotionilisopropilo); fosfato de isotridecilamonio y bis(di-(4-metilpent-2-il-oxi)tiofosforotionilisopropilo) |
406-240-6 |
— |
Flam. Liq. 3 Skin Corr. 1B Aquatic Chronic 2 |
H226 H314 H411 |
GHS02 GHS05 GHS09 Dgr |
H226 H314 H411 |
|
|
|
|
015-173-00-8 |
[2- (1,1-Dimetiletil)-6-metoxipirimidin-4-il]etilfosfonotioato de metilo |
414-080-3 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
015-174-00-3 |
1-Cloro-N,N-dietil-1,1-difenil-1-(fenilmetil)fosforamina |
411-370-1 |
Acute Tox. 3* Eye Dam. 1 Aquatic Chronic 2 |
H301 H318 H411 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H411 |
|
|
|
|
|
015-175-00-9 |
(Trifenilfosforaniliden)acetato de terc-butilo |
412-880-7 |
Acute Tox. 3* STOT RE 2* Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H301 H373** H319 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H373** H319 H317 H411 |
|
|
|
|
|
015-176-00-4 |
P, P,P',P'-Tetrakis-(o-metoxifenil)propano-1,3-difosfina |
413-430-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
015-177-00-X |
Ácido ((4-fenilbutil)hidroxifosforil)acético |
412-170-7 |
STOT RE 2* Eye Dam. 1 Skin Sens. 1 |
H373** H318 H317 |
GHS08 GHS05 Dgr |
H373** H318 H317 |
|
|
|
|
|
015-178-00-5 |
(-)-(1R, 2S)-(1,2-Epoxipropil)fosfonato de (R)-α-feniletilamonio monohidratado |
418-570-8 |
Repr. 2 Aquatic Chronic 2 |
H361f*** H411 |
GHS08 GHS09 Wng |
H361f*** H411 |
|
|
|
|
|
015-179-00-0 |
UVCB producto de condensación de: cloruro de tetrakis-hidroximetilfosfonio, urea y aminas de C16-18-alquilo de sebo destilado e hidrogenado |
422-720-8 |
Carc. 2 Acute Tox. 4* STOT RE 2* Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H302 H373** H314 H317 H410 |
|
|
|
|
|
015-180-00-6 |
Ácido [R-(R*,S*)]-[[2-metil-1-(1-oxopropoxi)propoxi]-(4-fenilbutil)fosfinil]acético, sal de (-)-cinconidina (1:1) |
415-820-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
015-181-00-1 |
Fosfina |
232-260-8 |
Flam. Gas 1 Press. Gas Acute Tox. 1 Skin Corr. 1B Aquatic Acute 1 |
H220 H330 H314 H400 |
GHS02 GHS04 GHS06 GHS05 GHS09 Dgr |
H220 H330 H314 H400 |
|
Por inhalación: ETA = 10 ppmV (gases) |
U |
|
|
015-182-00-7 |
(Diclorometanodiil)bis(fosfonato) de tetrapropan-2-ilo |
430-630-5 |
Acute Tox. 4* Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
|
015-183-00-2 |
Ácido (1-hidroxi-dodecilideno)difosfónico |
425-230-2 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
|
015-184-00-8 |
Sales de glifosato, excepto las especificadas en otras partes del presente anexo |
— |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
A |
|
015-186-00-9 |
Clorpirifós-metilo (ISO); fosforotioato de O, O-dimetilo y O-3,5,6-tricloro-2-piridilo |
227-011-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M = 10000 |
|
|
|
015-187-00-4 |
Masa de reacción de: (((2-hidroxietil)imino)bis(metilen))bisfosfonato de tetrasodio, N-óxido; ((tetrahidro-2- hidroxi-4H-1,4,2-oxazafosforin-4-il)metil)fosfonato de trisodio, N-óxido, P-óxido |
417-540-1 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
▼M8 ————— |
||||||||||
|
015-189-00-5 |
Óxido de fenilbis(2,4,6-trimetilbenzoil)fosfina |
423-340-5 |
Skin Sens. 1A Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
015-190-00-0 |
Difosfito de neopentilo y bis(2,4-dicumilfenilo); 3,9-bis[2,4-bis(1-metil-1-feniletil)fenoxi]-2,4,8,10-tetraoxa-3,9-difosfaespiro[5.5]undecano |
421-920-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
015-191-00-6 |
Fosfato de dodecilo y difenilo |
431-760-5 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
▼M29 ————— |
||||||||||
|
015-193-00-7 |
1,1,2,2,3,3,4,4,4-Nonafluoro-N-metil-1-butanosulfonamida de trifenil(fenilmetil)fosfonio (1:1) |
442-960-7 |
Acute Tox. 3* Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H400 H410 |
GHS05 GHS06 GHS09 Dgr |
H301 H318 H410 |
|
|
|
|
|
015-194-00-2 |
Nonafluorobutano-1-sulfonato de tetrabutilfosfonio |
444-440-5 |
Acute Tox. 4* Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
015-195-00-8 |
Masa de reacción de: o-toluenofosfonato de potasio; m-toluenofosfonato de potasio; p-toluenofosfonato de potasio |
433-860-4 |
— |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
015-196-00-3 |
Masa de reacción de: (2-(hidroximetilcarbamoil)etil)fosfonato de dimetilo; (2-(hidroximetilcarbamoil)etil)fosfonato de dietilo; (2-(hidroximetilcarbamoil)etil)fosfonato de metilo y etilo |
435-960-3 |
— |
Carc. 1B Muta. 1B Skin Sens. 1 |
H350 H340 H317 |
GHS08 GHS07 Dgr |
H350 H340 H317 |
|
|
|
|
015-197-00-9 |
Ácido bis(2,4,4-trimetilpentil)ditiofosfónico |
420-160-9 |
Flam. Liq. 3 Acute Tox. 3* Acute Tox. 4* Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H302 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H226 H331 H302 H314 H411 |
|
|
|
|
|
015-198-00-4 |
Ácido (4-fenilbutil)fosfínico |
420-450-5 |
Carc. 2 Eye Dam. 1 |
H351 H318 |
GHS05 GHS08 Dgr |
H351 H318 |
|
|
|
|
|
015-199-00-X |
Fosfato de tris[2-cloro-1-clorometil)etilo] |
237-159-2 |
Carc. 2 |
H351 |
GSH08 Wng |
H351 |
|
|
|
|
|
015-200-00-3 |
Fosfuro de indio |
244-959-5 |
Carc. 1B Repr. 2 STOT RE 1 |
H350 H361f H372 (pulmones) |
GHS08 Dgr |
H350 H361f H372 (pulmones) |
|
STOT RE 1; H372: C ≥0,1 % Carc 1B; H350: C ≥0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 % |
|
|
|
015-201-00-9 |
Fosfato de trixililo |
246-677-8 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
015-202-00-4 |
Fosfito de tris(nonilfenilo) |
247-759-6 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
015-203-00-X |
Óxido de difenil(2,4,6-trimetilbenzoil)fosfina |
278-355-8 |
Repr. 1B Skin Sens. 1B |
H360Fd H317 |
GHS08 GHS07 Dgr |
H360Fd H317 |
|
|
|
|
|
015-204-00-5 |
4-[1,1,1,3,3,3-Hexafluoro-2-(4-hidroxifenil)propan-2-il]fenolato de bencil(dietilamino)difenilfosfonio |
479-100-5 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
015-205-00-0 |
Sal de benciltrifenilfosfonio y 4,4’-[2,2,2-trifluoro-1-(trifluorometil)etiliden]bis[fenol] (1: 1) |
278-305-5 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
015-206-00-6 |
Masa de reacción de 4,4’-[2,2,2-trifluoro-1-(trifluorometil)etiliden]difenol y 4-[1,1,1,3,3,3-hexafluoro-2-(4-hidroxifenil)propan-2-il]fenolato de bencil(dietilamino)difenilfosfonio (1: 1) |
— |
— |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
015-207-00-1 |
Masa de reacción de 4,4’-[2,2,2-trifluoro-1-(trifluorometil)etiliden]difenol y sal de benciltrifenilfosfonio y 4,4’-[2,2,2-trifluoro-1-(trifluorometil)etiliden]difenol (1:1) |
— |
— |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
015-208-00-7 |
Propilfosfonato de dimetilo |
242-555-3 |
Muta. 1B Repr. 1B |
H340 H360Df |
GHS08 Dgr |
H340 H360Df |
|
|
|
|
|
016-001-00-4 |
Sulfuro de hidrógeno |
231-977-3 |
Flam. Gas 1A Press. Gas Acute Tox. 2 Aquatic Acute 1 |
H220 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H220 H330 H400 |
|
Por inhalación: ETA = 440 ppmV (gases) |
U |
|
|
016-002-00-X |
Sulfuro de bario |
244-214-4 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Wng |
H332 H302 H400 |
EUH031 |
|
|
|
|
016-003-00-5 |
Polisulfuros de bario |
256-814-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
|
016-004-00-0 |
Sulfuro de calcio |
243-873-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
|
016-005-00-6 |
Polisulfuros de calcio |
215-709-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
|
016-006-00-1 |
Sulfuro de dipotasio; sulfuro de potasio |
215-197-0 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
|
|
|
|
016-007-00-7 |
Polisulfuros de potasio |
253-390-1 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
|
|
|
|
016-008-00-2 |
Polisulfuros de amonio |
232-989-1 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
EUH031: C ≥1 % |
|
|
|
016-009-00-8 |
Sulfuro de disodio; sulfuro de sodio |
215-211-5 |
Acute Tox. 3* Acute Tox. 4* Skin Corr. 1B Aquatic Acute 1 |
H311 H302 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H311 H302 H314 H400 |
|
|
|
|
|
016-010-00-3 |
Polisulfuros de sodio |
215-686-9 |
Acute Tox. 3* Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H314 H400 |
EUH031 |
|
|
|
|
016-011-00-9 |
Dióxido de azufre |
231-195-2 |
Press. Gas Acute Tox. 3 STOT SE 1 Skin. Corr. 1B |
H331 H370 (vías respiratorias) (inhalación) H314 |
GHS04 GHS06 GHS08 GHS05 Dgr |
H331 H370 (vías respiratorias) (inhalación) H314 |
|
Por inhalación: ETA = 1 000 ppmV (gases) |
U, 5 |
|
|
016-012-00-4 |
Dicloruro de diazufre; monocloruro de azufre |
233-036-2 |
Acute Tox. 3* Acute Tox. 4* Skin Corr. 1A Aquatic Acute 1 |
H301 H332 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H332 H314 H400 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1 % |
|
|
|
016-013-00-X |
Dicloruro de azufre |
234-129-0 |
Skin Corr. 1B STOT SE 3 Aquatic Acute 1 |
H314 H335 H400 |
GHS05 GHS07 GHS09 Dgr |
H314 H335 H400 |
EUH014 |
STOT SE 3; H335: C ≥ 5 % |
|
|
|
016-014-00-5 |
Tetracloruro de azufre |
— |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH014 |
STOT SE 3; H335: C ≥ 5 % |
|
|
|
016-015-00-0 |
Dicloruro de tionilo; cloruro de tionilo |
231-748-8 |
Acute Tox. 4* Acute Tox. 4* Skin Corr. 1A |
H332 H302 H314 |
GHS05 GHS07 Dgr |
H332 H302 H314 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1 % |
|
|
|
016-016-00-6 |
Cloruro de sulfurilo |
232-245-6 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
|
016-017-00-1 |
Ácido clorosulfónico |
232-234-6 |
Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
|
016-018-00-7 |
Ácido fluorosulfónico |
232-149-4 |
Acute Tox. 4* Skin Corr. 1A |
H332 H314 |
GHS05 GHS07 Dgr |
H332 H314 |
|
|
|
|
|
016-019-00-2 |
Ácido sulfúrico fumante … % SO3 |
— |
— |
Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
B |
|
016-020-00-8 |
Ácido sulfúrico al … % |
231-639-5 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C < 15 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % |
B |
|
|
016-021-00-3 |
Metanotiol; metilmercaptano |
200-822-1 |
Flam. Gas. 1 Press. Gas Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H220 H331 H400 H410 |
GHS02 GHS04 GHS06 GHS09 Dgr |
H220 H331 H410 |
|
|
U |
|
|
016-022-00-9 |
Etanotiol; etilmercaptano |
200-837-3 |
Flam. Liq. 1 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 |
H224 H331 H302 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H224 H331 H302 H410 |
|
Por inhalación: ETA = 7,1 mg/l (vapores) Por vía oral: ETA = 680 mg/kg pc |
|
|
|
016-023-00-4 |
Sulfato de dimetilo |
201-058-1 |
Carc. 1B Muta. 2 Acute Tox. 2* Acute Tox. 3* Skin Corr. 1B Skin Sens. 1 |
H350 H341 H330 H301 H314 H317 |
GHS06 GHS08 GHS05 Dgr |
H350 H341 H330 H301 H314 H317 |
|
Carc. 1B; H350: C ≥ 0,01 % Muta. 2 H341: C ≥ 0,01 % STOT SE 3; H335: C ≥ 5 % |
|
|
|
016-024-00-X |
Dimexano (ISO); disulfuro de bis(metoxitiocarbonilo) |
215-993-8 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
016-025-00-5 |
Disul (ISO); hidrogenosulfato de 2-(2,4-diclorofenoxi)etilo; 2,4-DES |
205-259-5 |
Acute Tox. 4* Skin Irrit. 2 Eye Dam. 1 |
H302 H315 H318 |
GHS05 GHS07 Dgr |
H302 H315 H318 |
|
|
|
|
|
016-026-00-0 |
Ácido sulfamídico; ácido sulfámico |
226-218-8 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
|
016-027-00-6 |
Sulfato de dietilo |
200-589-6 |
Carc. 1B Muta. 1B Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Skin Corr. 1B |
H350 H340 H332 H312 H302 H314 |
GHS05 GHS08 GHS07 Dgr |
H350 H340 H332 H312 H302 H314 |
|
|
|
|
|
016-028-00-1 |
Ditionito de sodio; hidrosulfito de sodio |
231-890-0 |
Self-heat. 1 Acute Tox. 4* |
H251 H302 |
GHS02 GHS07 Dgr |
H251 H302 |
EUH031 |
|
|
|
|
016-029-00-7 |
Ácido p-toluenosulfónico (con más del 5 % de H2SO4) |
— |
— |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
|
|
016-030-00-2 |
Ácido p-toluenosulfonico (con un máximo del 5 % de H2SO4) |
203-180-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 20 % |
|
|
|
016-031-00-8 |
1,1-Dióxido de tetrahidrotiofeno; sulfolano |
204-783-1 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
016-032-00-3 |
1,3-Propanosultona; 2,2-dióxido de 1,2-oxatiolano |
214-317-9 |
Carc. 1B Acute Tox. 4* Acute Tox. 4* |
H350 H312 H302 |
GHS08 GHS07 Dgr |
H350 H312 H302 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
|
016-033-00-9 |
Cloruro de dimetilsulfamoílo |
236-412-4 |
Carc. 1B Acute Tox. 2* Acute Tox. 4* Acute Tox. 4* Skin Corr. 1B |
H350 H330 H312 H302 H314 |
GHS06 GHS05 GHS08 Dgr |
H350 H330 H312 H302 H314 |
|
|
|
|
|
016-034-00-4 |
3,3'-(Piperazina-1,4-diilbis((6-cloro-1,3,5-triazina-2,4-diil)imino(2-acetamido)-4,1-fenilenazo))bis(naftaleno-1,5-disulfonato) de tetrasodio |
400-010-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-035-00-X |
5-Anilino-3-(4-(4-(6-cloro-4-(3-sulfonatoanilino)-1,3,5-triazin-2-ilamino) -2,5-dimetilfenilazo)-2,5-disulfonatofenilazo)-4-hidroxinaftaleno-2,7-disulfonato de pentasodio |
400-120-7 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
016-036-00-5 |
5-(4,6-Dicloro-5-cianopirimidin-2-ilamino)-4- hidroxi-2,3-azodinaftaleno-1,2,5,7-disulfonato de tetrasodio |
400-130-1 |
— |
Resp. Sens. 1 Aquatic Chronic 2 |
H334 H411 |
GHS08 GHS09 Dgr |
H334 H411 |
|
|
|
|
016-037-00-0 |
1-Amino-4-(4-benceno-sulfonamido-3-sulfonatoanilino)antraquinona-2-sulfonato de disodio |
400-350-8 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
016-038-00-6 |
6-((4-Cloro-6-(N- metil)-2-toluidino)-1,3,5-triazin-2-ilamino)-1-hidroxi-2- (4-metoxi-2-sulfonatofenilazo)naftaleno-3-sulfonato de disodio |
400-380-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-039-00-1 |
2-(6-Cloro-4-(4-(2,5-dimetil-4-(2,5-disulfonatofenilazo)fenilazo)-3- ureidoanilino)-1,3,5-triazin-2-ilamino)benceno-1,4-disulfonato de tetrasodio |
400-430-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-040-00-7 |
Masa de reacción de 6-(2,4-dihidroxifenilazo)-3-(4-(4-(2,4-dihidroxifenilazo)anilino)-3-sulfonatofenilazo)-4-hidroxinaftaleno-2-sulfonato de disodio, 6-(2,4-diaminofenilazo)-3-(4-(4-(2,4-diaminofenilazo)anilino)-3-sulfonatofenilazo)-4-hidroxinaftaleno-2-sulfonato de disodio, y 6-(2,4-dihidroxifenilazo)-3-(4-(4-(7-(2,4-dihidroxifenilazo)-1-hidroxi-3- sulfonato-2-naftilazo)anilino)-3-sulfonatofenilazo)-4-hidroxinaftaleno-2-sulfonato de trisodio |
400-570-4 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
016-041-00-2 |
2,5-Dicloro-4-(4-((5-cloro-4-metil-2-sulfonatofenil)azo)-5-hidroxi-3-metilpirazol-1-il)bencenosulfonato de calcio |
400-710-4 |
— |
Acute Tox. 4* |
H332 |
GHS07 Wng |
H332 |
|
|
|
|
016-042-00-8 |
5-Benzamido-3-(5-(4-fluoro-6-(1-sulfonato-2-natilamino)-1,3,5-triazin-2- ilamino)-2-sulfonatofenilazo)-4-hidroxinaftaleno-2,7-disulfonato de tetrasodio |
400-790-0 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
|
016-043-00-3 |
6-Acetamido-4-hidroxi-3-(4-((2-sulfonatooxi)etilsulfonil)fenilazo)naftaleno-2-sulfonato) de dilitio |
401-010-1 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-044-00-9 |
S,S-Hexano-1,6-diildi(tiosulfato) de disodio, dihidratado |
401-320-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
016-045-00-4 |
4-Amino-6-(5-(5-cloro-2,6-difluoropirimidin-4-ilamino)-2- sulfonatofenilazo)-5-hidroxi-3-(4-(2-(sulfonatooxi)etilsulfonil)fenilazo)naftaleno-2,7-disulfonato de litio, sodio e hidrógeno |
401-560-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-046-00-X |
Hidrogenosulfato de sodio |
231-665-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
016-047-00-5 |
7-(4-(4-(4-(2,5-Disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ilamino)-2- metilfenilazo)-7-sulfonatonaftilazo)naftaleno-1,3,5- trisulfonato de hexasodio |
401-650-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-048-00-0 |
3,5-Dicloro-2-(5-ciano-2,6-bis(3-hidroxipropilamino)-4-metilpiridin-3-ilazo)bencenosulfonato de sodio |
401-870-8 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
016-049-00-6 |
Octadecilxilenosulfonato de calcio |
402-040-8 |
— |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
|
016-050-00-1 |
5-(4-Cloro-6-(N-(4-(4-cloro-6-(5-hidroxi-2,7-disulfonato-6-(2-sulfonatofenilazo)-4-naftilamino)-1,3,5-triazin-2-ilamino)fenil-N-metil)amino)-1,3,5-triazin-2-ilamino)-4-hidroxi-3- (2-sulfonatofenilazo)naftaleno-2,7-disulfonato de potasio y sodio |
402-150-6 |
— |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
016-051-00-7 |
7-(4-(6-Fluoro-4-(2-(2-vinilsulfoniletoxi)etilamino)-1,3,5-triazin-2-ilamino)-2-ureidofenilazo)naftaleno-1,3,6-trisulfonato de trisodio |
402-170-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-052-00-2 |
4-Hidroxinaftaleno-1-sulfonato de benciltributilamonio |
402-240-5 |
Acute Tox. 4* Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
|
016-053-00-8 |
2-((C16 o C18-n-Alquil)(C16 o C18-n-alquil)carbamoil)bencenosulfonato de (C16 o C18-n-alquil)(C16 o C18-n-alquil)amonio |
402-460-1 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
016-054-00-3 |
4-(2,4,4-Trimetilpentilcarboniloxi)bencenosulfonato de sodio |
400-030-8 |
— |
Acute Tox. 3* STOT RE 1 Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Sens. 1 |
H331 H372** H302 H319 H335 H317 |
GHS06 GHS08 Dgr |
H331 H372** H302 H319 H335 H317 |
|
|
|
|
016-055-00-9 |
4-Amino-3,6-bis(5-(6-cloro-4-(2-hidroxietilamino)-1,3,5-triazin-2-ilamino)-2-sulfonatofenilazo)-5-hidroxinaftaleno-2,7-sulfonato de tetrasodio (con > 35 % de cloruro de sodio y acetato de sodio) |
400-510-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
016-056-00-4 |
Hidrogenosulfato de potasio |
231-594-1 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
|
|
|
|
016-057-00-X |
Cloruro de estireno-4-sulfonilo |
404-770-2 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
|
016-058-00-5 |
Cloruro de tionilo, productos de reacción con 1,3,4-tiadiazol-2,5-ditiol, terc-nonanotiol y C12-14-terc-alquilamina |
404-820-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Wng |
H315 H317 H412 |
|
|
|
|
016-059-00-0 |
Diclorhidrato de N, N,N',N'-tetrametilditiobis(etilen)diamina |
405-300-9 |
Acute Tox. 4* Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H317 H410 |
|
|
|
|
|
016-060-00-6 |
Peroxodisulfato de diamonio; persulfato de amonio |
231-786-5 |
Ox. Sol. 3 Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Dgr |
H272 H302 H319 H335 H315 H334 H317 |
|
|
|
|
|
016-061-00-1 |
Peroxodisulfato de dipotasio; persulfato de potasio |
231-781-8 |
Ox. Sol. 3 Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Dgr |
H272 H302 H319 H335 H315 H334 H317 |
|
|
|
|
|
016-062-00-7 |
Bensultap (ISO); 1,3-bis(fenilsulfoniltio)-2-(N, N-dimetilamino)propano |
— |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
016-063-00-2 |
Metabisulfito de sodio |
231-673-0 |
Acute Tox. 4* Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
EUH031 |
|
|
|
|
016-064-00-8 |
Hidrogenosulfito de sodio al … %; bisulfito de sodio al … % |
231-548-0 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
EUH031 |
|
B |
|
|
016-065-00-3 |
1-Amino-4-[2-metil-5-(4-metilfenilsulfonilamino)fenilamino]antraquinona-2-sulfonato de sodio |
400-100-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
016-066-00-9 |
[5-((4-Amino-6-cloro-1,3,5-triazin-2-il)amino)-2-((2-hidroxi-3,5-disulfonatofenilazo)-2-sulfonatobencilidenohidrazino)benzoato] cobre(II) de tetrasodio |
404-070-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
016-067-00-4 |
Sulfonato de (4-metilfenil)mesitileno |
407-530-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
016-068-00-X |
3,5-Bis(tetradeciloxicarbonil)bencenosulfinato de sodio |
407-720-8 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
016-069-00-5 |
Ácido 3,5-bis(tetradeciloxicarbonil)bencenosulfínico |
407-990-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
016-070-00-0 |
4-Benciloxi-4'-(2,3-epoxi-2-metilprop-1-iloxi)difenilsulfona |
408-220-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
016-071-00-6 |
3-Amino-6,13-dicloro-10-((3-((4-cloro-6-(2- sulfofenilamino)-1,3,5-triazin-2-il)amino)propil)amino)-4,11- trifenoxidioxazinadisulfonato de trisodio |
410-130-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-072-00-1 |
3-Amino-4-hidroxi-N-(2-metoxietil)bencenosulfonamida |
411-520-6 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
|
016-073-00-7 |
Tetrakis(fenilmetil)tioperoxidi(carbotioamida) |
404-310-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
016-074-00-2 |
6-Fluoro-2-metil-3-(4-metiltiobencil)indeno |
405-410-7 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
016-075-00-8 |
2,2'-Dialil-4,4'-sulfonildifenol |
411-570-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
016-076-00-3 |
2,3-Bis((2-mercaptoetil)tio)-1-propanotiol |
411-290-7 |
Acute Tox. 4* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H410 |
|
|
|
|
|
016-077-00-9 |
2-Cloro-p-toluenosulfocloruro |
412-890-1 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H314 H317 H412 |
GHS05 GHS07 Dgr |
H314 H317 H412 |
|
|
|
|
|
016-078-00-4 |
4-Metil-N, N-bis(2-(((4-metilfenil)sulfonil)amino)etil)bencenosulfonamida |
413-300-5 |
Aquatic Chronic 4 |
H413 |
— |
|
|
|
|
|
|
016-079-00-X |
N, N-Bis(2-(p-toluenosulfoniloxi)etil)-p-toluenosulfonamida |
412-920-3 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
016-080-00-5 |
2-Anilino-5-(2-nitro-4-(N-fenilsulfamoil))anilinobencenosulfonato de sodio |
412-320-1 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
016-081-00-0 |
N-Etoxicarbonil-N-(p-tolilsulfonil)azanuro de hexahidrociclopenta[c]pirrol-1-(1H)-amonio |
418-350-1 |
— |
Muta. 2 Acute Tox. 4* Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H302 H319 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H302 H319 H317 H411 |
|
|
|
|
016-082-00-6 |
Etoxisulfurón (ISO); 1-(4,6-dimetoxipirimidin-2-il)-3-(2-etoxifenoxisulfonil)urea |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
016-083-00-1 |
Acibenzolar-S-metilo; éster S-metílico del ácido benzo[1,2,3]tiadiazol-7-carbotioico |
420-050-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H410 |
|
|
|
|
|
016-084-00-7 |
Prosulfurón (ISO); 1-(4-metoxi-6-metil-1,3,5-triazin-2-il)-3-[2-(3,3,3-trifluoropropil)fenilsulfonil]urea |
— |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=100 |
|
|
|
016-085-00-2 |
Flazasulfurón (ISO); 1-(4,6-dimetoxipirimidin-2-il)-3-(3-trifluorometil-2-piridilsulfonil)urea |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
016-086-00-8 |
10-Amino-6,13-dicloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ilamino)prop-3-ilamino)-5,12-dioxa-7,14-diaza-pentaceno-4,11-disulfonato de tetrasodio |
402-590-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
016-087-00-3 |
Masa de reacción de: bishexafluorofosfato de tiobis(4,1-fenilen)-S, S,S',S'-tetrafenildisulfonio; hexafluorofosfato de difenil(4-feniltiofenil)sulfonio; carbonato de propileno |
403-490-8 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H317 H410 |
|
|
|
|
|
016-088-00-9 |
Ácido 4-(bis(4-(dietilamino)fenil)metil)benceno-1,2-dimetanosulfónico |
407-280-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
016-089-00-4 |
Masa de reacción de ésteres de 5,5',6,6',7,7'-hexahidroxi-3,3,3',3'-tetrametil-1,1'-espirobiindano y 2-diazo-1,2-dihidro-1-oxo-5-sulfonaftaleno |
413-840-1 |
— |
Self-react. C**** Aquatic Chronic 4 |
H242 H413 |
GHS02 Dgr |
H242 H413 |
|
|
|
|
016-090-00-X |
4-Metil-N-(metilsulfonil)bencenosulfonamida |
415-040-8 |
Acute Tox. 4* STOT SE 3 Eye Dam. 1 |
H302 H335 H318 |
GHS05 GHS07 Dgr |
H302 H335 H318 |
|
|
|
|
|
016-091-00-5 |
1-Amino-9,10-dihidro-9,10-dioxo-4-(2,4,6-trimetilanilino)-antracen-2-sulfonato de C12-14-terc-alquilamonio |
414-110-5 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
016-092-00-0 |
Masa de reacción de: 4,7-bis(mercaptometil)-3,6,9-tritia-1,11-undecanoditiol; 4,8-bis(mercaptometil)-3,6,9- tritia-1,11-undecanoditiol, y 5,7-bis(mercaptometil)-3,6,9- tritia-1,11-undecanoditiol |
427-050-1 |
— |
Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f H315 H317 H410 |
|
|
|
|
016-093-00-6 |
Masa de reacción de: 4-(7-hidroxi-2,4,4-trimetil-2-cromanil)resorcinol-4-il-tris(6-diazo-5,6-dihidro-5-oxonaftaleno-1-sulfonato); 4-(7-hidroxi-2,4,4-trimetil-2-cromanil)resorcinolbis(6-diazo-5,6-dihidro-5-oxonaftaleno-1-sulfonato) (2:1) |
414-770-4 |
Self-react. C**** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
|
|
016-094-00-1 |
Azufre |
231-722-6 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
|
016-095-00-7 |
Masa de reacción de: producto de reacción de 4,4'-metilen-bis[2-(4-hidroxibencil)-3,6-dimetilfenol] y 6-diazo-5,6-dihidro-5-oxo-naftalenosulfonato (1:2); producto de reacción de 4,4'-metilen-bis[2-(4-hidroxibencil)-3,6-dimetilfenol] y 6-diazo-5,6-dihidro-5-oxo-naftalenosulfonato (1:3) |
417-980-4 |
— |
Self-react. C**** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
|
016-096-00-2 |
Tifensulfurón-metilo (ISO); 3-(4-metoxi-6-metil-1,3,5,-triazín-2-ilcarbamoilsulfamoil)tiofeno-2-carboxilato de metilo |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 M = 100 |
|
|
|
016-097-00-8 |
Clorhidrato de 1-amino-2-metil-2-propanotiol |
434-480-1 |
Acute Tox. 4* Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H302 H314 H317 H412 |
GHS05 GHS07 Dgr |
H302 H314 H317 H412 |
|
|
|
|
|
016-098-00-3 |
Disulfuro de dimetilo |
210-871-0 |
Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 STOT SE 3 STOT SE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H331 H301 H336 H370 (vías respiratorias superiores, por inhalación) H319 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H331 H301 H336 H370 (vías respiratorias superiores, por inhalación) H319 H317 H410 |
|
Por inhalación: ETA = 5 mg/l (vapores) Por vía oral: ETA = 190 mg/kg pc M = 1 M = 10 |
|
|
|
017-001-00-7 |
Cloro |
231-959-5 |
Ox. Gas 1 Press. Gas Acute Tox. 3* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H270 H331 H319 H335 H315 H400 |
GHS03 GHS04 GHS06 GHS09 Dgr |
H270 H331 H319 H335 H315 H400 |
|
M = 100 |
U |
|
|
017-002-00-2 |
Cloruro de hidrógeno |
231-595-7 |
Press. Gas Acute Tox. 3* Skin Corr. 1A |
H331 H314 |
GHS04 GHS06 GHS05 Dgr |
H331 H314 |
|
|
U5 |
|
|
017-002-01-X |
Acido clorhídrico al … % |
231-595-7 |
— |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % EyeIrrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % |
B |
|
017-003-00-8 |
Clorato de bario |
236-760-7 |
Ox. Sol. 1 Acute Tox. 4* Acute Tox. 4* Aquatic Chronic 2 |
H271 H332 H302 H411 |
GHS03 GHS07 GHS09 Dgr |
H271 H332 H302 H411 |
|
|
|
|
|
017-004-00-3 |
Clorato de potasio |
223-289-7 |
Ox. Sol. 1 Acute Tox. 3 |
H271 H301 |
GHS03 GHS06 Dgr |
H271 H301 |
|
Por vía oral: ETA = 100 mg/kg pc |
|
|
|
017-005-00-9 |
Clorato de sodio |
231-887-4 |
Ox. Sol. 1 Acute Tox. 3 |
H271 H301 |
GHS03 GHS06 Dgr |
H271 H301 |
|
Por vía oral: ETA = 100 mg/kg pc |
|
|
|
017-006-00-4 |
Ácido perclórico al … % |
231-512-4 |
Ox. Liq. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Dgr |
H271 H314 |
|
Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 % Skin Irrit. 2; H315: 1 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 10 % Ox. Liq. 1; H271: C > 50 %: Ox. Liq. 2; H272: C ≤ 50 %: |
B |
|
|
017-007-00-X |
Perclorato de bario |
236-710-4 |
Ox. Sol. 1 Acute Tox. 4* Acute Tox. 4* |
H271 H332 H302 |
GHS03 GHS07 Dgr |
H271 H332 H302 |
|
|
|
|
|
017-008-00-5 |
Perclorato de potasio |
231-912-9 |
Ox. Sol. 1 Acute Tox. 4* |
H271 H302 |
GHS03 GHS07 Dgr |
H271 H302 |
|
|
|
|
|
017-009-00-0 |
Perclorato de amonio |
232-235-1 |
Expl. 1.1 Ox. Sol. 1 |
H201 H271 |
GHS01 Dgr |
H201 H271 |
|
|
T |
|
|
017-010-00-6 |
Perclorato de sodio |
231-511-9 |
Ox. Sol. 1 Acute Tox. 4* |
H271 H302 |
GHS03 GHS07 Dgr |
H271 H302 |
|
|
|
|
|
017-011-00-1 |
Hipoclorito de sodio, solución … % Cl activo |
231-668-3 |
Skin Corr. 1B Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H318 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
EUH031 |
M = 10 M = 1 EUH031: C ≥ 5 % |
B |
|
|
017-012-00-7 |
Hipoclorito de calcio |
231-908-7 |
Ox. Sol. 2 Acute Tox. 4* Skin Corr. 1B Aquatic Acute 1 |
H272 H302 H314 H400 |
GHS03 GHS05 GHS07 GHS09 Dgr |
H272 H302 H314 H400 |
EUH031 |
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 3 % M = 10 |
T |
|
|
017-013-00-2 |
Cloruro de calcio |
233-140-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
017-014-00-8 |
Cloruro de amonio |
235-186-4 |
Acute Tox. 4* Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
017-015-00-3 |
Clorhidrato de (2-(aminometil)fenil)acetilcloruro |
417-410-4 |
Acute Tox. 4* Skin Corr. 1A Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
|
017-016-00-9 |
Cloruro de metiltrifenilfosfonio |
418-400-2 |
Acute Tox. 4* Acute Tox. 4* Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H312 H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H411 |
|
|
|
|
|
017-017-00-4 |
Cloruro de (Z)-13-docosenil-N,N-bis(2-hidroxietil)-N-metilamonio |
426-210-6 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
|
017-018-00-X |
Cloruro de N, N,N-trimetil-2,3-bis(estearoiloxi)propilamonio |
405-660-7 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
017-019-00-5 |
Clorhidrato de (R)-1,2,3,4-tetrahidro-6,7-dimetoxi-1-veratrilisoquinolina |
415-110-8 |
Acute Tox. 4* Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
017-020-00-0 |
Cloruro de etilpropoxialuminio |
421-790-7 |
Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
|
017-021-00-6 |
Cloruro de behenamidopropil-dimetil-(dihidroxipropil)amonio |
423-420-1 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
|
017-023-00-7 |
Tricloruros de [fosfinilidintris(oxi)]tris[3-aminopropil-2-hidroxi-N, N-dimetil-N-(C6-18-alquilo)] |
425-520-9 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
|
017-026-00-3 |
Dióxido de cloro |
233-162-8 |
Press. Gas Ox. Gas 1 Acute Tox. 2* Skin Corr. 1B Aquatic Acute 1 |
H270 H330 H314 H400 |
GHS04 GHS03 GHS06 GHS05 GHS09 Dgr |
H270 H330 H314 H400 |
|
M = 10 |
5 |
|
|
017-026-01-0 |
Dióxido de cloro al … % |
233-162-8 |
Acute Tox. 3* Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H314 H400 |
|
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,3 % ≤ C < 3 % STOT SE 3; H335: C ≥ 3 % M = 10 |
B |
|
|
019-001-00-2 |
Potasio |
231-119-8 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
|
019-002-00-8 |
Hidróxido de potasio; potasa cáustica |
215-181-3 |
Acute Tox. 4* Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % |
|
|
|
019-003-00-3 |
(E,E)-hexa-2,4-dienoato de potasio |
246-376-1 |
Eye Irrit. 2 |
H319 |
GSH07 Wng |
H319 |
|
|
|
|
|
020-001-00-X |
Calcio |
231-179-5 |
Water-react. 2 |
H261 |
GHS02 Dgr |
H261 |
|
|
|
|
|
020-002-00-5 |
Cianuro de calcio |
209-740-0 |
Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H410 |
EUH032 |
|
|
|
|
020-003-00-0 |
Masa de reacción de: (bis(2-hidroxi-5-tetrapropenilfenilmetil)metilamina)dihidróxido de dicalcio; (tris(2-hidroxi-5-tetrapropenilfenilmetil)metilamina)trihidróxido de tricalcio; poli[((2-hidroxi-5-tetrapropenilfenilmetil)metilamina)hidróxido de calcio] |
420-470-4 |
— |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
022-001-00-5 |
Tetracloruro de titanio |
231-441-9 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
EUH014 |
|
|
|
|
022-002-00-0 |
Oxalato de titanio(4+) |
403-260-7 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
022-003-00-6 |
Bis(η5-ciclopentadienil)-bis(2,6- difluoro-3-[pirrol-1-il]-fenil)titanio |
412-000-1 |
Flam. Sol. 1 Repr. 2 STOT RE 2* Aquatic Chronic 2 |
H228 H361f*** H373** H411 |
GHS02 GHS08 GHS09 Dgr |
H228 H361f*** H373** H411 |
|
|
T |
|
|
022-004-00-1 |
Óxido de potasio y titanio (K2Ti6O13) |
432-240-0 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
022-005-00-7 |
[N-(1,1-dimetiletil)-1,1-dimetil-1-[(1,2,3,4,5-η)-2,3,4,5-tetrametil-2,4-ciclopentadien-1-il]silanaminato(2-)-κN][1,2,3,4-η)-1,3-pentadieno]titanio |
419-840-8 |
Flam. Sol. 1**** Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H228 H314 H317 H413 |
GHS02 GHS05 GHS07 Dgr |
H228 H314 H317 H413 |
|
|
|
|
|
►C9 022-006-00-2 ◄ |
Dióxido de titanio; [en forma de polvo que contenga el 1 % o más de partículas con un diámetro aerodinámico ≤ 10 μm] |
236-675-5 |
Carc. 2 |
H351 (inhalación) |
GHS08 Wng |
H351 (inhalación) |
|
|
V, W, 10 |
|
|
023-001-00-8 |
Pentaóxido de divanadio; pentaóxido de vanadio |
215-239-8 |
Muta. 2 Carc. 1B Repr. 2 Lact. Acute Tox. 3 Acute Tox. 2 STOT SE 3 STOT RE 1 Aquatic Chronic 2 |
H341 H350 H361fd H362 H301 H330 H335 H372 (vías respiratorias, inhalación) H411 |
GHS06 GHS08 GHS09 Dgr |
H341 H350 H361fd H362 H301 H330 H335 H372 (vías respiratorias, inhalación) H411 |
|
Por inhalación: ETA = 0,05 mg/l (polvos o nieblas) Por vía oral: ETA = 220 mg/kg pc |
|
|
|
024-001-00-0 |
Trióxido de cromo(VI) |
215-607-8 |
Ox. Sol. 1 Carc. 1A Muta. 1B Repr. 2 Acute Tox. 2* Acute Tox. 3* Acute Tox. 3* STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H340 H361f*** H330 H311 H301 H372** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H271 H350 H340 H361f*** H330 H311 H301 H372** H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 1 % |
|
|
|
024-002-00-6 |
Dicromato de potasio |
231-906-6 |
Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Acute Tox. 4* Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H372** H312 H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
3 |
|
|
024-003-00-1 |
Dicromato de amonio |
232-143-1 |
Ox. Sol. 2**** Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Acute Tox. 4* Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H372** H312 H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 5 % Resp. Sens.; H334: C ≥0,2 % Skin Sens.; H317:C ≥0,2 % |
G3 |
|
|
024-004-00-7 |
Dicromato de sodio |
234-190-3 |
Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2* Acute Tox. 3* Acute Tox. 4* STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS05 GHS08 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H410 |
|
Resp. Sens. 1; H334: C ≥ 0,2 % Skin Sens. 1; H317:C ≥0,2 % STOT SE 3; H335: C ≥ 5 % |
3 |
|
|
▼M1 ————— |
||||||||||
|
024-005-00-2 |
Dicloruro de cromilo; oxicloruro crómico |
239-056-8 |
Ox. Liq. 1 Carc. 1B Muta. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350i H340 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Dgr |
H271 H350i H340 H314 H317 H410 |
|
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C < 10 % Skin Irrit. 2; H315: 0,5 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: 0,5 % ≤ C < 5 % Skin Sens. 1; H317: C ≥ 0,5 % |
T3 |
|
|
024-006-00-8 |
Cromato de potasio |
232-140-5 |
Carc. 1B Muta. 1B Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H340 H319 H335 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H340 H319 H335 H315 H317 H410 |
|
Skin Sens. 1; H317:C ≥ 0,5 % |
3 |
|
|
024-007-00-3 |
Cromatos de cinc, incluido el cromato de cinc y potasio |
— |
— |
Carc. 1A Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H410 |
|
|
A |
|
024-008-00-9 |
Cromato de calcio |
237-366-8 |
Carc. 1B Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
|
024-009-00-4 |
Cromato de estroncio |
232-142-6 |
Carc. 1B Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H400 H410 |
|
|
|
|
|
024-010-00-X |
Tris(cromato) de dicromo; cromato de cromo III; cromato crómico |
246-356-2 |
Ox. Sol. 1 Carc. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Dgr |
H271 H350 H314 H317 H410 |
|
|
T |
|
|
024-011-00-5 |
Bis(1-(3,5-dinitro-2-oxidofenilazo)-3-(N-fenilcarbamoil)-2-naftolato)cromato(1-) de amonio |
400-110-2 |
Self-react. C**** Aquatic Acute 1 Aquatic Chronic 1 |
H242 H400 H410 |
GHS02 GHS09 Dgr |
H242 H410 |
|
|
|
|
|
024-012-00-0 |
Bis(7-acetamido-2-(4-nitro-2-oxidofenilazo)-3-sulfonato-1-naftolato)cromato(1-) de trisodio |
400-810-8 |
— |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
|
024-013-00-6 |
(6-Anilino-2-(5-nitro-2-oxidofenilazo)-3-sulfonato-1-naftolato)(4-sulfonato-1,1'-azodi-2,2'-naftolato)cromato(1-) de trisodio |
402-500-8 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
024-014-00-1 |
Bis(2-(5-cloro-4-nitro-2-oxidofenilazo)-5-sulfonato-1-naftolato)cromato(1-) de trisodio |
402-870-0 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
024-015-00-7 |
(3-Metil-4-(5-nitro-2-oxidofenilazo)-1-fenilpirazololato)(1-(3-nitro-2-oxido-5-sulfonatofenilazo)-2-naftolato)cromato(1-) de disodio |
404-930-1 |
— |
Acute Tox. 4* Eye Dam. 1 Aquatic Chronic 2 |
H332 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H318 H411 |
|
|
|
|
024-016-00-2 |
Bis(1-(5-cloro-2-oxidofenilazo)-2-naftolato)cromato(1-) de tetradecilamonio |
405-110-6 |
STOT RE 2* Aquatic Chronic 4 |
H373** H413 |
GHS08 Wng |
H373** H413 |
|
|
|
|
|
024-017-00-8 |
Compuestos de cromo (VI), excepto el cromato de bario y los especificados en otras partes del presente anexo |
— |
— |
Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H317 H410 |
|
|
A |
|
024-018-00-3 |
Cromato de sodio |
231-889-5 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Acute Tox. 4* Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372** H312 H314 H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372** H312 H314 H334 H317 H410 |
|
Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317:C ≥ 0,2 % |
3 |
|
|
024-019-00-9 |
Componente principal: anilida del ácido acetoacético / 3-amino-1-hidroxibenceno (ATAN-MAP): {6-[(2 o 3 o 4)-amino-(4 o 5 o 6)-hidroxifenilazo]-5'-(fenilsulfamoil)-3-sulfonatonaftaleno-2-azobenceno-1,2'-diolato}-{6''-[1-(fenilcarbamoil)etilazo]-5'-(fenilsulfamoil)-3-sulfonatonaftaleno-2''-azobenceno-1'',2'''-diolato}cromato (III) de trisodio; subproducto 1: anilida del ácido acetoacético / anilida del ácido acetoacético (ATAN-ATAN): bis{6-[1-(fenilcarbamoil)etilazo]-5'''-(fenilsulfonil)-3''-sulfonatonaftaleno-2-azobenceno-1,2'-diolato}cromato (III) de trisodio; subproducto 2: 3-amino-1-hidroxibenceno/3-amino-1-hidroxibenceno (MAP-MAP): bis{6-[(2 o 3 o 4)-amino-(4 o 5 o 6)-hidroxifenilazo]-5'-(fenilsulfamoil)-3-sulfonatonaftaleno-2-azobenceno-1,2'-diolato}cromato (III) de trisodio |
419-230-1 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
024-020-00-4 |
Bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hidroxi-1-naftilazo)fenilsulfonilamino]pirimidin-5-azo)benceno-2',4-diolato)]cromato (III) de trisodio |
418-220-4 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
024-021-00-X |
Bis[(N, N'-n)-1'-(fenilcarbamoil)-3,5-disulfonatobencenoazo-1'-prop-1'-eno-2,2'-diolato]cromato (III) de potasio y tetrasodio |
425-830-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
025-001-00-3 |
Dióxido de manganeso |
215-202-6 |
Acute Tox. 4* Acute Tox. 4* |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
|
|
025-002-00-9 |
Permanganato de potasio |
231-760-3 |
Ox. Sol. 2 Repr. 2 Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H272 H361d H302 H400 H410 |
GHS03 GHS08 GHS07 GHS09 Dgr |
H272 H361d H302 H410 |
|
|
|
|
|
025-003-00-4 |
Sulfato de manganeso |
232-089-9 |
STOT RE 2* Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
|
|
025-004-00-X |
Di(hexafluorofosfato) de bis[(N, N',N"-trimetil-1,4,7-triazaciclononano)-trioxo-dimanganeso (IV) monohidratado |
411-760-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
025-005-00-5 |
Masa de reacción de: [29H,31H-ftalocianina-C, C,C-trisulfonato(6-)-N29,N30,N31,N32]manganato (3-) de trisodio; [29H,31H-ftalocianina-C, C,C, C-tetrasulfonato(6-)-N29,N30,N31,N32]manganato(3-) de tetrasodio; [29H,31H-ftalocianina-C, C,C, C-pentasulfonato(6-)-N29,N30,N31,N32]manganato(3-) de pentasodio |
417-660-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
026-001-00-6 |
Hexafluoroantimonato de (η-cumeno)-(η-ciclopentadienil)hierro (II) |
407-840-0 |
Acute Tox. 4* Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
026-002-00-1 |
Trifluorometanosulfonato de (η-cumeno)-(η-ciclopentadienil)hierro (II) |
407-880-9 |
Acute Tox. 4* Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
026-003-00-7 |
Sulfato de hierro (II) |
231-753-5 |
Acute Tox. 4* Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
|
026-003-01-4 |
Sulfato de hierro (II) (1:1) heptahidratado; ácido sulfúrico, sal de hierro (II), heptahidratado; sulfato ferroso heptahidratado |
231-753-5 |
Acute Tox. 4* Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
Skin Irrit.2; H315: C ≥ 25 % |
|
|
|
026-004-00-2 |
Ferrita de potasio |
430-010-4 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
|
027-001-00-9 |
Cobalto |
231-158-0 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 |
H350 H341 H360F H334 H317 H413 |
GHS08 Dgr |
H350 H341 H360F H334 H317 H413 |
|
|
|
|
|
027-002-00-4 |
Óxido de cobalto |
215-154-6 |
Acute Tox. 4* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=10 |
|
|
|
027-003-00-X |
Sulfuro de cobalto |
215-273-3 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M=10 |
|
|
|
027-004-00-5 |
Dicloruro de cobalto |
231-589-4 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4* Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360F*** H302 H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
|
027-005-00-0 |
Sulfato de cobalto |
233-334-2 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4* Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360F*** H302 H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
|
027-006-00-6 |
Di(acetato) de cobalto |
200-755-8 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 |
|
|
027-007-00-1 |
Complejo de hexacianocobaltato (III) de cinc, alcohol terc-butílico y polipropilenglicol |
425-240-7 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
027-008-00-7 |
Complejo de cobalto (III)-bis(N-fenil-4-(5-etilsulfonil-2-hidroxifenilazo)-3-hidroxinaftilamida), hidratado (n H2O, 2<n<3) |
427-390-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
027-009-00-2 |
Dinitrato de cobalto |
233-402-1 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 |
|
|
027-010-00-8 |
Carbonato de cobalto |
208-169-4 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
|
028-001-00-1 |
Tetracarbonilníquel; tetracarbonilo de níquel |
236-669-2 |
Flam. Liq. 2 Carc. 2 Repr. 1B Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H225 H351 H360D*** H330 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H351 H360D*** H330 H410 |
|
|
|
|
|
028-002-00-7 |
Níquel |
231-111-4 |
Carc. 2 STOT RE 1 Skin Sens. 1 |
H351 H372** H317 |
GHS08 GHS07 Dgr |
H351 H372** H317 |
|
|
S7 |
|
|
028-002-01-4 |
Níquel en polvo [diámetro de partícula < 1 mm] |
231-111-4 |
Carc. 2 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H351 H372** H317 H412 |
GHS08 GHS07 Dgr |
H351 H372** H317 H412 |
|
|
|
|
|
028-003-00-2 |
Monóxido de níquel; [1] óxido de níquel; [2] bunsenita [3] |
215-215-7[1] 234-323-5[2]-[3] |
1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
028-004-00-8 |
Dióxido de níquel |
234-823-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
|
028-005-00-3 |
Trióxido de diníquel |
215-217-8 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
|
028-006-00-9 |
Sulfuro de níquel (II); [1] sulfuro de níquel; [2] millerita [3] |
240-841-2[1] 234-349-7[2]-[3] |
16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] |
Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H372** H317 H410 |
|
|
|
|
028-007-00-4 |
Disulfuro de triníquel; subsulfuro de níquel; [1] heazlewoodita [2] |
234-829-6 [1] - [2] |
12035-72-2 [1] 12035-71-1 [2] |
Carc. 1A Muta. 2 Acute Tox. 3 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H331 H372** H317 H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H350i H341 H331 H372** H317 H410 |
|
Por inhalación: ETA = 0,92 mg/l (polvos o nieblas) |
|
|
028-008-00-X |
Dihidróxido de níquel; [1] hidróxido de níquel [2] |
235-008-5 [1] 234-348-1 [2] |
12054-48-7 [1] 11113-74-9 [2] |
Carc. 1A Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4* Acute Tox. 4* Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H410 |
|
|
|
|
028-009-00-5 |
Sulfato de níquel |
232-104-9 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4* Acute Tox. 4* Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
|
|
028-010-00-0 |
Carbonato de níquel; carbonato básico de níquel; ácido carbónico, sal de níquel(2+); [1] ácido carbónico, sal de níquel; [2] [μ-[carbonato(2-)-O:O']]dihidroxitriníquel; [3] [carbonato(2-)]tetrahidroxitriníquel [4] |
222-068-2 [1] 240-408-8 [2] 265-748-4 [3] 235-715-9 [4] |
3333-67-3 [1] 16337-84-1 [2] 65405-96-1 [3] 12607-70-4 [4] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4* Acute Tox. 4* Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
|
|
|
028-011-00-6 |
Dicloruro de níquel |
231-743-0 |
Carc. 1A Muta. 2 Repr. 1B Acute Tox. 3* Acute Tox. 3* STOT RE 1 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
|
|
028-012-00-1 |
Dinitrato de níquel; [1] ácido nítrico, sal de níquel [2] |
236-068-5 [1] 238-076-4 [2] |
13138-45-9 [1] 14216-75-2 [2] |
Ox. Sol. 2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4* Acute Tox. 4* Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H400 H410 |
GHS03 GHS05 GHS08 GHS07 GHS09 Dgr |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317 C ≥0,01 % M = 1 |
|
|
028-013-00-7 |
Matas de níquel |
273-749-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-014-00-2 |
Fangos y sedimentos, refinado electrolítico del cobre, descobreado, sulfato de níquel |
295-859-3 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4* Acute Tox. 4* Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
|
028-015-00-8 |
Fangos y sedimentos, refinado electrolítico del cobre, descobreado |
305-433-1 |
Carc. 1A Muta. 2 Repr. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
|
|
|
|
028-016-00-3 |
Diperclorato de níquel; ácido perclórico, sal de níquel (II) |
237-124-1 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
|
028-017-00-9 |
Bis(sulfato) de níquel y dipotasio; [1] bis(sulfato) de níquel y diamonio [2] |
237-563-9 [1] 239-793-2 [2] |
13842-46-1 [1] 15699-18-0 [2] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4* Acute Tox. 4* Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
028-018-00-4 |
Bis(sulfamidato) de níquel; sulfamato de níquel |
237-396-1 |
Carc. 1A Muta. 2 Repr. 1B Acute Tox. 4 STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H302 H372** H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H302 H372** H334 H317 H410 |
|
Por vía oral: ETA = 853 mg/kg pc (anhídrido) Por vía oral: ETA = 1098 mg/kg pc (tetrahidrato) STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
|
|
028-019-00-X |
Bis(tetrafluoroborato) de níquel |
238-753-4 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 |
|
|
|
028-021-00-0 |
Diformiato de níquel; [1] ácido fórmico, sal de níquel; [2] ácido fórmico, sal de cobre y níquel [3] |
222-101-0 [1] 239-946-6 [2] 268-755-0 [3] |
3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 |
|
|
028-022-00-6 |
Di(acetato) de níquel; [1] acetato de níquel [2] |
206-761-7 [1] 239-086-1 [2] |
373-02-4 [1] 14998-37-9 [2] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4* Acute Tox. 4* Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥ 0,01 % M = 1 |
|
|
028-024-00-7 |
Dibenzoato de níquel |
209-046-8 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥ 0,01 % M=1 |
|
|
|
028-025-00-2 |
Bis(4-ciclohexilbutirato) de níquel |
223-463-2 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 |
|
|
|
028-026-00-8 |
Estearato de níquel (II); octadecanoato de níquel (II) |
218-744-1 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C;≥0,01 % M=1 |
|
|
|
028-027-00-3 |
Dilactato de níquel |
— |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
|
028-028-00-9 |
Octanoato de níquel (II) |
225-656-7 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
|
028-029-00-4 |
Difluoruro de níquel; [1] dibromuro de níquel; [2] diyoduro de níquel; [3] fluoruro de níquel y potasio [4] |
233-071-3 [1] 236-665-0 [2] 236-666-6 [3] -[4] |
10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 |
|
|
028-030-00-X |
Hexafluorosilicato de níquel |
247-430-7 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
|
028-031-00-5 |
Seleniato de níquel |
239-125-2 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
|
028-032-00-0 |
Hidrogenofosfato de níquel; [1] bis(dihidrogenofosfato) de níquel; [2] bis(ortofosfato) de triníquel; [3] difosfato de diníquel; [4] bis(fosfinato) de níquel; [5] fosfinato de níquel; [6] ácido fosfórico, sal de calcio y níquel; [7] ácido difosfórico, sal de níquel (II) [8] |
238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] -[7] -[8] |
14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-033-00-6 |
Hexacianoferrato de diamonio y níquel |
— |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
|
028-034-00-1 |
Dicianuro de níquel |
209-160-8 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
EUH032 |
|
|
|
|
028-035-00-7 |
Cromato de níquel |
238-766-5 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
|
028-036-00-2 |
Silicato de níquel (II); [1] ortosilicato de diníquel; [2] silicato de níquel (4:3); [3] ácido silícico, sal de níquel; [4] hidroxibis[ortosilicato(4-)]triniquelato(3-) de trihidrógeno [5] |
244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] |
21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-037-00-8 |
Hexacianoferrato de diníquel |
238-946-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-038-00-3 |
Bis(arseniato) de triníquel; arseniato de níquel (II) |
236-771-7 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H372** H317 H410 |
|
|
|
|
|
028-039-00-9 |
Oxalato de níquel; [1] ácido oxálico, sal de níquel [2] |
208-933-7 [1] 243-867-2 [2] |
547-67-1 [1] 20543-06-0 [2] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-040-00-4 |
Telururo de níquel |
235-260-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-041-00-X |
Tetrasulfuro de triníquel |
— |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-042-00-5 |
Bis(arsenito) de triníquel |
— |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-043-00-0 |
Periclasa gris de cobalto y níquel; C.I. Pigment Black 25; C.I. 77332; [1] dióxido de cobalto y níquel; [2] óxido de cobalto y níquel [3] |
269-051-6 [1] 261-346-8 [2] -[3] |
68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-044-00-6 |
Trióxido de níquel y estaño; estannato de níquel |
234-824-9 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
|
028-045-00-1 |
Decaóxido de níquel y triuranio |
239-876-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
|
028-046-00-7 |
Ditiocianato de níquel |
237-205-1 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
EUH032 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
|
028-047-00-2 |
Dicromato de níquel |
239-646-5 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
|
028-048-00-8 |
Selenito de níquel (II) |
233-263-7 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
|
028-049-00-3 |
Seleniuro de níquel |
215-216-2 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-050-00-9 |
Ácido silícico, sal de plomo y níquel |
— |
Carc. 1A Repr. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360Df H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H360Df H372** H317 H410 |
|
|
|
|
|
028-051-00-4 |
Diarseniuro de níquel; [1] arseniuro de níquel [2] |
235-103-1 [1] 248-169-1 [2] |
12068-61-0 [1] 27016-75-7 [2] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-052-00-X |
Priderita de color amarillo pálido, de níquel, bario y titanio; C.I. Pigment Yellow 157; C.I. 77900 |
271-853-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
|
028-053-00-5 |
Diclorato de níquel; [1] dibromato de níquel; [2] hidrogenosulfato de etilo, sal de níquel (II) [3] |
267-897-0 [1] 238-596-1 [2] 275-897-7 [3] |
67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < % Skin Sens. 1; H317:C≥0,01 %1 M=1 |
|
|
028-054-00-0 |
Trifluoroacetato de níquel (II); [1] propionato de níquel (II); [2] bis(bencenosulfonato) de níquel; [3] hidrogenocitrato de níquel (II); [4] ácido cítrico, sal de amonio y níquel; [5] ácido cítrico, sal de níquel; [6] bis(2-etilhexanoato) de níquel; [7] ácido 2-etilhexanoico, sal de níquel; [8] ácido dimetilhexanoico, sal de níquel; [9] isooctanoato de níquel (II); [10] isooctanoato de níquel; [11] bis(isononanoato) de níquel; [12] neononanoato de níquel (II); [13] isodecanoato de níquel (II); [14] neodecanoato de níquel (II); [15] ácido neodecanoico, sal de níquel; [16] neoundecanoato de níquel (II); [17] bis(d-gluconato-O1,O2) de níquel; [18] 3,5-bis(terc-butil)-4-hidroxibenzoato de níquel (2:1); [19] palmitato de níquel (II); [20] (2-etilhexanoato-O)(isononanoato-O) níquel; [21] (isononanoato-O)(isooctanoato-O) níquel; [22] (isooctanoato-O)(neodecanoato-O) níquel; [23] (2-etilhexanoato-O)(isodecanoato-O) níquel; [24] 2-etilhexanoato-O)(neodecanoato-O) níquel; [25] (isodecanoato-O)(isooctanoato-O) níquel; [26] (isodecanoato-O)(isononanoato-O) níquel; [27] (isononanoato-O)(neodecanoato-O) níquel; [28] ácidos grasos, C6-19-ramificados, sales de níquel; [29] ácidos grasos, C8-18 y C18-insaturados, sales de níquel; [30] ácido 2,7-naftalenodisulfónico, sal de níquel (II); [31] |
240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 294-302-1 [29] 283-972-0 [30] -[31] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] |
16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
028-055-00-6 |
Sulfito de níquel (II); [1] trióxido de níquel y teluro; [2] tetraóxido de níquel y teluro; [3] hidróxido, óxido y fosfato de molibdeno y níquel [4] |
231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] |
7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-056-00-1 |
Boruro de níquel (NiB); [1] boruro de diníquel; [2] boruro de triníquel; [3] boruro de níquel; [4] siliciuro de diníquel; [5] disiliciuro de níquel; [6] fosfuro de diníquel; [7] fosfuro de níquel y boro [8] |
234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] -[8] |
12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-057-00-7 |
Tetraóxido de dialuminio y níquel; [1] trióxido de níquel y titanio; [2] óxido de níquel y titanio; [3] hexaóxido de níquel y divanadio; [4] octaóxido de cobalto, dimolibdeno y níquel; [5] trióxido de circonio y níquel; [6] tetraóxido de molibdeno y níquel; [7] tetraóxido de níquel y wolframio; [8] olivino, verde de níquel; [9] dióxido de litio y níquel; [10] óxido de molibdeno y níquel; [11] |
234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] -[10] -[11] |
12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-058-00-2 |
Óxido de cobalto, litio y níquel |
442-750-5 |
— |
Carc. 1A Acute Tox. 2* STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H330 H372** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350i H330 H372** H317 H410 |
|
|
|
|
029-001-00-4 |
Cloruro de cobre; cloruro de cobre (I); cloruro cuproso |
231-842-9 |
Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
|
029-002-00-X |
Óxido de dicobre; óxido de cobre (I) |
215-270-7 |
Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H318 H400 H410 |
GHS07 GHS05 GHS09 Dgr |
H332 H302 H318 H410 |
|
Por inhalación: ETA = 3,34 mg/l (polvos o nieblas) Por vía oral: ETA = 500 mg/kg pc M = 100 M = 10 |
|
|
|
029-003-00-5 |
Ácidos nafténicos, sales de cobre; naftenato de cobre |
215-657-0 |
Flam. Liq. 3 Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H400 H410 |
GHS02 GHS07 GHS09 Wng |
H226 H302 H410 |
|
|
|
|
|
029-004-00-0 |
Sulfato de cobre |
231-847-6 |
Acute Tox. 4* Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
|
029-005-00-6 |
(Tris(clorometil)ftalocianinato)cobre (II), productos de reacción con N-metilpiperazina y ácido metoxiacético |
401-260-1 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
029-006-00-1 |
(Trisulfonatoftalocianinato)cobre (II) de tris(octadec-9-enilamonio) |
403-210-4 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
029-007-00-7 |
Hidróxido de ((2-((3-(6-(2-cloro-5-sulfonato)anilino)-4-(3-carboxipiridinio)-1,3,5-triazin-2-ilamino)-2-oxido-5-sulfonatofenilazo)fenilmetilazo)-4-sulfonatobenzoato)cobre (3-) de trisodio) |
404-670-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
G |
|
|
029-008-00-2 |
Metanosulfonato de cobre (II) |
405-400-2 |
Acute Tox. 4* Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
|
|
029-009-00-8 |
Complejo de cobre con ftalocianina-N-[3-(dietilamino)propil]sulfonamida |
413-650-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
029-010-00-3 |
Masa de reacción de compuestos de (dodecakis(p-toliltio)ftalocianinato) de cobre (II) con (hexadecakis(p-toliltio)ftalocianinato) de cobre (II) |
407-700-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
029-011-00-9 |
Complejo de cobre con [29H,31H-ftalocianinato-(2-)-N29,N30,N31,N32]-((3-(N-metil-N-(2-hidroxietil)amino)propil)amino)sulfonilsulfonato de sodio |
412-730-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
029-012-00-4 |
((N-(3-Trimetilamoniopropil)sulfamoil)metilsulfonatoftalocianinato)cobre (II) de sodio |
407-340-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
029-013-00-X |
(2-(α-(3-(4-Cloro-6-(2-(2-(vinilsulfonil)etoxi)etilamino)-1,3,5-triazin-2-ilamino)-2-oxido-5-sulfonatofenilazo)bencilidenhidrazino)-4-sulfonatobenzoato)cobre (II) de trisodio |
407-580-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
029-014-00-5 |
Masa de reacción de: complejo de 2,2'-[[cis-1,2-ciclohexanodiilbis(nitrilometiliden)]bis[fenolato]](2-)N, N',O, O'-cobre; complejo de 2,2'-[[trans-1,2-ciclohexanodiilbis(nitrilometilidina)]bis[fenolato]](2-)N, N',O, O'-cobre |
419-610-7 |
STOT RE 2* Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
|
|
029-015-00-0 |
Tiocianato de cobre |
214-183-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
EUH032 |
M = 10 M = 10 |
|
|
|
029-016-00-6 |
Óxido de cobre (II) |
215-269-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 M = 10 |
|
|
|
029-017-00-1 |
Trihidroxicloruro de dicobre |
215-572-9 |
Acute Tox. 4 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H301 H400 H410 |
GHS06 GHS09 Dgr |
H332 H301 H410 |
|
Por inhalación: ETA = 2,83 mg/l (polvos o nieblas) Por vía oral: ETA = 299 mg/kg pc M = 10 M = 10 |
|
|
|
029-018-00-7 |
Hexahidroxisulfato de tetracobre; [1] hexahidroxisulfato de tetracobre hidratado [2] |
215-582-3 [1] 215-582-3 [2] |
1333-22-8 [1] 12527-76-3 [2] |
Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
Por vía oral: ETA = 500 mg/kg pc M = 10 M = 10 |
|
|
029-019-01-X |
Copos de cobre (recubiertos con ácido alifático) |
|
|
Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H319 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H319 H410 |
|
Por inhalación: ETA = 0,733 mg/l (polvos o nieblas) Por vía oral: ETA = 500 mg/kg pc M = 10 M = 1 |
|
|
029-020-00-8 |
Carbonato de cobre (II)--hidróxido de cobre (II) (1:1) |
235-113-6 |
Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H319 H410 |
|
Por inhalación: ETA = 1,2 mg/l (polvos o nieblas) Por vía oral: ETA = 500 mg/kg pc M = 10 M = 10 |
|
|
|
029-021-00-3 |
Dihidróxido de cobre; hidróxido de cobre (II) |
243-815-9 |
Acute Tox. 2 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H318 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H302 H318 H410 |
|
Por inhalación: ETA = 0,47 mg/l (polvos o nieblas) Por vía oral: ETA = 500 mg/kg pc M = 10 M = 10 |
|
|
|
029-022-00-9 |
Caldo bordelés; productos de la reacción de sulfato de cobre con dihidróxido de calcio |
- |
Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H318 H400 H410 |
GHS07 GHS05 GHS09 Dgr |
H332 H318 H410 |
|
Por inhalación: ETA = 1,97 mg/l (polvos o nieblas) M = 10 M = 1 |
|
|
|
029-023-00-4 |
Sulfato de cobre pentahidratado |
231-847-6 |
Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS07 GHS05 GHS09 Dgr |
H302 H318 H410 |
|
Por vía oral: ETA = 481 mg/kg pc M = 10 M = 1 |
|
|
|
▼M36 ————— |
||||||||||
|
029-025-00-5 |
Bis(N-hidroxi-N-nitrosociclohexilaminato-O,O’)cobre; bis(N-ciclohexil-diazenio-dioxi)-cobre; [Cu-HDO] |
239-703-4 |
Flam. Sol. 1 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H373 (hígado) H318 H400 H410 |
GHS02 GHS07 GHS08 GHS05 GHS09 Dgr |
H228 H302 H373 (hígado) H318 H410 |
|
Por vía oral: ETA = 360 mg/kg pc M = 1 M = 1 |
|
|
|
029-026-00-0 |
Cobre [superficie específica > 0,67 mm2/mg] |
231-159-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 10 M = 1 |
|
|
|
030-001-00-1 |
Cinc en polvo (pirofórico) |
231-175-3 |
Water-react. 1 Pyr. Sol. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H400 H410 |
GHS02 GHS09 Dgr |
H260 H250 H410 |
|
|
T |
|
|
030-001-01-9 |
Cinc en polvo (estabilizado) |
231-175-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
030-003-00-2 |
Cloruro de cinc |
231-592-0 |
Acute Tox. 4* Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
030-004-00-8 |
Dimetilcinc; [1] dietilcinc [2] |
208-884-1 [1] 209-161-3 [2] |
544-97-8 [1] 557-20-0 [2] |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H260 H314 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H250 H260 H314 H410 |
EUH014 |
|
|
|
030-005-00-3 |
Diamminodiisocianatocinc |
401-610-3 |
— |
Acute Tox. 4* Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 |
H302 H318 H334 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H318 H334 H317 H400 |
|
|
|
|
030-006-00-9 |
Sulfato de cinc (hidratado) (mono-, hexa- y heptahidratado); [1] sulfato de cinc (anhidro) [2] |
231-793-3 [1] 231-793-3 [2] |
7446-19-7 [1] 7733-02-0 [2] |
Acute Tox. 4* Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
|
030-007-00-4 |
Bis(3,5-di-terc-butilsalicilato-O1,O2) de cinc |
403-360-0 |
Flam. Sol. 1 Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H228 H302 H410 |
|
|
T |
|
|
030-008-00-X |
Hidroxo(2-(bencenesulfonamido)benzoato)cinc (II) |
403-750-0 |
Acute Tox. 4* Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
|
030-009-00-5 |
Bis(4-(n-octiloxicarbonilamino)salicilato) de cinc dihidratado |
417-130-2 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
030-010-00-0 |
Ácido 2-dodec-1-enilbutanodioico, éster 4-metílico, sal de cinc |
430-740-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
030-011-00-6 |
Bis(ortofosfato) de tricinc |
231-944-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
030-012-00-1 |
Carbonato, hidróxido de aluminio, magnesio ycinc |
423-570-6 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
|
030-013-00-7 |
Óxido de cinc |
215-222-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
030-015-00-8 |
Diacetato de tetracinc(2+) bis(hexacianocobalto(3+)) |
440-060-9 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
031-001-00-4 |
arseniuro de galio |
215-114-8 |
Repr. 1B Carc. 1B STOT RE 1 |
H360F H350 H372 (sistemas respiratorio y hematopoyético) |
GHS08 Dgr |
H360F H350 H372 (sistemas respiratorio y hematopoyético) |
|
|
|
|
|
033-001-00-X |
Arsénico |
231-148-6 |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
|
|
|
|
033-002-00-5 |
Compuestos de arsénico, excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
* |
A1 |
|
033-003-00-0 |
Trióxido de diarsénico; trióxido de arsénico |
215-481-4 |
Carc. 1A Acute Tox. 2* Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H300 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H300 H314 H410 |
|
|
|
|
|
033-004-00-6 |
Pentaóxido de diarsénico; pentaóxido de arsénico; óxido de arsénico |
215-116-9 |
Carc. 1A Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
|
|
|
033-005-00-1 |
Ácido arsénico y sus sales, excepto las especificadas en otras partes del presente anexo |
— |
— |
Carc. 1A Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
A |
|
033-006-00-7 |
Arsina |
232-066-3 |
Flam. Gas 1 Press. Gas Acute Tox. 2* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H220 H330 H373** H400 H410 |
GHS02 GHS04 GHS06 GHS08 GHS09 Dgr |
H220 H330 H373** H410 |
|
|
U |
|
|
033-007-00-2 |
terc-Butilarsina |
423-320-6 |
Pyr. Liq. 1 Acute Tox. 2* |
H250 H330 |
GHS02 GHS06 Dgr |
H250 H330 |
|
|
|
|
|
034-001-00-2 |
Selenio |
231-957-4 |
Acute Tox. 3* Acute Tox. 3* STOT RE 2* Aquatic Chronic 4 |
H331 H301 H373** H413 |
GHS06 GHS08 Dgr |
H331 H301 H373** H413 |
|
|
|
|
|
034-002-00-8 |
Compuestos de selenio, excepto el sulfoseleniuro de cadmio y los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 3* Acute Tox. 3* STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H373** H410 |
|
|
A |
|
034-003-00-3 |
Selenito de sodio |
233-267-9 |
Acute Tox. 2* Acute Tox. 3* Skin Sens. 1 Aquatic Chronic 2 |
H300 H331 H317 H411 |
GHS06 GHS09 Dgr |
H300 H331 H317 H411 |
EUH031 |
|
|
|
|
035-001-00-5 |
Bromo |
231-778-1 |
Acute Tox. 2* Skin Corr. 1A Aquatic Acute 1 |
H330 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H314 H400 |
|
|
|
|
|
035-002-00-0 |
Bromuro de hidrógeno |
233-113-0 |
Press. Gas Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS04 GHS05 GHS07 Dgr |
H314 H335 |
|
|
U |
|
|
035-002-01-8 |
Ácido bromhídrico al … % |
— |
— |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 % Eye Irrit. 2; H319: 10 % ≤ C < 40 % STOT SE 3; H335: C ≥ 10 % |
B |
|
035-003-00-6 |
Bromato de potasio |
231-829-8 |
Ox. Sol. 1 Carc. 1B Acute Tox. 3* |
H271 H350 H301 |
GHS03 GHS06 GHS08 Dgr |
H271 H350 H301 |
|
|
|
|
|
035-004-00-1 |
Perbromuro de 2-hidroxietilamonio |
407-440-6 |
— |
Ox. Sol. 2**** Acute Tox. 4* Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 |
H272 H302 H314 H317 H400 |
GHS03 GHS05 GHS07 GHS09 Dgr |
H272 H302 H314 H317 H400 |
|
|
|
|
035-005-00-7 |
Bromuro de amonio |
235-183-8 |
Repr. 1B Lact. STOT SE 3 STOT RE 1 Eye Irrit. 2 |
H360FD H362 H336 H372 (sistema nervioso) H319 |
GHS08 GHS07 Dgr |
H360FD H362 H336 H372 (sistema nervioso) H319 |
|
|
|
|
|
040-001-00-3 |
Circonio en polvo (pirofórico) |
231-176-9 |
Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Dgr |
H260 H250 |
|
|
T |
|
|
040-002-00-9 |
Circonio en polvo, seco (no pirofórico) |
— |
— |
Self-heat. 1 |
H251 |
GHS02 Dgr |
H251 |
|
|
T |
|
040-003-00-4 |
Producto de reacción de ácido 3,5-di-terc-butilsalicílico y oxicloruro de circonio, deshidratado, Zr básico: DTBS = 1,0:1,0 a 1,0:1,5 |
430-610-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
042-001-00-9 |
Trióxido de molibdeno |
215-204-7 |
Carc. 2 Eye Irrit. 2 STOT SE 3 |
H351 H319 H335 |
GHS08 GHS07 Wng |
H351 H319 H335 |
|
|
|
|
|
042-002-00-4 |
Hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolibdato(4-) de tetrakis(dimetilditetradecilamonio) |
404-760-8 |
Acute Tox. 3* Eye Dam. 1 |
H331 H318 |
GHS06 GHS05 Dgr |
H331 H318 |
|
|
|
|
|
042-003-00-X |
Hexa-μ -oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolibdato(4-) de tetrakis(trimetilhexadecilamonio) |
404-860-1 |
Flam. Sol. 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H228 H318 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H228 H318 H410 |
|
|
T |
|
|
042-004-00-5 |
Producto de reacción de molibdato de amonio y C12-C24-alquilamina dietoxilada (1:5-1:3) |
412-780-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
042-005-00-0 |
Masa de reacción de: mono- y di-gliceroles de aceite de canola; amida de ácidos de aceite de canola con 1,3-propanodiamina, N-[3-(trideciloxi)-propilo] ramificada; N, N-complejo de ditiocarbamato de molibdeno orgánico |
434-240-6 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
046-001-00-X |
Hidrogenocarbonato de tetraamminapaladio (II) |
425-270-0 |
Acute Tox. 4* STOT RE 2* Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H318 H317 H410 |
|
|
|
|
|
047-001-00-2 |
Nitrato de plata |
231-853-9 |
Ox. Sol. 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H272 H314 H400 H410 |
GHS03 GHS05 GHS09 Dgr |
H272 H314 H410 |
|
|
|
|
|
047-002-00-8 |
Ácido polifosfórico, sal de cobre, sodio, magnesio, calcio, plata y cinc |
416-850-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
047-003-00-3 |
Zeolita de plata y cinc (zeolita, tipo marco LTA, modificada en superficie con iones de plata y cinc) [esta entrada incluye a la zeolita de tipo de marco LTA (tipo A de Linde) que se ha modificado en superficie con iones tanto de plata como de cinc, con un contenido de Ag+ del 0,5 %-6 %, de Zn2+ del 5 %-16 %, y posiblemente con fósforo, NH4 +, Mg2+ o Ca2+, cada uno a un nivel < 3 %] |
— |
Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H361d H315 H318 H410 |
|
M = 100 M = 100 |
|
|
|
047-004-00-9 |
Plata masiva: [diámetro de partícula ≥ 1 mm] |
231-131-3 |
Repr. 2 STOT RE 2 |
H361f H373 (sistema nervioso) |
GHS08 Wng |
H361f H373 (sistema nervioso) |
|
|
|
|
|
047-005-00-4 |
Polvo de plata: [diámetro de partícula > 100 nm < 1 mm] |
231-131-3 |
Repr. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H373 (sistema nervioso) H400 H410 |
GHS08 GHS09 Wng |
H361f H373 (sistema nervioso) H410 |
|
M = 10 M = 10 |
|
|
|
047-006-00-X |
Nanopartículas de plata: [diámetro de partícula > 1 nm ≤ 100 nm] |
231-131-3 |
Repr. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H373 (sistema nervioso) H400 H410 |
GHS08 GHS09 Wng |
H361f H373 (sistema nervioso) H410 |
|
M = 1 000 M = 1 000 |
|
|
|
048-001-00-5 |
Compuestos de cadmio, excepto el sulfoseleniuro de cadmio (xCdS.yCdSe), la masa de reacción de sulfuro de cadmio con sulfuro de cinc (xCdS.yZnS), la masa de reacción de sulfuro de cadmio con sulfuro de mercurio(xCdS.yHgS), y los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
A1 |
|
048-002-00-0 |
Cadmio (no pirofórico); [1] óxido de cadmio (no pirofórico) [2] |
231-152-8 [1] 215-146-2 [2] |
7440-43-9 [1] 1306-19-0 [2] |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361fd H330 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361fd H330 H372** H410 |
|
|
|
|
048-003-00-6 |
Diformiato de cadmio; formiato de cadmio |
224-729-0 |
Acute Tox. 3* Acute Tox. 3* Carc. 2 STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373** H410 |
|
* STOT RE 2; H373: C ≥0,25 % |
|
|
|
048-004-00-1 |
Cianuro de cadmio |
208-829-1 |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Carc. 2 STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H351 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H351 H373** H410 |
EUH032 |
STOT RE 2; H373: C ≥0,1 % EUH032:C≥1 % |
|
|
|
048-005-00-7 |
Hexafluorosilicato(2-) de cadmio; fluorosílice de cadmio |
241-084-0 |
Acute Tox. 3* Acute Tox. 3* Carc. 2 STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373** H410 |
|
* STOT RE 2; H373: C ≥0,1 % |
|
|
|
048-006-00-2 |
Fluoruro de cadmio |
232-222-0 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2: 0,1 % ≤ C <7 % |
|
|
|
048-007-00-8 |
Yoduro de cadmio |
232-223-6 |
Acute Tox. 3* Acute Tox. 3* Carc. 2 STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373** H410 |
|
* STOT RE 2; H373: C ≥ 0,1 % |
|
|
|
048-008-00-3 |
Cloruro de cadmio |
233-296-7 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 % |
|
|
|
048-009-00-9 |
Sulfato de cadmio |
233-331-6 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2* Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373 0,1 % ≤ C < 7 % |
|
|
|
048-010-00-4 |
Sulfuro de cadmio |
215-147-8 |
Carc. 1B Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4* Aquatic Chronic 4 |
H350 H341 H361fd H372** H302 H413 |
GHS08 GHS07 Dgr |
H350 H341 H361fd H372** H302 H413 |
|
* STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1 % ≤ C < 10 % |
1 |
|
|
048-011-00-X |
Cadmio (pirofórico) |
231-152-8 |
Pyr. Sol. 1 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H250 H350 H341 H361fd H330 H372** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H250 H350 H341 H361fd H330 H372** H410 |
|
|
|
|
|
048-012-00-5 |
Carbonato de cadmio |
208-168-9 |
Carc. 1B Muta. 1B Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (riñones, huesos) H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H332 H312 H302 H372 (riñones, huesos) H410 |
|
|
A1 |
|
|
048-013-00-0 |
Hidróxido de cadmio; dihidróxido de cadmio |
244-168-5 |
Carc. 1B Muta. 1B Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (riñones, huesos) H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H332 H312 H302 H372 (riñones, huesos) H410 |
|
|
A1 |
|
|
048-014-00-6 |
Nitrato de cadmio; dinitrato de cadmio |
233-710-6 |
Carc. 1B Muta. 1B Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (riñones, huesos) H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H332 H312 H302 H372 (riñones, huesos) H410 |
|
Carc. 1B; H350: C ≥ 0,01 % |
A1 |
|
|
050-001-00-5 |
Tetracloruro de estaño; cloruro estánnico |
231-588-9 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
STOT SE 3; H335:C≥5 % |
|
|
|
050-002-00-0 |
Cihexatina (ISO); hidroxitriciclohexilestannano; hidróxido de tri(ciclohexil)estaño |
236-049-1 |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M=1000 |
|
|
|
050-003-00-6 |
Acetato de fentina (ISO); acetato de trifenilestaño |
212-984-0 |
Carc. 2 Repr. 2 Acute Tox. 2* Acute Tox. 3* Acute Tox. 3* STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
|
M=10 |
|
|
|
050-004-00-1 |
Hidróxido de fentina (ISO); hidróxido de trifenilestaño |
200-990-6 |
Carc. 2 Repr. 2 Acute Tox. 2* Acute Tox. 3* Acute Tox. 3* STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
|
M=10 |
|
|
|
050-005-00-7 |
Compuestos de trimetilestaño, excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
* |
A1 |
|
050-006-00-2 |
Compuestos de trietilestaño, excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
* |
A1 |
|
050-007-00-8 |
Compuestos de tripropilestaño, excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
* |
A1 |
|
050-008-00-3 |
compuestos de tributilestaño, excepto los especificados en otras partes del presente anexo |
— |
— |
Repr. 1B Acute Tox. 3 Acute Tox. 4 * STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H301 H312 H372 ** H315 H319 H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360FD H301 H312 H372 ** H315 H319 H410 |
|
* STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,25 % ≤ C < 1 % Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % M = 10 |
A 1 |
|
050-009-00-9 |
Fluorotripentilestannano; [1] hexapentildiestannoxano [2] |
243-546-7 [1] 247-143-7 [2] |
20153-49-5 [1] 25637-27-8 [2] |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
1 |
|
050-010-00-4 |
Fluorotrihexilestannano |
243-547-2 |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
1 |
|
|
050-011-00-X |
Compuestos de trifenilestaño, excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
* M=100 |
A1 |
|
050-012-00-5 |
Tetraciclohexilestannano; [1] clorotriciclohexilestannano; [2] butiltriciclohexilestannano [3] |
215-910-5 [1] 221-437-5 [2] 230-358-5 [3] |
1449-55-4 [1] 3091-32-5 [2] 7067-44-9 [3] |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
A1 |
|
050-013-00-0 |
Compuestos de trioctilestaño, excepto los especificados en otras partes del presente anexo |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 4 |
H319 H335 H315 H413 |
GHS07 Wng |
H319 H335 H315 H413 |
|
Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
A1 |
|
050-017-00-2 |
Óxido de fenbutatina (ISO); óxido de bis(tris(2-metil-2-fenilpropil)estaño) |
236-407-7 |
Acute Tox. 2* Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H319 H315 H400 H410 |
GHS06 GHS09 Dgr |
H330 H319 H315 H410 |
|
|
|
|
|
050-018-00-8 |
Metanosulfonato de estaño (II) |
401-640-7 |
Skin Corr. 1B Acute Tox. 4* Skin Sens. 1 Aquatic Chronic 2 |
H314 H302 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H317 H411 |
|
|
|
|
|
050-019-00-3 |
Azociclotina (ISO); 1-(triciclohexilestannil)-1H-1,2,4-triazol |
255-209-1 |
Acute Tox. 2* Acute Tox. 3* STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H301 H335 H315 H318 H410 |
|
|
|
|
|
050-020-00-9 |
Trioctilestannano |
413-320-4 |
STOT RE 1 Skin Irrit. 2 Aquatic Chronic 4 |
H372** H315 H413 |
GHS08 GHS07 Dgr |
H372** H315 H413 |
|
|
|
|
|
050-021-00-4 |
Diclorodioctilestannano |
222-583-2 |
Repr. 1B Acute Tox. 2 STOT RE 1 Aquatic Chronic 3 |
H360D H330 H372** H412 |
GHS08 GHS06 Dgr |
H360D H330 H372** H412 |
|
Repr. 1B; H360 D: C ≥ 0,03 % Por inhalación: ETA = 0,098 mg/l (polvos o nieblas) |
|
|
|
050-022-00-X |
Dicloruro de dibutilestaño; (DBTC) |
211-670-0 |
Muta. 2 Repr. 1B Acute Tox. 2* Acute Tox. 3* Acute Tox. 4* STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H360FD H330 H301 H312 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H341 H360FD H330 H301 H312 H372** H314 H410 |
|
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,01 % ≤ C < 3 % M=10 |
|
|
|
050-023-00-5 |
Masa de reacción de: bis[(2-etil-1-oxohexil)oxi]dioctilestannano; óxido de bis[((2-etil-1-oxohexil)oxi)dioctilestannilo]; bis(1-fenil-1,3-decanodionil)dioctilestannano; ((2-etil-1-oxohexil)oxi)-(1-fenil-1,3-decanodionil)dioctilestannano |
422-920-5 |
— |
STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
M=10 |
|
|
050-024-00-0 |
Masa de reacción de: hidróxido de tri-p-tolilestaño; hexa-p-tolil-diestannoxano |
432-230-6 |
— |
STOT RE 1 Acute Tox. 4* Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H372** H302 H315 H318 H317 H410 |
|
|
|
|
050-025-00-6 |
Triclorometilestannano |
213-608-8 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
|
050-026-00-1 |
10-Etil-4-[[2-[(2-etilhexil)oxi]-2-oxoetil]tio]-4-metil-7-oxo-8-oxa-3,5-ditia-4-estannatetradecanoato de 2-etilhexilo |
260-828-5 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
|
050-027-00-7 |
10-Etil-4,4-dioctil-7-oxo-8-oxa-3,5-ditia-4-estannatetradecanoato de 2-etilhexilo; [DOTE] |
239-622-4 |
Repr. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H372 (sistema inmunitario) H400 H410 |
GHS08 GHS09 Dgr |
H360D H372 (sistema inmunitario) H410 |
|
|
|
|
|
050-028-00-2 |
10-Etil-4,4-dimetil-7-oxo-8-oxa-3,5-ditia-4-estannatetradecanoato de 2-etilhexilo |
260-829-0 |
Repr. 2 Acute Tox. 4 STOT RE 1 Skin Sens. 1A |
H361d H302 H372 (sistema nervioso, sistema inmunitario) H317 |
GHS08 GHS07 Dgr |
H361d H302 H372 (sistema nervioso, sistema inmunitario) H317 |
|
|
|
|
|
050-029-00-8 |
Dicloruro de dimetilestaño |
212-039-2 |
Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B |
H361d H330 H301 H311 H372 (sistema nervioso, sistema inmunitario) H314 |
GHS08 GHS06 GHS05 Dgr |
H361d H330 H301 H311 H372 (sistema nervioso, sistema inmunitario) H314 |
EUH071 |
|
|
|
|
050-030-00-3 |
Dilaurato de dibutilestaño; dibutil-[bis(dodecanoiloxi)]-estannano |
201-039-8 |
Muta. 2 Repr. 1B STOT RE 1 |
H341 H360FD H372 (sistema inmunitario) |
GHS08 Dgr |
H341 H360FD H372 (sistema inmunitario) |
|
|
|
|
|
050-031-00-9 |
Dilaurato de dioctilestaño; [1] estannano, dioctil-, bis[(acilo de coco)oxi] derivados [2] |
222-883-3 [1] 293-901-5 [2] |
3648-18-8 [1] 91648-39-4 [2] |
Repr. 1B STOT RE 1 |
H360D H372 (sistema inmunitario) |
GHS08 Dgr |
H360D H372 (sistema inmunitario) |
|
|
|
|
050-032-00-4 |
Bis(2-etilhexanoato) de dibutilestaño |
220-481-2 |
Muta. 2 Repr. 1B STOT RE 1 |
H341 H360FD H372 (sistema inmunitario) |
GHS08 Dgr |
H341 H360FD H372 (sistema inmunitario) |
|
|
|
|
|
050-033-00-X |
Di(acetato) de dibutilestaño |
213-928-8 |
Muta 2 Repr. 1B STOT RE 1 |
H341 H360FD H372 (sistema inmunitario) |
GHS08 Dgr |
H341 H360FD H372 (sistema inmunitario) |
|
|
|
|
|
050-034-00-5 |
Maleato de dibutilestaño |
201-077-5 |
Muta. 2 Repr. 1B Acute Tox. 2 Acute Tox. 4 STOT RE 1 Skin Corr. 1 Eye Dam. 1 |
H341 H360FD H330 H302 H372 (sistema inmunitario) H314 H318 |
GHS08 GHS06 GHS05 Dgr |
H341 H360FD H330 H302 H372 (sistema inmunitario) H314 |
|
Por inhalación: ETA = 0,317 mg/l (polvos o nieblas) Por vía oral: ETA = 510 mg/kg pc |
|
|
|
050-035-00-0 |
Óxido de dibutilestaño |
212-449-1 |
Muta. 2 Repr. 1B Acute Tox. 3 STOT RE 1 Skin Irrit. 2 Eye Dam. 1 |
H341 H360FD H301 H372 (sistema inmunitario) H315 H318 |
GHS08 GHS06 GHS05 Dgr |
H341 H360FD H301 H372 (sistema inmunitario) H315 H318 |
|
Por vía oral: ETA = 170 mg/kg pc |
|
|
|
051-001-00-8 |
Tricloruro de antimonio |
233-047-2 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
STOT SE3; H335: C ≥ 5 % |
|
|
|
051-002-00-3 |
Pentacloruro de antimonio |
231-601-8 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
051-003-00-9 |
Compuestos de antimonio, excepto el tetraóxido (Sb2O4), el pentaóxido (Sb2O5), el trisulfuro (Sb2S3), el pentasulfuro (Sb2S5) y los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 4* Acute Tox. 4* Aquatic Chronic 2 |
H332 H302 H411 |
GHS07 GHS09 Wng |
H332 H302 H411 |
|
* |
A1 |
|
051-004-00-4 |
Trifluoruro de antimonio |
232-009-2 |
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Dgr |
H331 H311 H301 H411 |
|
|
|
|
|
051-005-00-X |
Trióxido de antimonio |
215-175-0 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
051-006-00-5 |
Hexafluoroantimoniato de difenil(4-feniltiofenil)sulfonio |
403-500-0 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
051-007-00-0 |
Hexafluoroantimoniato de bis(4-dodecilfenil)yodonio |
404-420-9 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
052-001-00-0 |
Telurio |
236-813-4 |
Repr. 1B Lact. |
H360Df H362 |
GHS08 Dgr |
H360Df H362 |
|
|
|
|
|
052-002-00-6 |
Dióxido de telurio |
231-193-1 |
Repr. 1B Lact. |
H360Df H362 |
GHS08 Dgr |
H360Df H362 |
|
|
|
|
|
053-001-00-3 |
Yodo |
231-442-4 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 |
H332 H312 H400 |
GHS07 GHS09 Wng |
H332 H312 H400 |
|
|
|
|
|
053-002-00-9 |
Yoduro de hidrógeno |
233-109-9 |
Press. Gas Skin Corr. 1A |
H314 |
GHS04 GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2 % ≤ C < 10 % Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 % Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 % STOT SE 3; H335: C ≥0,02 % |
U5 |
|
|
053-002-01-6 |
Ácido yodhídrico al … % |
— |
— |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
|
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
|
053-003-00-4 |
Yodoxibenceno |
— |
Expl.**** |
**** |
**** |
**** |
|
|
|
|
|
053-004-00-X |
Yodoxibenzoato de calcio |
— |
— |
Expl.**** |
**** |
**** |
**** |
|
|
C |
|
053-005-00-5 |
Tetrakis(pentafluorofenil)borato(1-) de (4-(1-metiletil)fenil)-(4-metilfenil)yodonio |
422-960-3 |
Acute Tox. 4* Acute Tox. 4* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H312 H302 H373** H410 |
|
|
|
|
|
056-001-00-1 |
Peróxido de bario |
215-128-4 |
Ox. Sol. 2 Acute Tox. 4* Acute Tox. 4* |
H272 H332 H302 |
GHS03 GHS07 Dgr |
H272 H332 H302 |
|
|
|
|
|
056-002-00-7 |
Sales de bario, excepto el sulfato de barrio, las sales del ácido 1-azo-2-hidroxinaftalenilarilsulfónico, y las sales especificadas en otras partes del presente anexo |
— |
— |
Acute Tox. 4* Acute Tox. 4* |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
A1 |
|
056-003-00-2 |
Carbonato de bario |
208-167-3 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
056-004-00-8 |
Cloruro de bario |
233-788-1 |
Acute Tox. 3* Acute Tox. 4* |
H301 H332 |
GHS06 Dgr |
H301 H332 |
|
|
|
|
|
056-005-00-3 |
Tetraóxido de bario y diboro |
237-222-4 |
Repr. 1B Acute Tox. 4 Acute Tox. 3 |
H360FD H332 H301 |
GHS08 GHS06 Dgr |
H360FD H332 H301 |
|
Por inhalación: ETA = 1,5 mg/l (polvos o nieblas) Por vía oral: ETA = 100 mg/kg pc |
|
|
|
064-001-00-8 |
Sulfito de gadolinio (III) trihidratado |
456-900-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
072-001-00-4 |
Tetra-n-butóxido de hafnio |
411-740-2 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
074-001-00-X |
Wolframato de hexasodio hidratado |
412-770-9 |
Acute Tox. 4* Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
074-002-00-5 |
Productos de reacción de hexacloruro de wolframio con 2-metilpropan-2-ol, nonilfenol y pentano-2,4-diona |
408-250-6 |
— |
Flam. Liq. 2 Acute Tox. 4* Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H332 H314 H317 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H314 H317 H410 |
|
|
|
|
076-001-00-5 |
Tetraóxido de osmio; ácido ósmico |
244-058-7 |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Skin Corr. 1B |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
|
|
|
|
078-001-00-0 |
Tetracloroplatinatos excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 3* Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
A |
|
078-002-00-6 |
Tetracloroplatinato de diamonio |
237-499-1 |
Acute Tox. 3* Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
|
078-003-00-1 |
Tetracloroplatinato de disodio |
233-051-4 |
Acute Tox. 3* Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
|
078-004-00-7 |
Tetracloroplatinato de dipotasio |
233-050-9 |
Acute Tox. 3* Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
|
078-005-00-2 |
Hexacloroplatinatos excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 3* Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
A |
|
078-006-00-8 |
Hexacloroplatinato de disodio |
240-983-5 |
Acute Tox. 3* Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
|
078-007-00-3 |
Hexacloroplatinato de dipotasio |
240-979-3 |
Acute Tox. 3* Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
|
078-008-00-9 |
Hexacloroplatinato de diamonio |
240-973-0 |
Acute Tox. 3* Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
|
078-009-00-4 |
Ácido hexacloroplatínico |
241-010-7 |
Acute Tox. 3* Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H301 H314 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H314 H334 H317 |
|
|
|
|
|
078-010-00-X |
Hidrogenocarbonato de tetraammina-platino (II) |
426-730-3 |
Acute Tox. 4* Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
078-011-00-5 |
Hidroxidisulfito de platino (II) ácido |
423-310-1 |
Acute Tox. 4* STOT RE 2* Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H373 H314 H334 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H302 H373 H314 H334 H317 H412 |
|
|
|
|
|
078-012-00-0 |
Nitrato de platino (IV) / solución de ácido nítrico |
432-400-1 |
— |
Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
080-001-00-0 |
Mercurio |
231-106-7 |
Repr. 1B Acute Tox. 2* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H330 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360D*** H330 H372** H410 |
|
|
|
|
|
080-002-00-6 |
Compuestos inorgánicos de mercurio excepto el sulfuro mercúrico y los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373** H410 |
|
* STOT RE 2; H373: C ≥ 0,1 % |
A1 |
|
080-003-00-1 |
Dicloruro de dimercurio; cloruro mercurioso; calomelano |
233-307-5 |
Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
|
|
|
080-004-00-7 |
Compuestos orgánicos de mercurio excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373** H410 |
|
* STOT RE 2; H373: C ≥0,1 % |
A1 |
|
080-005-00-2 |
Difulminato de mercurio; fulminato mercúrico; fulminato de mercurio |
211-057-8 |
Unst. Expl. Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H200 H331 H311 H301 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H200 H331 H311 H301 H373** H400 H410 |
|
|
|
|
|
080-005-01-X |
Difulminato de mercurio; fulminato mercúrico; fulminato de mercurio [≥ 20 % flegmatizante] |
211-057-8 |
Expl. 1.1 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373** H400 H410 |
|
|
|
|
|
080-006-00-8 |
Óxido de dicianuro de dimercurio; oxicianuro mercúrico |
215-629-8 |
Expl. 1.1 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373** H410 |
|
|
|
|
|
080-007-00-3 |
Dimetilmercurio; [1] dietilmercurio [2] |
209-805-3 [1] 211-000-7 [2] |
593-74-8 [1] 627-44-1 [2] |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373** H410 |
|
* STOT RE 2; H373: C ≥0,05 % |
1 |
|
080-008-00-9 |
Nitrato de fenilmercurio; [1] hidróxido de fenilmercurio; [2] nitrato básico de fenilmercurio [3] |
200-242-9 [1] 202-866-7 [2] -[3] |
55-68-5 [1] 100-57-2 [2] 8003-05-2 [3] |
Acute Tox. 3* STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372** H314 H410 |
|
|
|
|
080-009-00-4 |
Cloruro de 2-metoxietilmercurio |
204-659-7 |
Acute Tox. 3* STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372** H314 H410 |
|
|
|
|
|
080-010-00-X |
Dicloruro de mercurio; cloruro mercúrico |
231-299-8 |
Muta. 2 Repr. 2 Acute Tox. 2* STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H361f*** H300 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H341 H361f*** H300 H372** H314 H410 |
|
|
|
|
|
080-011-00-5 |
Acetato de fenilmercurio |
200-532-5 |
Acute Tox. 3* STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372** H314 H410 |
|
|
|
|
|
080-012-00-0 |
Cloruro de metilmercurio |
204-064-2 |
Carc. 2 Repr. 1A Lact. Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360Df H362 H330 H310 H300 H372 (sistema nervioso, riñones) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H351 H360Df H362 H330 H310 H300 H372 (sistema nervioso, riñones) H410 |
|
Por inhalación: ETA = 0,05 mg/l (polvos o nieblas) Por vía cutánea: ETA = 50 mg/kg pc Por vía oral: ETA = 5 mg/kg pc |
1 |
|
|
081-001-00-3 |
Talio |
231-138-1 |
Acute Tox. 2* Acute Tox. 2* STOT RE 2* Aquatic Chronic 4 |
H330 H300 H373** H413 |
GHS06 GHS08 Dgr |
H330 H300 H373** H413 |
|
|
|
|
|
081-002-00-9 |
Compuestos de talio, excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 2* Acute Tox. 2* STOT RE 2* Aquatic Chronic 2 |
H330 H300 H373** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H373** H411 |
|
|
A |
|
081-003-00-4 |
Sulfato de ditalio; sulfato tálico |
231-201-3 |
Acute Tox. 2* STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 |
H300 H372** H315 H411 |
GHS06 GHS08 GHS09 Dgr |
H300 H372** H315 H411 |
|
|
|
|
|
082-001-00-6 |
Compuestos de plomo, excepto los especificados en otras partes del presente anexo |
— |
— |
Repr. 1A Acute Tox. 4* Acute Tox. 4* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H332 H302 H373** H410 |
|
Repr.2 H361f: C ≥ 2,5 % * STOT RE 2; H373: C ≥0,5 % |
A1 |
|
082-002-00-1 |
Alquilos de plomo |
— |
— |
Repr. 1A Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H330 H310 H300 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360Df H330 H310 H300 H373** H410 |
|
Repr.1A; H360D: C≥ 0,1 % * STOT RE 2; H373: C ≥0,05 % |
A1 |
|
082-003-00-7 |
Diazida de plomo; azida de plomo |
236-542-1 |
Unst. Expl. Repr. 1A Acute Tox. 4* Acute Tox. 4* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H200 H360Df H332 H302 H373** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H200 H360Df H332 H302 H373** H410 |
|
|
1 |
|
|
082-003-01-4 |
Diazida de plomo; azida de plomo [≥ 20 % flegmatizante] |
236-542-1 |
Expl. 1.1 Repr. 1A Acute Tox. 4* Acute Tox. 4* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H201 H360Df H332 H302 H373** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H201 H360Df H332 H302 H373** H410 |
|
|
1 |
|
|
082-004-00-2 |
Cromato de plomo |
231-846-0 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
|
082-005-00-8 |
Di(acetato) de plomo |
206-104-4 |
Repr. 1A STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373** H410 |
|
|
1 |
|
|
082-006-00-3 |
Bis(ortofosfato) de triplomo |
231-205-5 |
Repr. 1A STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373** H410 |
|
|
1 |
|
|
082-007-00-9 |
Acetato de plomo, básico |
215-630-3 |
Carc. 2 Repr. 1A STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H351 H360Df H373** H410 |
|
|
1 |
|
|
082-008-00-4 |
Metanosulfonato de plomo (II) |
401-750-5 |
Repr. 1A Acute Tox. 4* Acute Tox. 4* STOT RE 2* Skin Irrit. 2 Eye Dam. 1 |
H360Df H332 H302 H373** H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H360Df H332 H302 H373** H315 H318 |
|
|
1 |
|
|
082-009-00-X |
Amarillo de sulfocromato de plomo; C.I. Pigment Yellow 34; [Esta sustancia está identificada en el Colour Index mediante el Colour Index Constitution Number, C.I. 77603.] |
215-693-7 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
|
082-010-00-5 |
Rojo de cromato, molibdato, sulfato de plomo; C.I. Pigment Red 104; [Esta sustancia está identificada en el Colour Index mediante el Colour Index Constitution Number, C.I. 77605.] |
235-759-9 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
|
082-011-00-0 |
Hidrogenoarseniato de plomo |
232-064-2 |
Carc. 1A Repr. 1A Acute Tox. 3* Acute Tox. 3* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H331 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H360Df H331 H301 H373** H410 |
|
|
1 |
|
|
082-012-00-6 |
Bromuro, cloruro, fluoruro, yoduro de bario, calcio, cesio, plomo, samario y estroncio, dopado con europio |
431-780-4 |
Acute Tox. 4* STOT RE 2* Aquatic Chronic 2 |
H302 H373** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H411 |
|
|
|
|
|
082-013-00-1 |
Polvo de plomo; [diámetro de partícula < 1 mm] |
231-100-4 |
Repr. 1A Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H362 H400 H410 |
GHS08 GHS09 Dgr |
H360FD H362 H410 |
|
Repr. 1A; H360D: C ≥ 0,03 % M = 10 M = 100 |
|
|
|
082-014-00-7 |
Plomo masivo: [diámetro de partícula ≥ 1 mm] |
231-100-4 |
Repr. 1A Lact. Aquatic Chronic 1 |
H360FD H362 H410 |
GHS08 GHS09 Dgr |
H360FD H362 H410 |
|
M = 10 |
|
|
|
092-001-00-8 |
Uranio |
231-170-6 |
Acute Tox. 2* Acute Tox. 2* STOT RE 2* Aquatic Chronic 4 |
H330 H300 H373** H413 |
GHS06 GHS08 Dgr |
H330 H300 H373** H413 |
|
|
|
|
|
092-002-00-3 |
Compuestos de uranio, excepto los especificados en otras partes del presente anexo |
— |
— |
Acute Tox. 2* Acute Tox. 2* STOT RE 2 Aquatic Chronic 2 |
H330 H300 H373** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H373** H411 |
|
|
A |
|
601-001-00-4 |
Metano |
200-812-7 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-002-00-X |
Etano |
200-814-8 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-003-00-5 |
Propano |
200-827-9 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-004-00-0 |
Butano; [1] e isobutano [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
C U |
|
601-004-01-8 |
Butano (con un contenido ≥ 0,1 % de butadieno (203-450-8)); [1] isobutano (con un contenido ≥ 0,1 % de butadieno (203-450-8)) [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
C S U |
|
601-005-00-6 |
2,2-Dimetilpropano; neopentano |
207-343-7 |
Flam. Gas 1 Press. Gas Aquatic Chronic 2 |
H220 H411 |
GHS02 GHS04 GHS09 Dgr |
H220 H411 |
|
|
U |
|
|
601-006-00-1 |
Pentano |
203-692-4 |
Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H336 H411 |
EUH066 |
|
C |
|
|
601-007-00-7 |
Hexano (con un contenido < 5 % de n-hexano (203-777-6)); 2-metilpentano; [1] 3-metilpentano; [2] 2,2-dimetilbutano; [3] 2,3-dimetilbutano [4] |
203-523-4 [1] 202-481-4 [2] 200-906-8 [3] 201-193-6 [4] |
107-83-5 [1] 96-14-0 [2] 75-83-2 [3] 79-29-8 [4] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
C |
|
601-008-00-2 |
Heptano; n-heptano; [1] 2,4-dimetilpentano; [2] 2,2,3-trimetilbutano; [3] 3,3-dimetilpentano; [4] 2,3-dimetilpentano; [5] 3-metilhexano; [6] 2,2-dimetilpentano; [7] 2-metilhexano; [8] 3-etilpentano; [9] isoheptano; [10] |
205-563-8 [1] 203-548-0 [2] 207-346-3 [3] 209-230-8 [4] 209-280-0 [5] 209-643-3 [6] 209-680-5 [7] 209-730-6 [8] 210-529-0 [9] 250-610-8 [10] |
142-82-5 [1] 108-08-7 [2] 464-06-2 [3] 562-49-2 [4] 565-59-3 [5] 589-34-4 [6] 590-35-2 [7] 591-76-4 [8] 617-78-7 [9] 31394-54-4 [10] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
C |
|
601-009-00-8 |
Octano; n-octano; [1] 2,2,4-trimetilpentano; [2] 2,3,3-trimetilpentano; [3] 3,3-dimetilhexano; [4] 2,2,3-trimetilpentano; [5] 2,3,4-trimetilpentano; [6] 3,4-dimetilhexano; [7] 2,3-dimetilhexano; [8] 2,4-dimetilhexano; [9] 4-metilheptano; [10] 3-metilheptano; [11] 2,2-dimetilhexano; [12] 2,5-dimetilhexano; [13] 2-metilheptano; [14] 2,2,3,3-tetrametilbutano; [15] 3-etil-2-metilpentano; [16] 3-etilhexano; [17] 3-etil-3-metilpentano; [18] isooctano; [19] |
203-892-1 [1] 208-759-1 [2] 209-207-2 [3] 209-243-9 [4] 209-266-4 [5] 209-292-6 [6] 209-504-7 [7] 209-547-1 [8] 209-649-6 [9] 209-650-1 [10] 209-660-6 [11] 209-689-4 [12] 209-745-8 [13] 209-747-9 [14] 209-855-6 [15] 210-187-2 [16] 210-621-0 [17] 213-923-0 [18] 247-861-0 [19] |
111-65-9 [1] 540-84-1 [2] 560-21-4 [3] 563-16-6 [4] 564-02-3 [5] 565-75-3 [6] 583-48-2 [7] 584-94-1 [8] 589-43-5 [9] 589-53-7 [10] 589-81-1 [11] 590-73-8 [12] 592-13-2 [13] 592-27-8 [14] 594-82-1 [15] 609-26-7 [16] 619-99-8 [17] 1067-08-9 [18] 26635-64-3 [19] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
C |
|
601-010-00-3 |
Etileno |
200-815-3 |
Flam. Gas 1 Press. Gas STOT SE 3 |
H220 H336 |
GHS02 GHS04 GHS07 Dgr |
H220 H336 |
|
|
U |
|
|
601-011-00-9 |
Propeno; propileno |
204-062-1 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-012-00-4 |
But-1-eno; [1] buteno, mezcla de isómeros 1- y 2-; [2] 2-metilpropeno; [3] (Z)-but-2-eno; [4] (E)-but-2-eno [5] |
203-449-2 [1] 203-452-9 [2] 204-066-3 [3] 209-673-7 [4] 210-855-3 [5] |
106-98-9 [1] 107-01-7 [2] 115-11-7 [3] 590-18-1 [4] 624-64-6 [5] |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
C U |
|
601-013-00-X |
1,3-Butadieno; buta-1,3-dieno |
203-450-8 |
Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
D U |
|
|
601-014-00-5 |
Isopreno (estabilizado) 2-metil-1,3-butadieno |
201-143-3 |
Flam. Liq. 1 Carc. 1B Muta. 2 Aquatic Chronic 3 |
H224 H350 H341 H412 |
GHS02 GHS08 Dgr |
H224 H350 H341 H412 |
|
|
D |
|
|
601-015-00-0 |
acetylene; ethyne |
200-816-9 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
►M4 — ◄ |
|
U |
|
|
601-016-00-6 |
Ciclopropano |
200-847-8 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-017-00-1 |
Ciclohexano |
203-806-2 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
|
|
|
601-018-00-7 |
Metilciclohexano |
203-624-3 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
|
|
|
601-019-00-2 |
1,4-Dimetilciclohexano |
209-663-2 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
|
|
|
601-020-00-8 |
Benceno |
200-753-7 |
Flam. Liq. 2 Carc. 1a Muta. 1B STOT RE 1 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H350 H340 H372** H304 H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H340 H372** H304 H319 H315 |
|
|
E |
|
|
601-021-00-3 |
Tolueno |
203-625-9 |
Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2* Skin Irrit. 2 STOT SE 3 |
H225 H361d*** H304 H373** H315 H336 |
GHS02 GHS08 GHS07 Dgr |
H225 H361d*** H304 H373** H315 H336 |
|
|
|
|
|
601-022-00-9 |
o-Xileno; [1] p-xileno; [2] m-xileno; [3] xileno [4] |
202-422-2 [1] 203-396-5 [2] 203-576-3 [3] 215-535-7 [4] |
95-47-6 [1] 106-42-3 [2] 108-38-3 [3] 1330-20-7 [4] |
Flam. Liq. 3 Acute Tox. 4* Acute Tox. 4* Skin Irrit. 2 |
H226 H332 H312 H315 |
GHS02 GHS07 Wng |
H226 H332 H312 H315 |
|
* |
C |
|
601-023-00-4 |
Etilbenceno |
202-849-4 |
Flam. Liq. 2 Acute Tox. 4* STOT RE 2 Asp. Tox. 1 |
H225 H332 H373 (órganos del oído) H304 |
GHS02 GHS07 GHS08 Dgr |
H225 H332 H373 (órganos del oído) H304 |
|
|
|
|
|
601-024-00-X |
Cumeno |
202-704-5 |
Flam. Liq. 3 Carc. 1B Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H226 H350 H304 H335 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H350 H304 H335 H411 |
|
|
|
|
|
601-025-00-5 |
Mesitileno; 1,3,5-trimetilbenceno |
203-604-4 |
Flam. Liq. 3 STOT SE 3 Aquatic Chronic 2 |
H226 H335 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H335 H411 |
|
STOT SE 3; H335: C ≥ 25 % |
|
|
|
601-026-00-0 |
Estireno |
202-851-5 |
Flam. Liq. 3 Repr. 2 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 |
H226 H361d H332 H372 (órganos del oído) H315 H319 |
GHS02 GHS08 GHS07 Dgr |
H226 H361d H332 H372 (órganos del oído) H315 H319 |
|
* |
D |
|
|
601-027-00-6 |
2-Fenilpropeno; α-metilestireno |
202-705-0 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H226 H319 H335 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H319 H335 H411 |
|
STOT SE 3; H335: C ≥ 25 % |
|
|
|
601-028-00-1 |
2-Metilestireno; 2-viniltolueno |
210-256-7 |
Acute Tox. 4* Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
|
601-029-00-7 |
Dipenteno; limoneno [1] S)-p-menta-1,8-dieno; l-limoneno [2] trans-1-metil-4-(1-metilvinil)ciclohexeno; [3] (±)-1-metil-4-(1-metilvinil)ciclohexeno [4] |
205-341-0 [1] 227-815-6 [2] 229-977-3 [3] 231-732-0 [4] |
138-86-3 [1] 5989-54-8 [2] 6876-12-6 [3] 7705-14-8 [4] |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H315 H317 H400 H410 |
GHS02 GHS07 GHS09 Wng |
H226 H315 H317 H410 |
|
|
C |
|
601-030-00-2 |
Ciclopentano |
206-016-6 |
Flam. Liq. 2 Aquatic Chronic 3 |
H225 H412 |
GHS02 Dgr |
H225 H412 |
|
|
|
|
|
601-031-00-8 |
2,4,4-Trimetilpent-1-eno |
203-486-4 |
Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Dgr |
H225 H411 |
|
|
|
|
|
601-032-00-3 |
Benzo[a]pireno; benzo[def]criseno |
200-028-5 |
Carc. 1B Muta. 1B Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H360FD H317 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
|
601-033-00-9 |
Benz[a]antraceno |
200-280-6 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
M=100 |
|
|
|
601-034-00-4 |
Benz[e]acefenantrileno |
205-911-9 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
601-035-00-X |
Benzo[j]fluoranteno |
205-910-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
601-036-00-5 |
Benzo[k]fluoranteno |
205-916-6 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
601-037-00-0 |
n-Hexano |
203-777-6 |
Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT SE 3 STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 |
H225 H361f*** H304 H336 H372 (nervous system) H315 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H361f*** H304 H336 H372 (sistema nervioso) H315 H411 |
|
|
|
|
|
601-041-00-2 |
Dibenz[a,h]antraceno |
200-181-8 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % M=100 |
|
|
|
601-042-00-8 |
Bifenilo; difenilo |
202-163-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
|
|
|
|
601-043-00-3 |
1,2,4-Trimetilbenceno |
202-436-9 |
Flam. Liq. 3 Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H332 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H319 H335 H315 H411 |
|
|
|
|
|
601-044-00-9 |
3a,4,7,7a-Tetrahidro-4,7-metanoindeno |
201-052-9 |
Flam. Liq. 2 Acute Tox. 4* Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H225 H332 H302 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H302 H319 H335 H315 H411 |
|
|
|
|
|
601-045-00-4 |
1,2,3,4-Tetrahidronaftaleno |
204-340-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
EUH019 |
|
|
|
|
601-046-00-X |
7-Metilocta-1,6-dieno |
404-210-7 |
Flam. Liq. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H400 H410 |
GHS02 GHS09 Wng |
H226 H410 |
|
|
|
|
|
601-047-00-5 |
m-Menta-1,3(8)-dieno |
404-150-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
601-048-00-0 |
Criseno |
205-923-4 |
Carc. 1B Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H400 H410 |
GHS08 GHS09 Dgr |
H350 H341 H410 |
|
|
|
|
|
601-049-00-6 |
Benzo[e]pireno |
205-892-7 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
601-051-00-7 |
4-Fenilbut-1-eno |
405-980-7 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
601-052-00-2 |
Naftaleno |
202-049-5 |
Carc. 2 Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS07 GHS08 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
|
601-053-00-8 |
Nonilfenol; [1] 4-nonilfenol, ramificado [2] |
246-672-0 [1] 284-325-5 [2] |
25154-52-3 [1] 84852-15-3 [2] |
Repr. 2 Acute Tox. 4* Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361fd H302 H314 H410 |
|
|
|
|
601-054-00-3 |
Masa de reacción de isómeros de: dibencilbenceno; dibencil(metil)benceno; dibencil(dimetil)benceno; dibencil(trimetil)benceno |
405-570-8 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
601-055-00-9 |
Masa de reacción de isómeros de: mono-(2-tetradecil)naftalenos; di-(2-tetradecil)naftalenos; tri-(2-tetradecil)naftalenos |
410-190-0 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
|
|
601-056-00-4 |
Masa de reacción de isómeros de: metildifenilmetano; dimetildifenilmetano |
405-470-4 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
601-057-00-X |
Tosilato de N-dodecil-[3-(4-(dimetilamino)benzamido)propil]dimetilamonio |
421-130-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
|
601-058-00-5 |
Di-L-para-menteno |
417-870-6 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
|
601-059-00-0 |
2-Benciliden-3-oxobutirato de metilo |
420-940-9 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
|
601-060-00-6 |
1,2-Bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaftalen-3-ilazo)-1-hidroxi-3,6-disulfo-8-aminonaftalen-7-ilazo)fenilamino}-1,3,5-triazin-2-ilamino]etano; sales de x-sodio, y-potasio x = 7,755 y =0,245 |
417-610-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
601-061-00-1 |
(Etil-1,2-etanodiil)[-2-[[[(2-hidroxietil)metilamino]acetil]-propil]ω-(nonilfenoxi)poli]oxi-(metil-1,2-etanodiilo) |
418-960-8 |
— |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
601-062-00-7 |
Masa de reacción de: triacontano ramificado; dotriacontano ramificado; tetratriacontano ramificado; hexatriacontano ramificado |
417-030-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
601-063-00-2 |
Masa de reacción de isómeros de tetracosano ramificado |
417-060-2 |
Acute Tox. 4* Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
|
▼M23 ————— |
||||||||||
|
601-065-00-3 |
Masa de reacción de: (1'α, 3'α, 6'α)-2,2,3' ,7', 7'-pentametilespiro(1,3-dioxano-5,2'-norcarano); (1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentametilespiro(1,3-dioxano-5,2'-norcarano) |
416-930-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
601-066-00-9 |
1-(4-(trans-4-Heptilciclohexil)fenil)etanona |
426-820-2 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
601-067-00-4 |
Arseniato de trietilo |
427-700-2 |
Carc. 1A Acute Tox. 3* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
|
|
|
601-068-00-X |
1,2-Diacetoxibut-3-eno |
421-720-5 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
601-069-00-5 |
Bromuro de 2-etil-1-(2-(1,3-dioxanil)etil)piridinio |
422-680-1 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
601-070-00-0 |
Masa de reacción de: icosano ramificado; docosano ramificado; tetracosano ramificado |
417-050-8 |
Acute Tox. 4* Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
|
601-071-00-6 |
1-Dimetoximetil-2-nitrobenceno |
423-830-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
601-072-00-1 |
Masa de reacción de: 1-(4-isopropilfenil)-1-feniletano; 1-(3- isopropilfenil)-1-feniletano; 1-(2- isopropilfenil)-1-feniletano |
430-690-2 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
601-073-00-7 |
1-Bromo-3,5-difluorobenceno |
416-710-2 |
Flam. Liq. 3 Acute Tox. 4* STOT RE 2* Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373** H315 H317 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Wng |
H226 H302 H373** H315 H317 H410 |
|
|
|
|
|
601-074-00-2 |
Masa de reacción de: 4-(2,2,3-trimetilciclopent-3-en-1-il)-1-metil-2-oxabiciclo[2.2.2]octano; 1-(2,2,3-trimetilciclopent-3-en-1-il)-5-metil-6-oxabiciclo[3.2.1]octano; espiro[ciclohex-3-en-1-il-[(4,5,6,6a-tetrahidro-3,6',6',6'a-tetrametil)-1,3'(3'aH)-[2H]ciclopenta[b]furano]; espiro[ciclohex-3-en-1-il-[4,5,6,6a-tetrahidro-4,6',6',6'a-tetrametil)-1,3'(3'aH)-[2H]ciclopenta[b]]furano] |
422-040-1 |
— |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
601-075-00-8 |
4,4'-bis(N-Carbamoil-4-metilbencenosulfonamida)difenilmetano |
418-770-5 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
601-076-00-3 |
Etinilciclopropano |
425-430-1 |
Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H315 H318 H412 |
GHS02 GHS05 Dgr |
H225 H315 H318 H412 |
|
|
|
|
|
601-077-00-9 |
Masa de reacción de: 1-heptil-4-etil-2,6,7-trioxabiciclo[2.2.2]octano; 1-nonil-4-etil-2,6,7-trioxabiciclo[2.2.2]octano |
426-510-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
601-078-00-4 |
Masa de reacción de: 1,7-dimetil-2-[(3-metilbiciclo[2.2.1]hept-2-il)metil]biciclo[2.2.1]heptano; 2,3-dimetil-2-[(3-metilbiciclo[2.2.1]hept-2-il)metil]biciclo[2.2.1]heptano |
427-040-5 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
601-079-00-X |
Masa de reacción de: trans-trans-ciclohexadeca-1,9-dieno; cis-trans-ciclohexadeca-1,9-dieno |
429-620-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
601-080-00-5 |
Masa de reacción de: mezcla de isómeros de sec-butilfenil(fenil)metano; mezcla de isómeros de 1-sec-butilfenil(fenil)-2-feniletano; mezcla de isómeros de 1-sec-butilfenil-1-feniletano |
431-100-6 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
601-081-00-0 |
Ciclohexadeca-1,9-dieno |
431-730-1 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
|
601-082-00-6 |
Masa de reacción de: endo-2-metil-exo-3-metil-exo-2-[(exo-3-metilbiciclo[2.2.1]hept-exo-2-il)metil]biciclo[2.2.1]heptano; exo-2-metil-exo-3-metil-endo-2-[(endo-3-metilbiciclo[2.2.1]hept-exo-2-il)metil]biciclo[2.2.1]heptano |
434-420-4 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
601-083-00-1 |
5-endo-Hexil-biciclo[2.2.1]hept-2-eno |
435-000-3 |
Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 4 |
H304 H315 H413 |
GHS08 GHS07 Dgr |
H304 H315 H413 |
|
|
|
|
|
601-084-00-7 |
Masa de reacción de: 5-endo-butil-biciclo[2.2.1]hept-2-eno; 5-exo-butil-biciclo[2.2.1]hept-2-eno (80:20) |
435-180-3 |
— |
Asp. Tox. 1 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H304 H315 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H304 H315 H410 |
|
|
|
|
601-085-00-2 |
Isopentano; 2-metilbutano |
201-142-8 |
Flam. Liq. 1 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H224 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H224 H304 H336 H411 |
EUH066 |
|
|
|
|
601-087-00-3 |
2,4,4-Trimetilpenteno |
246-690-9 |
Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 |
H225 H304 H336 |
GHS02 GHS07 GHS08 Dgr |
H225 H304 H336 |
|
|
D |
|
|
601-088-00-9 |
4-Vinilciclohexeno |
202-848-9 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
601-089-00-4 |
Muscalura; cis-tricos-9-eno |
248-505-7 |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
601-090-00-X |
Benzo[rst]pentafeno |
205-877-5 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
|
|
|
|
601-091-00-5 |
Dibenzo[b,def]criseno; dibenzo(a,h)pireno |
205-878-0 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
|
|
|
|
601-092-00-0 |
Dibenzo[def,p]criseno; dibenzo[a,l]pireno |
205-886-4 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
Carc. 1B; H350: C ≥ 0,001 % |
|
|
|
601-093-00-6 |
1,4-Dimetilnaftaleno |
209-335-9 |
Acute Tox. 4 Asp. Tox. 1 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 3 |
H302 H304 H319 H400 H412 |
GHS07 GHS08 GHS09 Dgr |
H302 H304 H319 H410 |
|
Por vía oral: ETA = 1 300 mg/kg pc M = 1 |
|
|
|
601-094-00-1 |
1-Isopropil-4-metilbenceno; p-cimeno |
202-796-7 |
Flam. Liq. 3 Acute Tox. 3 Asp. Tox. 1 Aquatic Chronic 2 |
H226 H331 H304 H411 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H331 H304 H411 |
|
Por inhalación: ETA = 3 mg/l (vapores) |
|
|
|
601-095-00-7 |
p-Menta-1,3-dieno; 1-isopropil-4-metilciclohexa-1,3-dieno; alfa-terpineno |
202-795-1 |
Flam. Liq. 3 Acute Tox. 4 Skin Sens. 1 Asp. Tox. 1 Aquatic Chronic 2 |
H226 H302 H317 H304 H411 |
GHS02 GHS07 GHS08 GHS09 Dgr |
H226 H302 H317 H304 H411 |
|
Por vía oral: ETA = 1 680 mg/kg pc |
|
|
|
601-096-00-2 |
(R)-p-Menta-1,8-dieno; d-limoneno |
227-813-5 |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1B Asp. Tox. 1 Aquatic Acute 1 Aquatic Chronic 3 |
H226 H315 H317 H304 H400 H412 |
GHS02 GHS07 GHS08 GHS09 Dgr |
H226 H315 H317 H304 H410 |
|
M = 1 |
|
|
|
601-097-00-8 |
Propilbenceno |
203-132-9 |
Flam. Liq. 3 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H226 H304 H335 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H304 H335 H411 |
|
|
|
|
|
602-001-00-7 |
Clorometano; cloruro de metilo |
200-817-4 |
Flam. Gas 1 Press. Gas Carc. 2 STOT RE 2* |
H220 H351 H373** |
GHS02 GHS04 GHS08 Dgr |
H220 H351 H373** |
|
|
U |
|
|
602-002-00-2 |
Bromometano; bromuro de metilo |
200-813-2 |
Press. Gas Muta. 2 Acute Tox. 3* Acute Tox. 3* STOT RE 2* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Ozone 1 |
H341 H331 H301 H373** H319 H335 H315 H400 H420 |
GHS04 GHS06 GHS08 GHS09 Dgr |
H341 H331 H301 H373** H319 H335 H315 H400 H420 |
|
|
U |
|
|
602-003-00-8 |
Dibromometano |
200-824-2 |
Acute Tox. 4* Aquatic Chronic 3 |
H332 H412 |
GHS07 Wng |
H332 H412 |
|
* |
|
|
|
602-004-00-3 |
Diclorometano; cloruro de metileno |
200-838-9 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
602-005-00-9 |
Yoduro de metilo; yodometano |
200-819-5 |
Carc. 2 Acute Tox. 4* Acute Tox. 3* Acute Tox. 3* STOT SE 3 Skin Irrit. 2 |
H351 H312 H331 H301 H335 H315 |
GHS06 GHS08 Dgr |
H351 H312 H331 H301 H335 H315 |
|
|
|
|
|
602-006-00-4 |
Cloroformo; triclorometano |
200-663-8 |
Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H351 H361d H331 H302 H372 H319 H315 |
GHS06 GHS08 Dgr |
H351 H361d H331 H302 H372 H319 H315 |
|
|
|
|
|
602-007-00-X |
Bromoformo; tribromometano |
200-854-6 |
Acute Tox. 3* Acute Tox. 4* Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H331 H302 H319 H315 H411 |
GHS06 GHS09 Dgr |
H331 H302 H319 H315 H411 |
|
|
|
|
|
602-008-00-5 |
Tetracloruro de carbono; tetraclorometano |
200-262-8 |
Carc. 2 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT RE 1 Aquatic Chronic 3 Ozone 1 |
H351 H331 H311 H301 H372** H412 H420 |
GHS06 GHS08 Dgr |
H351 H331 H311 H301 H372** H412 H420 |
|
* STOT RE 1; H372:C≥1 % STOT RE 2; H373:0,2 % ≤C < 1 % |
|
|
|
602-009-00-0 |
Cloroetano |
200-830-5 |
Flam. Gas 1 Press. Gas Carc. 2 Aquatic Chronic 3 |
H220 H351 H412 |
GHS02 GHS04 GHS08 Dgr |
H220 H351 H412 |
|
|
U |
|
|
602-010-00-6 |
1,2-Dibromoetano |
203-444-5 |
Carc. 1B Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H350 H331 H311 H301 H319 H335 H315 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H319 H335 H315 H411 |
|
* |
|
|
|
602-011-00-1 |
1,1-Dicloroetano |
200-863-5 |
Flam. Liq. 2 Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H225 H302 H319 H335 H412 |
GHS02 GHS07 Dgr |
H225 H302 H319 H335 H412 |
|
* |
|
|
|
602-012-00-7 |
1,2-Dicloroetano; dicloruro de etileno |
203-458-1 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H302 H319 H335 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H302 H319 H335 H315 |
|
|
|
|
|
602-013-00-2 |
1,1,1-Tricloroetano; metilcloroformo |
200-756-3 |
Acute Tox. 4* Ozone 1 |
H332 H420 |
GHS07 Wng |
H332 H420 |
|
|
F |
|
|
602-014-00-8 |
1,1,2-Tricloroetano |
201-166-9 |
Carc. 2 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* |
H351 H332 H312 H302 |
GHS08 GHS07 Wng |
H351 H332 H312 H302 |
EUH066 |
* |
|
|
|
602-015-00-3 |
1,1,2,2-Tetracloroetano |
201-197-8 |
Acute Tox. 2* Acute Tox. 1 Aquatic Chronic 2 |
H330 H310 H411 |
GHS06 GHS09 Dgr |
H330 H310 H411 |
|
|
|
|
|
602-016-00-9 |
1,1,2,2-Tetrabromoetano |
201-191-5 |
Acute Tox. 2* Eye Irrit. 2 Aquatic Chronic 3 |
H330 H319 H412 |
GHS06 Dgr |
H330 H319 H412 |
|
|
|
|
|
602-017-00-4 |
Pentacloroetano |
200-925-1 |
Carc. 2 STOT RE 1 Aquatic Chronic 2 |
H351 H372** H411 |
GHS08 GHS09 Dgr |
H351 H372** H411 |
|
STOT RE 1; H372: C≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
|
|
|
602-018-00-X |
1-Cloropropano; [1] 2-cloropropano [2] |
208-749-7 [1] 200-858-8 [2] |
540-54-5 [1] 75-29-6 [2] |
Flam. Liq. 2 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
C |
|
602-019-00-5 |
1-Bromopropano; bromuro de n-propilo |
203-445-0 |
Flam. Liq. 2 Repr. 1B STOT RE 2* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 STOT SE 3 |
H225 H360FD H373** H319 H335 H315 H336 |
GHS02 GHS08 GHS07 Dgr |
H225 H360FD H373** H319 H335 H315 H336 |
|
|
|
|
|
602-020-00-0 |
1,2-dicloropropano; dicloruro de propileno |
201-152-2 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* |
H225 H350 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H302 |
|
|
|
|
|
602-021-00-6 |
1,2-Dibromo-3-cloropropano |
202-479-3 |
Carc. 1B Muta. 1B Repr. 1A Acute Tox. 3* STOT RE 2* Aquatic Chronic 3 |
H350 H340 H360F*** H301 H373** H412 |
GHS06 GHS08 Dgr |
H350 H340 H360F*** H301 H373** H412 |
|
|
|
|
|
602-022-00-1 |
1-Cloropentano; [1] 2-cloropentano; [2] 3-cloropentano [3] |
208-846-4 [1] 210-885-7 [2] 210-467-4 [3] |
543-59-9 [1] 625-29-6 [2] 616-20-6 [3] |
Flam. Liq. 2 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
C |
|
602-023-00-7 |
Cloruro de vinilo; cloroetileno |
200-831-0 |
Press. Gas Flam. Gas 1 Carc. 1A |
H220 H350 |
GHS02 GHS08 Dgr |
H220 H350 |
|
|
D U |
|
|
602-024-00-2 |
Bromoetileno |
209-800-6 |
Press. Gas Flam. Gas 1 Carc. 1B |
H220 H350 |
GHS02 GHS08 Dgr |
H220 H350 |
|
|
U |
|
|
602-025-00-8 |
1,1-Dicloroetileno; cloruro de vinilideno |
200-864-0 |
Flam. Liq. 1 Carc. 2 Acute Tox. 4* |
H224 H351 H332 |
GHS02 GHS08 GHS07 Dgr |
H224 H351 H332 |
|
* |
D |
|
|
602-026-00-3 |
1,2-Dicloroetileno; [1] cis-dicloroetileno; [2] trans-dicloroetileno [3] |
208-750-2 [1] 205-859-7 [2] 205-860-2 [3] |
540-59-0 [1] 156-59-2 [2] 156-60-5 [3] |
Flam. Liq. 2 Acute Tox. 4* Aquatic Chronic 3 |
H225 H332 H412 |
GHS02 GHS07 Dgr |
H225 H332 H412 |
|
* |
C |
|
602-027-00-9 |
Tricloroetileno; tricloroeteno |
201-167-4 |
Carc. 1B Muta. 2 Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H350 H341 H319 H315 H336 H412 |
GHS08 GHS07 Dgr |
H350 H341 H319 H315 H336 H412 |
|
|
|
|
|
602-028-00-4 |
Tetracloroetileno |
204-825-9 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
|
|
602-029-00-X |
3-Cloropropeno; cloruro de alilo |
203-457-6 |
Flam. Liq. 2 Carc. 2 Muta. 2 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT RE 2* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H351 H341 H332 H312 H302 H373** H319 H335 H315 H400 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H351 H341 H332 H312 H302 H373** H319 H335 H315 H400 |
|
|
D |
|
|
602-030-00-5 |
1,3-Dicloropropeno; [1] (Z)-1,3-dicloropropeno [2] |
208-826-5 [1] 233-195-8 [2] |
542-75-6 [1] 10061-01-5 [2] |
Flam. Liq. 3 Acute Tox. 3* Acute Tox. 3* Acute Tox. 4* Asp. Tox. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H410 |
|
|
C D |
|
602-031-00-0 |
1,1-Dicloropropeno |
209-253-3 |
Flam. Liq. 2 Acute Tox. 3* Aquatic Chronic 3 |
H225 H301 H412 |
GHS02 GHS06 Dgr |
H225 H301 H412 |
|
|
|
|
|
602-032-00-6 |
3-Cloro-2-metilpropeno |
209-251-2 |
Flam. Liq. 2 Acute Tox. 4* Acute Tox. 4* Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H302 H314 H317 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H302 H314 H317 H411 |
|
|
|
|
|
602-033-00-1 |
clorobenceno |
203-628-5 |
Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H332 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H315 H411 |
|
|
|
|
|
602-034-00-7 |
1,2-Diclorobenceno; o-diclorobenceno |
202-425-9 |
Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
* |
|
|
|
602-035-00-2 |
1,4-Diclorobenceno; p-diclorobenceno |
203-400-5 |
Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H400 H410 |
GHS08 GHS09 Wng |
H351 H319 H410 |
|
|
|
|
|
602-036-00-8 |
Cloropreno (estabilizado); 2-clorobuta-1,3-dieno (estabilizado) |
204-818-0 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* STOT RE 2* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H332 H302 H373** H319 H335 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H302 H373** H319 H335 H315 |
|
|
D |
|
|
602-037-00-3 |
α-Clorotolueno; cloruro de bencilo |
202-853-6 |
Carc. 1B Acute Tox. 3* Acute Tox. 4* STOT RE 2* STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H373** H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H350 H331 H302 H373** H335 H315 H318 |
|
|
|
|
|
602-038-00-9 |
α, α,α-Triclorotolueno; triclorometilbenceno |
202-634-5 |
Carc. 1B Acute Tox. 3* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H350 H331 H302 H335 H315 H318 |
|
|
|
|
|
602-039-00-4 |
Policlorobifenilos; PCB |
215-648-1 |
STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
STOT RE 2; H373: C ≥ 0,005 % |
C |
|
|
602-040-00-X |
2-Clorotolueno; [1] 3-clorotolueno; [2] 4- clorotolueno; [3] clorotolueno [4] |
202-424-3 [1] 203-580-5 [2] 203-397-0 [3] 246-698-2 [4] |
95-49-8 [1] 108-41-8 [2] 106-43-4 [3] 25168-05-2 [4] |
Acute Tox. 4* Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
C |
|
602-041-00-5 |
Pentacloronaftaleno |
215-320-8 |
Acute Tox. 4* Acute Tox. 4* Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H410 |
|
|
C |
|
|
602-042-00-0 |
1,2,3,4,5,6-Hexaclorociclohexanos, excepto los especificados en otras partes del presente anexo |
— |
— |
Carc. 2 Acute Tox. 3* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H312 H410 |
|
|
A C |
|
602-043-00-6 |
Lindano (ISO); γ-HCH o γ-BHC; γ-1,2,3,4,5,6-hexaclorociclohexano |
200-401-2 |
Acute Tox. 3* Acute Tox. 4* Acute Tox. 4* STOT RE 2* Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H373** H362 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H332 H312 H373** H362 H410 |
|
M=10 |
|
|
|
602-044-00-1 |
Camfecloro (ISO); toxafeno |
232-283-3 |
Carc. 2 Acute Tox. 3* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H312 H335 H315 H410 |
|
|
|
|
|
602-045-00-7 |
DDT (ISO); clofenotano (DCI); dicofano; 1,1,1-tricloro-2,2-bis(4-clorofenil)etano; diclorodifeniltricloroetano |
200-024-3 |
Carc. 2 Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H372** H410 |
|
|
|
|
|
602-046-00-2 |
Heptacloro (ISO); 1,4,5,6,7,8,8-heptacloro-3a,4,7,7a-tetrahidro-4,7-metanoindeno |
200-962-3 |
Carc. 2 Acute Tox. 3* Acute Tox. 3* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H373** H410 |
|
|
|
|
|
602-047-00-8 |
Clordano (ISO); 1,2,4,5,6,7,8,8-octacloro-3a,4,7,7a-tetrahidro-4,7-metanoindano |
200-349-0 |
Carc. 2 Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H312 H302 H410 |
|
|
|
|
|
602-048-00-3 |
Aldrina (ISO) |
206-215-8 |
Carc. 2 Acute Tox. 3* Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H372** H410 |
|
|
|
|
|
602-049-00-9 |
Dieldrina (ISO) |
200-484-5 |
Carc. 2 Acute Tox. 1 Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H310 H301 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H310 H301 H372** H410 |
|
|
|
|
|
602-050-00-4 |
Isodrina; (1α,4α,4aβ, 5β,8β,8aβ)-1,2,3,4,10,10-hexacloro-1,4,4a,5,8,8a-hexahidro-1,4:5,8-dimetanonaftaleno |
207-366-2 |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
M=100 |
|
|
|
602-051-00-X |
Endrina (ISO); 1,2,3,4,10,10-hexacloro-6,7-epoxi-1,4,4a,5,6,7,8,8a-octahidro-1,4:5,8-dimetanonaftaleno |
200-775-7 |
Acute Tox. 2* Acute Tox. 3* Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
|
602-052-00-5 |
Endosulfano (ISO); sulfito de 1,2,3,4,7,7-hexacloro-8,9,10-trinorborn-2-en-5,6-ilendimetileno; sulfito de 1,4,5,6,7,7-hexacloro-8,9,10-trinorborn-5-en-2,3-ilendimetileno |
204-079-4 |
Acute Tox. 2* Acute Tox. 2* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H312 H410 |
|
|
|
|
|
602-053-00-0 |
Isobenzán (ISO); 1,3,4,5,6,7,8,8-octacloro-1,3,3a,4,7,7a-hexahidro-4,7-metanoisobenzofurano |
206-045-4 |
Acute Tox. 1 Acute Tox. 2* Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
|
602-054-00-6 |
3-Yodopropeno; yoduro de alilo |
209-130-4 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
|
602-055-00-1 |
Bromoetano; bromuro de etilo |
200-825-8 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4* Acute Tox. 4* |
H225 H351 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H332 H302 |
|
|
|
|
|
602-056-00-7 |
α, α,α-Trifluorotolueno; trifluorometilbenceno |
202-635-0 |
Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Dgr |
H225 H411 |
|
|
|
|
|
602-057-00-2 |
α-Bromotolueno; bromuro de bencilo |
202-847-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
|
|
|
|
602-058-00-8 |
α, α-Diclorotolueno; cloruro de bencilideno; diclorometilbenceno |
202-709-2 |
Carc. 2 Acute Tox. 3* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H351 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H351 H331 H302 H335 H315 H318 |
|
|
|
|
|
602-059-00-3 |
1-Clorobutano; cloruro de butilo |
203-696-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
602-060-00-9 |
Bromobenceno |
203-623-8 |
Flam. Liq. 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H315 H411 |
|
|
|
|
|
602-061-00-4 |
Hexafluoropropeno; hexafluoropropileno |
204-127-4 |
Press. Gas Acute Tox. 4* STOT SE 3 |
H332 H335 |
GHS07 Wng |
H332 H335 |
|
|
U |
|
|
602-062-00-X |
1,2,3-Tricloropropano |
202-486-1 |
Carc. 1B Repr. 1B Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* |
H350 H360F*** H332 H312 H302 |
GHS08 GHS07 Dgr |
H350 H360F*** H332 H312 H302 |
|
|
D |
|
|
602-063-00-5 |
Heptacloro epóxido; 2,3-epoxi-1,4,5,6,7,8,8-heptacloro-3a,4,7,7a-tetrahidro-4,7-metanoindano |
213-831-0 |
Carc. 2 Acute Tox. 3* STOT RE 2* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H373** H410 |
|
|
|
|
|
602-064-00-0 |
1,3-Dicloro-2-propanol |
202-491-9 |
Carc. 1B Acute Tox. 3* Acute Tox. 4* |
H350 H301 H312 |
GHS06 GHS08 Dgr |
H350 H301 H312 |
|
|
|
|
|
602-065-00-6 |
Hexaclorobenceno |
204-273-9 |
Carc. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372** H400 H410 |
GHS08 GHS09 Dgr |
H350 H372** H410 |
|
|
|
|
|
602-066-00-1 |
Tetracloro-p-benzoquinona |
204-274-4 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
|
|
602-067-00-7 |
1,3-Diclorobenceno |
208-792-1 |
Acute Tox. 4* Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
602-068-00-2 |
Bis(tricloroacetato) de etileno |
219-732-9 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
|
602-069-00-8 |
Dicloroacetileno |
— |
Unst. Expl. Carc. 2 STOT RE 2* |
H200 H351 H373** |
GHS01 GHS08 Wng |
H200 H351 H373** |
|
|
|
|
|
602-070-00-3 |
3-Cloro-4,5,α, α, α-pentafluorotolueno |
401-930-3 |
Flam. Liq. 3 Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 |
H226 H332 H302 H400 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H302 H400 |
|
|
|
|
|
602-071-00-9 |
Bromobencilbromotolueno, masa de reacción de isómeros |
402-210-1 |
STOT RE 2* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373** H317 H410 |
|
|
|
|
|
602-072-00-4 |
Dicloro[(diclorofenil)metil]metilbenceno, masa de reacción de isómeros; (diclorofenil)(diclorotolil)metano, masa de reacción de isómeros (IUPAC) |
278-404-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
602-073-00-X |
1,4-Diclorobut-2-eno |
212-121-8 |
Carc. 1B Acute Tox. 2* Acute Tox. 3* Acute Tox. 3* Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H330 H311 H301 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H330 H311 H301 H314 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % STOT SE 3; H335:C≥5 % |
|
|
|
602-074-00-5 |
Pentaclorobenceno |
210-172-0 |
Flam. Sol. 1 Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H228 H302 H410 |
|
|
T |
|
|
602-075-00-0 |
4,4,5,5-Tetracloro-1,3-dioxolan-2-ona |
404-060-2 |
Acute Tox. 2* Acute Tox. 4* Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS05 Dgr |
H330 H302 H314 |
|
|
|
|
|
602-076-00-6 |
2,3,4-Triclorobut-1-eno |
219-397-9 |
Carc. 2 Acute Tox. 3* Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H302 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H331 H302 H319 H335 H315 H410 |
|
Carc. 2; H351: C ≥ 0,1 % |
|
|
|
602-077-00-1 |
Dodecacloropentaciclo[5.2.1.02,6.03,9.05,8]-decano; mirex |
219-196-6 |
Carc. 2 Repr. 2 Lact. Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361fd H362 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361fd H362 H312 H302 H410 |
|
|
|
|
|
602-078-00-7 |
Hexaclorociclopentadieno |
201-029-3 |
Acute Tox. 2* Acute Tox. 3* Acute Tox. 4* Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H302 H314 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H311 H302 H314 H410 |
|
|
|
|
|
602-079-00-2 |
2,3-Dicloropropeno; 2,3-dicloropropileno |
201-153-8 |
Flam. Liq. 2 Muta. 2 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
|
|
|
|
|
602-080-00-8 |
Alcanos, C10-13, cloro; parafinas cloradas, C10-13 |
287-476-5 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
EUH066 |
|
|
|
|
602-081-00-3 |
Ácido 2-cloro-4,5-difluorobenzoico |
405-380-5 |
— |
Acute Tox. 4* Acute Tox. 4* Eye Dam. 1 Skin Sens. 1 |
H312 H302 H318 H317 |
GHS05 GHS07 Dgr |
H312 H302 H318 H317 |
|
|
|
|
602-082-00-9 |
2,2,6,6-Tetrakis(bromometil)-4-oxaheptano-1,7-diol |
408-020-5 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
602-083-00-4 |
Éter difenílico, derivado pentabromado; éter pentabromodifenílico |
251-084-2 |
STOT RE 2* Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H373** H362 H400 H410 |
GHS08 GHS09 Wng |
H373** H362 H410 |
|
|
|
|
|
602-084-00-X |
1,1-Dicloro-1-fluoroetano |
404-080-1 |
Aquatic Chronic 3 Ozone 1 |
H412 H420 |
GHS07 Wng |
H412 H420 |
|
|
|
|
|
602-085-00-5 |
2-Bromopropano |
200-855-1 |
Flam. Liq. 2 Repr. 1a STOT RE 2* |
H225 H360F*** H373** |
GHS02 GHS08 Dgr |
H225 H360F*** H373** |
EUH066 |
|
|
|
|
602-086-00-0 |
Trifluoroyodometano; yoduro de trifluorometilo |
219-014-5 |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
|
|
602-087-00-6 |
1,2,4-Triclorobenceno |
204-428-0 |
Acute Tox. 4* Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
602-088-00-1 |
2,3-Dibromopropan-1-ol; 2,3-dibromo-1-propanol |
202-480-9 |
Carc. 1B Repr. 2 Acute Tox. 3* Acute Tox. 4* Acute Tox. 4* Aquatic Chronic 3 |
H350 H361f*** H311 H332 H302 H412 |
GHS08 GHS07 Dgr |
H350 H361f*** H311 H332 H302 H412 |
|
|
|
|
|
602-089-00-7 |
4-Bromo-2-clorofluorobenceno |
405-580-2 |
Acute Tox. 4* Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
602-090-00-2 |
1-Alil-3-cloro-4-fluorobenceno |
406-630-6 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
602-091-00-8 |
1,3-Dicloro-4-fluorobenceno |
406-160-1 |
Acute Tox. 4* STOT RE 2* Skin Irrit. 2 |
H302 H373** H315 H411 |
GHS08 GHS07 Wng |
H302 H373** H315 H411 |
|
|
|
|
|
602-092-00-3 |
1-Bromo-3,4,5-trifluorobenceno |
418-480-9 |
Flam. Liq. 3 Carc. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H351 H315 H318 H411 |
GHS02 GHS08 GHS05 GHS09 Dgr |
H226 H351 H315 H318 H411 |
|
|
|
|
|
602-093-00-9 |
α, α, α,4-Tetraclorotolueno; tricloruro de p-clorobencilo |
226-009-1 |
Carc. 1B Repr. 2 STOT RE 1 Acute Tox. 4* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 |
H350 H361f*** H372** H312 H302 H335 H315 |
GHS08 GHS07 Dgr |
H350 H361f*** H372** H312 H302 H335 H315 |
|
|
|
|
|
602-094-00-4 |
Éter difenílico; derivado octabromado |
251-087-9 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
|
602-095-00-X |
Alcanos, C14-17, cloro; parafinas cloradas, C14-17 |
287-477-0 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
EUH066 |
|
|
|
|
602-096-00-5 |
Clorhidrato de verde de malaquita; [1] oxalato de verde de malaquita [2] |
209-322-8 [1] 219-441-7 [2] |
569-64-2 [1] 2437-29-8 [2] |
Repr. 2 Acute Tox. 4* Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H302 H318 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361d*** H302 H318 H410 |
|
|
|
|
602-097-00-0 |
1-Bromo-9-(4,4,5,5,5-pentafluoropentiltio)nonano |
422-850-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
602-098-00-6 |
2-(3-Bromofenoxi)tetrahidro-2H-pirano |
429-030-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
602-099-00-1 |
Cloruro de 3-(4-fluorofenil)-2-metilpropionilo |
426-370-7 |
— |
Skin Corr. 1A Acute Tox. 4* Aquatic Chronic 3 |
H314 H302 H412 |
GHS05 GHS07 Dgr |
H314 H302 H412 |
EUH014 EUH029 |
|
|
|
602-100-00-5 |
Masa de reacción de: (R, R)-1,1,1,2,2,3,4,5,5,5-decafluoropentano; (S, S)-1,1,1,2,2,3,4,5,5,5-decafluoropentano |
420-640-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
602-101-00-0 |
Carbonato de 2-cloro-4-fluoro-5-nitrofenilo e isobutilo |
427-020-6 |
STOT RE 2* Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373** H317 H410 |
|
|
|
|
|
602-102-00-6 |
1,1,1,3,3-Pentafluorobutano |
430-250-1 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
602-103-00-1 |
1-(Clorofenilmetil)-2-metilbenceno |
431-450-1 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
602-104-00-7 |
1,1,2,2,3,3,4-Heptafluorociclopentano |
430-710-1 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
602-105-00-2 |
1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanosulfinato de sodio |
422-100-7 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
602-106-00-8 |
2-Bromo-4,6-difluoroanilina |
429-430-0 |
Acute Tox. 4* Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
602-107-00-3 |
3,3,4,4-Tetrafluoro-4-yodo-1-buteno |
439-500-2 |
Acute Tox. 4* Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Wng |
H302 H315 H411 |
|
|
|
|
|
602-108-00-9 |
(2,3,5,6-Tetrafluorofenil)metanol |
443-840-7 |
Acute Tox. 4* Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
|
602-109-00-4 |
Hexabromociclododecano [1] 1,2,5,6,9,10-hexabromociclododecano [2] |
247-148-4 [1] 221-695-9[2] |
25637-99-4[1] 3194-55-6[2] |
Repr. 2 Lact. |
H361 H362 |
GHS08 Wng |
H361 H362 |
|
|
|
|
602-110-00-X |
Tetrafluoretileno |
204-126-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
603-001-00-X |
Metanol |
200-659-6 |
Flam. Liq. 2 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT SE 1 |
H225 H331 H311 H301 H370** |
GHS02 GHS06 GHS08 Dgr |
H225 H331 H311 H301 H370** |
|
* STOT SE 1; H370: C≥10 % STOT SE 2; H371: 3 % ≤ C<10 % |
|
|
|
603-002-00-5 |
Etanol; alcohol etílico |
200-578-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
603-003-00-0 |
Propan-1-ol; n-propanol |
200-746-9 |
Flam. Liq. 2 Eye Dam. 1 STOT SE 3 |
H225 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H225 H318 H336 |
|
|
|
|
|
603-004-00-6 |
Butan-1-ol; n-butanol |
200-751-6 |
Flam. Liq. 3 Acute Tox. 4* STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H302 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H335 H315 H318 H336 |
|
|
|
|
|
603-005-00-1 |
2-Metilpropan-2-ol; alcohol terc-butílico |
200-889-7 |
Flam. Liq. 2 Acute Tox. 4* Eye Irrit. 2 STOT SE 3 |
H225 H332 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H319 H335 |
|
|
|
|
|
603-006-00-7 |
Isómeros de pentanol, excepto los especificados en otras partes del presente anexo |
250-378-8 |
|
Flam. Liq. 3 Acute Tox. 4* STOT SE 3 |
H226 H332 H335 |
GHS02 GHS07 Wng |
H226 H332 H335 |
EUH066 |
|
C |
|
603-007-00-2 |
2-Metilbutan-2-ol; terc-pentanol |
200-908-9 |
Flam. Liq. 2 Acute Tox. 4* STOT SE 3 Skin Irrit. 2 |
H225 H332 H335 H315 |
GHS02 GHS07 Dgr |
H225 H332 H335 H315 |
|
|
|
|
|
603-008-00-8 |
4-Metilpentan-2-ol; metilisobutilcarbinol |
203-551-7 |
Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Wng |
H226 H335 |
|
STOT SE 3; H335: C ≥ 25 % |
|
|
|
603-009-00-3 |
Ciclohexanol |
203-630-6 |
Acute Tox. 4* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 |
H332 H302 H335 H315 |
GHS07 Wng |
H332 H302 H335 H315 |
|
|
|
|
|
603-010-00-9 |
Mezcla de isómeros de 2-metilciclohexanol; [1] cis-2-metilciclohexanol; [2] trans-2-metilciclohexanol [3] |
209-512-0 [1] 231-187-9 [2] 231-186-3 [3] |
583-59-5 [1] 7443-70-1 [2] 7443-52-9 [3] |
Acute Tox. 4* |
H332 |
GHS07 Wng |
H332 |
|
|
C |
|
603-011-00-4 |
2-Metoxietanol; éter monometílico de etilenglicol |
203-713-7 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H332 H312 H302 |
|
|
|
|
|
603-012-00-X |
2-Etoxietanol; éter monoetílico de etilenglicol |
203-804-1 |
Flam. Liq. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 |
H226 H360FD H331 H302 |
GHS02 GHS08 GHS06 Dgr |
H226 H360FD H331 H302 |
|
|
|
|
|
603-013-00-5 |
2-Isopropoxietanol; éter monoisopropílico de etilenglicol |
203-685-6 |
Acute Tox. 4* Acute Tox. 4* Eye Irrit. 2 |
H332 H312 H319 |
GHS07 Wng |
H332 H312 H319 |
|
|
|
|
|
603-014-00-0 |
2-Butoxietanol; éter monobutílico de etilenglicol |
203-905-0 |
Acute Tox. 3 Acute Tox. 4 Skin Irrit. 2 Eye Irrit. 2 |
H331 H302 H315 H319 |
GHS06 Dgr |
H331 H302 H315 H319 |
|
Por inhalación: ETA = 3 mg/l (vapores) Por vía oral: ETA = 1 200 mg/kg pc |
|
|
|
603-015-00-6 |
Alcohol alílico |
203-470-7 |
Flam. Liq. 2 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H331 H311 H301 H319 H335 H315 H400 |
GHS02 GHS06 GHS09 Dgr |
H225 H331 H311 H301 H319 H335 H315 H400 |
|
|
|
|
|
603-016-00-1 |
4-Hidroxi-4-metilpentan-2-ona; alcohol de diacetona |
204-626-7 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
Eye Irrit. 2; H319: C≥ 10 % |
|
|
|
603-018-00-2 |
Alcohol furfurílico |
202-626-1 |
Carc. 2 Acute Tox. 3* Acute Tox. 4* Acute Tox. 4* STOT RE 2* Eye Irrit. 2 STOT SE 3 |
H351 H331 H312 H302 H373** H319 H335 |
GHS06 GHS08 Dgr |
H351 H331 H312 H302 H373** H319 H335 |
|
|
|
|
|
603-019-00-8 |
Éter dimetílico |
204-065-8 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
603-020-00-3 |
Éter de etilo y metilo |
— |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
603-021-00-9 |
Éter de metilo y vinilo |
203-475-4 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
D U |
|
|
603-022-00-4 |
Éter dietílico; éter |
200-467-2 |
Flam. Liq. 1 Acute Tox. 4* STOT SE 3 |
H224 H302 H336 |
GHS02 GHS07 Dgr |
H224 H302 H336 |
EUH019 EUH066 |
|
|
|
|
603-023-00-X |
Óxido de etileno; oxirano |
200-849-9 |
Flam. Gas 1 Press. Gas Carc. 1B Muta. 1B Repr. 1B Acute Tox. 3 Acute Tox. 3 STOT SE 3 STOT SE 3 STOT RE 1 Skin Corr. 1 Eye Dam. 1 |
H220 H350 H340 H360Fd H331 H301 H335 H336 H372 (sistema nervioso) H314 H318 |
GHS02 GHS08 GHS06 GHS05 Dgr |
H220 H350 H340 H360Fd H331 H301 H335 H336 H372 (sistema nervioso) H314 |
|
Por inhalación: ETA = 700ppm (gases) Por vía oral: ETA = 100 mg/kg pc |
U |
|
|
603-024-00-5 |
1,4-Dioxano |
204-661-8 |
Flam. Liq. 2 Carc. 1B STOT SE 3 Eye Irrit. 2 |
H225 H350 H335 H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H335 H319 |
EUH019 EUH066 |
|
D |
|
|
603-025-00-0 |
Tetrahidrofurano |
203-726-8 |
Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H225 H351 H319 H335 |
GHS02 GHS07 GHS08 Dgr |
H225 H351 H319 H335 |
EUH019 |
STOT SE 3; H335: C≥25 % Eye Irrit.2; H319: C ≥ 25 % |
|
|
|
603-026-00-6 |
1-Cloro-2,3-epoxipropano; epiclorhidrina |
203-439-8 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H350 H331 H311 H301 H314 H317 |
|
* |
|
|
|
603-027-00-1 |
Etanodiol; etilenglicol |
203-473-3 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
603-028-00-7 |
2-Cloroetanol; clorhidrina de etileno |
203-459-7 |
Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
|
603-029-00-2 |
Éter bis(2-cloroetílico) |
203-870-1 |
Carc. 2 Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* |
H351 H330 H310 H300 |
GHS06 GHS08 Dgr |
H351 H330 H310 H300 |
|
|
|
|
|
603-030-00-8 |
2-Aminoetanol; etanolamina |
205-483-3 |
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Skin Corr. 1B |
H332 H312 H302 H314 |
GHS05 GHS07 Dgr |
H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
603-031-00-3 |
1,2-Dimetoxietano; éter dimetílico de etilenglicol; EGDME |
203-794-9 |
Flam. Liq. 2 Repr. 1B Acute Tox. 4* |
H225 H360FD H332 |
GHS02 GHS08 GHS07 Dgr |
H225 H360FD H332 |
EUH019 |
|
|
|
|
603-032-00-9 |
Dinitrato de etileno; dinitrato de etilenglicol |
211-063-0 |
Unst. Expl. Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* STOT RE 2 |
H200 H330 H310 H300 H373** |
GHS01 GHS06 GHS08 Dgr |
H200 H330 H310 H300 H373** |
|
|
|
|
|
603-033-00-4 |
Dinitrato de oxidietileno; dinitrato de dietilenglcol; dinitrato de digol |
211-745-8 |
Unst. Expl Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* STOT RE 2* Aquatic Chronic 3 |
H200 H330 H310 H300 H373** H412 |
GHS01 GHS06 GHS08 Dgr |
H200 H330 H310 H300 H373** H412 |
|
|
|
|
|
603-033-01-1 |
Dinitrato de oxidietileno; dinitrato de dietilenglicol; dinitrato de digol; [> 25 % flegmatizante] |
211-745-8 |
Expl. 1.1 Acute Tox. 2* Acute Tox. 1 Acute Tox. 2* STOT RE 2* Aquatic Chronic 3 |
H201 H330 H310 H300 H373** H412 |
GHS01 GHS06 GHS08 Dgr |
H201 H330 H310 H300 H373** H412 |
|
|
|
|
|
603-034-00-X |
Trinitrato de glicerol; nitroglicerina |
200-240-8 |
Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H200 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H200 H330 H310 H300 H373 ** H411 |
|
|
|
|
|
603-034-01-7 |
Trinitrato de glicerol; nitroglicerina; [> 40 % flegmatizante] |
200-240-8 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H201 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H330 H310 H300 H373 ** H411 |
|
|
|
|
|
603-035-00-5 |
Tetranitrato de pentaeritritol; tetranitrato de pentaeritrita; P.E.T.N. |
201-084-3 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
|
603-035-01-2 |
Tetranitrato de pentaeritritol; tetranitrato de pentaeritrita; P.E.T.N.;[> 20 % flegmatizante] |
201-084-3 |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
T |
|
|
603-036-00-0 |
Hexanitrato de manitol; nitromanita |
239-924-6 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
|
603-036-01-8 |
Hexanitrato de manitol; nitromanita; [> 40 % flegmatizante] |
239-924-6 |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
|
|
|
603-037-00-6 |
Nitrato de celulosa; nitrocelulosa |
— |
— |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
T |
|
603-038-00-1 |
Éter de alilo y glicidilo; éter de alilo y 2,3-epoxipropilo; éter de prop-2-en-1-ilo y 2,3-epoxipropilo |
203-442-4 |
Flam. Liq. 3 Carc. 2 Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
|
|
|
|
|
603-039-00-7 |
Éter de butilo y glicidilo; éter de butilo y 2,3-epoxipropilo |
219-376-4 |
Flam. Liq. 3 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H332 H302 H335 H317 H412 |
GHS02 GHS08 GHS07 Wng |
H226 H351 H341 H332 H302 H335 H317 H412 |
|
|
|
|
|
603-040-00-2 |
Metanolato de sodio; metóxido de sodio; [1] metanolato de potasio; metóxido de potasio; [2] metanolato de litio; metóxido de litio [3] |
204-699-5 [1] 212-736-1 [2] 212-737-7 [3] |
124-41-4 [1] 865-33-8 [2] 865-34-9 [3] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Dgr |
H251 H314 |
EUH014 |
|
T |
|
603-041-00-8 |
Etanolato de potasio; etóxido de potasio; [1] etanolato de sodio; etóxido de sodio [2] |
213-029-0 [1] 205-487-5 [2] |
917-58-8 [1] 141-52-6 [2] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Dgr |
H251 H314 |
EUH014 |
|
T |
|
603-042-00-3 |
Triisopropóxido de aluminio |
209-090-8 |
Flam. Sol. 1 |
H228 |
GHS02 Dgr |
H228 |
|
|
T |
|
|
603-043-00-9 |
Triarimol (ISO); alcohol 2,4-dicloro-α-(pirimidin-5-il)bencidrílico |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
603-044-00-4 |
Dicofol (ISO); 2,2,2-tricloro-1,1-bis(4-clorofenil)etanol |
204-082-0 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H315 H317 H410 |
|
|
|
|
|
603-045-00-X |
Éter diisopropílico; [1] éter dipropílico [2] |
203-560-6 [1] 203-869-6 [2] |
108-20-3 [1] 111-43-3 [2] |
Flam. Liq. 2 STOT SE 3 |
H225 H336 |
GHS02 GHS07 Dgr |
H225 H336 |
EUH019 EUH066 |
|
C |
|
603-046-00-5 |
Éter bis(clorometílico); oxibis(clorometano) |
208-832-8 |
Flam. Liq. 2 Carc. 1A Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * |
H225 H350 H330 H311 H302 |
GHS02 GHS06 GHS08 Dgr |
H225 H350 H330 H311 H302 |
|
Carc. 1A; H350: C ≥ 0,001 % |
|
|
|
603-047-00-0 |
2-Dimetilaminoetanol; N,N-dimetiletanolamina |
203-542-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
|
|
603-048-00-6 |
2-Dietilaminoetanol; N,N-dietiletanolamina |
202-845-2 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
|
|
603-049-00-1 |
Clorfenetol (ISO); 1,1-bis(4-clorofenil)etanol |
201-246-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
603-050-00-7 |
1-(2-Butoxipropoxi)propan-2-ol |
246-011-6 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
603-051-00-2 |
2-Etilbutan-1-ol |
202-621-4 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
603-052-00-8 |
3-Butoxipropan-2-ol; éter monobutílico de propilenglicol |
225-878-4 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
|
603-053-00-3 |
2-Metilpentano-2,4-diol |
203-489-0 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
|
603-054-00-9 |
Éter di-n-butílico; éter dibutílico |
205-575-3 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 |
H226 H319 H335 H315 H412 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H412 |
|
STOT SE 3; H335: C≥10 % |
|
|
|
603-055-00-4 |
óxido de propileno; 1,2-epoxipropano; metiloxirano |
200-879-2 |
Flam. Liq. 1 Carc. 1B Muta. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 |
H 224 H350 H340 H331 H311 H302 H335 H319 |
GHS02 GHS08 GHS06 Dgr |
H224 H350 H340 H331 H311 H302 H335 H319 |
|
|
|
|
|
603-056-00-X |
[(p-Toliloxi)metil]oxirano; [1] [(m-toliloxi)metil]oxirano; [2] éter de 2,3-epoxipropilo y o-tolilo; [3] [(toliloxi)metil]oxirano; éter de cresilo y glicidilo [4] |
218-574-8 [1] 218-575-3 [2] 218-645-3 [3] 247-711-4 [4] |
2186-24-5 [1] 2186-25-6 [2] 2210-79-9 [3] 26447-14-3 [4] |
Muta. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H315 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H315 H317 H411 |
|
|
C |
|
603-057-00-5 |
Alcohol bencílico |
202-859-9 |
Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1B |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
Por vía oral: ETA = 1 200 mg/kg pc |
|
|
|
603-058-00-0 |
Óxido de 1,3-propileno |
207-964-3 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
|
|
|
603-059-00-6 |
Hexan-1-ol |
203-852-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
603-060-00-1 |
2,2'-Bioxirano; 1,2:3,4-diepoxibutano |
215-979-1 |
Carc. 1B Muta. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H350 H340 H330 H311 H301 H314 |
GHS06 GHS08 GHS05 Dgr |
H350 H340 H330 H311 H301 H314 |
|
|
|
|
|
603-061-00-7 |
Tetrahidro-2-furilmetanol; alcohol tetrahidrofurfurílico |
202-625-6 |
Repr. 1B Eye Irrit. 2 |
H360Df H319 |
GHS08 GHS07 Dgr |
H360Df H319 |
|
|
|
|
|
603-062-00-2 |
Tetrahidrofuran-2,5-diildimetanol |
203-239-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥10 % |
|
|
|
603-063-00-8 |
2,3-Epoxipropan-1-ol; glicidol; oxiranometanol |
209-128-3 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
GHS06 GHS08 Dgr |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
|
|
|
|
|
603-064-00-3 |
1-Metoxi-2-propanol; éter monometílico de propilenglicol |
203-539-1 |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
|
|
|
|
|
603-065-00-9 |
m-Bis(2,3-epoxipropoxi)benceno; éter diglicidílico de resorcinol |
202-987-5 |
Carc. 1B Muta. 2 Acute Tox. 3 Acute Tox. 4 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H311 H302 H315 H319 H317 H412 |
GHS08 GHS06 Dgr |
H350 H341 H311 H302 H315 H319 H317 H412 |
|
Por vía cutánea: ETA = 300 mg/kg pc Por vía oral: ETA = 500 mg/kg bw |
|
|
|
603-066-00-4 |
7-Oxa-3-oxiranilbiciclo[4.1.0]heptano; 1,2-epoxi-4-epoxietilciclohexano; diepóxido de 4-vinilciclohexeno |
203-437-7 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 |
H350 H341 H360F H331 H302 |
GHS08 GHS06 Dgr |
H350 H341 H360F H331 H302 |
|
Por inhalación: ETA = 0,5 mg/l (polvos o nieblas) Por vía oral: ETA = 1 847 mg/kg pc |
|
|
|
603-067-00-X |
Éter de fenilo y glicidilo; éter fenílico de 2,3-epoxipropilo; 1,2-epoxi-3-fenoxipropano |
204-557-2 |
Carc. 1B Muta. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H332 H335 H315 H317 H412 |
GHS08 GHS07 Dgr |
H350 H341 H332 H335 H315 H317 H412 |
|
|
|
|
|
603-068-00-5 |
Éter de 2,3-epoxipropil-2-etilciclohexilo; éter de etilciclohexilglicidilo |
— |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
|
603-069-00-0 |
2,4,6-Tris(dimetilaminometil)fenol |
202-013-9 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
|
603-070-00-6 |
2-Amino-2-metilpropanol |
204-709-8 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
|
603-071-00-1 |
2,2'-Iminodietanol; dietanolamina |
203-868-0 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H315 H318 |
|
|
|
|
|
603-072-00-7 |
1,4-Bis(2,3-epoxipropoxi)butano; éter diglicidílico de butanodiol |
219-371-7 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H312 H319 H315 H317 |
GHS07 Wng |
H332 H312 H319 H315 H317 |
|
|
|
|
|
603-073-00-2 |
Bis-[4-(2,3-epoxipropoxi)fenil]propano |
216-823-5 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
Eye Irrit. 2; H319: C≥ 5 % Skin Irrit. 2; H315: C≥5 % |
|
|
|
603-074-00-8 |
Producto de reacción: bisfenol-A-(epiclorhidrina); resina epoxídica (peso molecular medio en número ≤ 700) |
500-033-5 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H315 H317 H411 |
|
Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C≥ 5 % |
|
|
|
603-075-00-3 |
Éter de clorometilo y metilo; éter clorodimetílico |
203-480-1 |
Flam. Liq. 2 Carc. 1A Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H312 H302 |
|
|
|
|
|
603-076-00-9 |
But-2-ino-1,4-diol; 2-butino-1,4-diol |
203-788-6 |
Skin Corr. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H331 H301 H312 H373 ** H317 |
GHS06 GHS05 GHS08 Dgr |
H314 H331 H301 H312 H373 ** H317 |
|
Skin Corr. 1B; H314: C≥50 % Skin Irrit. 2; H315: 25 %≤ C < 50 % Eye Irrit. 2; H319: 25 %≤ C<50 % |
D |
|
|
603-077-00-4 |
1-Dimetilaminopropan-2-ol; dimepranol (DCI) |
203-556-4 |
Flam. Liq. 3 Acute Tox. 4 * Skin Corr. 1B |
H226 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H314 |
|
|
|
|
|
603-078-00-X |
Prop-2-in-1-ol; alcohol propargílico |
203-471-2 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H311 H301 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H226 H331 H311 H301 H314 H411 |
|
|
|
|
|
603-079-00-5 |
2,2'-(Metilimino)dietanol; N-metildietanolamina |
203-312-7 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-080-00-0 |
2-Metilaminoetanol; N-metiletanolamina; N-metil-2-etanolamina; N-metil-2-amino-etanol; 2-(metilamino)etanol |
203-710-0 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
|
|
603-081-00-6 |
2,2'-Tiodietanol; tiodiglicol |
203-874-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-082-00-1 |
1-Aminopropan-2-ol; isopropanolamina |
201-162-7 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
603-083-00-7 |
1,1'-Iminodipropan-2-ol; di-isopropanolamina |
203-820-9 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-084-00-2 |
Óxido de estireno; (epoxietil)benceno; feniloxirano |
202-476-7 |
Carc. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H312 H319 |
GHS08 GHS07 Dgr |
H350 H312 H319 |
|
|
|
|
|
603-085-00-8 |
Bronopol (DCI); 2-bromo-2-nitropropano-1,3-diol |
200-143-0 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H312 H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H335 H315 H318 H400 |
|
M=10 |
|
|
|
603-086-00-3 |
Etirimol (ISO); 5-butil-2-etilamino-6-metilpirimidin-4-ol |
245-949-3 |
Acute Tox. 4 * |
H312 |
GHS07 Wng |
H312 |
|
|
|
|
|
603-087-00-9 |
2-Etilhexano-1,3-diol; octilenglicol; etohexadiol |
202-377-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
603-088-00-4 |
2-(Octiltio)etanol; sulfuro de 2-hidroxietilo y octilo |
222-598-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
603-089-00-X |
7,7-Dimetil-3-oxa-6-azaoctan-1-ol |
400-390-6 |
— |
Skin Corr. 1A Acute Tox. 4 * |
H314 H302 |
GHS05 GHS07 Dgr |
H314 H302 |
|
|
|
|
603-090-00-5 |
2-(2-Bromoetoxi)anisol |
402-010-4 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
603-091-00-0 |
exo-1-Metil-4-(1-metiletil)-7-oxabiciclo[2.2.1]heptan-2-ol |
402-470-6 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
603-092-00-6 |
2-Metil-4-fenilpentanol |
402-770-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
603-093-00-1 |
Cinmetilina (ISO); exo-(±)-1-metil-2-(2-metilbenciloxi)-4-isopropil-7-oxabiciclo(2.2.1)heptano |
402-410-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Dgr |
H332 H411 |
|
|
|
|
|
603-094-00-7 |
1,3-Bis(2,3-epoxipropoxi)-2,2-dimetilpropano |
241-536-7 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
|
603-095-00-2 |
2-(Propiloxi)etanol; EGPE |
220-548-6 |
Acute Tox. 4 * Eye Irrit. 2 |
H312 H319 |
GHS07 Wng |
H312 H319 |
|
|
|
|
|
603-096-00-8 |
2-(2-Butoxietoxi)etanol; éter monobutílico de dietilenglicol |
203-961-6 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-097-00-3 |
1,1’,1’-Nitrilotripropan-2-ol; triisopropanolamina |
204-528-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-098-00-9 |
2-Fenoxietanol |
204-589-7 |
Acute Tox. 4 STOT SE 3 Eye Dam. 1 |
H302 H335 H318 |
GHS05 GHS07 Dgr |
H302 H335 H318 |
|
Por vía oral: ETA = 1 394 mg/kg pc |
|
|
|
603-099-00-4 |
Clorhidrato de 3-(N-metil-N-(4-metilamino-3-nitrofenil)amino)propano-1,2-diol |
403-440-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
603-100-00-8 |
1,2-Dimetoxipropano |
404-630-0 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH019 |
|
|
|
|
603-101-00-3 |
Tetrahidro-2-isobutil-4-metilpiran-4-ol, mezcla de isómeros (cis y trans) |
405-040-6 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-102-00-9 |
1,2-epoxibutano |
203-438-2 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 |
H225 H351 H302 H312 H332 H335 H315 H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H302 H312 H332 H335 H315 H319 |
|
|
|
|
|
603-103-00-4 |
Oxirano, derivados mono[(C12-14-alquiloxi)metílicos] |
271-846-8 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
|
603-104-00-X |
Fenarimol (ISO); alcohol 2,4'-dicloro-α-(pirimidin-5-il)bencidrílico |
262-095-7 |
Repr. 2 Lact. Aquatic Chronic 2 |
H361fd H362 H411 |
GHS08 GHS09 Wng |
H361fd H362 H411 |
|
|
|
|
|
603-105-00-5 |
Furano |
203-727-3 |
Flam. Liq. 1 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Aquatic Chronic 3 |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
GHS02 GHS08 GHS07 Dgr |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
EUH019 |
|
|
|
|
603-106-00-0 |
2-Metoxipropanol |
216-455-5 |
Flam. Liq. 3 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H360D *** H335 H315 H318 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H360D *** H335 H315 H318 |
|
|
|
|
|
603-107-00-6 |
2-(2-Metoxietoxi)etanol; éter monometílico de dietilenglicol |
203-906-6 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
Repr. 1B; H360D: C ≥ 3 % |
|
|
|
603-108-00-1 |
2-Metilpropan-1-ol; iso-butanol |
201-148-0 |
Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H226 H335 H315 H318 H336 |
|
|
|
|
|
603-109-00-7 |
Masa de reacción de: 1-etoxi-1,1,2,3,3,3-hexafluoro-2-(trifluorometil)propano; 1-etoxi-1,1,2,2,3,3,4,4,4-nonafluorobutano |
425-340-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-110-00-2 |
Masa de reacción de: cis-2-isobutil-5-metil-1,3-dioxano; trans-2-isobutil-5-metil-1,3-dioxano |
426-130-1 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
603-111-00-8 |
Masa de reacción de: 1-(1,1-dimetilpropil)-4-etoxi-cis-ciclohexano; 1-(1,1-dimetilpropil)-4-etoxi-trans-ciclohexano |
426-530-6 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
603-112-00-3 |
Éter de ciclopentilo y 2-feniletilo |
428-340-9 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
603-113-00-9 |
6-Glicidiloxinaft-1-il-oximetiloxirano |
429-960-2 |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H341 H312 H315 H317 H412 |
GHS08 GHS07 Wng |
H341 H312 H315 H317 H412 |
|
|
|
|
|
603-114-00-4 |
9-(2-Propeniloxi)triciclo[5.2.1.0(2,6)]dec-3(o - 4-)-eno |
430-830-2 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
603-115-00-X |
Masa de reacción de: O, O',O''-(metilsilanotriil)tris(oxima de 4-metil-2-pentanona) (3 estereoisómeros) |
423-580-0 |
— |
STOT RE 2 * Aquatic Chronic 4 |
H373** H413 |
GHS08 Wng |
H373** H413 |
|
|
|
|
603-116-00-5 |
Monoclorhidrato de (Z)-(2,4-difluorofenil)piperidin-4-ilmetanona-oxima |
424-740-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
603-117-00-0 |
Propan-2-ol; alcohol isopropílico; isopropanol |
200-661-7 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
|
|
|
|
|
603-118-00-6 |
6-Dimetilaminohexan-1-ol |
404-680-3 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Dgr |
H302 H314 H412 |
|
|
|
|
|
603-119-00-1 |
1,1'-(1,3-Fenilenedioxi)bis(3-(2-(prop-2-enil)fenoxi)propan-2-ol) |
405-840-5 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
603-120-00-7 |
2-Metil-5-fenilpentanol |
405-890-8 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
|
603-121-00-2 |
4-[4-(1,3-Dihidroxiprop-2-il)fenilamino]-1,8-dihidroxi-5-nitroantraquinona |
406-057-1 |
Carc. 2 Skin Sens. 1 Aquatic Chronic 4 |
H351 H317 H413 |
GHS08 GHS07 Wng |
H351 H317 H413 |
|
|
|
|
|
603-122-00-8 |
2-Etilhexanolato de sodio |
406-150-7 |
Flam. Sol. 1 Skin Corr. 1B Aquatic Chronic 3 |
H228 H314 H412 |
GHS02 GHS05 Dgr |
H228 H314 H412 |
|
|
T |
|
|
603-123-00-3 |
4-Metil-8-metilentriciclo[3.3.1.13,7]decan-2-ol |
406-330-5 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
|
603-124-00-9 |
1,4-Bis[2-(viniloxi)etoxi]benceno |
406-900-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-125-00-4 |
2-(2,4-Diclorofenil)-1-(1H—1,2,4-triazol-1-il)pent-4-en-2-ol |
407-850-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
603-126-00-X |
2-((4-Metil-2-nitrofenil)amino)etanol |
408-090-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
|
603-127-00-5 |
Butan-2-ol; [1] (S)-butan-2-ol; [2] (R)-butan-2-ol; [3] (±)-butan-2-ol [4] |
201-158-5 [1] 224-168-1 [2] 238-967-8 [3] 240-029-8 [4] |
78-92-2 [1] 4221-99-2 [2] 14898-79-4 [3] 15892-23-6 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H226 H319 H335 H336 |
GHS02 GHS07 Wng |
H226 H319 H335 H336 |
|
|
C |
|
603-128-00-0 |
2-(Fenilmetoxi)naftaleno |
405-490-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-129-00-6 |
1-terc-Butoxipropan-2-ol |
406-180-0 |
Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Dgr |
H226 H318 |
|
|
|
|
|
603-130-00-1 |
Masa de reacción de isómeros de: α-((dimetil)bifenil)-ω-hidroxipoli(oxietileno) |
406-325-8 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-131-00-7 |
Masa de reacción de: 1-desoxi-1-[metil-(1-oxododecil)amino]-D-glucitol; 1-desoxi-1-[metil-(1-oxotetradecil)amino]-D-glucitol (3:1) |
407-290-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-132-00-2 |
2-Hidroximetil-9-metil-6-(1-metiletil)-1,4-dioxaespiro[4.5]decano |
408-200-3 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
|
603-133-00-8 |
Masa de reacción de: 3-[(4-amino-2-cloro-5-nitrofenil)amino]-propano-1,2-diol; 3,3'-(2-cloro-5-nitro-1,4-fenilendiimino)bis(propano-1,2-diol) |
408-240-1 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-134-00-3 |
Masa de reacción de éteres difenílicos sustituidos de dodecilo y/o tetradecilo. La sustancia se produce mediante la reacción de Friedel Crafts. El catalizador se retira del producto de reacción. El éter difenílico se sustituye con grupos alquílicos C1-C10. Los grupos alquílicos se unen aleatoriamente entre C1 y C6. C12 y C14 lineales, al 50/50. |
410-450-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-135-00-9 |
Bis[[2,2',2''-nitrilotris-[etanolato]]-1-N, O]-bis[2-(2-metoxietoxi)etoxi]-titanio |
410-500-4 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
603-136-00-4 |
3-((4-(Bis(2-hidroxietil)amino)-2-nitrofenil)amino)-1-propanol |
410-910-3 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
603-137-00-X |
Masa de reacción de 1-desoxi-1-[metil-(1-oxohexadecil)amino]-D-glucitol; 1-desoxi-1-[metil-(1-oxooctadecil)amino]-D-glucitol |
411-130-6 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-138-00-5 |
3-(2,2-Dimetil-3-hidroxipropil)tolueno; 2,2-dimetil-3-(3-metilfenil)propanol |
403-140-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
603-139-00-0 |
Éter de bis(2-metoxietilo) |
203-924-4 |
Flam. Liq. 3 Repr. 1B |
H226 H360FD |
GHS02 GHS08 Dgr |
H226 H360FD |
EUH019 |
|
|
|
|
603-140-00-6 |
2,2'-Oxibisetanol; dietilenglicol |
203-872-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
603-141-00-1 |
Masa de reacción de: dodeciloxi-1-metil-1-[oxi-poli-(2-hidroximetiletanoxi)]pentadecano; dodeciloxi-1-metil-1-[oxi-poli-(2-hidroximetiletanoxi)]heptadecano |
413-780-6 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-142-00-7 |
2-(2-(2-Hidroxietoxi)etil)-2-aza-biciclo[2.2.1]heptano |
407-360-1 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H373 ** H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H312 H302 H373 ** H315 H318 |
|
|
|
|
|
603-143-00-2 |
R—2,3-Epoxi-1-propanol |
404-660-4 |
Self-react. C **** Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
|
|
|
|
|
603-144-00-8 |
Masa de reacción de: 2,6,9-trimetil-2,5,9-ciclododecatrien-1-ol; 6,9-dimetil-2-metilen-5,9-ciclododecadien-1-ol |
413-530-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
603-145-00-3 |
2-Isopropil-2-(1-metilbutil)-1,3-dimetoxipropano |
406-970-5 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
603-146-00-9 |
2-[(2-[2-(Dimetilamino)etoxi]etil)metilamino]etanol |
406-080-7 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Dgr |
H302 H314 H412 |
|
|
|
|
|
603-147-00-4 |
(-)-trans-4-(4'-Fluorofenil)-3-hidroximetil-N-metilpiperidina |
406-030-4 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
603-148-00-X |
1,4-Bis[(viniloxi)metil]ciclohexano |
413-370-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
603-149-00-5 |
Masa de reacción de diastereoisómeros de 1-(1-hidroxietil)-4-(1-metiletil)ciclohexano |
407-640-3 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
|
603-150-00-0 |
(±) trans-3,3-Dimetil-5-(2,2,3-trimetil-ciclopent-3-en-1-il)-pent-4-en-2-ol |
411-580-3 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
603-151-00-6 |
(±)-2-(2,4-Diclorofenil)-3-(1H-1,2,4-triazol-1-il)propan-1-ol |
413-570-4 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-152-00-1 |
2-(4-terc-Butilfenil)etanol |
410-020-5 |
Repr. 2 STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H361f *** H373 ** H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H361f *** H373 ** H318 H411 |
|
|
|
|
|
603-153-00-7 |
3-((2-Nitro-4-(trifluorometil)fenil)amino)propano-1,2-diol |
410-010-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
603-154-00-2 |
1-[(2-terc-Butil)ciclohexiloxi]-2-butanol |
412-300-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
603-156-00-3 |
2-(2,4-Diclorofenil)-2-(2-propenil)oxirano |
411-210-0 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
|
603-157-00-9 |
6,9-Bis(hexadeciloximetil)-4,7-dioxanonano-1,2,9-triol |
411-450-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-158-00-4 |
Masa de reacción de 4 diastereoisómeros de 2,7-dimetil-10-(1-metiletil)-1-oxaespiro[4.5]deca-3,6-dieno |
412-460-3 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
603-159-00-X |
2-Ciclododecilpropan-1-ol |
411-410-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-160-00-5 |
1,2-Dietoxipropano |
412-180-1 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH019 |
|
|
|
|
603-161-00-0 |
1,3-Dietoxipropano |
413-140-6 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
|
603-162-00-6 |
α[2-[[[(2-Hidroxietil)metilamino]acetil]amino]propil]-ω-nonilfenoxi)poli[oxo(metil-1,2-etanodiilo)] |
413-420-8 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
|
603-163-00-1 |
2-Fenil-1,3-propanodiol |
411-810-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
603-164-00-7 |
2-Butil-4-cloro-4,5-dihidro-5-hidroximetil-1-[2'-(2-trifenilmetil-1,2,3,4-2H-tetrazol-5-il)-1,1'-bifenil-4-metil]-1H-imidazol |
412-420-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-165-00-2 |
Masa de reacción de: 4-alil-2,6-bis(2,3-epoxipropil)fenol; 4-alil-6-[3-[6-[3-[6-[3-(4-alil-2,6-bis(2,3-epoxipropil)fenoxi)-2-hidroxipropil]-4-alil-2-(2,3-epoxipropil)fenoxi]-2-hidroxipropil]-4-alil-2-(2,3-epoxipropil)fenoxi]-2-hidroxipropil]-2-(2,3-epoxipropil)fenol; 4-alil-6-[3-(4-alil-2,6-bis(2,3-epoxipropil)fenoxi)-2-hidroxipropil]-2-(2,3-epoxipropil)fenol; 4-alil-6-[3-[6-[3-(4-alil-2,6-bis(2,3-epoxipropil)fenoxi)-2-hidroxipropil]-4-alil-2-(2,3-epoxipropil)fenoxi]-2-hidroxipropil]-2-(2,3-epoxipropil)fenol |
417-470-1 |
— |
Muta. 2 Skin Sens. 1 |
H341 H317 |
GHS08 GHS07 Wng |
H341 H317 |
|
|
|
|
603-166-00-8 |
R-1-Cloro-2,3-epoxipropano |
424-280-2 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H350 H331 H311 H301 H314 H317 |
|
|
|
|
|
603-167-00-3 |
3,3',5,5'-Tetra-terc-butilbifenil-2,2'-diol |
407-920-5 |
Aquatic Chronic 4 |
H413 |
GHS05 Dgr |
H413 |
|
|
|
|
|
603-168-00-9 |
3-(2-Etilhexiloxi)propano-1,2-diol |
408-080-2 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
603-169-00-4 |
(±)-trans-4-(4-Fluorofenil)-3-hidroximetil-N-metilpiperidina |
415-550-0 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
603-170-00-X |
Masa de reacción de: 2-metil-1-(6-metilbiciclo[2.2.1]hept-5-en-2-il)pent-1-en-3-ol; 2-metil-1-(1-metilbiciclo[2.2.1]hept-5-en-2-il)-pent-1-en-3-ol; 2-metil-1-(5-metilbiciclo[2.2.1]hept-5-en-2-il)pent-1-en-3-ol |
415-990-3 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
|
603-171-00-5 |
5-Tiazolilmetanol |
414-780-9 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
603-172-00-0 |
trans-Butenodioato de mono-2-[2-(4-dibenzo[b,f][1,4]tiazepin-11-il)piperazinio-1-il]etoxi)etanol |
415-180-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
603-173-00-6 |
4,4-Dimetil-3,5,8-trioxabiciclo[5.1.0]octano |
421-750-9 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
|
603-174-00-1 |
4-Ciclohexil-2-metil-2-butanol |
420-630-3 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
603-175-00-7 |
2-(2-Hexiloxietoxi)etanol; DEGHE; éter monohexílico de dietilenglicol; 3,6-dioxa-1-dodecanol; hexil-carbitol; 3,6-dioxadodecan-1-ol |
203-988-3 |
Acute Tox. 4 * Eye Dam. 1 |
H312 H318 |
GHS05 GHS07 Dgr |
H312 H318 |
|
|
|
|
|
603-176-00-2 |
1,2-Bis(2-metoxietoxi)etano; TEGDME; éter dimetílico de trietilenglicol; triglimo |
203-977-3 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
EUH019 |
|
|
|
|
603-177-00-8 |
1-Etoxipropan-2-ol; 2PG1EE; 1-etoxi-2-propanol; éter monoetílico de propilenglicol; [1] acetato de 2-etoxi-1-metiletilo; 2PG1EEA [2] |
216-374-5 [1] 259-370-9 [2] |
1569-02-4 [1] 54839-24-6 [2] |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
|
|
|
|
603-178-00-3 |
2-Hexiloxietanol; éter monohexílico de etilenglicol; n-hexilglicol |
203-951-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
|
603-179-00-9 |
Ergocalciferol (ISO); vitamina D2 |
200-014-9 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 |
H330 H311 H301 H372 ** |
GHS06 GHS08 Dgr |
H330 H311 H301 H372 ** |
|
|
|
|
|
603-180-00-4 |
Colecalciferol; vitamina D3 |
200-673-2 |
Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 |
H330 H310 H300 H372 |
GHS06 GHS08 Dgr |
H330 H310 H300 H372 |
|
Por inhalación: ETA = 0,05 mg/l (polvos o nieblas) Por vía cutánea: ETA = 50 mg/kg pc Por vía oral: ETA = 35 mg/kg pc STOT RE 1; H372: C ≥ 3 % STOT RE 2; H373: 0,3 % ≤ C < 3 % |
|
|
|
603-181-00-X |
Éter de terc-butilo y metilo; MTBE; 2-metoxi-2-metilpropano |
216-653-1 |
Flam. Liq. 2 Skin Irrit. 2 |
H225 H315 |
GHS02 GHS07 Dgr |
H225 H315 |
|
|
|
|
|
603-182-00-5 |
Producto de reacción de: alcoholes parcialmente esterificados, saturados, monoinsaturados y multiinsaturados, de cadena larga, de origen vegetal (Brassica napus L., Brassica rapa L., Heliantus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) con O, O-diisobutilditiofosfato y 2-etilhexilamina y peróxido de hidrógeno |
428-630-5 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
603-183-00-0 |
2-[2-(2-Butoxietoxi)etoxi]etanol; TEGBE; éter monobutílico de trietilenglicol; butoxitrietilenglicol |
205-592-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
Eye Dam.1; H318: C≥30 % Eye Irrit. 2; H319: 20 % ≤C< 30 % |
|
|
|
603-184-00-6 |
2-(Hidroximetil)-2-[[2-hidroxi-3-(isooctadeciloxi)propoxi]metil]-1,3-propanodiol |
416-380-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-185-00-1 |
2,4-Dicloro-3-etil-6-nitrofenol |
420-740-1 |
Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H317 H410 |
|
|
|
|
|
603-186-00-7 |
trans-(5RS,6SR)-6-amino-2,2-dimetil-1,3-dioxepan-5-ol |
419-050-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
603-187-00-2 |
Dicloruro de 2-((4,6-bis(4-(2-(1-metilpiridinio-4-il)vinil)fenilamino)-1,3,5-triazin-2-il)(2-hidroxietil)amino)etanol |
419-360-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-188-00-8 |
Masa de reacción de: 6,7-epoxi-1,2,3,4,5,6,7,8-octahidro-1,1,2,4,4,7-hexametilnaftaleno; 7,8-epoxi-1,2,3,4,6,7,8,8a-octahidro-1,1,2,4,4,7-hexametilnaftaleno |
426-970-9 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
603-189-00-3 |
Masa de reacción de complejos de: titanio, 2,2'-oxidietanol, lactato de amonio, nitrilotris(2-propanol) y etilenglicol |
405-250-8 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-190-00-9 |
8,8-Dimetil-7-isopropil-6,10-dioxaespiro[4.5]decano |
424-030-2 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
603-191-00-4 |
2-(4,6-Bis(2,4-dimetilfenil)-1,3,5-triazin-2-il)-5-(3-((2-etilhexil)oxi)-2-hidroxipropoxi)fenol |
419-740-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-192-00-X |
(E,E)-3,7,11-Trimetildodeca-1,4,6,10-tetraen-3-ol |
423-240-1 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
603-193-00-5 |
9,10-Antracenodióxido de disodio |
426-030-8 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
603-194-00-0 |
2-(2-Aminoetilamino)etanol; (AEEA) |
203-867-5 |
Repr. 1B Skin Corr. 1B Skin Sens. 1 |
H360Df H314 H317 |
GHS05 GHS08 GHS07 Dgr |
H360Df H314 H317 |
|
STOT SE 3; H335: C≥5 % |
|
|
|
603-195-00-6 |
2-[4-(4-Metoxifenil)-6-fenil-1,3,5-triazin-2-il]-fenol |
430-810-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
603-196-00-1 |
2-(7-Etil-1H-indol-3-il)etanol |
431-020-1 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
|
|
603-197-00-7 |
tebuconazol (ISO); 1-(4-clorofenil)-4,4-dimetil-3-(1,2,4-triazol-1-ilmetil)pentan-3-ol |
403-640-2 |
Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d *** H302 H410 |
|
M = 1 M = 10 |
|
|
|
603-199-00-8 |
Etoxazol (ISO); (RS)-5-terc-butil-2-[2-(2,6-difluorofenil)-4,5-dihidro-1,3-oxazol-4-il]fenetol |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 |
|
|
|
603-200-00-1 |
1-Pentanol; [1] 3-pentanol [2] |
200-752-1 [1] 209-526-7 [2] |
71-41-0 [1] 584-02-1 [2] |
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H226 H332 H335 H315 |
GHS02 GHS07 Wng |
H226 H332 H335 H315 |
|
|
|
|
603-201-00-7 |
(E)-(7R,11R)-3,7,11,15-Tetrametilhexadec-2-en-1-ol |
416-120-5 |
— |
Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Wng |
H315 H413 |
|
|
|
|
603-202-00-2 |
4,4,5,5,5-Pentafluoropentan-1-ol |
421-360-9 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
603-203-00-8 |
(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-Hexametil-4,6-dioxatetraciclo[6.5.1.01,10.03,7]tetradecano |
427-580-1 |
— |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
603-204-00-3 |
Masa de reacción de: 2,2'-(heptano-1,7-diil)bis-1,3-dioxolano; 2,2'-(heptano-1,6-diil)bis-1,3-dioxolano |
428-110-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-205-00-9 |
Clorhidrato de (1S-cis)-4-(2-amino-6-cloro-9H-purin-9-il)-2-ciclopenteno-1-metanol |
426-200-1 |
STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H372** H302 H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H372** H302 H318 H317 H412 |
|
|
|
|
|
603-206-00-4 |
2,2-Dicloro-1,3-benzodioxol |
426-850-6 |
Flam. Liq. 3 Skin Corr. 1A Acute Tox. 4 * Skin Sens. 1 |
H226 H314 H302 H317 |
GHS02 GHS05 GHS07 Dgr |
H226 H314 H302 H317 |
EUH014 |
|
|
|
|
603-207-00-X |
2-Isobutil-2-isopropil-1,3-dimetoxipropano |
430-800-9 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
603-208-00-5 |
1,2-Dietoxietano |
211-076-1 |
Flam. Liq. 2 Repr. 1A Eye Irrit. 2 |
H225 H360Df H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H360Df H319 |
EUH019 |
|
|
|
|
603-209-00-0 |
Espinosad (ISO) (masa de reacción de espinosina A y espinosina D en proporciones de entre 95:5 y 50:50); masa de reacción de 50-95 % de (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-desoxi-2,3,4-tri-O-metil-α-l-manopiranosiloxi)-13-(4-dimetilamino-2,3,4,6-tetradesoxi-β-d-eritropiranosiloxi)-9-etil-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahidro-14-metil-1H-8-oxaciclododeca[b]as-indaceno-7,15-diona y 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-desoxi-2,3,4-tri-O-metil-α-l-manopiranosiloxi)-13-(4-dimetilamino-2,3,4,6-tetradesoxi-β-d-eritropiranosiloxi)-9-etil-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahidro-4,14-dimetil-1H-8-oxaciclododeca[b]as-indaceno-7,15-diona; [1] espinosina A; [2] espinosina D [3] |
-[1] -[2] -[3] |
-[1] 131929-60-7 [2] 131929-63-0 [3] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=10 |
|
|
603-210-00-6 |
2,4-Dietil-1,5-pentanodiol |
429-310-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
603-211-00-1 |
Cloruro de 2,3-epoxipropiltrimetilamonio al … %; cloruro de glicidiltrimetilamonio al … % |
221-221-0 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
|
|
B |
|
|
603-212-00-7 |
1,3,4,6,7,8-Hexahidro-4,6,6,7,8,8-hexametilindeno[5,6-c]pirano; galaxólido; (HHCB) |
214-946-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-213-00-2 |
2-Metoxi-2-metilbutano; éter de terc-amilo y metilo |
213-611-4 |
Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 |
H225 H302 H336 |
GHS02 GHS07 Dgr |
H225 H302 H336 |
|
|
|
|
|
603-214-00-8 |
1,1-Diisopropoxiciclohexano |
413-740-8 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
603-215-00-3 |
Bis(tetrafluoroborato) de 1-hidroxi-4-fluoro-1,4-diazoniabiciclo[2.2.2]octano |
418-330-2 |
Expl. 1.1**** Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H302 H373** H318 H317 H400 H410 |
GHS01 GHS05 GHS08 GHS07 GHS09 Dgr |
H201 H302 H373** H318 H317 H410 |
|
|
|
|
|
603-216-00-9 |
cis-1-Amino-2,3-dihidro-1H-inden-2-ol |
422-660-2 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
603-217-00-4 |
Fosfito de 2-butil-2-etil-1,3-propanodiol y de 2,4,6-tri-terc-butilfenilo |
423-560-1 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
603-220-00-0 |
1-{Bencil[2-(2-metoxifenoxi)etil]amino}-3-(9H-carbazol-4-iloxi)propan-2-ol |
432-890-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-221-00-6 |
Clorhidrato de 1-(2-amino-5-clorofenil)-2,2,2-trifluoro-1,1-etanodiol; [con un contenido < 0,1 % de 4-cloroanilina (n.o CE 203-401-0)] |
433-580-2 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
|
|
603-221-01-3 |
Clorhidrato de 1-(2-amino-5-clorofenil)-2,2,2-trifluoro-1,1-etanodiol; [con un contenido ≥ 0,1 % de 4-cloroanilina (n.o CE 203-401-0)] |
433-580-2 |
Carc. 1B Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H350 H302 H314 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H350 H302 H314 H411 |
|
|
|
|
|
603-222-00-1 |
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-Dimetilamino-3-hidroxi-6-metiltetrahidropiran-2-il)oxi]-2-etil-3,4,12-trihidroxi-9-metoxi-3,5,7,9,11,13-hexametil-6,14-dioxo-1-oxaciclotetradecano |
433-820-6 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-223-00-7 |
2-Ciclopentilidenciclopentanol; 1,1'-bi(ciclopentiliden)-2-ol |
434-270-1 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
|
603-224-00-2 |
3-Etoxi-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluorometil)-hexano |
435-790-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-225-00-8 |
Eritromicina A9-oxima (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxi-3-C-metil-3-O-metil-α-L-ribo-hexopiranosil)oxi)-14-etil-7,12,13-trihidroxi-3,5,7,9,11,13-hexametil-6-((3,4,6-tridesoxi-3-dimetilamino-β-d-xilohexapiranosil)oxi)oxaciclotetradecan-2-ona-10-oxima (E) |
437-070-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
603-226-00-3 |
4,4'(4-(4-Metoxifenil)-1,3,5-triazin-2,4-diil)bisbenceno-1,3-diol |
444-500-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
603-227-00-9 |
Éter de α-hidro-ω-[[[(1,1-dimetiletil)dioxi]carbonil]oxi]-poli[oxi(metil-1,2-etanodiilo)] con 2,2-bis(hidroximetil)-1,3-propanodiol (4:1); producto de reacción de: éter de α-hidro-ω-((clorocarbonil)oxi)-poli(oxi(metil-1,2-etanodiilo)) con 2,2-bis(hidroximetil)-1,3-propanodiol con 1,1-dimetiletilperoxalato de potasio |
445-060-2 |
**** Aquatic Acute 1 Aquatic Chronic 1 |
**** H400 H410 |
**** GHS09 Wng |
**** H410 |
|
|
|
|
|
603-228-00-4 |
(+/–)-(R*,R*)-6-Fluoro-3,4-dihidro-2-oxiranil-2H-1-benzopirano; 6-fluoro-2-(2-oxiranil)cromano |
419-620-1 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
603-229-00-X |
(Z)-3-Cloro-3-(4-clorofenil)-1-hidroxi-2-propeno-1-sulfonato de sodio |
420-800-7 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
603-230-00-5 |
2,6,6,7,8,8-Hexametildecahidro-2H-indeno[4,5-b]furano |
440-030-5 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 4 |
H315 H318 H413 |
GHS05 Dgr |
H315 H318 H413 |
|
|
|
|
603-231-00-0 |
(S)-1,1-Difenil-1,2-propanodiol |
443-220-6 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-232-00-6 |
3,3,8,8,10,10-Hexametil-9-[1-(4-oxiranilmetoxifenil)-etoxi]-1,5-dioxa-9-azaespiro[5.5]undecano |
444-420-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-233-00-1 |
Masa de reacción de: 4-(1,3a,4,6,7,7a-hexahidro-4,7-metanoinden-5-iliden)-3-metilbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahidro-4,7-metanoinden-5-iliden)-3-metilbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahidro-4,7-metanoinden-5-iliden)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahidro-4,7-metanoinden-5-iliden)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahidro-1H-4,7-metanoinden-5-il)-3-metilbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahidro-3H-4,7-metanoinden-5-il)-3-metilbut-3-en-2-ol |
444-430-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-234-00-7 |
(1R,4R)-4-Metoxi-2,2,7,7-tetrametiltriciclo(6.2.1.0(1,6))undec-5-eno |
444-480-3 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
603-235-00-2 |
Linalol; 3,7-dimetil-1,6-octadien-3-ol; dl-linalol; [1] coriandrol; (S)-3,7-dimetil-1,6-octadien-3-ol; d-linalol; [2] licareol; (R)-3,7-dimetil-1,6-octadien-3-ol; l-linalol [3] |
201-134-4 [1] 204-810-7 [2] 204-811-2 [3] |
78-70-6 [1] 126-90-9 [2] 126-91-0 [3] |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
603-236-00-8 |
Etanol, 2,2 '-iminobis-, N - derivs. (alquilos lineares y ramificados C13-15). |
308-208-6 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
|
|
|
603-237-00-3 |
Ipconazol (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-clorobencil)-5-isopropil-1-(1H-1,2,4-triazol-1-ilmetil)ciclopentanol |
- |
Repr. 1B Acute Tox. 4 STOT RE 2 Aquatic Chronic 1 |
H360D H302 H373 (ojos, piel, hígado) H410 |
GHS08 GHS07 GHS09 Dgr |
H360D H302 H373 (ojos, piel, hígado) H410 |
|
Por vía oral: ETA = 500 mg/kg pc M = 100 |
|
|
|
603-238-00-9 |
Bis(2-(2-metoxietoxi)etil)éter; tetraglima |
205-594-7 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
603-239-00-4 |
Paclobutrazol (ISO); (2RS,3RS)-1-(4-clorofenil)-4,4-dimetil-2-(1H-1,2,4-triazol-1-il)pentan-3-ol |
- |
Repr. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H332 H302 H319 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H332 H302 H319 H410 |
|
Por inhalación: ETA = 3,13 mg/l (polvos o nieblas) Por vía oral: ETA = 490 mg/kg pc M = 10 M = 10 |
|
|
|
603-240-00-X |
2,2-Bis(bromometil)propano-1,3-diol |
221-967-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
|
|
|
603-241-00-5 |
Geraniol; (2E)-3,7-dimetilocta-2,6-dien-1-ol |
203-377-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
603-243-00-6 |
2,2-Dimetilpropan-1-ol, tribromoderivado; 3-bromo-2,2-bis(bromometil)propan-1-ol |
253-057-0 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
|
|
|
|
603-244-00-1 |
Masa de reacción de 1-(2,3-epoxipropoxi)-2,2-bis[(2,3-epoxipropoxi)metil]butano y 1-(2,3-epoxipropoxi)-2-[(2,3-epoxipropoxi)metil]-2-hidroximetilbutano |
— |
— |
Muta. 2 Repr. 1B |
H341 H360F |
GHS08 Dgr |
H341 H360F |
|
|
|
|
603-245-00-7 |
2,2’-({3-Metil-4-[(4-nitrofenil)azo]fenil}imino)bisetanol |
221-665-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
603-246-00-2 |
3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctan-1-ol |
211-477-1 |
STOT RE 2 Aquatic Chronic 1 |
H373 (dientes, huesos) H410 |
GHS08 GHS09 Wng |
H373 (dientes, huesos) H410 |
|
M = 1 |
|
|
|
603-247-00-8 |
Masa de reacción del 1,3-dioxan-5-ol y el 1,3-dioxolan-4-ilmetanol; |
— |
— |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
604-001-00-2 |
Fenol; ácido carbólico; monohidroxibenceno; alcohol fenílico |
203-632-7 |
Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B |
H341 H331 H311 H301 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H341 H331 H311 H301 H373 ** H314 |
|
* Skin Corr. 1B; H314: C ≥ 3 % Skin Irrit. 2; H315 1 % ≤ C<3 % Eye Irrit. 2; H319:1 % ≤C<3 % |
|
|
|
604-002-00-8 |
Pentaclorofenol |
201-778-6 |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H330 H311 H301 H319 H335 H315 H410 |
|
|
|
|
|
604-003-00-3 |
Pentaclorofenolato de sodio; [1] pentaclorofenolato de potasio [2] |
205-025-2 [1] 231-911-3 [2] |
131-52-2 [1] 7778-73-6 [2] |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H330 H311 H301 H319 H335 H315 H410 |
|
|
|
|
604-004-00-9 |
m-Cresol; [1] o-cresol; [2] p-cresol; [3] mezcla de cresoles [4] |
203-577-9 [1] 202-423-8 [2] 203-398-6 [3] 215-293-2 [4] |
108-39-4 [1] 95-48-7 [2] 106-44-5 [3] 1319-77-3 [4] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Dgr |
H311 H301 H314 |
|
* |
C |
|
604-005-00-4 |
1,4-Dihidroxibenceno; hidroquinona; quinol |
204-617-8 |
Carc. 2 Muta. 2 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H351 H341 H302 H318 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H351 H341 H302 H318 H317 H400 |
|
M=10 |
|
|
|
604-006-00-X |
3,4-Xilenol; [1] 2,5-xilenol; [2] 2,4-xilenol; [3] 2,3-xilenol; [4] 2,6-xilenol; [5] xilenol; [6] 2,4(o 2,5)-xilenol [7] |
202-439-5 [1] 202-461-5 [2] 203-321-6 [3] 208-395-3 [4] 209-400-1 [5] 215-089-3 [6] 276-245-4 [7] |
95-65-8 [1] 95-87-4 [2] 105-67-9 [3] 526-75-0 [4] 576-26-1 [5] 1300-71-6 [6] 71975-58-1 [7] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H301 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H301 H314 H411 |
|
|
C |
|
604-007-00-5 |
2-Naftol |
205-182-7 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Wng |
H332 H302 H400 |
|
|
|
|
|
604-008-00-0 |
2-Clorofenol; [1] 4-clorofenol; [2] 3-clorofenol; [3] clorofenol [4] |
202-433-2 [1] 203-402-6 [2] 203-582-6 [3] 246-691-4 [4] |
95-57-8 [1] 106-48-9 [2] 108-43-0 [3] 25167-80-0 [4] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H312 H302 H411 |
GHS07 GHS09 Wng |
H332 H312 H302 H411 |
|
|
C |
|
604-009-00-6 |
Pirogalol; 1,2,3-trihidroxibenceno |
201-762-9 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H341 H332 H312 H302 H412 |
GHS08 GHS07 Wng |
H341 H332 H312 H302 H412 |
|
* |
|
|
|
604-010-00-1 |
Resorcinol; 1,3-bencenodiol |
203-585-2 |
Acute Tox. 4 STOT SE 1 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 B Aquatic Acute 1 |
H302 H370 (sistema nervioso) H315 H319 H317 H400 |
GHS07 GHS08 GHS09 Dgr |
H302 H370 (sistema nervioso) H315 H319 H317 H400 |
|
Por vía oral: ETA = 500 mg/kg pc M = 1 |
|
|
|
604-011-00-7 |
2,4-Diclorofenol |
204-429-6 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H302 H314 H411 |
|
|
|
|
|
604-012-00-2 |
4-Cloro-o-cresol; 4-cloro-2-metilfenol |
216-381-3 |
Acute Tox. 3 * Skin Corr. 1A Aquatic Acute 1 |
H331 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H314 H400 |
|
STOT SE 3; H335: C≥1 % |
|
|
|
604-013-00-8 |
2,3,4,6-Tetraclorofenol |
200-402-8 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H319 H315 H400 H410 |
GHS06 GHS09 Dgr |
H301 H319 H315 H410 |
|
* Eye Irrit. 2; H319:C≥5 % Skin Irrit. 2; H315: C≥5 % |
|
|
|
604-014-00-3 |
Clorocresol; 4-cloro-m-cresol; 4-cloro-3-metilfenol |
200-431-6 |
Acute Tox. 4 Skin Corr. 1C Eye Dam. 1 STOT SE 3 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 3 |
H302 H314 H318 H335 H317 H400 H412 |
GHS07 GHS05 GHS09 Dgr |
H302 H314 H335 H317 H410 |
|
M = 1 |
|
|
|
604-015-00-9 |
2,2'-Metilen-bis-(3,4,6-triclorofenol); hexaclorofeno |
200-733-8 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
* |
|
|
|
604-016-00-4 |
1,2-Dihidroxibenceno; pirocatecol |
204-427-5 |
Carc. 1Β Muta. 2 Acute Tox. 3 Acute Tox. 3 Skin Irrit. 2 Eye Irrit. 2 |
H350 H341 H311 H301 H315 H319 |
GHS08 GHS06 Dgr |
H350 H341 H311 H301 H315 H319 |
|
Por vía oral: ETA = 300 mg/kg pc Por vía cutánea: ETA = 600 mg/kg pc |
|
|
|
604-017-00-X |
2,4,5-Triclorofenol |
202-467-8 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
* Eye Irrit. 2; H319: C≥5 % Skin Irrit.2; H315: C ≥5 % |
|
|
|
604-018-00-5 |
2,4,6-Triclorofenol |
201-795-9 |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H319 H315 H410 |
|
|
|
|
|
604-019-00-0 |
Diclorofeno (ISO) |
202-567-1 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
|
|
604-020-00-6 |
Bifenil-2-ol; 2-fenilfenol; 2-hidroxibifenilo |
201-993-5 |
Carc. 2 Skin Corr. 1 Eye Dam. 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H351 H314 H318 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H314 H317 H410 |
|
M = 1 M = 1 |
|
|
|
604-021-00-1 |
2-Bifenilato de sodio; sal sódica de 2-fenilfenol |
205-055-6 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Wng |
H302 H335 H315 H318 H400 |
|
|
|
|
|
604-022-00-7 |
2,2-Dimetil-1,3-benzodioxol-4-ol |
400-900-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
604-023-00-2 |
2,4-Dicloro-3-etilfenol |
401-060-4 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
604-024-00-8 |
4,4-Isobutiletilidendifenol |
401-720-1 |
Repr. 1B Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360F *** H319 H400 H410 |
GHS08 GHS09 Dgr |
H360F *** H319 H410 |
|
|
|
|
|
604-025-00-3 |
2,5-Bis(1,1-dimetilbutil)hidroquinona |
400-220-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-026-00-9 |
2,2-Espirobi(6-hidroxi-4,4,7-trimetilcromano) |
400-270-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-027-00-4 |
2-Metil-5-(1,1,3,3-tetrametilbutil)hidroquinona |
400-530-6 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
604-028-00-X |
4-Amino-3-fluorofenol |
402-230-0 |
Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H302 H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H411 |
|
|
|
|
|
604-029-00-5 |
1-Naftol |
201-969-4 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H335 H315 H318 |
GHS05 GHS07 Dgr |
H312 H302 H335 H315 H318 |
|
|
|
|
|
604-030-00-0 |
4,4′-Isopropilidendifenol; bisfenol A |
201-245-8 |
Repr. 1B STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360F H335 H318 H317 H400 H410 |
GHS08 GHS07 GHS05 GHS09 Dgr |
H360F H335 H318 H317 H410 |
|
M = 1 M = 10 |
|
|
|
604-031-00-6 |
Guayacol |
201-964-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
|
604-032-00-1 |
Timol |
201-944-8 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
|
|
604-033-00-7 |
But-3-enoato de isobutilo |
401-170-2 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
|
604-034-00-2 |
4,4'-Tiodi-o-cresol |
403-330-7 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
|
604-035-00-8 |
4-Nonilfenol, productos de reacción con formaldehído y dodecano-1-tiol |
404-160-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
604-036-00-3 |
4,4'-Oxibis(etilentio)difenol |
404-590-4 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
604-037-00-9 |
3,5-Xilenol; 3,5-dimetilfenol |
203-606-5 |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Dgr |
H311 H301 H314 |
|
|
|
|
|
604-038-00-4 |
4-Cloro-3,5-dimetilfenol; [1] cloroxilenol [2] |
201-793-8 [1] 215-316-6 [2] |
88-04-0 [1] 1321-23-9 [2] |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H315 H317 |
GHS07 Wng |
H302 H319 H315 H317 |
|
|
|
|
604-039-00-X |
2-[4-[(6-Clorobenzoxazol-2-il)oxi]fenoxi]propionato de etilo; fenoxaprop-etilo |
266-362-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
604-040-00-5 |
Fomesafeno (ISO); 5-[2-cloro-4-(trifluorometil)fenoxi]-N-(metilsulfonil)-2-nitrobenzamida |
276-439-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
604-041-00-0 |
Acifluorfeno (ISO); ácido 5-[2-cloro-4-(trifluorometil)fenoxi]-2-nitrobenzoico [1] 5-[2-cloro-4-(trifluorometil) fenoxi]-2-nitrobenzoato de sodio; acifluorfeno-sodio [2] |
256-634-5 [1] 263-560-7 [2] |
50594-66-6 [1] 62476-59-9 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
|
|
604-042-00-6 |
4-Nitrosofenol |
203-251-6 |
Muta. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H341 H302 H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H341 H302 H318 H411 |
|
|
|
|
|
604-043-00-1 |
Monobenzona; éter de 4-hidroxifenilo y bencilo; éter monobencílico de hidroquinona |
203-083-3 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
|
604-044-00-7 |
Mequinol; 4-metoxifenol; éter monometílico de hidroquinona |
205-769-8 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
|
604-045-00-2 |
2,3,5-Trimetilhidroquinona |
211-838-3 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H335 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H332 H335 H315 H318 H317 H410 |
|
|
|
|
|
604-046-00-8 |
4-(4-Isopropoxifenilsulfonil)fenol |
405-520-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
604-047-00-3 |
4-(4-Toliloxi)bifenilo |
405-730-7 |
STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Wng |
H373 ** H413 |
|
|
|
|
|
604-048-00-9 |
4,4',4''-(Etan-1,1,1-triil)trifenol |
405-800-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
604-049-00-4 |
4-4'-Metilen-bis(oxietilentio)difenol |
407-480-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
604-051-00-5 |
3,5-Bis((3,5-di-terc-butil-4-hidroxi)bencil)-2,4,6-trimetilfenol |
401-110-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
604-052-00-0 |
2,2'-Metilen-bis(6-(2H-benzotriazol-2-il)-4-(1,1,3,3-tetrametilbutil)fenol) |
403-800-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
604-053-00-6 |
2-Metil-4-(1,1-dimetiletil)-6-(1-metilpentadecil)fenol |
410-760-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
|
604-054-00-1 |
Masa de reacción de: 2-metoxi-4-(tetrahidro-4-metilen-2H-piran-2-il)-fenol; 4-(3,6-dihidro-4-metil-2H-piran-2-il)-2-metoxifenol |
412-020-0 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
604-055-00-7 |
2,2'-((3,3', 5,5'-Tetrametil-(1,1'-bifenil)-4,4'-diil)-bis(oximetilen))-bis-oxirano |
413-900-7 |
Carc. 2 Skin Sens. 1 |
H351 H317 |
GHS08 GHS07 Wng |
H351 H317 |
|
|
|
|
|
604-056-00-2 |
2-(2-Hidroxi-3,5-dinitroanilino)etanol |
412-520-9 |
Flam. Sol. 2 Repr. 2 Acute Tox. 4 * |
H228 H361f *** H302 |
GHS02 GHS07 GHS08 Dgr |
H228 H361f *** H302 |
|
|
|
|
|
604-057-00-8 |
Masa de reacción de: isómeros de 2-(2H-benzotriazol-2-il)-4-metil-(n)-dodecilfenol; isómeros de 2-(2H-benzotriazol-2-il)-4-metil-(n)-tetracosilfenol; isómeros de 2-(2H-benzotriazol-2-il)-4-metil-5,6-didodecilfenol n = 5 o 6 |
401-680-5 |
— |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
604-058-00-3 |
1,2-Bis(3-metilfenoxi)etano |
402-730-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
604-059-00-9 |
2-n-Hexadecilhidroquinona |
406-400-5 |
— |
STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H373 ** H315 H317 H413 |
GHS08 GHS07 Wng |
H373 ** H315 H317 H413 |
|
|
|
|
604-060-00-4 |
9,9-Bis(4-hidroxifenil)fluoreno |
406-950-6 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
|
|
604-061-00-X |
Masa de reacción de: 2-cloro-5-sec-tetradecilhidroquinonas, siendo sec-tetradecil= 1-metiltridecil; 1-etildodecil; 1-propilundecil; 1-butildecil; 1-pentilnonil; 1-hexiloctil |
407-740-7 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Wng |
H315 H317 H412 |
|
|
|
|
604-062-00-5 |
2,4-Dimetil-6-(1-metil-pentadecil)fenol |
411-220-5 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
604-063-00-0 |
5,6-Dihidroxiindol |
412-130-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
604-064-00-6 |
2-(4,6-Difenil-1,3,5-triazin-2-il)-5-((hexil)oxi)fenol |
411-380-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
604-065-00-1 |
4,4',4''-(1-Metilpropan-1-il-3-iliden)tris(2-ciclohexil-5-metilfenol) |
407-460-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
604-066-00-7 |
Masa de reacción de: fenol, 6-(1,1-dimetiletil)-4-tetrapropil-2-[(2-hidroxi-5-tetrapropilfenil)metil (C41-compuesto) y metano, 2,2'-bis[6-(1,1-dimetiletil)-1-hidroxi-4-tetrapropilfenil)]- (C45-compuesto); 2,6-bis(1,1-dimetiletil)-4-tetrapropilfenol y 2-(1,1-dimetiletil)-4-tetrapropilfenol; 2,6-bis[(6-(1,1-dimetiletil)-1-hidroxi-4-tetrapropilfenil)metil]-4-(tetrapropil)fenol y 2-[(6-(1,1-dimetiletil)-1-hidroxi-4-tetrapropilfenilmetil]-6-[1-hidroxi-4-tetrapropilfenil)metil]-4-(tetrapropil)fenol |
414-550-8 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
604-067-00-2 |
Masa de reacción de: 2,2'-[[(2-hidroxietil)imino]bis(metilen)bis[4-dodecilfenol]; formaldehído, oligómero con 4-dodecilfenol y 2-aminoetanol (n = 2); formaldehído, oligómero con 4-dodecilfenol y 2-aminoetanol (n = 3, 4 y superior) |
414-520-4 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
604-068-00-8 |
Clorhidrato de (±)-4-[2-[[3-(4-hidroxifenil)-1-metilpropil]amino]-1-hidroxietil]fenol |
415-170-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 |
H332 H302 H317 |
GHS07 Wng |
H332 H302 H317 |
|
|
|
|
|
604-069-00-3 |
2-(1-Metilpropil)-4-terc-butilfenol |
421-740-4 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
|
|
604-070-00-9 |
Triclosán; éter de 2,4,4'-tricloro-2'-hidroxidifenilo; 5-cloro-2-(2,4-diclorofenoxi)fenol |
222-182-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
M = 100 |
|
|
|
604-071-00-4 |
4,4'-(1-{4-[1-(4-Hidroxifenil)-1-metiletil]fenil}etiliden)difenol |
425-600-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
604-072-00-X |
1,2-Bis(fenoximetil)benceno |
428-620-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
604-073-00-5 |
(E)-3-[1-[4-[2-(Dimetilamino)etoxi]fenil]-2-fenilbut-1-enil]fenol |
428-010-4 |
Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360F*** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H351 H360F*** H317 H410 |
|
|
|
|
|
604-074-00-0 |
2,2’,6,6’-Tetrabromo-4,4’-isopropilidendifenol; tetrabromobisfenol-A |
201-236-9 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
604-075-00-6 |
4-(1,1,3,3-Tetrametilbutil)fenol; 4-terc-octilfenol |
205-426-2 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
M=10 |
|
|
|
604-076-00-1 |
Fenolftaleína |
201-004-7 |
Carc. 1B Muta. 2 Repr. 2 |
H350 H341 H361f*** |
GHS08 Dgr |
H350 H341 H361f*** |
|
Carc. 1B; H350: C ≥1 % |
|
|
|
604-077-00-7 |
2-Benzotriazol-2-il-4-metil-6-(2-metilalil)fenol |
419-750-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
604-079-00-8 |
4,4'-(1,3-Fenilenbis(1-metiletiliden))bisfenol |
428-970-4 |
Repr. 2 Skin Sens. 1 Aquatic Chronic 2 |
H361f*** H317 H411 |
GHS08 GHS07 GHS09 Wng |
H361f*** H317 H411 |
|
|
|
|
|
604-080-00-3 |
4-Fluoro-3-trifluorometilfenol |
432-560-0 |
Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Chronic 2 |
H332 H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H314 H317 H411 |
|
|
|
|
|
604-081-00-9 |
1,1-Bis(4-hidroxifenil)-1-feniletano |
433-130-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
604-082-00-4 |
2-Cloro-6-fluorofenol |
433-890-8 |
Muta. 1B Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H340 H361f*** H302 H314 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H340 H361f*** H302 H314 H317 H411 |
|
|
|
|
|
▼M22 ————— |
||||||||||
|
604-084-00-5 |
1-Etoxi-2,3-difluorobenceno |
441-000-4 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
604-087-00-1 |
Masa de reacción de: monoéster de 1,2-naftoquinonadiazida-5-sulfonilcloruro (o ácido sulfónico) con 4,4'-(1-(4-(1-(4-hidroxifenil)-1-metiletil)fenil)etiliden)bisfenol; diéster de 1,2-naftoquinonadiazida-5-sulfonilcloruro (o ácido sulfónico) con 4,4'-(1-(4-(1-(4-hidroxifenil)-1-metiletil)fenil)etiliden)bisfenol; triéster de 1,2-naftoquinonadiazida-5-sulfonilcloruro (o ácido sulfónico) con 4,4'-(1-(4-(1-(4-hidroxifenil)-1-metiletil)fenil)etiliden)bisfenol |
433-640-8 |
— |
Pyr. Sol. 1 Aquatic Chronic 4 |
H250 H413 |
GHS02 Dgr |
H250 H413 |
EUH044 |
|
|
|
604-089-00-2 |
2-Metil-5-terc-butiltiofenol |
444-970-7 |
— |
Flam. Liq. 3 Repr. 2 STOT RE 2 * Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H361d*** H373** H304 H319 H315 H317 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H361d*** H373** H304 H319 H315 H317 H336 H410 |
|
|
|
|
604-090-00-8 |
4-terc-Butilfenol |
202-679-0 |
Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 1 |
H361f H315 H318 H410 |
GHS08 GHS05 GHS09 Dgr |
H361f H315 H318 H410 |
|
M = 1 |
|
|
|
604-091-00-3 |
Etofenprox (ISO); éter de 2-(4-etoxifenil)-2-metilpropilo y 3-fenoxibencilo |
407-980-2 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
|
M = 100 M = 1 000 |
|
|
|
604-092-00-9 |
fenol, dodecil-, ramificado; [1] fenol, 2-dodecil-, ramificado; [2] fenol, 3-dodecil-, ramificado; [3] fenol, 4-dodecil-, ramificado; [4] fenol, derivados tetrapropenílicos [5] |
310-154-3 [1] [2] [3] [4] [5] |
121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5] |
Repr. 1B Skin Corr. 1C Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360F H314 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H360F H314 H410 |
|
M = 10 M = 10 |
|
|
604-093-00-4 |
Clorofeno; 2-bencil-4-clorofenol |
204-385-8 |
Carc. 2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Eye Dam. 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361f H332 H315 H317 H318 H373 (riñones) H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H361f H332 H315 H317 H318 H373 (riñones) H410 |
|
M = 1 M = 100 |
|
|
|
604-094-00-X |
Isoeugenol; [1] (E)-2-metoxi-4-(prop-1-enil)fenol; [2] (Z)-2-metoxi-4-(prop-1-enil)fenol [3] |
202-590-7 [1] 227-678-2 [2] 227-633-7 [3] |
97-54-1 [1] 5932-68-3 [2] 5912-86-7 [3] |
Skin Sens. 1A |
H317 |
GHS07 Wng |
H317 |
|
Skin Sens. 1A; H317: C ≥ 0,01 % |
|
|
604-095-00-5 |
6,6’-Di-terc-butil-2,2’-metilendi-p-cresol; [DBMC] |
204-327-1 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
604-096-00-0 |
Butóxido de piperonilo (ISO); éter de 2-(2-butoxietoxi)etil y 6-propilpiperonilo |
200-076-7 |
STOT SE 3 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H319 H400 H410 |
GHS07 GHS09 Wng |
H335 H319 H410 |
EUH066 |
M = 1 M = 1 |
|
|
|
604-097-00-6 |
2,4,6-Tri-terc-butilfenol |
211-989-5 |
Repr. 1B Acute Tox. 4 STOT RE 2 Skin Sens. 1B |
H360D H302 H373 (hígado) H317 |
GHS08 GHS07 Dgr |
H360D H302 H373 (hígado) H317 |
|
Por vía oral: ETA = 500 mg/kg pc |
|
|
|
604-098-00-1 |
4,4’-Sulfonildifenol; bisfenol S |
201-250-5 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
604-099-00-7 |
4,4’-[2,2,2-Trifluoro-1-(trifluorometil)etiliden]difenol; bisfenol AF |
216-036-7 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
604-100-00-0 |
Nonilfenol, ramificado y lineal, etoxilado (con una masa molecular media menor o igual a 1 540 g/mol) [incluye los isómeros orto-, meta-, para- o cualquier combinación de ellos] |
500-315-8 500-024-6 500-045-0 500-209-1 248-762-5 243-816-4 248-291-5 — 230-770-5 248-743-1 247-555-7 248-293-6 — y otros |
1119449-38-5 7311-27-5 27942-27-4 26264-02-8 27177-05-5 14409-72-4 y otros |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 1 M = 10 |
|
|
605-001-00-5 |
Formaldehído ... % |
200-001-8 |
Carc. 1B Muta. 2 Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1A |
H350 H341 H330 H302 H314 H317 |
GHS08 GHS06 GHS05 Dgr |
H350 H341 H330 H302 H314 H317 |
EUH071 |
Por inhalación: ETA = 100 ppmV (gases) Por vía oral: ETA = 500 mg/kg pc STOT SE 3; H335: C ≥ 5 % Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 5 % ≤ C < 25 % |
B, D, F |
|
|
605-002-00-0 |
1,3,5-Trioxano; trioximetileno |
203-812-5 |
Flam. Sol. 1 Repr. 2 STOT SE 3 |
H228 H361d *** H335 |
GHS02 GHS08 GHS07 Dgr |
H228 H361d *** H335 |
|
|
T |
|
|
605-003-00-6 |
Acetaldehído; etanal |
200-836-8 |
Flam. Liq. 1 Carc. 1B Muta. 2 STOT SE 3 Eye Irrit. 2 |
H224 H350 H341 H335 H319 |
GHS02 GHS08 GHS07 Dgr |
H224 H350 H341 H335 H319 |
|
|
|
|
|
605-004-00-1 |
2,4,6-Trimetil-1,3,5-trioxane; paraldehído |
204-639-8 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
|
605-005-00-7 |
Metaldehído (ISO); 2,4,6,8-tetrametil-1,3,5,7-tetraoxaciclooctano |
203-600-2 |
Flam. Sol. 2 Repr. 2 Acute Tox. 3 Aquatic Chronic 3 |
H228 H361f H301 H412 |
GHS02 GHS08 GHS06 Dgr |
H228 H361f H301 H412 |
|
Por vía oral: ETA = 283 mg/kg pc |
|
|
|
605-006-00-2 |
Butiraldehído |
204-646-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
605-007-00-8 |
1,1-Dimetoxietano; dimetilacetal |
208-589-8 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
605-008-00-3 |
Acroleína; prop-2-enal; acrilaldehído |
203-453-4 |
Flam. Liq. 2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H225 H330 H300 H311 H314 H400 H410 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H225 H330 H300 H311 H314 H410 |
EUH071 |
Skin Corr. 1B; H314:C≥ 0,1 % M = 100 M = 1 |
D |
|
|
605-009-00-9 |
Crotonaldehído; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehído [2] |
224-030-0 [1] 204-647-1 [2] |
4170-30-3 [1] 123-73-9 [2] |
Flam. Liq. 2 Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
|
|
|
|
605-010-00-4 |
2-Furaldehído |
202-627-7 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H331 H301 H312 H319 H335 H315 |
GHS06 GHS08 Dgr |
H351 H331 H301 H312 H319 H335 H315 |
|
|
|
|
|
605-011-00-X |
2-Clorobenzaldehído; o-clorobenzaldehído |
201-956-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
605-012-00-5 |
Benzaldehído |
202-860-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
605-013-00-0 |
cloralosa (DCI); (R)-1,2-O-(2,2,2-tricloroetiliden)-α-D-glucofuranosa; glucocloralosa; anhidroglucocloral |
240-016-7 |
Acute Tox. 4* Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H301 H336 H400 H410 |
GHS06 GHS09 Dgr |
H332 H301 H336 H410 |
|
M = 10 M = 10 |
C |
|
|
605-014-00-6 |
Hidrato de cloral; 2,2,2-tricloroetano-1,1-diol |
206-117-5 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Dgr |
H301 H319 H315 |
|
|
|
|
|
605-015-00-1 |
1,1-Dietoxietano; acetal |
203-310-6 |
Flam. Liq. 2 Eye Irrit. 2 Skin Irrit. 2 |
H225 H319 H315 |
GHS02 GHS07 Dgr |
H225 H319 H315 |
|
|
|
|
|
605-016-00-7 |
Glioxal al … %; etanodial al … % |
203-474-9 |
Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H341 H332 H319 H315 H317 |
GHS07 GHS08 Wng |
H341 H332 H319 H315 H317 |
|
* |
B |
|
|
605-017-00-2 |
1,3-Dioxolano |
211-463-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
605-018-00-8 |
Propanal; propionaldehído |
204-623-0 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
|
|
|
|
|
605-019-00-3 |
Citral |
226-394-6 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
|
605-020-00-9 |
Safrol; 5-alil-1,3-benzodioxol |
202-345-4 |
Carc. 1B Muta. 2 Acute Tox. 4 * |
H350 H341 H302 |
GHS08 GHS07 Dgr |
H350 H341 H302 |
|
|
|
|
|
605-021-00-4 |
Formaldehído, productos de reacción con butilfenol |
294-145-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
605-022-00-X |
glutaral; glutaraldehído; 1,5-pentanodial |
203-856-5 |
Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 2 |
H330 H301 H335 H314 H334 H317 H400 H411 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H330 H301 H335 H314 H334 H317 H410 |
EUH071 |
STOT SE 3; H335: 0,5 % ≤ C < 5 % M = 1 |
|
|
|
605-023-00-5 |
5-Cloro-2-(4-clorofenoxi)fenol; [DCPP] |
429-290-0 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
M = 10 M = 10 |
|
|
|
605-024-00-0 |
2-Bromo-5-hidroxi-4-metoxibenzaldehído |
426-540-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
605-025-00-6 |
Cloroacetaldehído |
203-472-8 |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H351 H330 H311 H301 H314 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H330 H311 H301 H314 H400 |
|
STOT SE 3; H335: C≥ 5 % |
|
|
|
605-026-00-1 |
2,5,7,7-Tetrametiloctanal |
405-690-0 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
|
605-027-00-7 |
Masa de reacción de: 3a,4,5,6,7,7a-hexahidro-4,7-metano-1H-indeno-6-carboxaldehído; 3a,4,5,6,7,7a-hexahidro-4,7-metano-1H-indeno-5-carboxaldehído |
410-480-7 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
605-028-00-2 |
β-Metil-3-(1-metiletil)-bencenopropanal |
412-050-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
605-029-00-8 |
2-Ciclohexilpropanal |
412-270-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
605-030-00-3 |
Oxima de 1-(p-metoxifenil)acetaldehído |
411-510-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
605-031-00-9 |
Masa de reacción de: 2,2-dimetoxietanal [Se considera que este componente es anhidro en cuanto a su identidad, estructura y composición. Sin embargo, existe el 2,2-dimetoxietanal en forma hidratada. Un 60 % de forma anhidra equivale a un 70,4 % de forma hidratada; agua (incluida el agua libre y el agua del 2,2-dimetoxietanal hidratado)] |
421-890-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-032-00-4 |
3-[3-(4-Fluorofenil)-1-(1-metiletil)-1H-indol-2-il]-(E)-2-propenal |
425-370-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
605-033-00-X |
Masa de reacción de: 3,7,11-trimetil-cis-6,10-dodecadienal; 3,7,11-trimetil-trans-6,10-dodecadienal |
425-910-9 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
605-034-00-5 |
Masa de reacción de: (1RS,2RS,3SR,6RS,9SR)-9-metoxitriciclo[5.2.1.0(2,6)]decano-3-carbaldehído; (1RS,2RS,3RS,6RS,8SR)-8-metoxitriciclo[5.2.1.0(2,6)]decano-3-carbaldehído; (1RS,2RS,4SR,6RS,8SR)-8-metoxitriciclo[5.2.1.0(2,6)]decano-4-carbaldehído |
429-860-9 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
605-035-00-0 |
(E)-3-(4-(4-Fluorofenil)-5-metoximetil-2,6-bis(1-metoximetil)piridin-3-il)prop-2-enal |
426-330-9 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H319 H317 H413 |
GHS07 Wng |
H319 H317 H413 |
|
|
|
|
|
605-036-00-6 |
2-Bromomalonaldehído |
430-470-6 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
605-037-00-1 |
trans-3-[2-(7-Cloro-2-quinolinil)vinil]benzaldehído; 3-[(E)-2-(7-cloro-2-quinolinil)vinil]benzaldehído |
421-800-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
605-038-00-7 |
3-Metil-5-fenilpentan-1-al |
433-900-0 |
Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H302 H315 H317 H411 |
GHS07 GHS09 Wng |
H302 H315 H317 H411 |
|
|
|
|
|
605-039-00-2 |
3,4-Dihidroxi-5-nitrobenzaldehído |
441-810-8 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
|
605-040-00-8 |
hidroxiisohexil 3-ciclohexeno carboxaldehído (INCI); masa de reacción de 4-(4-hidroxi-4-metilpentil)ciclohex-3-eno-1-carbaldehído y 3-(4-hidroxi-4-metilpentil)ciclohex-3-eno-1-carbaldehído; [1] 4-(4-hidroxi-4-metilpentil)ciclohex-3-eno-1-carbaldehído; [2] 3-(4-hidroxi-4-metilpentil)ciclohex-3-eno-1-carbaldehído [3] |
- [1] 250-863-4 [2] 257-187-9 [3] |
130066-44-3 [1] 31906-04-4 [2] 51414-25-6 [3] |
Skin Sens. 1A |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-041-00-3 |
2-(4-tert-Butilbencil)propionaldehído |
201-289-8 |
Repr. 1B |
H360Fd |
GHS08 Dgr |
H360Fd |
|
|
|
|
|
605-042-00-9 |
α-Metil-1,3-benzodioxol-5-propionaldehído [1] (S)-α-metil-1,3-benzodioxol-5-propionaldehído; (2S)-3-(1,3-benzodioxol-5-il)-2-metilpropanal [2] (R)-α-metil-1,3-benzodioxol-5-propionaldehído; (2R)-3-(1,3-benzodioxol-5-il)-2-metilpropanal [3] |
214-881-6 [1] - [2] - [3] |
1205-17-0 [1] 737776-68-0 [2] 737776-59-9 [3] |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-043-00-4 |
2,4-Dimetilciclohex-3-eno-1-carbaldehído [1] (1α,2α,5α)-2,5-dimetilciclohex-3-ene-1-carbaldehído [2] 2,6-dimetilciclohex-3-eno-1-carbaldehído [3] 3,5-dimetilciclohex-3-eno-1-carbaldehído [4] 3,6-dimetilciclohex-3-eno-1-carbaldehído [5] 4,6-dimetilciclohex-3-eno-1-carbaldehído [6] masa de reacción del 3,5-dimetilciclohex-3-eno-1-carbaldehído y 2,4-dimetilciclohex-3-ene-1-carbaldehído [7] dimetilciclohex-3-eno-1-carbaldehído [8] dimetilciclohex-3-eno-1-carbaldehído [9] 1,2,4(o 1,3,5)-trimetilciclohex-3-eno-1-carbaldehído [10] 1,3,4-trimetilciclohex-3-eno-1-carbaldehído [11] 2,2,4-trimetilciclohex-3-eno-1-carbaldehído [12] 2,4,6-trimetilciclohex-3-enocarbaldehído [13] isociclocitral [14] 3,5,6-trimetilciclohex-3-eno-1-carbaldehído [15] 4,6,6-trimetilciclohex-3-eno-1-carbaldehído [16] |
268-264-1 [1] 252-395-6 [2] - [3] 268-263-6 [4] 267-186-5 [5] 253-139-6 [6] - [7] 248-742-6 [8] 272-113-5 [9] 276-055-1 [10] - [11] - [12] 215-833-7 [13] 215-638-7 [14] 266-810-3 [15] - [16] |
68039-49-6 [1] 35145-02-9 [2] 6975-94-6 [3] 68039-48-5 [4] 67801-65-4 [5] 36635-35-5 [6] - [7] 27939-60-2 [8] 68737-61-1 [9] 71832-78-5 [10] 40702-26-9 [11] 1726-47-2 [12] 1423-46-7 [13] 1335-66-6 [14] 67634-07-5 [15] 6754-27-4 [16] |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
606-001-00-8 |
Acetona; propan-2-ona; propanona |
200-662-2 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
|
606-002-00-3 |
Butanona; etilmetilcetona |
201-159-0 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
|
606-003-00-9 |
Heptan-3-ona; butiletilcetona |
203-388-1 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 |
H226 H332 H319 |
GHS02 GHS07 Wng |
H226 H332 H319 |
|
|
|
|
|
606-004-00-4 |
4-Metilpentan-2-ona; isobutilmetilcetona |
203-550-1 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 |
H225 H351 H332 H336 H319 |
GHS02 GHS07 GHS08 Dgr |
H225 H351 H332 H336 H319 |
EUH066 |
Por inhalación: ETA = 11 mg/l (vapores) |
|
|
|
606-005-00-X |
2,6-Dimetilheptan-4-ona; diisobutilcetona |
203-620-1 |
Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Wng |
H226 H335 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
606-006-00-5 |
Pentan-3-ona; dietilcetona |
202-490-3 |
Flam. Liq. 2 STOT SE 3 STOT SE 3 |
H225 H335 H336 |
GHS02 GHS07 Dgr |
H225 H335 H336 |
EUH066 |
|
|
|
|
606-007-00-0 |
3-Metilbutan-2-ona; metilisopropilcetona |
209-264-3 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
606-009-00-1 |
4-Metilpent-3-en-2-ona; óxido de mesitilo |
205-502-5 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H312 H302 |
GHS02 GHS07 Wng |
H226 H332 H312 H302 |
|
* |
|
|
|
606-010-00-7 |
Ciclohexanona |
203-631-1 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-011-00-2 |
2-Metilciclohexanona |
209-513-6 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-012-00-8 |
3,5,5-Trimetilciclohex-2-enona; isoforona |
201-126-0 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H351 H312 H302 H319 H335 |
GHS08 GHS07 Wng |
H351 H312 H302 H319 H335 |
|
STOT SE 3; H335: C ≥10 % |
|
|
|
606-013-00-3 |
p-Benzoquinona; quinona |
203-405-2 |
Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H331 H301 H319 H335 H315 H400 |
GHS06 GHS09 Dgr |
H331 H301 H319 H335 H315 H400 |
|
M=10 |
|
|
|
606-014-00-9 |
clorofacinona (ISO); 2-[(4-clorofenil)(fenil)acetil]-1H-indeno-1,3(2H)-diona |
223-003-0 |
Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (sangre) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (sangre) H410 |
|
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (sangre): C ≥ 0,1 % STOT RE 2; H373 (sangre): 0,01 % ≤ C < 0,1 % M = 1 M = 1 |
|
|
|
606-016-00-X |
Pindona (ISO); 2-pivaloilindan-1,3-diona |
201-462-8 |
Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H372 ** H410 |
|
|
|
|
|
606-017-00-5 |
Diceteno; dicetén |
211-617-1 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
D |
|
|
606-018-00-0 |
Diclona (ISO); 2,3-dicloro-1,4-naftoquinona |
204-210-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
|
606-019-00-6 |
Clordecona (ISO); percloropentaciclo[5,3,0,02,6,03,9,04,8]decan-5-ona; decacloropentaciclo[5,2,1,02,6,03,9,05,8]decan-4-ona |
205-601-3 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H410 |
|
|
|
|
|
606-020-00-1 |
5-Metilheptan-3-ona |
208-793-7 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Wng |
H226 H319 H335 |
|
STOT SE 3; H335: C≥10 % |
|
|
|
606-021-00-7 |
N-metil-2-pirrolidona; 1-metil-2-pirrolidona |
212-828-1 |
Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 |
H360D*** H335 H315 H319 |
GHS08 GHS07 Dgr |
H360D*** H335 H315 H319 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
606-022-00-2 |
1-Fenil-3-pirazolidona |
202-155-1 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
606-023-00-8 |
4-Metoxi-4-metilpentan-2-ona |
203-512-4 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-024-00-3 |
Heptan-2-ona; metilamilcetona |
203-767-1 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H302 |
GHS02 GHS07 Wng |
H226 H332 H302 |
|
|
|
|
|
606-025-00-9 |
Ciclopentanona |
204-435-9 |
Flam. Liq. 3 Eye Irrit. 2 Skin Irrit. 2 |
H226 H319 H315 |
GHS02 GHS07 Wng |
H226 H319 H315 |
|
|
|
|
|
606-026-00-4 |
5-Metilhexan-2-ona; isoamilmetilcetona |
203-737-8 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-027-00-X |
Heptan-4-ona; di-n-propilcetona |
204-608-9 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-028-00-5 |
2,4-Dimetilpentan-3-ona; di-isopropilcetona |
209-294-7 |
Flam. Liq. 2 Acute Tox. 4 * |
H225 H332 |
GHS02 GHS07 Dgr |
H225 H332 |
|
|
|
|
|
606-029-00-0 |
Pentano-2,4-diona; acetilacetona |
204-634-0 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H302 |
GHS02 GHS07 Wng |
H226 H302 |
|
|
|
|
|
606-030-00-6 |
Hexan-2-ona; metilbutilcetona; butilmetilcetona; metil-n-butil-cetona |
209-731-1 |
Flam. Liq. 3 Repr. 2 STOT RE 1 STOT SE 3 |
H226 H361f *** H372 ** H336 |
GHS02 GHS08 GHS07 Dgr |
H226 H361f *** H372 ** H336 |
|
|
|
|
|
606-031-00-1 |
3-Propanólido; 1,3-propiolactona |
200-340-1 |
Carc. 1B Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 |
H350 H330 H319 H315 |
GHS06 GHS08 Dgr |
H350 H330 H319 H315 |
|
|
|
|
|
606-032-00-7 |
Hexacloroacetona |
204-129-5 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
606-033-00-2 |
2-(3,4-Diclorofenil)-4-metil-1,2,4-oxadiazolidinadiona; metazol |
243-761-6 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H312 H302 H319 H315 H411 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H411 |
|
|
|
|
|
606-034-00-8 |
Metribuzina (ISO); 4-amino-6-tert-butil-3-metiltio-1,2,4-triazin-5(4H)-ona; 4-amino-4,5-dihidro-6-(1,1-dimetiletil)-3-metiltio-1,2,4-triazin-5-ona |
244-209-7 |
Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 (sistema sanguíneo) H400 H410 |
GHS07 GHS08 GHS09 Wng |
H302 H373 (sistema sanguíneo) H410 |
|
Por vía oral: ETA = 320 mg/kg pc M = 10 M = 10 |
|
|
|
606-035-00-3 |
Cloridazón (ISO); 5-amino-4-cloro-2-fenilpiridazina-3-(2H)-ona; pirazón |
216-920-2 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
606-036-00-9 |
Quinometionato; chinometionato (ISO); 6-metil-1,3-ditiolo(4,5-b)quinoxalin-2-ona |
219-455-3 |
Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H332 H312 H302 H373 ** H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f *** H332 H312 H302 H373 ** H319 H317 H410 |
|
|
|
|
|
606-037-00-4 |
Triadimefón (ISO); 1-(4-clorofenoxi)-3,3-dimetil-1-(1,2,4-triazol-1-il)butanona |
256-103-8 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
606-038-00-X |
Difacinona (ISO); 2-difenilacetilindan-1,3-diona |
201-434-5 |
Acute Tox. 2 * STOT RE 1 |
H300 H372 ** |
GHS06 GHS08 Dgr |
H300 H372 ** |
|
|
|
|
|
606-039-00-5 |
5(o 6)-terc-Butil-2'-cloro-6'-etilamino-3',7'-dimetilespiro(isobenzofuran-1(1H),9'-xanten)-3-ona |
400-680-2 |
— |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H400 H410 |
GHS07 GHS09 Wng |
H332 H410 |
|
|
|
|
606-040-00-0 |
Clorhidrato de (N-bencil-N-etil)amino-3-hidroxiacetofenona |
401-840-4 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
606-041-00-6 |
2-Metil-1-(4-(metiltiofenil)-2-morfolinopropan-1-ona |
400-600-6 |
Repr. 1B Acute Tox. 4* Aquatic Chronic 2 |
H360FD H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H360FD H302 H411 |
|
|
|
|
|
606-042-00-1 |
Acetofenona |
202-708-7 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
606-043-00-7 |
2,4-di-terc-Butilciclohexanona |
405-340-7 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
606-044-00-2 |
2,4,6-Trimetilbenzofenona |
403-150-9 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
|
|
606-045-00-8 |
Oxadiazón (ISO); 3-[2,4-dicloro-5-(1-metiletoxi)fenil]-5-(1,1-dimetiletil)-1,3,4-oxadiazol-2(3H)-ona |
243-215-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-046-00-3 |
Masa de reacción de cis- y trans-ciclohexadec-8-en-1-ona |
401-700-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-047-00-9 |
2-Bencil-2-dimetilamino-4′-morfolinobutirofenona |
404-360-3 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360D H400 H410 |
GHS08 GHS09 Dgr |
H360D H410 |
|
|
|
|
|
606-048-00-4 |
2'-Anilino-3'-metil-6'-dipentilaminoespiro(isobenzofuran-1(1H),9'-xanten)-3-ona |
406-480-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-049-00-X |
4-(trans-4-Propilciclohexil)acetofenona |
406-700-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-050-00-5 |
6-Anilino-1-benzoil-4-(4-terc-pentilfenoxi)nafto[1,2,3-de]quinolina-2,7-(3H)-diona |
412-480-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-051-00-0 |
4-Pentilciclohexanona |
406-670-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-052-00-6 |
4-(N,N-Dibutilamino)-2-hidroxi-2'-carboxibenzofenona |
410-410-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
606-053-00-1 |
Flurtamona (ISO); (RS)-5-metilamino-2-fenil-4-(α, α,α-trifluoro-m-tolil)furan-3(2H)-ona |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-054-00-7 |
isoxaflutol (ISO); 5-ciclopropil-1,2-oxazol-4-il α,α,α-trifluor-2-mesil-p-tolil cetona |
— |
Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H400 H410 |
GHS08 GHS09 Wng |
H361d *** H410 |
|
M = 10 M = 100 |
|
|
|
606-055-00-2 |
1-(2,3-Dihidro-1,3,3,6-tetrametil-1-(1-metiletil)-1H-inden-5-il)etanona |
411-180-9 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
|
|
606-056-00-8 |
4-Cloro-3',4'-dimetoxibenzofenona |
404-610-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-057-00-3 |
4-Propilciclohexanona |
406-810-4 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
606-058-00-9 |
4'-Fluoro-2,2-dimetoxiacetofenona |
407-500-1 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
606-059-00-4 |
Clorhidrato de 2,4-difluoro-α-(1H-1,2,4-triazol-1-il)acetofenona |
412-390-3 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
|
606-060-00-X |
Masa de reacción de: trans-2,4-dimetil-2-(5,6,7,8-tetrahidro-5,5,8,8-tetrametil-naftalen-2-il)-1,3-dioxolano; cis-2,4-dimetil-2-(5,6,7,8-tetrahidro-5,5,8,8-tetrametil-naftalen-2-il)-1,3-dioxolano |
412-950-7 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-061-00-5 |
(3-Clorofenil)-(4-metoxi-3-nitrofenil)metanona |
423-290-4 |
Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H400 H410 |
GHS08 GHS09 Wng |
H341 H410 |
|
|
|
|
|
606-062-00-0 |
Tetrahidrotiopirano-3-carboxaldehído |
407-330-8 |
Repr. 1B Eye Dam. 1 Aquatic Chronic 3 |
H360D *** H318 H412 |
GHS08 GHS05 Dgr |
H360D *** H318 H412 |
|
|
|
|
|
606-063-00-6 |
(E)-3-(2-Clorofenil)-2-(4-fluorofenil)propenal |
410-980-5 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
|
606-064-00-1 |
Bis(etilencetal) de la pregn-5-eno-3,20-diona |
407-450-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-065-00-7 |
1-(4-Morfolinofenil)butan-1-ona |
413-790-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-066-00-2 |
(E)-5[(4-Clorofenil)metilen]-2,2-dimetilciclopentanona |
410-440-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-067-00-8 |
Masa de reacción de: 1-(2,3,6,7,8,9-hexahidro-1,1-dimetil-1H-benc(g)inden-4-il)etanona; 1-(2,3,5,6,7,8-hexahidro-1,1-dimetil-1H-benc(f)inden-4-il)etanona; 1-(2,3,6,7,8,9-hexahidro-1,1-dimetil-1H-benc(g)inden-5-il)etanona; 1-(2,3,6,7,8,9-hexahidro-3,3-dimetil-1H-benc(g)inden-5-il)etanona |
414-870-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-068-00-3 |
2,7,11-Trimetil-13-(2,6,6-trimetilciclohex-1-en-1-il)tridecahexaen-2,4,6,8,10,12-al |
415-770-7 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H317 H412 |
GHS08 GHS07 Wng |
H373 ** H317 H412 |
|
|
|
|
|
606-069-00-9 |
Espiro[1,3-dioxolano-2,5'-(4',4',8',8'-tetrametil-hexahidro-3',9'-metanonaftaleno)] |
415-460-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-070-00-4 |
Butroxidim (ISO); 5-(3-butiril-2,4,6-trimetilfenil)-2-[1-(etoxiimino)propil]-3-hidroxiciclohex-2-en-1-ona |
414-790-3 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361fd H302 H315 H410 |
|
|
|
|
|
606-071-00-X |
17-Espiro(5,5-dimetil-1,3-dioxan-2-il)androsta-1,4-dien-3-ona |
421-050-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-072-00-5 |
3-Acetil-1-fenil-pirrolidina-2,4-diona |
421-600-2 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
|
|
606-073-00-0 |
4,4'-Bis(dimetilamino)benzofenona; cetona de Michler |
202-027-5 |
Carc. 1B Muta. 2 Eye Dam. 1 |
H350 H341 H318 |
GHS08 GHS05 Dgr |
H350 H341 H318 |
|
|
|
|
|
606-074-00-6 |
Masa de reacción de: (1R*,2S*)-2-acetil-1,2,3,4,5,6,7,8-octahidro-1,2,8,8-tetrametilnaftaleno; (2R*,3S*)-2-acetil-1,2,3,4,5,6,7,8-octahidro-2,3,8,8-tetrametilnaftaleno |
425-570-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-075-00-1 |
1-Bencil-5-etoxiimidazolidina-2,4-diona |
417-340-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
606-076-00-7 |
1-((2-Quinolinil-carbonil)oxi)-2,5-pirrolidinadiona |
418-630-3 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
606-077-00-2 |
(3S,4S)-3-Hexil-4-[(R)-2-hidroxitridecil]-2-oxetanona |
418-650-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-078-00-8 |
1-Octilazepin-2-ona |
420-040-6 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
|
606-079-00-3 |
2-n-Butil-benzo[d]isotiazol-3-ona |
420-590-7 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
606-081-00-4 |
(3β, 5α, 6β)-3-(Acetiloxi)-5-bromo-6-hidroxi-androstan-17-ona |
419-790-7 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
606-082-00-X |
Masa de reacción de: oxima de butan-2-ona; syn-O,O'-di(oxima de butan-2-ona)dietoxisilano |
406-930-7 |
|
STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H372 ** H317 H412 |
GHS08 GHS07 Dgr |
H372 ** H317 H412 |
|
|
|
|
606-083-00-5 |
2-Cloro-5-sec-hexadecilhidroquinona |
407-750-1 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H315 H317 H412 |
GHS07 Wng |
H319 H315 H317 H412 |
|
|
|
|
|
606-084-00-0 |
1-(4-Metoxi-5-benzofuranil)-3-fenil-1,3-propanodiona |
414-540-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-085-00-6 |
(1R,4S)-2-Azabiciclo[2.2.1]hept-5-en-3-ona |
418-530-1 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
|
606-086-00-1 |
1-(3,3-Dimetilciclohexil)pent-4-en-1-ona |
422-330-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-087-00-7 |
6-Etil-5-fluoro-4(3H)-pirimidona |
422-460-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
606-088-00-2 |
2,4,4,7-Tetrametil-6-octen-3-ona |
422-520-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
606-089-00-8 |
Masa de reacción de: 1,4-diamino-2-cloro-3-fenoxiantraquinona; 1,4-diamino-2,3-bisfenoxiantraquinona |
423-220-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-090-00-3 |
1-[3-[(Dimetilamino)metil]-4-hidroxifenil]etanona |
430-920-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
606-091-00-9 |
6-Cloro-5-(2-cloroetil)-1,3-dihidroindol-2-ona |
421-320-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-092-00-4 |
Masa de reacción de: (E)-oxaciclohexadec-12-en-2-ona; (E)-oxaciclohexadec-13-en-2-ona; a) (Z)-oxaciclohexadec-(12)-en-2-ona y b) (Z)-oxaciclohexadec-(13)-en-2-ona |
422-320-3 |
|
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-093-00-X |
5-Etil-2,4-dihidro-4-(2-fenoxietil)-3H-1,2,4-triazol-3-ona |
414-470-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
606-094-00-5 |
N-[Etil(3-metilbutil)amino]-3-metil-1-fenil-espiro[[1]benzopirano[2,3-c]pirazol-4(1H),1'(3'H)-isobenzofuran]-3'-ona |
417-460-7 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-095-00-0 |
(R, S)-2-Azabiciclo[2.2.1]hept-5-en-3-ona |
421-830-3 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
|
606-096-00-6 |
3-(6-O-(6-Desoxi-α-l-manopiranosil-O-(α-d-glucopiranosil)-(β-d-glucopiranosil)oxi)-2-(3,4-dihidroxifenil)-5,7-dihidroxi-4H-1-benzopiran-4-ona |
424-170-4 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
606-097-00-1 |
2,2''-Dihidroxi-4,4''-(2-hidroxi-propano-1,3-diildioxi)dibenzofenona |
424-210-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-098-00-7 |
1-Bencil-5-(hexadeciloxi)-2,4-imidazolidinadiona |
431-220-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-099-00-2 |
5-Metoxi-4'-(trifluorometil)valerofenona |
425-000-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-100-00-6 |
2-Butiril-3-hidroxi-5-tiociclohexan-3-il-ciclohex-2-en-1-ona |
425-150-8 |
Repr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H360F*** H302 H317 H412 |
GHS08 GHS07 Dgr |
H360F*** H302 H317 H412 |
|
|
|
|
|
606-101-00-1 |
Masa de reacción de: 1,5-bis[(2-etilhexil)amino]-9,10-antracenodiona; 1-[(2-etilhexil)amino]-5-[3-[(2-etilhexil)oxi]propil]amino-9,10-antracenodiona; 1,5-bis[3-[(2-etilhexil)oxi]propil]amino-9,10-antracenodiona; 1-[(2-etilhexil)amino]-5-[(3-metoxipropil)amino]-9,10-antracenodiona; 1-[3-[(2-etilhexil)oxi]propil]amino-5-[(3-metoxipropil)amino]-9,10-antracenodiona; 1,5-bis[(3-metiloxipropil)amino]-9,10-antracenodiona |
426-050-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-102-00-7 |
4-(3-Trietoxisililpropoxi)-2-hidroxibenzofenona |
431-490-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-103-00-2 |
1-(4-(trans-4-Etilciclohexil)fenil)etanona |
426-460-6 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
606-104-00-8 |
1-(4-(trans-4-Pentilciclohexil)fenil)etanona |
426-830-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-105-00-3 |
3,4,3', 4'-Tetrafenil-1,1'-etanodiilbispirol-2,5-diona |
431-500-0 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-106-00-9 |
1-(4-(trans-4-Butilciclohexil)fenil)etanona |
427-320-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-107-00-4 |
8-Azaespiro[4.5]decano-7,9-diona |
427-770-4 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
|
|
606-108-00-X |
1,1,1,2,2,4,5,5,5-Nonafluoro-4-(trifluorometil)-3-pentanona |
436-710-6 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
606-109-00-5 |
2-(4-Metil-3-pentenil)antraquinona |
428-320-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 4 |
H302 H317 H413 |
GHS07 Wng |
H302 H317 H413 |
|
|
|
|
|
606-110-00-0 |
5-Etoxi-5H-furan-2-ona |
428-330-4 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H312 H302 H373** H317 |
GHS05 GHS08 GHS07 Dgr |
H314 H312 H302 H373** H317 |
|
|
|
|
|
606-111-00-6 |
5-Amino-6-metil-1,3-dihidrobenzoimidazol-2-ona |
428-410-9 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
606-112-00-1 |
(4aR*,8aR*)-4a,5,9,10,11,12-Hexahidro-3-metoxi-11-metil-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ona |
428-690-2 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 3 |
H302 H319 H412 |
GHS07 Wng |
H302 H319 H412 |
|
|
|
|
|
606-113-00-7 |
1-[4-(4-Benzoilfenilsulfanil)fenil]-2-metil-2-(4-metilfenilsulfonil)propan-1-ona |
429-040-0 |
Eye Dam. 1 Aquatic Chronic 4 |
H318 H413 |
GHS05 Dgr |
H318 H413 |
|
|
|
|
|
606-114-00-2 |
4,4',5,5',6,6',7,7'-Octacloro-(2,2')biisoindolil-1,1',3,3'-tetraona |
429-150-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-115-00-8 |
Profoxidim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-Clorofenoxi)propoxiimino]butil}-3-hidroxi-5-(tian-3-il)ciclohex-2-en-1-ona |
— |
Carc. 2 Repr. 2 Skin Sens. 1 |
H351 H361d H317 |
GHS08 GHS07 Wng |
H351 H361d H317 |
|
|
|
|
|
606-116-00-3 |
Tepraloxidim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-Cloroaliloxiimino]propil}-3-hidroxi-5-perhidropiran-4-il-ciclohex-2-en-1-ona |
— |
Carc. 2 Repr. 2 |
H351 H361fd |
GHS08 Wng |
H351 H361fd |
|
|
|
|
|
606-117-00-9 |
2,6-Bis(1,1-dimetiletil)-4-(fenilenmetilen)ciclohexa-2,5-dien-1-ona |
429-460-4 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-118-00-4 |
N-(1,3-Dimetilbutil)-N'-(fenil)-1,4-benzoquinonadiimina |
429-640-2 |
Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H400 H410 |
GHS07 GHS09 Wng |
H319 H410 |
|
|
|
|
|
606-119-00-X |
(E)-3-Metil-5-ciclopentadecen-1-ona |
429-900-5 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
606-120-00-5 |
2,5-Dihidroxi-5-metil-3-(morfolin-4-il)-2-ciclopenten-1-ona |
430-170-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
606-121-00-0 |
(+)-(1S,2S,3S,5R)-2,6,6-Trimetilbiciclo[3.1.1]heptano-3-espiro-1'-(ciclohex-2'-en-4'-ona) |
430-460-1 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
|
|
606-122-00-6 |
3-(2-Bromopropionoil)-4,4-dimetil-1,3-oxazolan-2-ona |
430-820-8 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H315 H318 H317 H410 |
|
|
|
|
|
606-123-00-1 |
4-Hexadecil-1-fenilpirazolidin-3-ona |
430-840-7 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
606-124-00-7 |
1-Ciclopropil-3-(2-metiltio-4-trifluorometilfenil)-1,3-propanodiona |
421-080-7 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
|
|
|
|
606-125-00-2 |
1-Bencilimidazolidina-2,4-diona |
421-340-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
606-126-00-8 |
1,4-Bis(2,3-dihidroxipropilamino)antraquinona |
421-470-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-128-00-9 |
2,2'-(1,3-Fenilen)bis[5-cloro-1H-isoindol]-1,3(2H)-diona |
422-650-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-129-00-4 |
5-Amino-[2S-di(metilfenil)amino]-1,6-difenil-4Z-hexen-3-ona; (2S,4Z)-5-amino-2-(dibencilamino)-1,6-difenilhex-4-en-3-ona |
423-090-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-130-00-X |
4-(1,4-Dioxaespiro[4.5]dec-8-il)-ciclohexanona |
423-860-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
606-131-00-5 |
3-(1,2-Etanodiilacetal) cíclico de la estra-5(10),9(11)-dien-3,17-diona |
427-230-8 |
Repr. 1B STOT RE 2 * Aquatic Chronic 2 |
H360F*** H373** H411 |
GHS08 GHS09 Dgr |
H360F*** H373** H411 |
|
|
|
|
|
606-132-00-0 |
(6β)-6,19-Epoxiandrost-4-en-3,17-diona |
433-490-3 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
606-134-00-1 |
Androsta-1,4,9(11)-trien-3,17-diona |
433-560-3 |
Repr. 2 |
H361f*** |
GHS08 Wng |
H361f*** |
|
|
|
|
|
606-135-00-7 |
Ciclohexadecanona |
438-930-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-136-00-2 |
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-Dibencil-3,9,15,21-tetraisobutil-4,10,12,16,22,24-hexametil-1,7,13,19-tetraoxa-4,10,16,22-tetraazaciclo-tetracosan-2,5,8,11,14,17,20,23-octaona |
444-350-6 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
|
|
606-137-00-8 |
trans-7,7'-Dimetil-(4H,4H')-(2,2')bi[benzo[1,4]tiaziniliden]-3,3'-diona |
444-750-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-138-00-3 |
(2-Butil-5-nitrobenzofuran-3-il)[4-(3-dibutilaminopropoxi)fenil]metanona |
444-800-1 |
Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373** H315 H318 H317 H400 H410 |
GHS02 GHS05 GHS08 GHS07 GHS09 Dgr |
H226 H302 H373** H315 H318 H317 H410 |
|
M=10 |
|
|
|
606-139-00-9 |
(S)-4-(3,4-Diclorofenil)-3,4-dihidro-2H-naftalen-1-ona |
444-830-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-140-00-4 |
2-Hidroxi-1-(4-(4-(2-hidroxi-2-metilpropionil)bencil)fenil)-2-metilpropan-1-ona |
444-860-9 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wn |
H373** H410 |
|
|
|
|
|
606-141-00-X |
3-(Metoxicarbonil)-4-oxo-3,4,5,6-tetrahidro-2-piridinolato de sodio |
418-410-7 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
606-142-00-5 |
Masa de reacción de: (1RS, 2SR,7SR, 8SR, E) 9 y 10-etiliden-3-oxatriciclo[6.2.1.0(2,7)]undecan-4-ona; (1RS,2SR,7SR,8SR, Z)-10-etiliden-3-oxatriciclo[6.2.1.0(2,7)]undecan-4-ona; (1RS, 2SR,7SR,8SR, Z)-9-etiliden-3-oxatriciclo[6.2.1.0(2,7)]undecan-4-ona |
434-290-9 |
— |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
606-143-00-0 |
Abamectina (combinación de avermectina B1a y avermectina B1b) (ISO) [1] avermectina B1a (pureza ≥ 80 %); [2] |
_ [1] 265-610-3 [2] |
71751-41-2 [1] 65195-55-3 [2] |
Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H300 H330 H372 (sistema nervioso) H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d H300 H330 H372 (sistema nervioso) H410 |
|
STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C< 5 % M = 10 000 |
|
|
606-144-00-6 |
Acequinocilo (ISO); acetato de 3-dodecil-1,4-dioxo-1,4-dihidronaftalen-2-ilo |
— |
Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H370 (pulmones) (inhalación) H373 (sistema sanguíneo) H400 H410 |
GHS07 GHS08 GHS09 Dgr |
H317 H370 (pulmones) (inhalación) H373 (sistema sanguíneo) H410 |
|
M = 1 000 |
|
|
|
606-145-00-1 |
Sulcotriona (ISO); 2-[2-cloro-4-(metilsulfonil)benzoil]ciclohexano-1,3-diona |
|
Repr. 2 STOT RE 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H361d H373 (riñones) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H373 (riñones) H317 H410 |
|
M = 1 M = 10 |
|
|
|
606-146-00-7 |
Tralkoxidim (ISO); 2-(N-etoxipropanimidoil)-3-hidroxi-5-mesitilciclohex-2-en-1-ona |
— |
Carc. 2 Acute Tox. 4 Aquatic Chronic 2 |
H351 H302 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H411 |
|
|
|
|
|
606-147-00-2 |
Cicloxidim (ISO); 2-(N-etoxibutanimidoil)-3-hidroxi-5-(tetrahidro-2H-tiopiran-3-il)ciclohex-2-en-1-ona |
405-230-9 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
|
606-148-00-8 |
carvona (ISO); 2-metil-5-(prop-1-en-2-il)ciclohex-2-en-1-ona; [1] d-carvona; (5S)-2-metil-5-(prop-1-en-2-il)ciclohex-2-en-1-ona; [2] l-carvona; (5R)-2-metil-5-(prop-1-en-2-il)ciclohex-2-en-1-ona [3] |
202-759-5 [1] 218-827-2 [2] 229-352-5 [3] |
99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3] |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
606-149-00-3 |
tembotriona (ISO); 2-{2-cloro-4-(metilsulfonil)-3-[(2,2,2-trifluoroetoxi)metil]benzoil}ciclohexano-1,3-diona |
— |
Repr. 2 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H373 (ojos, riñones, hígado) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H373 (ojos, riñones, hígado) H317 H410 |
|
M = 100 M = 10 |
|
|
|
606-150-00-9 |
Cletodim (ISO); (5RS)-2-{(1EZ)-1- [(2E)-3-cloroaliloxiimino]propil}-5-[(2RS)-2-(etiltio)propil]-3-hidroxiciclohex-2-en-1-ona |
— |
Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
EUH066 |
|
|
|
|
606-151-00-4 |
Antraquinona |
201-549-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
606-152-00-X |
(5-Cloro-2-metoxi-4-metil-3-piridil)(4,5,6-trimetoxi-o-tolil)metanona; piriofenona |
- |
Carc. 2 Aquatic Chronic 1 |
H351 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 1 |
|
|
|
606-153-00-5 |
Benzofenona |
204-337-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
606-154-00-0 |
Quinoclamina (ISO); 2-amino-3-cloro-1,4-naftoquinona |
220-529-2 |
Carc. 2 Repr. 2 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d H302 H373 (sistema sanguíneo, riñones) H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361d H302 H373 (sistema sanguíneo, riñones) H319 H317 H410 |
|
Por vía oral: ETA = 500 mg/kg pc M = 10 M = 10 |
|
|
|
606-155-00-6 |
Cinamaldehído; 3-fenilprop-2-enal; aldehído cinámico; cinamal [1] (2E)-3-fenilprop-2-enal [2] |
203-213-9 [1]-[2] |
104-55-2 [1] 14371-10-9 [2] |
Skin Sens. 1A |
H317 |
GHS07 Wng |
H317 |
|
►C15 Skin Sens. 1A; H317: C ≥ 0,01 % ◄ |
|
|
606-156-00-1 |
Oxima de acetona |
204-820-1 |
Carc. 1B Acute Tox. 4 STOT SE 3 STOT RE 2 Eye Dam. 1 Skin Sens. 1 |
H350 H312 H336 H373 (sistema sanguíneo) H318 H317 |
GHS08 GHS07 GHS05 Dgr |
H350 H312 H336 H373 (sistema sanguíneo) H318 H317 |
|
Por vía cutánea: ETA = 1 100 mg/kg pc |
|
|
|
606-157-00-7 |
(3E)-Dec-3-en-2-ona |
— |
Acute Tox. 4 Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 2 |
H332 H304 H315 H411 |
GHS07 GHS08 GHS09 Dgr |
H332 H304 H315 H411 |
EUH071 |
Por inhalación: ETA = 1,5 mg/l (polvos o nieblas) |
|
|
|
606-158-00-2 |
2-(Dimetilamino)-2-[(4-metilfenil)metil]-1-[4-(morfolin-4-il)fenil]butan-1-ona |
438-340-0 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H400 H410 |
GHS08 GHS09 Dgr |
H360Df H410 |
|
M = 1 M = 1 |
|
|
|
607-001-00-0 |
Ácido fórmico ... % |
200-579-1 |
Flam. Liq. 3 Met. Corr. 1 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Eye Dam. 1 |
H226 H290 H331 H302 H314 H318 |
GHS02 GHS05 GHS06 Dgr |
H226 H290 H331 H302 H314 |
EUH071 |
Por inhalación: ETA = 7,4 mg/l (vapores) Por vía oral: ETA = 500 mg/kg pc Flam. Liq. 3; H226: C > 85 % Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; 314: 10 % ≤ C < 90 % Skin Irrit. 2; H315: 2 % ≤ C < 10 % Eye Dam. 1; H318: C ≥ 10 % Eye Irrit. 2; H319: 2 % ≤ C < 10 % |
B |
|
|
607-002-00-6 |
Ácido acético al … % |
200-580-7 |
Flam. Liq. 3 Skin Corr. 1A |
H226 H314 |
GHS02 GHS05 Dgr |
H226 H314 |
|
Skin Corr. 1A; H314: C ≥90 % Skin Corr. 1B; H314: 25 %≤ C <90 % Skin Irrit. 2; H315: 10 % ≤C <25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
|
|
607-003-00-1 |
Ácido cloroacético |
201-178-4 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H331 H311 H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H400 |
|
STOT SE 3; H335: C≥ 5 % |
|
|
|
607-004-00-7 |
TCA (ISO); ácido tricloroacético |
200-927-2 |
Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
STOT SE 3; H335: C ≥ 1 % |
|
|
|
607-005-00-2 |
TCA-sodio (ISO); tricloroacetato de sodio |
211-479-2 |
STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H400 H410 |
GHS07 GHS09 Wng |
H335 H410 |
|
|
|
|
|
607-006-00-8 |
Ácido oxálico |
205-634-3 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
* |
|
|
|
607-007-00-3 |
Sales del ácido oxálico, excepto las especificadas en otras partes del presente anexo |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
* |
A |
|
607-008-00-9 |
Anhídrido acético |
203-564-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H302 H314 |
|
Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤C < 25 % Eye Dam. 1; H318: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 1 % ≤C < 5 % STOT SE 3; H335: C ≥ 5 % |
|
|
|
607-009-00-4 |
Anhídrido ftálico |
201-607-5 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H302 H335 H315 H318 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H335 H315 H318 H334 H317 |
|
|
|
|
|
607-010-00-X |
Anhídrido propiónico |
204-638-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
|
|
|
607-011-00-5 |
Cloruro de acetilo |
200-865-6 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
EUH014 |
|
|
|
|
607-012-00-0 |
Cloruro de benzoílo |
202-710-8 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H332 H312 H302 H314 H317 |
GHS05 GHS07 Dgr |
H332 H312 H302 H314 H317 |
|
|
|
|
|
607-013-00-6 |
Carbonato de dimetilo |
210-478-4 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
607-014-00-1 |
Formiato de metilo |
203-481-7 |
Flam. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H224 H332 H302 H319 H335 |
GHS02 GHS07 Dgr |
H224 H332 H302 H319 H335 |
|
|
|
|
|
607-015-00-7 |
Formiato de etilo |
203-721-0 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H302 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H302 H319 H335 |
|
|
|
|
|
607-016-00-2 |
Formiato de propilo; [1] formiato de isopropilo [2] |
203-798-0 [1] 210-901-2 [2] |
110-74-7 [1] 625-55-8 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H225 H319 H335 H336 |
GHS02 GHS07 Dgr |
H225 H319 H335 H336 |
|
|
C |
|
607-017-00-8 |
Formiato de butilo; [1] formiato de terc-butilo; [2] formiato de isobutilo [3] |
209-772-5 [1] 212-105-0 [2] 208-818-1 [3] |
592-84-7 [1] 762-75-4 [2] 542-55-2 [3] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Dgr |
H225 H319 H335 |
|
|
C |
|
607-018-00-3 |
Formiato de isopentilo; [1] 2-formiato de metilbutilo [2] |
203-769-2 [1] 252-343-2 [2] |
110-45-2 [1] 35073-27-9 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Dgr |
H225 H319 H335 |
|
|
C |
|
607-019-00-9 |
Cloroformiato de metilo |
201-187-3 |
Flam. Liq. 2 Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H225 H330 H312 H302 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H330 H312 H302 H314 |
|
|
|
|
|
607-020-00-4 |
Cloroformiato de etilo |
208-778-5 |
Flam. Liq. 2 Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H225 H330 H302 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H330 H302 H314 |
|
|
|
|
|
607-021-00-X |
Acetato de metilo |
201-185-2 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
|
607-022-00-5 |
Acetato de etilo |
205-500-4 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
|
607-023-00-0 |
Acetato de vinilo |
203-545-4 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 STOT SE 3 |
H225 H351 H332 H335 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H332 H335 |
|
|
D |
|
|
607-024-00-6 |
Acetato de propilo; [1] acetato de isopropilo [2] |
203-686-1 [1] 203-561-1 [2] |
109-60-4 [1] 108-21-4 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
C |
|
607-025-00-1 |
Acetato de n-butilo |
204-658-1 |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
EUH066 |
|
|
|
|
607-026-00-7 |
Acetato de sec-butilo; [1] acetato de isobutilo; [2] acetato de terc-butilo [3] |
203-300-1 [1] 203-745-1 [2] 208-760-7 [3] |
105-46-4 [1] 110-19-0 [2] 540-88-5 [3] |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH066 |
|
C |
|
607-027-00-2 |
Propionato de metilo |
209-060-4 |
Flam. Liq. 2 Acute Tox. 4 * |
H225 H332 |
GHS02 GHS07 Dgr |
H225 H332 |
|
|
|
|
|
607-028-00-8 |
Propionato de etilo |
203-291-4 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
607-029-00-3 |
Propionato de n-butilo; [1] propionato de sec-butilo; [2] propionato de iso-butilo [3] |
209-669-5 [1] -[2] 208-746-0 [3] |
590-01-2 [1] 591-34-4 [2] 540-42-1 [3] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
607-030-00-9 |
Propionato de propilo |
203-389-7 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
607-031-00-4 |
Butirato de butilo |
203-656-8 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
|
607-032-00-X |
Acrilato de etilo |
205-438-8 |
Flam. Liq. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 |
H225 H331 H312 H302 H335 H315 H319 H317 |
GHS02 GHS06 Dgr |
H225 H331 H312 H302 H335 H315 H319 H317 |
|
Por inhalación: ETA = 9 mg/l (vapores) Por vía cutánea: ETA = 1 800 mg/kg pc Por vía oral: ETA = 1 120 mg/kg pc STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % |
D |
|
|
607-033-00-5 |
Metacrilato de n-butilo |
202-615-1 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H317 |
|
|
D |
|
|
607-034-00-0 |
Acrilato de metilo; propenoato de metilo |
202-500-6 |
Flam. Liq. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 |
H225 H331 H312 H302 H335 H315 H319 H317 |
GHS02 GHS06 Dgr |
H225 H331 H312 H302 H335 H315 H319 H317 |
|
Por inhalación: ETA = 3 mg/l (vapores) Por vía cutánea: ETA = 1 100 mg/kg pc Por vía oral: ETA = 500 mg/kg pc |
D |
|
|
607-035-00-6 |
Metacrilato de metilo; 2-metilprop-2-enoato de metilo; 2-metilpropenoato de metilo |
201-297-1 |
Flam. Liq. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H335 H315 H317 |
|
|
D |
|
|
607-036-00-1 |
Acetato de 2-metoxietilo; acetato de metilglicol |
203-772-9 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H360FD H332 H312 H302 |
GHS08 GHS07 Dgr |
H360FD H332 H312 H302 |
|
|
|
|
|
607-037-00-7 |
Acetato de 2-etoxietilo; acetato de etilglicol |
203-839-2 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H332 H312 H302 |
|
|
|
|
|
607-038-00-2 |
Acetato de 2-butoxietilo; acetato de butilglicol |
203-933-3 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 |
GHS07 Wng |
H332 H312 |
|
|
|
|
|
607-039-00-8 |
2,4-D (ISO); ácido 2,4-diclorofenoxiacético |
202-361-1 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H335 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H335 H318 H317 H412 |
|
|
|
|
|
607-040-00-3 |
Sales de 2,4-D |
— |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
A |
|
607-041-00-9 |
2,4,5-T (ISO); ácido 2,4,5-triclorofenoxiacético |
202-273-3 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
|
|
|
607-042-00-4 |
Sales y ésteres de 2,4,5-T; sales y ésteres del ácido 2,4,5-triclorofenoxi-acético |
— |
— |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
A |
|
607-043-00-X |
Dicamba (ISO); ácido 2,5-dicloro-6-metoxibenzoico; acido 3,6-dicloro-2-metoxibenzoico |
217-635-6 |
Acute Tox. 4 Acute Tox. 4 STOT SE 3 STOT SE 3 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 2 |
H332 H302 H335 H336 H318 H400 H411 |
GHS07 GHS05 GHS09 Dgr |
H332 H302 H335 H336 H318 H410 |
|
Por inhalación: ETA = 4,0 mg/l (polvos o nieblas) Por vía oral: ETA = 1 500 mg/kg pc M = 1 |
|
|
|
607-044-00-5 |
Ácido 3,6-dicloro-o-anísico, compuesto con dimetilamina (1:1); [1] 3,6-dicloro-o-anisato de potasio [2] |
218-951-7 [1] 233-002-7 [2] |
2300-66-5 [1] 10007-85-9 [2] |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
607-045-00-0 |
Diclorprop (ISO); ácido 2-(2,4-diclorofenoxi)propiónico |
204-390-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H315 H318 |
GHS05 GHS07 Dgr |
H312 H302 H315 H318 |
|
|
|
|
|
607-046-00-6 |
Sales de diclorprop |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
A |
|
607-047-00-1 |
Fenoprop (ISO); ácido 2-(2,4,5-triclorofenoxi)propiónico |
202-271-2 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
607-048-00-7 |
Sales de fenoprop; sales del ácido 2-(2,4,5-triclorofenoxi)propiónico |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
|
607-049-00-2 |
Mecoprop (ISO); ácido 2-(4-cloro-o-toliloxi)propiónico; ácido (RS)-2-(4-cloro-o-toliloxi)propiónico; [1] ácido 2-(4-cloro-2-metilfenoxi)propiónico [2] |
230-386-8 [1] 202-264-4 [2] |
7085-19-0 [1] 708519-0 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
M=100 |
|
|
607-050-00-8 |
Sales de mecoprop |
— |
— |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
A |
|
607-051-00-3 |
MCPA (ISO); ácido 4-cloro-o-toliloxiacético |
202-360-6 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
|
|
|
607-052-00-9 |
Sales y ésteres de MCPA |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
|
607-053-00-4 |
MCPB (ISO); ácido 4-(4-cloro-o-toliloxi)butírico |
202-365-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-054-00-X |
Sales y ésteres de MCPB |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
A |
|
607-055-00-5 |
Endotal-sodio (ISO); 7-oxabiciclo(2,2,1)heptano-2,3-dicarboxilato de disodio |
204-959-8 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Dgr |
H301 H312 H319 H335 H315 |
|
|
|
|
|
607-056-00-0 |
warfarina (ISO); 4-hidroxi-3-(3-oxo-1-fenilbutil)-2H-cromen-2-ona; [1] (S)-4-hidroxi-3-(3-oxo-1-fenilbutil)-2-benzopirona; [2] (R)-4-hidroxi-3-(3-oxo-1-fenilbutil)-2-benzopirona [3] |
201-377-6 [1] 226-907-3 [2] 226-908-9 [3] |
81-81-2 [1] [2] [3] |
Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 2 STOT RE 1 Aquatic Chronic 2 |
H360D H330 H310 H300 H372 (sangre) H411 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (sangre) H411 |
|
Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (sangre): C ≥ 0,5 % STOT RE 2; H373 (sangre): 0,05 % ≤ C < 0,5 % |
|
|
607-057-00-6 |
Cumacloro (ISO); 3-[1-(4-clorofenil)-3-oxobutil]-4-hidroxicumarina |
201-378-1 |
STOT RE 2 * Aquatic Chronic 3 |
H373 ** H412 |
GHS08 Wng |
H373 ** H412 |
|
|
|
|
|
607-058-00-1 |
Cumafurilo (ISO); fumarina; (RS)-3-(1-(2-furil)-3-oxobutil)-4-hidroxicumarina; 4-hidroxi-3-[3-oxo-1-(2-furil)butil]cumarina |
204-195-5 |
Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 |
H301 H372 ** H412 |
GHS06 GHS08 Dgr |
H301 H372 ** H412 |
|
|
|
|
|
607-059-00-7 |
cumatetralilo (ISO); 4-hidroxi-3-(1,2,3,4-tetrahidro-1-naftil)cumarina |
227-424-0 |
Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Aquatic Chronic 1 |
H360D H330 H311 H300 H372 (sangre) H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H311 H300 H372 (sangre) H410 |
|
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (sangre): C ≥ 1,0 % STOT RE 2; H373 (sangre) 0,1 % ≤ C < 1,0 % M = 10 |
|
|
|
607-060-00-2 |
Dicumarol; 4,4'-dihidroxi-3,3'-metilenbis(2H-cromen-2-ona) |
200-632-9 |
STOT RE 1 Acute Tox. 4 * Aquatic Chronic 2 |
H372 ** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H302 H411 |
|
|
|
|
|
607-061-00-8 |
Ácido acrílico; ácido prop-2-enoico |
201-177-9 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H226 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H314 H400 |
|
STOT SE 3; H335: C ≥ 1 % |
D |
|
|
607-062-00-3 |
Acrilato de n-butilo |
205-480-7 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H317 |
|
|
D |
|
|
607-063-00-9 |
Ácido isobutírico |
201-195-7 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
607-064-00-4 |
Cloroformiato de bencilo |
207-925-0 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
607-065-00-X |
Ácido bromoacético |
201-175-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 |
H331 H311 H301 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H317 H400 |
|
|
|
|
|
607-066-00-5 |
Ácido dicloroacético |
201-207-0 |
Skin Corr. 1A Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
|
|
|
|
607-067-00-0 |
Cloruro de dicloroacetilo |
201-199-9 |
Skin Corr. 1A Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
|
|
|
|
607-068-00-6 |
Ácido yodoacético |
200-590-1 |
Acute Tox. 3 * Skin Corr. 1A |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
|
|
|
|
607-069-00-1 |
Bromoacetato de etilo |
203-290-9 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
|
607-070-00-7 |
Cloroacetato de etilo |
203-294-0 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 |
H331 H311 H301 H400 |
GHS06 GHS09 Dgr |
H331 H311 H301 H400 |
|
|
|
|
|
607-071-00-2 |
Metacrilato de etilo |
202-597-5 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H319 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 H317 |
|
|
D |
|
|
607-072-00-8 |
Acrilato de 2-hidroxietilo |
212-454-9 |
Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 |
H311 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H311 H314 H317 H400 |
|
* Skin Sens. 1; H317: C ≥ 0,2 % |
D |
|
|
607-073-00-3 |
4-CPA (ISO); ácido 4-clorofenoxiacético |
204-581-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-074-00-9 |
Clorfenac (ISO); ácido 2,3,6-triclorofenilacético |
201-599-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-075-00-4 |
Clorfenprop-metilo; 2-cloro-3-(4-clorofenil)propionato de metilo |
238-413-5 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
607-076-00-X |
Dodina (ISO); acetato de dodecilguanidinio |
219-459-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
|
607-077-00-5 |
Erbón (ISO); 2,2-dicloropropionato de 2-(2,4,5-triclorofenoxi)etilo |
— |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-078-00-0 |
Fluenetilo (ISO); bifenil-4-ilacetato de 2-fluoroetilo |
— |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
607-079-00-6 |
Keleván (ISO); 5-(percloro-5-hidroxipentaciclo[5,3,0,02,6,03,9,04,8]decan-5-il)-4-oxopentanoato de etilo; 5-(1,2,3,5,6,7,8,9,10,10-decacloro-4-hidroxipentaciclo(5,2,1,02,6,03,9,05,8)dec-4-il)-4-oxovalerato de etilo |
— |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 |
H311 H302 H411 |
GHS06 GHS09 Dgr |
H311 H302 H411 |
|
|
|
|
|
607-080-00-1 |
Cloruro de cloroacetilo |
201-171-6 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1A Aquatic Acute 1 |
H331 H311 H301 H372 ** H314 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H331 H311 H301 H372 ** H314 H400 |
EUH014 EUH029 |
|
|
|
|
607-081-00-7 |
Ácido fluoroacético |
205-631-7 |
Acute Tox. 2 * Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Dgr |
H300 H400 |
|
|
|
|
|
607-082-00-2 |
Fluoroacetatos, solubles |
— |
— |
Acute Tox. 2 * Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Dgr |
H300 H400 |
|
|
A |
|
607-083-00-8 |
2,4-DB (ISO); ácido 4-(2,4-diclorofenoxi)butírico |
202-366-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-084-00-3 |
Sales de 2,4-DB |
— |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
A |
|
607-085-00-9 |
Benzoato de bencilo |
204-402-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-086-00-4 |
Ftalato de dialilo |
205-016-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-088-00-5 |
Ácido metacrílico; ácido 2-metilpropenoico |
201-204-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1 % |
D |
|
|
607-089-00-0 |
Ácido propiónico al … % |
201-176-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % |
B |
|
|
607-090-00-6 |
Ácido tioglicólico |
200-677-4 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H331 H311 H301 H314 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 |
|
* |
|
|
|
607-091-00-1 |
Ácido trifluoroacético al … % |
200-929-3 |
Acute Tox. 4 * Skin Corr. 1A Aquatic Chronic 3 |
H332 H314 H412 |
GHS05 GHS07 Dgr |
H332 H314 H412 |
|
* |
B |
|
|
607-092-00-7 |
Lactato de metilo; [1] (±)-lactato de metilo; [2] (R)-lactato de metilo; [3] (S)-(-)-lactato de metilo [4] |
208-930-0 [1] 218-449-8 [2] 241-420-6 [3] 248-704-9 [4] |
547-64-8 [1] 2155-30-8 [2] 17392-83-5 [3] 27871-49-4 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Wng |
H226 H319 H335 |
|
|
C |
|
607-093-00-2 |
Cloruro de propionilo |
201-170-0 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
EUH014 |
|
B D |
|
|
607-094-00-8 |
Ácido paracético ... % |
201-186-8 |
Org. Perox. D Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H242 H330 H310 H301 H314 H400 H410 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H242 H330 H310 H301 H314 H410 |
EUH071 |
Por inhalación: ETA = 0,2 mg/l (polvos o nieblas) Por vía cutánea: ETA = 60 mg/kg pc Por vía oral: ETA = 80 mg/kg pc STOT SE 3; H335: C ≥ 1 % M = 10 M = 100 |
B, D, T |
|
|
607-095-00-3 |
Ácido maleico |
203-742-5 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H335 H315 H317 |
GHS07 Wng |
H302 H319 H335 H315 H317 |
|
Skin Sens. 1; H317: C ≥0,1 % |
|
|
|
607-096-00-9 |
Anhídrido maleico |
203-571-6 |
Acute Tox. 4 STOT RE 1 Skin Corr. 1B Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1A |
H302 H372 (vías respiratorias) (inhalación) H314 H318 H334 H317 |
GHS07 GHS08 GHS05 Dgr |
H302 H372 (vías respiratorias) (inhalación) H314 H334 H317 |
EUH071 |
Skin Sens. 1A; H317: C ≥ 0,001 % |
|
|
|
607-097-00-4 |
1,2-Anhídrido del ácido benceno-1,2,4-tricarboxílico; anhídrido trimelítico |
209-008-0 |
STOT SE 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H335 H318 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H335 H318 H334 H317 |
|
|
|
|
|
607-098-00-X |
Dianhídrido benceno-1,2:4,5-tetracarboxílico; dianhídrido piromelítico |
201-898-9 |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
|
|
|
607-099-00-5 |
Anhídrido 1,2,3,6-tetrahidroftálico; [1] anhídrido cis-1,2,3,6-tetrahidroftálico; [2] anhídrido 3,4,5,6-tetrahidroftálico; [3] anhídrido tetrahidroftálico [4] |
201-605-4 [1] 213-308-7 [2] 219-374-3 [3] 247-570-9 [4] |
85-43-8 [1] 935-79-5 [2] 2426-02-0 [3] 26266-63-7 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H334 H317 H412 |
GHS08 GHS05 Dgr |
H318 H334 H317 H412 |
|
|
C |
|
607-100-00-9 |
Dianhídrido benzofenona-3,3',4,4'-tetracarboxílico; 4,4'-carbonildi(anhídrido ftálico) |
219-348-1 |
Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Wng |
H319 H335 |
|
Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
|
|
607-101-00-4 |
Anhídrido 1,4,5,6,7,7-hexaclorobiciclo[2.2.1]hept-5-eno-2,3-dicarboxílico; anhídrido cloréndico |
204-077-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
|
|
607-102-00-X |
Anhídrido ciclohexano-1,2-dicarboxílico; [1] anhídrido cis-ciclohexano-1,2-dicarboxílico; [2] anhídrido trans-ciclohexano-1,2-dicarboxílico [3] |
201-604-9 [1] 236-086-3 [2] 238-009-9 [3] |
85-42-7 [1] 13149-00-3 [2] 14166-21-3 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-103-00-5 |
Anhídrido succínico |
203-570-0 |
Acute Tox. 4 Skin Corr. 1 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H302 H314 H318 H334 H317 |
GHS07 GHS05 GHS08 Dgr |
H302 H314 H334 H317 |
EUH071 |
|
|
|
|
607-104-00-0 |
Dianhídrido ciclopentano-1,2,3,4-tetracarboxílico |
227-964-7 |
Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Wng |
H319 H335 |
|
Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
|
|
607-105-00-6 |
Anhídrido 8,9,10-trinorborn-5-eno-2,3-dicarboxílico; [1] anhídrido 1,2,3,6-tetrahidro-3,6-metanoftálico; [2] anhídrido (1α,2α,3β,6β)-1,2,3,6-tetrahidro-3,6-metanoftálico [3] |
204-957-7 [1] 212-557-9 [2] 220-384-5 [3] |
129-64-6 [1] 826-62-0 [2] 2746-19-2 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-106-00-1 |
Anhídrido 8,9-dinorborn-5-eno-2,3-dicarboxílico |
— |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H302 H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H302 H319 H335 H315 H334 |
|
STOT SE 3; H335: C ≥ 10 % |
C |
|
|
607-107-00-7 |
Acrilato de 2-etilhexilo |
203-080-7 |
STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H335 H315 H317 |
GHS07 Wng |
H335 H315 H317 |
|
|
D |
|
|
607-108-00-2 |
Acrilato de 2-hidroxi-1-metiletilo; [1] acrilato de 2-hidroxipropilo; [2] ácido acrílico, monoéster con propano-1,2-diol [3] |
220-852-9 [1] 213-663-8 [2] 247-118-0 [3] |
2918-23-2 [1] 999-61-1 [2] 25584-83-2 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 H317 |
|
* Skin Sens. 1; H317:C ≥0,2 % |
C D |
|
607-109-00-8 |
Diacrilato de hexametileno; diacrilato de hexano-1,6-diol |
235-921-9 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-110-00-3 |
Triacrilato de pentaeritritol |
222-540-8 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-111-00-9 |
Diacrilato de 2-etil-2-{[(1-oxoalil)oxi]metil}-1,3-propanodiilo; acrilato de 2,2-bis(acriloiloximetil)butilo; triacrilato de trimetilolpropano |
239-701-3 |
Carc. 2 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H315 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H315 H319 H317 H410 |
|
M = 1 M = 1 |
D |
|
|
607-112-00-4 |
Diacrilato de 2,2-dimetiltrimetileno; diacrilato de neopentilglicol |
218-741-5 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Dgr |
H311 H319 H315 H317 |
|
* |
D |
|
|
607-113-00-X |
Metacrilato de isobutilo |
202-613-0 |
Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Skin Sens. 1B |
H226 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H335 H315 H317 |
|
|
D |
|
|
607-114-00-5 |
Dimetacrilato de etileno |
202-617-2 |
STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Wng |
H335 H317 |
|
STOT SE 3; H335: C ≥ 10 % |
D |
|
|
607-115-00-0 |
Acrilato de isobutilo |
203-417-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 |
H226 H332 H312 H315 H317 |
GHS02 GHS07 Wng |
H226 H332 H312 H315 H317 |
|
|
D |
|
|
607-116-00-6 |
Acrilato de ciclohexilo |
221-319-3 |
STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H335 H315 H411 |
GHS07 GHS09 Wng |
H335 H315 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
D |
|
|
607-117-00-1 |
Acrilato de 2,3-epoxipropilo; acrilato de glicidilo |
203-440-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 H317 |
|
* Skin Sens. 1; H317:C ≥0,2 % |
D |
|
|
607-118-00-7 |
Diacrilato de 1-metiltrimetileno; diacrilato de 1,3-butilenglicol |
243-105-9 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Dgr |
H312 H314 H317 |
|
|
D |
|
|
607-119-00-2 |
Diacrilato de tetrametileno; diacrilato de 1,4-butilenglicol |
213-979-6 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Dgr |
H312 H314 H317 |
|
|
D |
|
|
607-120-00-8 |
Diacrilato de 2,2'-oxidietilo; diacrilato de dietilenglicol |
223-791-6 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Dgr |
H311 H319 H315 H317 |
|
* Skin Sens. 1; H317:C≥0,2 % |
D |
|
|
607-121-00-3 |
Acrilato de 8,9,10-trinorborn-2-ilo |
— |
Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 |
H312 H315 H317 |
GHS07 Wng |
H312 H315 H317 |
|
|
D |
|
|
607-122-00-9 |
Tetraacrilato de pentaeritritol |
225-644-1 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-123-00-4 |
Metacrilato de 2,3-epoxipropilo; metacrilato de glicidilo |
203-441-9 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 STOT RE 1 Eye Dam. 1 Skin Corr. 1C Skin Sens. 1 |
H350 H341 H360F H311 H302 H335 H372 (vías respiratorias) (inhalación) H318 H314 H317 |
GHS08 GHS06 GHS05 Dgr |
H350 H341 H360F H311 H302 H335 H372 (vías respiratorias) (inhalación) H314 H317 |
|
|
D |
|
|
607-124-00-X |
Metacrilato de 2-hidroxietilo |
212-782-2 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-125-00-5 |
Metacrilato de 2-hidroxipropilo; [1] metacrilato de 3-hidroxipropilo [2] |
213-090-3 [1] 220-426-2 [2] |
923-26-2 [1] 2761-09-3 [2] |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
C D |
|
607-126-00-0 |
Diacrilato de 2,2'-(etilendioxi)dietilo; diacrilato de trietilenglicol |
216-853-9 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-127-00-6 |
Metacrilato de 2-dietilaminoetilo |
203-275-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H319 H315 H317 |
GHS07 Wng |
H332 H319 H315 H317 |
|
|
D |
|
|
607-128-00-1 |
Metacrilato de 2-terc-butilaminoetilo |
223-228-4 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-129-00-7 |
Lactato de etilo; DL-lactato de etilo; [1] (S)-2-hidroxipropionato de etilo; L-lactato de etilo; (S)-lactato de etilo [2] |
202-598-0 [1] 211-694-1 [2] |
97-64-3 [1] 687-47-8 [2] |
Flam. Liq. 3 STOT SE 3 Eye Dam. 1 |
H226 H335 H318 |
GHS02 GHS05 GHS07 Dgr |
H226 H335 H318 |
|
|
C |
|
607-130-00-2 |
Acetato de pentilo; [1] acetato de isopentilo; [2] acetato de 1-metilbutilo; [3] acetato de 2-metilbutilo; [4] acetato de 2 (o 3)-metilbutilo [5] |
211-047-3 [1] 204-662-3 [2] 210-946-8 [3] 210-843-8 [4] 282-263-3 [5] |
628-63-7 [1] 123-92-2 [2] 626-38-0 [3] 624-41-9 [4] 84145-37-9 [5] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
EUH066 |
|
C |
|
607-131-00-8 |
Propionato de isopentilo; [1] propionato de pentilo; [2] propionato de 2-metilbutilo [3] |
203-322-1 [1] 210-852-7 [2] 219-449-0 [3] |
105-68-0 [1] 624-54-4 [2] 2438-20-2 [3] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
607-132-00-3 |
Metacrilato de 2-dimetilaminoetilo |
220-688-8 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H312 H302 H319 H315 H317 |
GHS07 Wng |
H312 H302 H319 H315 H317 |
|
|
D |
|
|
607-133-00-9 |
Ésteres monoalquílicos o monoarílicos o monoalquilarílicos del ácido acrílico, excepto los especificados en otras partes del presente anexo |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H335 H315 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
A |
|
607-134-00-4 |
Ésteres monoalquílicos o monoarílicos o monoalquilarílicos del ácido metacrílico, excepto los especificados en otras partes del presente anexo |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOTSE 3; H335: C ≥ 10 % |
A |
|
607-135-00-X |
Ácido butírico |
203-532-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
607-136-00-5 |
Cloruro de butirilo |
205-498-5 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
|
607-137-00-0 |
Acetoacetato de metilo |
203-299-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-138-00-6 |
Cloroformiato de butilo; éster butílico del ácido clorofórmico |
209-750-5 |
Flam. Liq. 3 Acute Tox. 3 * Skin Corr. 1B |
H226 H331 H314 |
GHS02 GHS06 GHS05 Dgr |
H226 H331 H314 |
|
|
|
|
|
607-139-00-1 |
Ácido 2-cloropropiónico |
209-952-3 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
|
607-140-00-7 |
Cloruro de isobutirilo |
201-194-1 |
Flam. Liq. 2 Skin Corr. 1A |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
|
607-141-00-2 |
Bis(cloroformiato) de oxidietileno |
203-430-9 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H411 |
|
|
|
|
|
607-142-00-8 |
Cloroformiato de propilo; éster propílico del ácido clorofórmico; cloroformiato de n-propilo |
203-687-7 |
Flam. Liq. 2 Acute Tox. 3 * Skin Corr. 1B |
H225 H331 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H331 H314 |
|
|
|
|
|
607-143-00-3 |
Ácido valérico |
203-677-2 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
|
|
607-144-00-9 |
Ácido adípico |
204-673-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-145-00-4 |
Ácido metanosulfónico |
200-898-6 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
607-146-00-X |
Ácido fumárico |
203-743-0 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-147-00-5 |
Éster dietílico del ácido oxálico; oxalato de dietilo |
202-464-1 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
607-148-00-0 |
Cloruro de guanidinio; clorhidrato de guanidina |
200-002-3 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
|
607-149-00-6 |
Uretano (DCI); carbamato de etilo |
200-123-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
607-150-00-1 |
Endotal (ISO); ácido 7-oxabiciclo(2,2,1)heptano-2,3-dicarboxílico |
205-660-5 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Dgr |
H301 H312 H319 H335 H315 |
|
|
|
|
|
607-151-00-7 |
Propargita (ISO); sulfito de 2-(4-terc-butilfenoxi)ciclohexilo y prop-2-inilo |
219-006-1 |
Carc. 2 Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H315 H318 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H331 H315 H318 H410 |
|
M = 10 |
|
|
|
607-152-00-2 |
2,3,6-TBA (ISO); ácido 2,3,6-triclorobenzoico |
200-026-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-153-00-8 |
Benazolina (ISO); ácido 4-cloro-2,3-dihidro-2-oxo-1,3-benzotiazol-3-ilacético |
223-297-0 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
|
607-154-00-3 |
N-Benzoil-N-(3,4-diclorofenil)-DL-alaninato de etilo; benzoilprop-etilo (ISO) |
244-845-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-155-00-9 |
Ácido 3-(3-amino-5-(1-metilguanidino)-1-oxopentilamino-6-(4-amino-2-oxo-2,3-dihidro-pirimidin-1-il)-2,3-dihidro-(6H)-piran-2-carboxílico; blasticidina-s |
— |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
|
|
607-156-00-4 |
Clorfensón (ISO); 4-clorobencenosulfonato de 4-clorofenilo |
201-270-4 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
607-157-00-X |
difenácum (ISO); 3-(3-bifenil-4-il-1,2,3,4-tetrahidro-1-naftil)-4-hidroxicumarina |
259-978-4 |
Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (sangre) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (sangre) H410 |
|
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (sangre): C ≥ 0,02 % STOT RE 2; H373 (sangre): 0,002 % ≤ C < 0,02 % M = 10 M = 10 |
|
|
|
607-158-00-5 |
Sal sódica del ácido cloroacético; cloroacetato de sodio |
223-498-3 |
Acute Tox. 3 * Skin Irrit. 2 Aquatic Acute 1 |
H301 H315 H400 |
GHS06 GHS09 Dgr |
H301 H315 H400 |
|
|
|
|
|
607-159-00-0 |
Clorobencilato (ISO); 2,2-di(4-clorofenil)-2-hidroxiacetato de etilo; 4,4'-diclorobencilato de etilo |
208-110-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-160-00-6 |
2-(4-(4-Clorofenoxi)fenoxi)propionate de isobutilo; clofop-isobutilo (ISO) |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-161-00-1 |
Sal del 4-CPA con dietanolamina |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-162-00-7 |
Dalapón; ácido 2,2-dicloropropiónico; [1] dalapón-sodio; 2,2-dicloropropionato de sodio [2] |
200-923-0 [1] 204-828-5 [2] |
75-99-0 [1] 127-20-8 [2] |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
607-163-00-2 |
3-Acetil-6-metil-2H-pirano-2,4(3H)-diona; ácido dehidroacético |
208-293-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-164-00-8 |
1-(3,4-Dihidro-6-metil-2,4-dioxo-2H-piran-3-iliden)etonolato de sodio; dehidroacetato de sodio |
224-580-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-165-00-3 |
Diclofop-metilo (ISO); 2-(4-(2,4-diclorofenoxi)fenoxi)propionate de metilo; (RS)-2-[4-(2,4-diclorofenoxi)fenoxi]propionate de metilo |
257-141-8 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
|
607-166-00-9 |
Medinoterb-acetato (ISO); acetato de 6-terc-butil-3-metil-2,4-dinitrofenilo |
219-634-6 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
|
|
607-167-00-4 |
3-Cloroacrilato de sodio |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
607-168-00-X |
6,7-Metilendioxi-1,2,3,4-tetrahidro-3-metilnaftaleno-1,2-dicarboxilato de dipropilo; propilisomo |
— |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H302 H400 H410 |
GHS06 GHS09 Dgr |
H311 H302 H410 |
|
|
|
|
|
607-169-00-5 |
Fluoroacetato de sodio |
200-548-2 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H330 H310 H300 H400 |
GHS06 GHS09 Dgr |
H330 H310 H300 H400 |
|
|
|
|
|
607-170-00-0 |
Oxalato de bis(1,2,3-tritiaciclohexildimetilamonio); tiociclam-oxalato |
250-859-2 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
607-172-00-1 |
brodifácum (ISO); 4-hidroxi-3-(3-(4′-bromo-4-bifenilil)-1,2,3,4-tetrahidro-1-naftil)cumarina |
259-980-5 |
Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (sangre) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (sangre) H410 |
|
Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (sangre): C ≥ 0,02 % STOT RE 2; H373 (sangre): 0,002 % ≤ C < 0,02 % M = 10 M = 10 |
|
|
|
607-173-00-7 |
(3-Metil-4-(5-nitro-3-etoxicarbonil-2-tienil)azo)fenilnitrilodipropionato de dimetilo |
400-460-6 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-174-00-2 |
Masa de reacción de 3-(2,2,4,4-tetrametil-21-oxo-7-oxa-3,20-diazadiespiro(5,1,11,2)henicosan-20-il)propionato de dodecilo y 3-(2,2,4,4-tetrametil-21-oxo-7-oxa-3,20-diazadiespiro(5,1,11,2)henicosan-20-il)propionato de tetradecilo |
400-580-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-175-00-8 |
2-(2-Nitrobenciliden)acetoacetato de metilo |
400-650-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-176-00-3 |
Masa de reacción de α-3-(3-(2H-benzotriazol-2-il)-5-terc-butil-4-hidroxifenil)propionil-ω-hidroxipoli(oxietileno) y α-3-(3-(2H-benzotriazol-2-il)-5-terc-butil-4-hidroxifenil)propionil-ω-3-(3-(2H-benzotriazol-2-il)-5-terc-butil-4-hidroxifenil)propioniloxipoli(oxietileno) |
400-830-7 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-177-00-9 |
Tribenurón-metilo (ISO); 2-[N-(4-metoxi-6-metil-1,3,5-triazin-2-il)-N-metilcarbamoilsulfamoil]benzoato de metilo |
401-190-1 |
STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 H317 H410 |
|
M = 100 M = 100 |
|
|
|
607-178-00-4 |
α-((4,6-Dimetoxipirimidin-2-il)ureidosulfonil)-o-toluato de metilo |
401-340-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-179-00-X |
Ácido (benzotiazol-2-iltio)succínico |
401-450-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-180-00-5 |
2-Hidroxicarbazol-1-carboxilato de potasio |
401-630-2 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H302 H319 H335 H412 |
GHS07 Wng |
H302 H319 H335 H412 |
|
|
|
|
|
607-181-00-0 |
Fluoruro de 3,5-dicloro-2,4-difluorobenzoílo |
401-800-6 |
Acute Tox. 3 * Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H331 H314 H302 H317 H412 |
GHS06 GHS05 Dgr |
H331 H314 H302 H317 H412 |
EUH029 |
|
|
|
|
607-182-00-6 |
3-Sulfamoil-2-tenoato de metilo |
402-050-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-183-00-1 |
2-Hidroxi-5-C13-18-alquilbenzoato de cinc |
402-280-3 |
— |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
607-184-00-7 |
19-Isocianato-11-(6-isocianatohexil)-10,12-dioxo-2,9,11,13-tetraazanonadecanotioato de S-(3-trimetoxisilil)propilo |
402-290-8 |
Flam. Liq. 3 Resp. Sens. 1 Skin Sens. 1 |
H226 H334 H317 |
GHS02 GHS08 Dgr |
H226 H334 H317 |
|
|
|
|
|
607-185-00-2 |
trans-3-Dimetilaminoacrilato de etilo |
402-650-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-186-00-8 |
Quinclorac (ISO); ácido 3,7-dicloroquinolina-8-carboxílico |
402-780-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-187-00-3 |
Succinato de bis(2,2,6,6-tetrametil-4-piperidilo) |
402-940-0 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
|
607-188-00-9 |
N-Carboxilatoetil-N-octadec-9-enilmaleamato de hidrógeno y sodio |
402-970-4 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-189-00-4 |
Ácido trimetilendiaminotetraacético |
400-400-9 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
607-190-00-X |
Acrilamidometoxiacetato de metilo (con ≥ 0,1 % de acrilamida) |
401-890-7 |
Carc. 1B Muta. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H340 H302 H319 |
GHS08 GHS07 Dgr |
H350 H340 H302 H319 |
|
|
|
|
|
607-191-00-5 |
3,4-Epoxibutirato de isobutilo |
401-920-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
|
607-192-00-0 |
N-Carboximetil-N-(2-(2-hidroxietoxi)etil)glicinato de disodio |
402-360-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-194-00-1 |
Carbonato de propileno |
203-572-1 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-195-00-7 |
Acetato de 2-metoxi-1-metiletilo |
203-603-9 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
|
607-196-00-2 |
Ácido heptanoico |
203-838-7 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
607-197-00-8 |
ácido nonanoico |
203-931-2 |
Skin Irrit. 2 Eye Irrit. 2 Aquatic Chronic 3 |
H315 H319 H412 |
GHS07 Wng |
H315 H319 H412 |
|
|
|
|
|
607-198-00-3 |
3,4,5-Trihidroxibenzoato de propilo |
204-498-2 |
Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
Por vía oral: ETA = 1 700 mg/kg pc M = 1 M = 1 |
|
|
|
607-199-00-9 |
3,4,5-Trihidroxibenzoato de octilo |
213-853-0 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
|
607-200-00-2 |
3,4,5-Trihidroxibenzoato de dodecilo |
214-620-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-201-00-8 |
Cloruro de tiocarbonilo |
207-341-6 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H331 H302 H319 H335 H315 |
GHS06 Dgr |
H331 H302 H319 H335 H315 |
|
|
|
|
|
607-203-00-9 |
[[[3,5-Bis(1,1-dimetiletil)-4-hidroxifenil]metil]tio]acetato de 2-etilhexilo |
279-452-8 |
Repr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H360D *** H317 H412 |
GHS08 GHS07 Dgr |
H360D *** H317 H412 |
|
|
|
|
|
607-204-00-4 |
(Clorofenil)(clorotolil)metano, mezcla de isómeros |
400-140-6 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-205-00-X |
Cloroacetato de metilo |
202-501-1 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H331 H301 H335 H315 H318 |
GHS02 GHS06 GHS05 Dgr |
H226 H331 H301 H335 H315 H318 |
|
|
|
|
|
607-206-00-5 |
Cloroacetato de isopropilo |
203-301-7 |
Flam. Liq. 3 Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H226 H301 H319 H335 H315 |
GHS02 GHS06 Dgr |
H226 H301 H319 H335 H315 |
|
|
|
|
|
607-207-00-0 |
Haloxifop-etotilo (ISO); 2-(4-(3-cloro-5-trifluorometil-2-piridiloxi)fenoxi)propionato de 2-etoxietilo; haloxifop-(2-etoxietilo) |
402-560-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-208-00-6 |
Ácido 4,8,12-trimetiltrideca-3,7,11-trienoico, mezcla de isómeros |
403-000-2 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
607-209-00-1 |
Masa de reacción de (pentatio)ditioformiato de O, O'-diisopropilo y (tritio)ditioformiato de O, O'-diisopropilo y (tetratio)ditioformiato de O, O'-diisopropilo |
403-030-6 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
607-210-00-7 |
Acrilamidoglicolato de metilo (con ≥ 0,1 % de acrilamida) |
403-230-3 |
Carc. 1B Muta. 1B Skin Corr. 1B Skin Sens. 1 |
H350 H340 H314 H317 |
GHS08 GHS05 GHS07 Dgr |
H350 H340 H314 H317 |
|
|
|
|
|
607-211-00-2 |
3-(3-terc-Butil-4-hidroxi-5-metilfenil)propionato de metilo |
403-270-1 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-212-00-8 |
Poli(oxipropilencarbonil-co-oxi(etiletilen)carbonilo), con un 27 % de hidroxivalerato |
403-300-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-213-00-3 |
3,3-Bis(terc-pentilperoxi)butirato de etilo |
403-320-2 |
Org. Perox. D**** Flam. Liq. 3 Aquatic Chronic 2 |
H242 H226 H411 |
GHS02 GHS09 Dgr |
H242 H226 H411 |
|
|
|
|
|
607-214-00-9 |
Ácido N, N-hidrazinodiacético |
403-510-5 |
Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H301 H373 ** H317 H412 |
GHS06 GHS08 Dgr |
H301 H373 ** H317 H412 |
|
|
|
|
|
607-215-00-4 |
Ácido 3-(3-terc-butil-4-hidroxifenil)propiónico |
403-920-4 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
607-216-00-X |
Ácido glutámico, productos de reacción con N-(C12-14-alquil)propilendiamina |
403-950-8 |
— |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H330 H302 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H302 H314 H400 |
|
|
|
|
607-217-00-5 |
2-(4-(2,6-Dihidro-2,6-dioxo-7-fenil-1,5-dioxaindacen-3-il)fenoxi)acetato de 2-etoxietilo |
403-960-2 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-218-00-0 |
Diclorprop-P (ISO); ácido (+)-R-2-(2,4-diclorofenoxi)propiónico |
403-980-1 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-219-00-6 |
Ditiodiacetato de bis(2-etilhexilo) |
404-510-8 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
607-221-00-7 |
Ácido 6-docosiloxi-1-hidroxi-4-(1-(4-hidroxi-3-metilfenantren-1-il)-3-oxo-2-oxafenalen-1-il)naftaleno-2-carboxílico |
404-550-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-222-00-2 |
Metacrilato de 6-(2,3-dimetilmaleimido)hexilo |
404-870-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-223-00-8 |
Transflutrina (ISO); (1R,3S)-3-(2,2-diclorovinil)-2,2-dimetilciclopropanocarboxilato de 2,3,5,6-tetrafluorobencilo |
405-060-5 |
Carc. 2 Acute Tox. 4 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H370 (sistema nervioso) H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H370 (sistema nervioso) H410 |
EUH066 |
Por vía oral: ETA = 580 mg/kg pc M = 1 000 M = 1 000 |
|
|
|
607-224-00-3 |
2-(3-Nitrobenciliden)acetoacetato de metilo |
405-270-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
607-225-00-9 |
Ácido 3-azidosulfonilbenzoico |
405-310-3 |
Self-React. C **** STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H241 H373 ** H318 H317 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H241 H373 ** H318 H317 |
|
|
|
|
|
607-226-00-4 |
Masa de reacción de ciclohexano-1,2-dicarboxilato de 2-acriloiloxietilo e hidrógeno, y ciclohexano-1,2-dicarboxilato de 2-metacriloiloxietilo e hidrógeno |
405-360-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H315 H318 H317 H412 |
GHS05 GHS07 Dgr |
H315 H318 H317 H412 |
|
|
|
|
607-227-00-X |
2-Amino-2-metilpropionato de potasio octahidratado |
405-560-3 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
|
607-228-00-5 |
Ftalato de bis(2-metoxietilo) |
204-212-6 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
|
607-229-00-0 |
Cloruro de dietilcarbamoílo |
201-798-5 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H332 H302 H319 H335 H315 |
GHS08 GHS07 Wng |
H351 H332 H302 H319 H335 H315 |
|
|
|
|
|
607-230-00-6 |
Ácido 2-etilhexanoico y sus sales, excepto las especificadas en otras partes del presente anexo |
- |
- |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
A, X, 12 |
|
607-231-00-1 |
Clopiralida (ISO); ácido 3,6-dicloropiridina-2-carboxílico |
216-935-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-232-00-7 |
Piridato (ISO); O S-octil-tiocarbonato de 6-cloro-3-fenilpiridazin-4-ilo |
259-686-7 |
Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H317 H410 |
|
Por vía oral: ETA = 500 mg/kg pc M=1 M = 10 |
|
|
|
607-233-00-2 |
Acrilato de hexilo |
219-698-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H411 |
|
|
|
|
|
607-234-00-8 |
Flurenol (ISO); ácido 9-hidroxi-9H-fluoreno-9-carboxílico |
207-397-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-235-00-3 |
Mecrilato; 2-cianoacrilato de metilo |
205-275-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-236-00-9 |
2-Cianoacrilato de etilo |
230-391-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-237-00-4 |
2-Cloro-4-(trifluorometil)tiazol-5-carboxilato de bencilo; flurazol |
276-942-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-238-00-X |
Tau-fluvalinato (ISO); N-[2-cloro-4-(trifluorometil)fenil]-D-valinato de ciano-(3-fenoxifenil)metilo |
— |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
607-239-00-5 |
Fenpropatrina (ISO); 2,2,3,3-tetrametilciclopropanocarboxilato de α-ciano-3-fenoxibencilo |
254-485-0 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H312 H410 |
|
|
|
|
|
607-240-00-0 |
Anhídrido cis-1,2,3,6-tetrahidro-4-metilftálico; [1] anhídrido 1,2,3,6-tetrahidro-4-metilftálico; [2] anhídrido 1,2,3,6-tetrahidro-3-metilftálico; [3] anhídrido tetrahidrometilftálico; [4] anhídrido 1,2,3,6-tetrahidrometilftálico; [5] anhídrido tetrahidro-4-metilftálico; [6] anhídrido 2,3,5,6-tetrahidro-2-metilftálico [7] |
216-906-6 [1] 222-323-8 [2] 226-247-6 [3] 234-290-7 [4] 247-830-1 [5] 251-823-9 [6] 255-853-3 [7] |
1694-82-2 [1] 3425-89-6 [2] 5333-84-6 [3] 11070-44-3 [4] 26590-20-5 [5] 34090-76-1 [6] 42498-58-8 [7] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-241-00-6 |
Anhídrido hexahidro-4-metilftálico; [1] anhídrido hexahidrometilftálico; [2] anhídrido hexahidro-1-metilftálico; [3] anhídrido hexahidro-3-metilftálico [4] |
243-072-0 [1] 247-094-1 [2] 256-356-4 [3] 260-566-1 [4] |
19438-60-9 [1] 25550-51-0 [2] 48122-14-1 [3] 57110-29-9 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-242-00-1 |
Anhídrido tetracloroftálico |
204-171-4 |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H317 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H318 H334 H317 H410 |
|
|
|
|
|
607-243-00-7 |
3,6-Dicloro-o-anisato de sodio; [1] ácido 3,6-dicloro-o-anísico, compuesto con 2,2'-iminodietanol (1:1); [2] ácido 3,6-dicloro-o-anísico, compuesto con 2-aminoetanol (1:1) [3] |
217-846-3 [1] 246-590-5 [2] 258-527-9 [3] |
1982-69-0 [1] 25059-78-3 [2] 53404-28-7 [3] |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-244-00-2 |
Acrilato de isooctilo |
249-707-8 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-245-00-8 |
Acrilato de terc-butilo |
216-768-7 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H312 H302 H335 H315 H317 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H312 H302 H335 H315 H317 H411 |
|
|
D |
|
|
607-246-00-3 |
Metacrilato de alilo; éster de 2-propenilo del ácido 2-metil-2-propenoico |
202-473-0 |
Flam. Liq. 3 Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 |
H226 H330 H311 H302 H400 |
GHS02 GHS06 GHS09 Dgr |
H226 H330 H311 H302 H400 |
|
Por inhalación: ETA = 1,5 mg/l (vapores) Por vía cutánea: ETA = 300 mg/kg pc Por vía oral: ETA = 400 mg/kg pc |
|
|
|
607-247-00-9 |
Metacrilato de dodecilo |
205-570-6 |
STOT SE 3 |
H335 |
GHS07 Wng |
H335 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-248-00-4 |
Naptalam-sodio (ISO); N-naft-1-ilftalamato de sodio |
205-073-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-249-00-X |
Diacrilato de (1-metil-1,2-etanodiil)bis[oxi(metil-2,1-etanodiilo)] |
256-032-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-250-00-5 |
4H-3,1-Benzoxazina-2,4(1H)-diona |
204-255-0 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
|
607-251-00-0 |
Acetato de 2-metoxipropilo |
274-724-2 |
Flam. Liq. 3 Repr. 1B STOT SE 3 |
H226 H360D *** H335 |
GHS02 GHS08 GHS07 Dgr |
H226 H360D *** H335 |
|
|
|
|
|
607-252-00-6 |
Lambda-cihalotrina (ISO); masa de reacción de (Z)-(1R)-cis-3-(2-cloro-3,3,3-trifluoropropenil)-2,2-dimetilciclopropanocarboxilato de (S)-α-ciano-3-fenoxibencilo y (Z)-(1S)-cis-3-(2-cloro-3,3,3-trifluoropropenil)-2,2-dimetilciclopropanocarboxilato de (R)-α-ciano-3-fenoxibencilo (1:1) |
415-130-7 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H312 H410 |
|
M=10000 |
|
|
|
607-253-00-1 |
Ciflutrina (ISO); 3-(2,2-diclorovinil)-2,2-dimetilciclopropanocarboxilato de α-ciano-4-fluoro-3-fenoxibencilo |
269-855-7 |
Lact. Acute Tox. 2 Acute Tox. 2 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H362 H330 H300 H370 (sistema nervioso) H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H362 H330 H300 H370 (sistema nervioso) H410 |
|
Por inhalación: ETA = 0,14 mg/l (polvos o nieblas) Por vía oral: ETA = 14 mg/kg pc M = 1 000 000 M = 1 000 000 |
|
|
|
607-254-00-7 |
Beta-ciflutrina (ISO); masa de reacción de (1S,3S)-3-(2,2-dicloroetenil)-2,2-dimetilciclopropano-1-carboxilato de rel-(R)-ciano(4-fluoro-3-fenoxifenil)metilo y (1S,3R)-3-(2,2-dicloroetenil)-2,2-dimetilciclopropano-1-carboxilato de rel-(R)-ciano(4-fluoro-3-fenoxifenil)metilo |
- |
Lact. Acute Tox. 2 Acute Tox. 2 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H362 H330 H300 H370 (sistema nervioso) H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H362 H330 H300 H370 (sistema nervioso) H410 |
|
Por inhalación: ETA = 0,081 mg/l (polvos o nieblas) Por vía oral: ETA = 11 mg/kg pc M = 1 000 000 M = 1 000 000 |
|
|
|
607-255-00-2 |
Fluroxipir (ISO); ácido 4-amino-3,5-dicloro-6-fluoro-2-piridiloxiacético |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-256-00-8 |
Azoxistrobina (ISO); (E)-2-{2-[6-(2-cianofenoxi)pirimidin-4-iloxi]fenil}-3-metoxiacrilato de metilo |
- |
Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H400 H410 |
GHS06 GHS09 Dgr |
H331 H410 |
|
Por inhalación: ETA = 0,7 mg/l (polvos o nieblas) M = 10 M = 10 |
|
|
|
607-257-00-3 |
Propionato de isopropilo |
211-300-8 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
607-258-00-9 |
3-(2-(3-Bencil-4-etoxi-2,5-dioxoimidazolidin-1-il)-3-(4-metoxibenzoil)acetamido)-4-clorobenzoato de dodecilo |
403-990-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-259-00-4 |
2R,3S-(-)-3-(4-Metoxifenil)oxiranocarboxilato de metilo |
404-130-2 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
607-260-00-X |
2-(3-Nitrobenciliden)acetoacetato de etilo |
404-490-0 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
607-261-00-5 |
(3,5-Di-terc-butil-4-hidroxifenil)metiltioacetato de iso(C10-C14)alquilo |
404-800-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-262-00-0 |
Ácido 7-cloro-1-ciclopropil-6-fluoro-1,4-dihidro-4-oxoquinolina-3-carboxílico |
405-050-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
607-263-00-6 |
1,3-Propanodiamina-N, N,N',N'-tetraacetato de potasio y hierro (III) hemihidratado |
405-680-6 |
— |
Self-heat. 2 **** Aquatic Chronic 2 |
H252 H411 |
GHS02 GHS09 Wng |
H252 H411 |
|
|
|
|
607-264-00-1 |
Ácido 2-cloro-4-(metilsulfonil)benzoico |
406-520-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-265-00-7 |
2-Cloro-2,2-difenilacetato de etilo |
406-580-5 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
607-266-00-2 |
Masa de reacción de: bis[2-hidroxi-3,5-di-terc-butilbenzoato] de hidroxialuminio; ácido 3,5-di-terc-butilsalicílico |
406-890-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-267-00-8 |
(5S,6R,7R)-3-Bromometil-5,8-dioxo-7-(2-(2-fenilacetamido)-5-tia-1-azabiciclo[4.2.0]oct-2-eno-2-carboxilato de terc-butilo |
407-620-4 |
Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H334 H317 H412 |
GHS08 Dgr |
H334 H317 H412 |
|
|
|
|
|
607-268-00-3 |
(R)-2-Hidroxipropanoato de 2-metilpropilo |
407-770-0 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-269-00-9 |
Ácido (R)-2-(4-hidroxifenoxi)propanoico |
407-960-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-270-00-4 |
3,9-Bis(2-(3-(3-terc-butil-4-hidroxi-5-metilfenil)propioniloxi-1,1-dimetiletil)-2,4,8,10-tetraoxaespiro[5.5]undecano |
410-730-5 |
Acute Tox. 4 * |
H312 |
GHS07 Wng |
H312 |
|
|
|
|
|
607-271-00-X |
2-Isopropil-5-metilciclohexiloxicarboniloxi-2-hidroxipropano |
417-420-9 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
|
607-272-00-5 |
Fluroxipir-meptilo (ISO); O-(4-amino-3,5-dicloro-6-fluoro-2-piridiloxi)acetato de metilheptilo; [1] fluroxipir-butometilo (ISO); O-(4-amino-3,5-dicloro-6-fluoro-2-piridiloxi)acetato de 2-butoxi-1-metiletilo [2] |
279-752-9 [1] -[2] |
81406-37-3 [1] 154486-27-8 [2] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-273-00-0 |
7-(2,6-Dimetil-8-(2,2-dimetilbutiriloxi)-1,2,6,7,8,8a-hexahidro-1-naftil)-3,5-dihidroxiheptanoato de amonio |
404-520-2 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-274-00-6 |
3-Amino-2-butenoato de 2-(N-bencil-N-metilamino)etilo |
405-350-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-275-00-1 |
Benzoiloxibenceno-4-sulfonato de sodio |
405-450-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-276-00-7 |
Bis[(1-metilimidazol)-(2-etilhexanoato)], complejo de cinc |
405-635-0 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-277-00-2 |
Masa de reacción de clorhidrato de 2-(hexiltio)etilamina; propionato de sodio |
405-720-2 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
607-278-00-8 |
Masa de reacción de isómeros de: fenetilnaftalenosulfonato de sodio; naftiletilbencenosulfonato de sodio |
405-760-0 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-279-00-3 |
Masa de reacción de: bis(hidrogenomaleato) de n-octadecilaminodietilo; hidrogenomaleato e hidrogenoftalato de n-octadecilaminodietilo |
405-960-8 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-280-00-9 |
4-Cloro-1-hidroxibutano-1-sulfonato de sodio |
406-190-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
|
607-281-00-4 |
Masa de reacción de 3-[3-(2H-benzotriazol-2-il)-5-(1,1-dimetiletil)-4-hidroxifenil]propionatos de C7-C9–alquilos ramificados y lineales |
407-000-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-282-00-X |
Acetato de 2-acetoximetil-4-benciloxibut-1-ilo |
407-140-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-283-00-5 |
(E)-4-Oxo-4-fenilcrotonato de etilo |
408-040-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H317 H410 |
|
|
|
|
|
607-284-00-0 |
Masa de reacción de: 3,3'-(1,4-fenilen-bis(carbonilimino-3,1-propanodiilimino))bis(10-amino-6,13-dicloro-4,11-trifenodioxazinadisulfonato) de sodio; 3,3'-(1,4-fenilen-bis(carbonilimino-3,1-propanodiilimino))bis(10-amino-6,13-dicloro)-4,11-trifenodioxazinadisulfonato de litio (9:1) |
410-040-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-285-00-6 |
Masa de reacción de: ácido 7-(((3-aminofenil)sulfonil)amino)naftaleno-1,3-disulfónico; 7-(((3-aminofenil)sulfonil)amino)naftaleno-1,3-disulfonato de sodio; 7-(((3-aminofenil)sulfonil)amino)naftaleno-1,3-disulfonato de potasio |
410-065-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
|
|
|
|
|
607-286-00-1 |
Masa de reacción de: 7-[[[3-[[4-((2-hidroxinaftil)azo)fenil]azo]fenil]sulfonil]amino]naftaleno-1,3-disulfonato de sodio/potasio |
410-070-8 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-287-00-7 |
1,2,3,6-Tetrahidroftalato de O'-metilo y O-(1-metil-2-metacriloiloxi-etilo) |
410-140-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-288-00-2 |
(c-(3-(1-(3-(e-6-Dicloro-5-cianopirimidin-f-il(metil)amino)propil)-1,6-dihidro-2-hidroxi-4-metil-6-oxo-3-piridilazo)-4-sulfonatofenilsulfamoil)ftalocianina-a, b,d-trisulfonato(6-)) niquelato II de tetrasodio, donde a es 1 o 2 o 3 o 4, b es 8 o 9 o 10 u 11, c es 15 o 16 o 17 o 18, d es 22 o 23 o 24 o 25, y donde e y f juntos son 2 y 4 o 4 y 2 respectivamente |
410-160-7 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
|
607-289-00-8 |
Ácido 3-(3-(4-(2,4-bis(1,1-dimetilpropil)fenoxi)butilaminocarbonil-4-hidroxi-1-naftalenil)tio)propanoico |
410-370-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-290-00-3 |
Masa de reacción (en proporción desconocida) de: 1-C14-C18-alquiloxicarbonil-2-(3-aliloxi-2-hidroxipropoxicarbonil)etano-1-sulfonato de amonio; 2-C14-C18-alquiloxicarbonil-1-(3-aliloxi-2-hidroxipropoxicarbonil)etano-1-sulfonato de amonio |
410-540-2 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
607-291-00-9 |
Carboxilato de dodecil-ω-(C5/C6-cicloalquil)alquilo |
410-630-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-292-00-4 |
Masa de reacción de: ácido [1-(metoximetil)-2-(C12-alcoxi)-etoxi]acético; ácido [1-(metoximetil)-2-(C14-alcoxi)-etoxi]acético |
410-640-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-293-00-X |
Masa de reacción de: disulfonato de éter mono-2,4,6-trimetilnonildifenílico de N-aminoetilpiperazonio; disulfonato de éter di-2,4,6-trimetilnonildifenílico de N-aminoetilpiperazonio |
410-650-0 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
607-294-00-5 |
2-Benzoiloxi-1-hidroxietano-sulfonato de sodio |
410-680-4 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-295-00-0 |
Masa de reacción de: fosfonoetano-1,2-dicarboxilato de tetrasodio; fosfonobutano-1,2,3,4-tetracarboxilato de hexasodio |
410-800-5 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-296-00-6 |
Masa de reacción de: tetraésteres del pentaeritritol con ácido heptanoico y ácido 2-etilhexanoico acid |
410-830-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-297-00-1 |
Ácido (E-E)-3,3'-(1,4-fenilendimetiliden)bis(2-oxobornane-10-sulfónico) |
410-960-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-298-00-7 |
2-(Trimetilamonio)etoxicarboxibenceno-4-sulfonato |
411-010-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-299-00-2 |
3-(Acetiltio)-2-metilpropanoato de metilo |
411-040-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
|
607-300-00-6 |
[2-(5-Cloro-2,6-difluoropirimidin-4-ilamino)-5-(b-sulfamoil-c, d-sulfonatoftalocianin-a-il-K4,N29,N30,N31,N32-sulfonilamino)benzoato(5-)]cuprato (II) de trisodio, donde a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25 |
411-430-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-301-00-1 |
Masa de reacción de: ácido dodecanoico; ésteres con poli(1-7)lactato del ácido dodecanoico |
411-860-5 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-302-00-7 |
Masa de reacción de: ácido tetradecanoico; ésteres con poli(1-7)lactato del ácido tetradecanoico |
411-910-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
607-303-00-2 |
Ácido 1-ciclopropil-6,7-difluoro-1,4-dihidro-4-oxoquinolina-3-carboxílico |
413-760-7 |
Repr. 2 Aquatic Chronic 3 |
H361f *** H412 |
GHS08 Wng |
H361f *** H412 |
|
|
|
|
|
607-304-00-8 |
Fluazifop-butilo (ISO); (RS)-2-[4-(5-trifluorometil-2-piridiloxi)fenoxi]propionato de butilo |
274-125-6 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H400 H410 |
GHS08 GHS09 Dgr |
H360D *** H410 |
|
|
|
|
|
607-305-00-3 |
Fluazifop-P-butilo (ISO); (R)-2-[4-(5-trifluorometil-2-piridiloxi)fenoxi]propionato de butilo |
— |
Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H400 H410 |
GHS08 GHS09 Wng |
H361d *** H410 |
|
|
|
|
|
607-306-00-9 |
Clozolinato (ISO); (RS)-3-(3,5-diclorofenil)-5-metil-2,4-dioxo-oxazolidina-5-carboxilato de etilo |
282-714-4 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
|
|
607-307-00-4 |
Vinclozolina (ISO); N-3,5-diclorofenil-5-metil-5-vinil-1,3-oxazolidina-2,4-diona |
256-599-6 |
Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H351 H360FD H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360FD H317 H411 |
|
|
|
|
|
607-308-00-X |
Ésteres de 2,4-D |
— |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
A |
|
607-309-00-5 |
Carfentrazona-etilo (ISO); (RS)-2-cloro-3-[2-cloro-4-fluoro-5-[4-difluorometil-4,5-dihidro-3-metil-5-oxo-1H-1,2,4-triazol-1-il]fenil]propionato de etilo |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-310-00-0 |
Kresoxim-metilo (ISO); (E)-2-metoxiimino-[2-(o-toliloximetil)fenil]acetato de metilo |
— |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
|
|
607-311-00-6 |
Benazolina-etilo; 4-cloro-2-oxo-2H-benzotiazol-3-acetato de etilo |
246-591-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-312-00-1 |
Ácido metoxiacético |
210-894-6 |
Repr. 1B Acute Tox. 4 * Skin Corr. 1B |
H360FD H302 H314 |
GHS08 GHS05 GHS07 Dgr |
H360FD H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
607-313-00-7 |
Cloruro de neodecanoílo |
254-875-0 |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS06 Dgr |
H330 H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
607-314-00-2 |
Etofumesato (ISO); metanosulfonato de (RS)-2-etoxi-2,3-dihidro-3,3-dimetilbenzofuran-5-ilo |
247-525-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 1 M = 1 |
|
|
|
607-315-00-8 |
Glifosato (ISO); N-(fosfonometil)glicina |
213-997-4 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
607-316-00-3 |
Glifosato-trimesio; glifosato-trimetilsulfonio |
— |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-317-00-9 |
Ftalato de bis(2-etilhexilo); ftalato de di-(2-etilhexilo); DEHP |
204-211-0 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
607-318-00-4 |
Ftalato de dibutilo; DBP |
201-557-4 |
Repr. 1B Aquatic Acute 1 |
H360Df H400 |
GHS08 GHS09 Dgr |
H360Df H400 |
|
|
|
|
|
607-319-00-X |
Deltametrina (ISO); (1R,3R)-3-(2,2-dibromovinil)-2,2-dimetilciclopropanocarboxilato de (S)-α-ciano-3-fenoxibencilo |
258-256-6 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
M=1000000 |
|
|
|
607-320-00-5 |
1,3-Bencenodicarboxilato de bis[4-(eteniloxi)butilo] |
413-930-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
607-321-00-0 |
(S)-2-Cloropropionato de metilo |
412-470-8 |
Flam. Liq. 3 STOT RE 2 * Eye Irrit. 2 |
H226 H373 ** H319 |
GHS02 GHS08 Wng |
H226 H373 ** H319 |
|
|
|
|
|
607-322-00-6 |
Ácido 4-(4,4-dimetil-3-oxo-pirazolidin-1-il)-benzoico |
413-120-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-323-00-1 |
Acrilato de 2-(1-(2-hidroxi-3,5-di-terc-pentil-fenil)etil)-4,6-di-terc-pentilfenilo |
413-850-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-324-00-7 |
Masa de reacción de: ácido N, N-di(alquil hidrogenado C14-C18)ftalámico; (alquil dihidrogenado C14-C18)amina |
413-800-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-325-00-2 |
Ácido (S)-2-cloropropiónico |
411-150-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
|
607-326-00-8 |
Masa de reacción de: 2-(α-2,4,6-trimetilnon-2-enil)succinato de isobutilo e hidrógeno; 2-(ß-2,4,6-trimetilnon-2-enil)succinato de isobutilo e hidrógeno |
410-720-0 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
607-327-00-3 |
Diacetato de 2-(2-yodoetil)-1,3-propanodiol |
411-780-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-328-00-9 |
4-Bromometil-3-metoxibenzoato de metilo |
410-310-1 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
607-329-00-4 |
Masa de reacción de: 2-(C12-18-n-alquil)amino-1,4-butanodioato de sodio; 2-octadecenil-amino-1,4-butanodioato de sodio |
411-250-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-330-00-X |
Ácido (S)-2,3-dihidro-1H-indol-2-carboxílico |
410-860-2 |
Repr. 2 STOT RE 2 * Skin Sens. 1 |
H361f *** H373 ** H317 |
GHS08 GHS07 Wng |
H361f *** H373 ** H317 |
|
|
|
|
|
607-331-00-5 |
Masa de reacción de: 1,10-decanodioato de bis(2,2,6,6-tetrametil-1-octiloxipiperidin-4-ilo); 1,8-bis[(2,2,6,6-tetrametil-4-((2,2,6,6-tetrametil-1-octiloxipiperidin-4-il)-decan-1,10-dioil)piperidin-1-il)oxi]octano |
406-750-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-332-00-0 |
Cloroformiato de ciclopentilo |
411-460-0 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H226 H331 H302 H373 ** H318 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H331 H302 H373 ** H318 H317 |
|
|
|
|
|
607-333-00-6 |
Masa de reacción de: N-(2,2,6,6-tetrametilpiperidin-4-il)-β-alaninato de dodecilo; N-(2,2,6,6-tetrametilpiperidin-4-il)-β-alaninato de tetradecilo |
405-670-1 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H410 |
|
|
|
|
607-334-00-1 |
1-Etil-6,7,8-trifluoro-1,4-dihidro-4-oxoquinolina-3-carboxilato de etilo |
405-880-3 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-335-00-7 |
(R)-2-(4-(3-Cloro-5-trifluorometil-2-piridiloxi)fenoxi)propionato de metilo |
406-250-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-336-00-2 |
Acetato de 4-metil-8-metilentriciclo[3.3.1.13,7]dec-2-ilo |
406-560-6 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
|
607-337-00-8 |
2-Benzotiazoliltiosuccinato de di-terc-(C12-14)-alquilamonio |
406-052-4 |
Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H302 H315 H318 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H302 H315 H318 H411 |
|
|
|
|
|
607-338-00-3 |
2-Hidroxi-2-metilbut-3-enoato de 2-metilpropilo |
406-235-9 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
|
607-339-00-9 |
Cloruro de 2,3,4,5-tetraclorobenzoílo |
406-760-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
|
607-340-00-4 |
Acetato de 1,3-bis(4-benzoil-3-hidroxifenoxi)prop-2-ilo |
406-990-4 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-341-00-X |
(9S)-9-Amino-9-desoxieritromicina |
406-790-7 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
|
607-342-00-5 |
Veratrato de 4-clorobutilo |
410-950-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-343-00-0 |
Bis(2-carboxibenzoato) de 4,7-metanooctahidro-1H-indeno-diildimetilo |
407-410-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-344-00-6 |
Masa de reacción de: ácido 3-(N-(3-dimetilaminopropil)-(C4-8)perfluoroalquilsulfonamido)propiónico; propionato de N-(dimetil-3-(C4-8)perfluoroalquilsulfonamido)propilamonio; propionato de ácido 3-(N-(3-dimetilpropilamonio)-(C4-8)perfluoroalquilsulfonamido)propiónico |
407-810-7 |
— |
STOT RE 2 * |
H373 ** |
GHS08 Wng |
H373 ** |
|
|
|
|
607-345-00-1 |
2-(2,4-Diclorofenoxi)-(R)-propionato de potasio |
413-580-9 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-346-00-7 |
3-Icosil-4-henicosilideno-2-oxetanona |
401-210-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-347-00-2 |
(R)-2-(2,4-Diclorofenoxi)propionato de sodio |
413-340-3 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-348-00-8 |
Bis((R)-2-(2,4-diclorofenoxi)propionato) de magnesio |
413-360-2 |
— |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
607-349-00-3 |
2,2'-Ditiobisbenzoato de mono-(tetrapropilamonio) e hidrógeno |
411-270-8 |
— |
Aquatic Chronic 3 |
H412 |
|
H412 |
|
|
|
|
607-350-00-9 |
Bis(4-(1,2-bis(etoxicarbonil)etilamino)-3-metilciclohexil)metano |
412-060-9 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-351-00-4 |
O-(4-Amino-3,5-dicloro-6-fluoropiridin-2-iloxi)acetato de metilo |
407-550-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-352-00-X |
Anhídrido 4,4'-oxidiftálico |
412-830-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-353-00-5 |
Masa de reacción de: exo-triciclo[5.2.1.02,6]decano-endo-2-carboxilato de etilo; endo-triciclo[5.2.1.02,6]decano-exo-2-carboxilato de etilo |
407-520-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
607-354-00-0 |
2-Ciclohexilpropionato de etilo |
412-280-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-355-00-6 |
4-Clorobenzoato de p-tolilo |
411-530-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
607-356-00-1 |
trans-2,2,6-Trimetilciclohexanocarboxilato de etilo |
412-540-8 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-357-00-7 |
Masa de reacción de: trans-4-acetoxi-4-metil-2-propil-tetrahidro-2H-pirano; cis-4-acetoxi-4-metil-2-propil-tetrahidro-2H-pirano |
412-450-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-358-00-2 |
1-Dioxo-6-fenilacetamido-penam-3-carboxilato de (1S,3S,5R,6R)-(4-nitrofenilmetilo) |
412-670-5 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
|
|
607-359-00-8 |
3-Metilen-1-oxo-7-fenilacetamido-cefam-4-carboxilato de (1S,4R,6R,7R)-(4-nitrofenilmetilo) |
412-800-0 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
|
|
607-360-00-3 |
3-Acetoacetilamino-4-metoxitolil-6-sulfonato de sodio |
411-680-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-361-00-9 |
(R)-2-(4-Hidroxifenoxi)propionato de metilo |
411-950-4 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
607-362-00-4 |
Masa de reacción de: 2-(2-(bis(2-hidroxietil)amino)etoxicarbonilmetil)-hexadec-4-enoato de (3-metoxi)propilamonio / [tris-(2-hidroxietil)]amonio; 2-(2-(bis(2-hidroxietil)amino)etoxicarbonilmetil)-tetradec-4-enoato de (3-metoxi)propilamonio / [tris-(2-hidroxietil)]amonio; 2-(3-metoxipropilcarbamoilmetil)-hexadec-4-enoato de (3-metoxi)propilamonio / [tris-(2-hidroxietil)]amonio; 2-(3-metoxipropilcarbamoilmetil)tetradec-4-enoato de (3-metoxi)propilamonio / [tris-(2-hidroxietil)]amonio |
413-500-2 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H315 H318 H411 |
GHS05 GHS09 Dgr |
H315 H318 H411 |
|
|
|
|
607-363-00-X |
3-Metoxiacrilato de metilo |
412-900-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-364-00-5 |
3-Fenil-7-[4-(tetrahidrofurfuriloxi)fenil]-1,5-dioxa-s-indaceno-2,6-diona |
413-330-9 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
|
607-365-00-0 |
Clorhidrato de cloruro de 2-(2-amino-1,3-tiazol-4-il)-(Z)-2-metoxiiminoacetilo |
410-620-7 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
|
607-366-00-6 |
Cloruro de 3,5-dimetilbenzoílo |
413-010-9 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
|
607-367-00-1 |
Bis(N-carboximetil)-N-metil-glicinato-(2-)N, O,O, N)-ferrato-(1-) de potasio monohidratado |
411-640-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-368-00-7 |
1-(N,N-Dimetilcarbamoil)-3-terc-butil-5-carbetoximetiltio-1H-1,2,4-triazol |
411-650-3 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
|
|
|
|
607-369-00-2 |
Masa de reacción de: ácido trans-(2R)-5-acetoxi-1,3-oxatiolano-2-carboxílico; ácido cis-(2R)-5-acetoxi-1,3-oxatiolano-2-carboxílico |
411-660-8 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-370-00-8 |
2-[[2-(Acetiloxi)-3-(1,1-dimetiletil)-5-metilfenil]metil]-6-(1,1-dimetiletil)-4-metilfenol |
412-210-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-371-00-3 |
4-(2-Clorofenil)-1,4-dihidro-2-[2-(1,3-dihidro-1,3-dioxo-(2H)isoindol-2-il)-etoximetil]-6-metil-3,5-piridinadicarboxilato de 3-etilo y 5-metilo |
413-410-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-372-00-9 |
Di(norborneno-carboxilato) de bisfenol A etoxilado |
412-410-0 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-373-00-4 |
Quizalofop-P-tefurilo (ISO); (+/–) (R)-2-[4-(6-cloroquinoxalín-2-iloxi)feniloxi]propionato de tetrahidrofurfurilo |
414-200-4 |
Carc. 2 Repr. 2 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361fd H302 H373 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361fd H302 H373 H410 |
|
M = 1 M = 1 |
|
|
|
607-374-00-X |
Dicloruro de 5-amino-2,4,6-triyodo-1,3-bencenodicarbonilo |
417-220-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-375-00-5 |
flocumafén (ISO); masa de reacción de: cis-4-hidroxi-3-(1,2,3,4-tetrahidro-3-(4-(4-trifluorometilbenciloxi)fenil)-1-naftil)cumarina y trans-4-hidroxi-3-(1,2,3,4-tetrahidro-3-(4-(4-trifluorometilbenciloxi)fenil)-1-naftil)cumarina |
421-960-0 |
Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (sangre) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (sangre) H410 |
|
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (sangre): C ≥ 0,05 % STOT RE 2; H373 (sangre): 0,005 % ≤ C < 0,05 % M = 10 M = 10 |
|
|
|
607-376-00-0 |
2,4-Dibromobutanoato de bencilo |
420-710-8 |
Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f *** H315 H317 H410 |
|
|
|
|
|
607-377-00-6 |
Monoclorhidrato de trans-4-ciclohexil-L-prolina |
419-160-1 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H361f *** H302 H315 H318 H317 |
GHS08 GHS05 GHS07 Dgr |
H361f *** H302 H315 H318 H317 |
|
|
|
|
|
607-378-00-1 |
(Z)-α-Metoxiimino-2-furilacetato de amonio |
405-990-1 |
Flam. Sol. 2 |
H228 |
GHS02 Dgr |
H228 |
|
|
T |
|
|
607-379-00-7 |
Masa de reacción de: estearato de 2-[N-(2-hidroxietil)estearamido]etilo; [bis[2-(estearoiloxi)etil]amino]metilsulfonato de sodio; [bis(2-hidroxietil)amino]metilsulfonato de sodio; N, N-bis(2-hidroxietil)estearamida |
401-230-8 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-380-00-2 |
Masa de reacción de: 1,2-bis(hexiloxicarbonil)etanosulfonato de amonio; 1-hexiloxicarbonil-2-octiloxicarboniletanosulfonato de amonio; 2-hexiloxicarbonil-1-octiloxicarboniletanosulfonato de amonio |
407-320-3 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
607-381-00-8 |
Masa de reacción de triésteres de 2,2-bis(hidroximetil)butanol con ácidos C7-alcanoicos y con ácido 2-etilhexanoico |
413-710-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-382-00-3 |
Ácido 2-((4-amino-2-nitrofenil)amino)benzoico |
411-260-3 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
607-383-00-9 |
Masa de reacción de: hexadecanoato de 2,2,6,6-tetrametilpiperidin-4-ilo; octadecanoato de 2,2,6,6-tetrametilpiperidin-4-ilo |
415-430-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
|
607-384-00-4 |
Masa de reación de: ésteres de alcoholes ramificados C14-C15 con ácido 3,5-di-t-butil-4-hidroxifenilpropiónico; 3,5-bis(1,1-dimetiletil)-4-hidroxibencenopropanoato de alquilos lineales y ramificados C15; 3,5-bis(1,1-dimetiletil)-4-hidroxibencenopropanoato de alquilos lineales y ramificados C13 |
413-750-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-385-00-X |
Copolímero de alcohol vinílico y acetato de vinilo acetilizado parcialmente con metilsulfato de 4-(2-(4-formilfenil)etenil)-1-metilpiridinio |
414-590-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-386-00-5 |
Masa de reacción de ácido tetradecanoico (42,5-47,5 %); ésteres de poli(1-7)lactato con el ácido tetradecanoico (52,5-57,5 %) |
412-580-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
607-387-00-0 |
Masa de reacción de: ácido dodecanoico (35-40 %); ésteres de poli(1-7)lactato con el ácido dodecanoico (60-65 %) |
412-590-0 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
607-388-00-6 |
Ácido 4-etilamino-3-nitrobenzoico |
412-090-2 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
|
607-389-00-1 |
N, N-Bis(carboximetil)-3-amino-2-hidroxipropionato de trisodio |
414-130-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-390-00-7 |
1,2,3,4-Tetrahidro-6-nitroquinoxalina |
414-270-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-391-00-2 |
Ciclopropano-1,1-dicarboxilato de dimetilo |
414-240-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-392-00-8 |
4-((5-Ciano-1,6-dihidro-2-hidroxi-1,4-dimetil-6-oxo-3-piridinil)azo)benzoato de 2-fenoxietilo |
414-260-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-393-00-3 |
Ácido 3-(cis-1-propenil)-7-amino-8-oxo-5-tia-1-azabiciclo[4.2.0]oct-2-eno-2-carboxílico |
415-750-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-394-00-9 |
Ácido 5-metilpirazina-2-carboxílico |
413-260-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-395-00-4 |
Masa de reacción de: 1-tridecil-4-alil-(2 o 3)-sulfobutanodioato de sodio; 1-dodecil-4-alil-(2 o 3)-sulfobutanodioato de sodio |
410-230-7 |
— |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
607-396-00-X |
2-(4-Metoxibenciliden)malonato de bis(1,2,2,6,6-pentametil-4-piperidinilo) |
414-840-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-397-00-5 |
Masa de reacción de: salicilatos de Ca (con alquilos ramificados C10-14 y C18-30); fenatos de Ca (con alquilos ramificados C10-14 y C18-30); fenatos azufrados de Ca (con alquilos ramificados C10-14 y C18-30) |
415-930-6 |
— |
Repr. 2 Skin Sens. 1 |
H361f*** H317 |
GHS08 GHS07 Wng |
H361f*** H317 |
|
|
|
|
607-398-00-0 |
N-(5-Cloro-3-(4-(dietilamino)-2-metilfenilimino)-4-metil-6-oxo-1,4-ciclohexadienil)carbamato de etilo |
414-820-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-399-00-6 |
3-Metil-3-butenilpropanoato de 2,2-dimetilo |
415-610-6 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
607-400-00-X |
3-[[(Dibutilamino)tioxometil]tio]propanoato de metilo |
414-400-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-401-00-5 |
3-Hidroxi-5-oxo-3-ciclohexeno-1-carboxilato de etilo |
414-450-4 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
|
607-402-00-0 |
N-(Fenoxicarbonil)-L-valinato de metilo |
414-500-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-403-00-6 |
Masa de reacción de: succinato de bis(1S,2S,4S)-(1-bencil-4-terc-butoxicarboxamido-2-hidroxi-5-fenil)pentilamonio; alcohol isopropílico |
414-810-0 |
— |
STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H318 H410 |
|
|
|
|
607-404-00-1 |
Masa de reacción de: ácido ((Z)-3,7-dimetil-2,6-octadienil)oxicarbonilpropanoico; butanodioato de di-((E)-3,7-dimetil-2,6-octadienilo); butanodioato de di-((Z)-3,7-dimetil-2,6-octadienilo); butanodioato de (Z)-3,7-dimetil-2,6-octadienilo; ácido ((E)-3,7-dimetil-2,6-octadienil)oxicarbonilpropanoico |
415-190-4 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-405-00-7 |
p-Hidroxibenzoato de 2-hexildecilo |
415-380-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-406-00-2 |
2,5-Diclorobenzoato de potasio |
415-700-5 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
607-407-00-8 |
2-Carboxi-3-(2-tienil)propionato de etilo |
415-680-8 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
|
607-408-00-3 |
N-(4-Fluorofenil)glicinato de potasio |
415-710-1 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H318 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H373 ** H318 H317 H412 |
|
|
|
|
|
607-409-00-9 |
Masa de reacción de: ácido (3R)-[1S-(1α,2α, 6β-((2S)-2-metil-1-oxo-butoxi)-8aγ)hexahidro-2,6-dimetil-1-naftaleno]-3,5-dihidroxiheptanoico; biomasa inerte de Aspergillus terreus |
415-840-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-410-00-4 |
2-(Hexadec-2-enil)butanodioato de mono[2-(dimetilamino)etilo] y monohidrógeno, y/o 3-(hexadec-2-enil)butanodioato de mono[2-(dimetilamino)etilo] y monohidrógeno |
415-880-5 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
607-411-00-X |
Oxiranometanol, 4-metilbencenosulfonato, (S)- |
417-210-7 |
Carc. 1B Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H350 H341 H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H350 H341 H318 H317 H411 |
|
|
|
|
|
607-412-00-5 |
2-(1-Cianociclohexil)acetato de etilo |
415-970-4 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373 ** H412 |
GHS08 GHS07 Wng |
H302 H373 ** H412 |
|
|
|
|
|
607-413-00-0 |
trans-4-Fenil-L-prolina |
416-020-1 |
Repr. 2 Skin Sens. 1 |
H361f *** H317 |
GHS08 GHS07 Wng |
H361f *** H317 |
|
|
|
|
|
▼M18 ————— |
||||||||||
|
607-415-00-1 |
Poli(metacrilato de metilo)-co-(metacrilato de butilo)-co-(carbamato de 4-acriloxibutil-isopropenil-α, α-dimetilbencilo)-co-(anhídrido maleico) |
419-590-1 |
— |
Flam. Sol. 1 Skin Sens. 1 |
H228 H317 |
GHS02 GHS07 Dgr |
H228 H317 |
|
|
T |
|
607-416-00-7 |
4-(2-Carboximetiltio)etoxi-1-hidroxi-5-isobutiloxicarbonilamino-N-(3-dodeciloxipropil)-2-naftamida |
420-730-7 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-417-00-2 |
Cloroformiato de 3-cloropropilo |
425-770-9 |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H331 H302 H373** H315 H318 H317 |
GHS06 GHS05 GHS08 Dgr |
H331 H302 H373** H315 H318 H317 |
|
|
|
|
|
607-418-00-8 |
4-Aminobenzoato de 2-etilhexilo |
420-170-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-419-00-3 |
Ácido (3'-carboximetil-5-(2-(3-etil-3H-benzotiazol-2-iliden)-1-metiletiliden)-4,4'-dioxo-2'-tioxo-(2,5')bitiazolidiniliden-3-il)acético |
422-240-9 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
607-420-00-9 |
Ácido 2,2-bis(hidroximetil)butanoico |
424-090-1 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
607-421-00-4 |
Cipermetrina (ISO); 3-(2,2-diclorovinil)-2,2-dimetilciclopropanocarboxilato de α-ciano-3-fenoxibencilo; cipermetrina cis/trans +/- 40/60 |
257-842-9 |
Acute Tox. 4 Acute Tox. 4 STOT SE 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H335 H373 (sistema nervioso) H400 H410 |
GHS07 GHS08 GHS09 Wng |
H332 H302 H335 H373 (sistema nervioso) H410 |
|
Por vía oral: ETA = 500 mg/kg pc Por inhalación: ETA = 3,3 mg/l (polvos o nieblas) M = 100000 M = 100000 |
|
|
|
607-422-00-X |
α-Cipermetrina (ISO); mezcla racémica de (1S,3S)-3-(2,2-diclorovinil)-2,2-dimetilciclopropanocarboxilato de (R)-α-ciano-3-fenoxibencilo y (1R, 3R)-3-(2,2-diclorovinil)-2,2-dimetilciclopropanocarboxilato de (S)-α-ciano-3-fenoxibencilo |
257-842-9 |
Acute Tox. 3 * STOT RE 2 * STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373** H335 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H373** H335 H410 |
|
M=1000 |
|
|
|
607-423-00-5 |
Ésteres de mecoprop y de mecoprop-P |
— |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
A |
|
607-424-00-0 |
Trifloxistrobina (ISO); (E)-metoxi-imino-{(E)-α-[1-(α,α,α-trifluoro-m-tolil)etilidenaminooxil]-o-tolilacetato de metilo |
- |
Lact. Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H362 H317 H400 H410 |
GHS07 GHS09 Wng |
H362 H317 H410 |
|
M = 100 M = 10 |
|
|
|
607-425-00-6 |
Metalaxilo (ISO); N-(2,6-dimetilfenil)-N-(metoxiacetil)-DL-alaninato de metilo |
260-979-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
|
607-426-00-1 |
Ácido 1,2-bencenodicarboxílico, dipentilésteres, ramificados y lineales; [1] ftalato de n-pentilo-isopentilo; [2] ftalato de di-n-pentilo; [3] ftalato de diisopentilo [4] |
284-032-2 [1] -[2] 205-017-9 [3] 210-088-4 [4] |
84777-06-0 [1] -[2] 131-18-0 [3] 605-50-5 [4] |
Repr. 1B Aquatic Acute 1 |
H360FD H400 |
GHS08 GHS09 Dgr |
H360FD H400 |
|
|
|
|
607-427-00-7 |
Bromoxinilo-heptanoato (ISO); heptanoato de 2,6-dibromo-4-cianofenilo |
260-300-4 |
Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H332 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d *** H332 H302 H317 H410 |
|
|
|
|
|
607-428-00-2 |
Etilendiaminotetraacetato de tetrasodio |
200-573-9 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
607-429-00-8 |
Ácido edético; (EDTA) |
200-449-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-430-00-3 |
BBP; ftalato de bencilo y butilo |
201-622-7 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H400 H410 |
GHS08 GHS09 Dgr |
H360Df H410 |
|
|
|
|
|
607-431-00-9 |
Praletrina (ISO); ETOC; 2,2-dimetil-3-(2-metilprop-1-enil)ciclopropanocarboxilato de 2-metil-4-oxo-3-(prop-2-inil)ciclopent-2-en-1-ilo |
245-387-9 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H410 |
|
|
|
|
|
607-432-00-4 |
S-metolacloro (ISO); 2-cloro-N-(2-etil-6-metilfenil)-N-[(2S)-1-metoxipropan-2-il]acetamida; (R a S a)-2-cloro-N-(6-etil-o-tolilo)-N-[(1S)-2-metoxi-1-metiletil]acetamida [contiene 80-100 % 2-cloro-N-(2-etil-6-metilfenil)-N-[(2S)-1-metoxipropan-2-il]acetamida y 0-20 % 2-cloro-N-(2-etil-6-metilfenil)-N-[(2R)-1-metoxipropan-2-il]acetamida] |
— |
Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H317 H410 |
EUH066 |
M = 10 M = 10 |
|
|
|
607-433-00-X |
Cipermetrina cis/trans +/-80/20; (1RS;3RS;1RS,3SR)-3-(2,2-diclorovinil)-2,2-dimetilciclopropanocarboxilato de (RS)-α-ciano-3-fenoxibencilo |
257-842-9 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H335 H315 H317 H410 |
|
|
|
|
|
607-434-00-5 |
Mecoprop-P (ISO) [1] y sus sales; ácido (R)-2-(4-cloro-2-metilfenoxi)propiónico [1] y sus sales |
240-539-0 [1] |
16484-77-8 [1] |
Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS07 GHS05 GHS09 Dgr |
H302 H318 H410 |
|
Por vía oral: ETA = 431 mg/kg pc M = 10 M = 10 |
|
|
607-435-00-0 |
2,2-Dihidroxiacetato de 2S-isopropil-5R-metil-1R-ciclohexilo |
416-810-6 |
STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H373 ** H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H318 H411 |
|
|
|
|
|
607-436-00-6 |
Neodecanoato de 2-hidroxi-3-(2-etil-4-metilimidazoil)propilo |
417-350-9 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-437-00-1 |
Ácido 3-(4-aminofenil)-2-ciano-2-propenoico |
417-480-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-438-00-7 |
2-[(Aminosulfonil)metil]benzoato de metilo |
419-010-5 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
607-439-00-2 |
Tetrahidro-2-furancarboxilato de metilo |
420-670-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-440-00-8 |
2-Aminosulfonil-6-(trifluorometil)piridina-3-carboxilato de metilo |
421-220-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-441-00-3 |
Ácido 3-[3-(2-dodeciloxi-5-metilfenilcarbamoil)-4-hidroxi-1-naftiltio]propiónico |
421-490-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-442-00-9 |
[Hidroxi-(4-fenilbutil)fosfinil]acetato de bencilo |
416-050-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
607-444-00-X |
Masa de reacción de: dibenzoato de cis-1,4-dimetilciclohexilo; dibenzoato de trans-1,4-dimetilciclohexilo |
416-230-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-445-00-5 |
Tris(4-metilbencenosulfonato) de hierro (III) |
420-960-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-446-00-0 |
2-[4-(2-Cloro-4-nitrofenilazo)-3-(1-oxopropil)amino]fenilaminopropionato de metilo |
416-240-8 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
607-447-00-6 |
4-[4-(4-Hidroxifenilazo)fenilamino]-3-nitrobencenosulfonato de sodio |
416-370-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-448-00-1 |
Ácido 2,3,5,6-tetrafluorobenzoico |
416-800-1 |
Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Dgr |
H315 H318 |
|
|
|
|
|
607-449-00-7 |
Masa de reacción de: tri[bis(2-metilpropil)naftalenosulfonato] de 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazina-1,3,5-triil)tris[metilen(3,5,5-trimetil-3,1-ciclohexanodiil)iminocarboniloxi-2,1-etanodiil(etil)amino]]trisbencenodiazonio; tetra[bis(2-metilpropil)naftalenosulfonato] de 4,4',4'',4'''-[[5,5'-[carbonilbis[imino(1,5,5-trimetil-3,1-ciclohexanodiil)metilen]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazina-1,1',3,3'-tetrail]tetrakis[metilen(3,5,5-trimetil-3,1-ciclohexanodiil)iminocarboniloxi-2,1-etanodiil(etil)amino]]tetrakisbencenodiazonio |
417-080-1 |
— |
Self-react. D **** Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H317 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H242 H317 H410 |
|
|
|
|
607-450-00-2 |
Isopropoxiiminoacetato de 2-mercaptobenzotiazolil-(Z)-(2-aminotiazol-4-il)-2-(terc-butoxicarbonilo) |
419-040-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-451-00-8 |
Ácido 4-[4-amino-5-hidroxi-3-(4-(2-sulfoxietilsulfonil)fenilazo)-2,7-disulfonaft-6-ilazo]-6-[3-(4-amino-5-hidroxi-3-(4-(2-sulfoxietilsulfonil)fenilazo)-2,7-disulfonaft-6-ilazo]fenilcarbonilamino]bencenosulfónico, sal de sodio |
417-640-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
607-453-00-9 |
Bis(2,2-dimetiloctanoato) de 4-bencil-2,6-dihidroxi-4-aza-heptileno |
418-100-1 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
607-454-00-4 |
Masa de reacción de: ácido trans-2-(1-metiletil)-1,3-dioxano-5-carboxílico; ácido cis-2-(1-metiletil)-1,3-dioxano-5-carboxílico |
418-170-3 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
607-455-00-X |
Ácido 1-amino-4-(3-[4-cloro-6-(2,5-disulfofenilamino)-1,3,5-triazin-2-ilamino]-2,2-dimetilpropilamino)-antraquinona-2-sulfónico, sal de sodio/litio |
419-520-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-456-00-5 |
Ácido 3-amino-4-clorobenzoico, éster hexadecílico |
419-700-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-457-00-0 |
1,1''-Dihidroxi-8,8''-[p-fenilbis(imino-{6-[4-(2-aminoetil)piperazin-1-il]}-1,3,5-triazina-4,2-diilimino)]bis(2,2'-azonaftaleno-1',3,6-trisulfonato) de tetrasodio y dihidrógeno |
420-350-1 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
607-458-00-6 |
Masa de reacción de: 2-etil-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hidroxietoxi)fenil]-1-metiletil]fenoxi]propenoato; dipropenoato de 2,2'-dietil-[4,4'-bis(2,6-dibromofenoxi)-1-metiletilideno]; 2,2'-[(1-metiletiliden)bis[[2,6-dibromo-4,1-fenilen)oxi]etanol]] |
420-850-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-459-00-1 |
4-{2-[5-Ciano-1,2,3,6-tetrahidro-1-(2-isopropoxietoxi-carbonilmetil)-4-metil-2,6-dioxo-3-piridiliden]hidrazino}benzoato de isopentilo |
418-930-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-460-00-7 |
9-Octadecenoato de 3-trideciloxipropilamonio |
418-990-1 |
STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H319 H315 H410 |
|
|
|
|
|
607-461-00-2 |
Masa de reacción de: 2-{4-{3-metil-4-[6-sulfonato-4-(2-sulfonato-fenilazo)-naftalen-1-ilazo]-fenilamino}-6-[3-(2-sulfato-etanosulfonil)-fenilamino]-1,3,5-triazin-2-ilamino}-benceno-1,4-disulfonato de pentasodio; 2-{4-{3-metil-4-[7-sulfonato-4-(2-sulfonato-fenilazo)-naftalen-1-ilazo]-fenilamino}-6-[3-(2-sulfato-etanosulfonil)-fenilamino]-1,3,5-triazin-2-ilamino}-benceno-1,4-disulfonato de pentasodio |
421-160-1 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-462-00-8 |
Masa de reacción de: acetato de 1-hexilo; acetato de 2-metil-1-pentilo; acetato de 3-metil-1-pentilo; acetato de 4-metil-1-pentilo; otros acetatos de alquilos C6 mezcla de lineales y ramificados |
421-230-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-463-00-3 |
Ácido 3-(fenotiazin-10-il)propiónico |
421-260-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-464-00-9 |
Masa de reacción de: ácido 7-cloro-1-etil-6-fluoro-1,4-dihidro-4-oxo-quinolina-3-carboxílico; ácido 5-cloro-1-etil-6-fluoro-1,4-dihidro-4-oxo-quinolina-3-carboxílico |
421-280-4 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-465-00-4 |
7-{4-[4-(2-Cianoamino-4-hidroxi-6-oxidopirimidin-5-ilazo)benzamido]-2-etoxi-fenilazo}naftaleno-1,3-disulfonato de tris(2-hidroxietil)amonio |
421-440-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-466-00-X |
Masa de reacción de: 1-(1-[2-cloro-5-(hexadeciloxicarbonil)fenilcarbamoil]-3,3-dimetil-2-oxobutil)-1H-2,3,3a,7a-tetrahidrobenzotriazol-5-carboxilato de fenilo; 2-(1-(2-cloro-5-(hexadeciloxicarbonil)fenilcarbamoil)-3,3-dimetil-2-oxobutil)-1H-2,3,3a,7a-tetrahidrobenzotriazol-5-carboxilato de fenilo; 3-(1-(2-cloro-5-(hexadeciloxicarbonil)fenilcarbamoil)-3,3-dimetil-2-oxobutil)-1H-2,3,3a,7a-tetrahidrobenzotriazol-5-carboxilato de fenilo |
421-480-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-467-00-5 |
1,3-Diestañooxidicaprilato de 1,1,3,3-tetrabutilo |
419-430-9 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H314 H410 |
|
|
|
|
|
607-468-00-0 |
Masa de reacción de: 4-((4-(5-sulfonato-2-metoxifenilamino)-6-cloro-1,3,5-triazin-2-il)amino)-2-((1,4-dimetil-6-oxido-2-oxo-5-sulfonatometil-1,2-dihidropiridin-3-il)azo)bencenosulfonato de monosodio; 4-((4-(5-sulfonato-2-metoxifenilamino)-6-cloro-1,3,5-triazin-2-il)amino)-2-((1,4-dimetil-6-oxido-2-oxo-5-sulfonatometil-1,2-dihidropiridin-3-il)azo)bencenosulfonato de disodio; 4-((4-(5-sulfonato-2-metoxifenilamino)-6-cloro-1,3,5-triazin-2-il)amino)-2-((1,4-dimetil-6-oxido-2-oxo-5-sulfonatometil-1,2-dihidropiridin-3-il)azo)bencenosulfonato de trisodio; 4-((4-(5-sulfonato-2-metoxifenilamino)-6-cloro-1,3,5-triazin-2-il)amino)-2-((1,4-dimetil-6-oxido-2-oxo-5-sulfonatometil-1,2-dihidropiridin-3-il)azo)bencenosulfonato de tetrasodio |
419-450-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-469-00-6 |
7-((4,6-Bis(3-dietilaminopropilamino)-1,3,5-triazin-2-il)amino)-4-hidroxi-3-(4-(4-sulfonatofenilazo)fenilazo)-2-naftalenosulfonato de disodio |
419-460-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-470-00-1 |
6,13-Dicloro-3,10-bis{2-[4-[3-(2-hidroxisulfoniloxietanosulfonil)fenilamino]-6-(2,5-disulfonatofenilamino)-1,3,5-triazin-2-ilamino]etilamino}benzo[5,6][1,4]oxazino[2,3-b]fenoxazina-4,11-disulfonato de potasio y sodio |
414-100-0 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
607-471-00-7 |
1,6-Bis((dibenciltiocarbamoil)disulfanil)hexano |
429-280-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
607-473-00-8 |
Pentaeritritol, dipentaeritritol, ácidos grasos, C6-10, mezcla de ésteres con ácido adípico, ácido heptanoico y ácido isoesteárico |
426-590-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-474-00-3 |
Ácido (4-(4-(4-dimetilaminobenciliden-1-il)-3-metil-5-oxo-2-pirazolin-1-il)benzoico |
410-430-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-475-00-9 |
Masa de reacción de: 7-(4-[4-cloro-6-[metil-(3-sulfonatofenil)amino]-1,3,5-triazin-2-ilamino]-2-ureidofenilazo)naftaleno-1,3,6-trisulfonato de tetrasodio; 7-(4-[4-cloro-6-[metil-(4-sulfonatofenil)amino]-1,3,5-triazin-2-ilamino]-2-ureidofenilazo)naftaleno-1,3,6-trisulfonato de tetrasodio (1:1) |
412-940-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-476-00-4 |
N, N-Bis(carboximetil)-β-alaninato de trisodio |
414-070-9 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
|
|
607-477-00-X |
(1α5α6α)-6-Nitro-3-bencil-3-azabiciclo[3.1.0]hexano, sal con metanosulfonato |
426-740-8 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
607-478-00-5 |
Ftalato de tetrametilamonio e hidrógeno |
416-900-5 |
Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H301 H373 ** H400 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H400 |
|
|
|
|
|
607-479-00-0 |
4-Cloro-3-[2-(5,5-dimetil-2,4-dioxo-1,3-oxazolidin-3-il)-4,4-dimetil-3-oxopentamido]benzoato de hexadecilo |
418-550-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-480-00-6 |
Ácido 1,2-bencenodicarboxílico; ésteres de dialquilos C7-11 ramificados y lineales |
271-084-6 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
|
607-481-00-1 |
Masa de reacción de: citrato de trihexilo; citrato de dihexiloctilo; citrato de dioctilhexilo; citrato de dihexildecilo |
430-290-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-482-00-7 |
Anhídrido del ácido N-[1-(S)-etoxicarbonil-3-fenilpropil]-L-alanil-N-carboxílico |
430-360-8 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
607-483-00-2 |
Ácido 1,2-bencenodicarboxílico; diésteres de alquilos C6-8 ramificados, ricos en C7 |
276-158-1 |
Repr. 1B |
H360D*** |
GHS08 Dgr |
H360D*** |
|
|
|
|
|
607-484-00-8 |
2-{[3-Acetilamino-4-(6-bromo-2-metil-1,3-dioxo-2,3-dihidro-1H-isoindol-5-ilazo)fenil]etilamino}propionato de etilo |
430-480-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-485-00-3 |
(3S-trans)-3-[(1,3-Benzodioxol-5-iloxi)metil]-4-(4-fluorofenil)-1-piperidinacarboxilato de fenilo |
430-510-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-486-00-9 |
5'-(6-Cloro-4-(2-(2-vinilsulfoniletoxi)etilamino)-1,3,5-triazin-2-ilamino)-4'-hidroxi-2,3'-azodinaftaleno-1,2',5,7'-disulfonato de potasio y sodio |
402-110-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-487-00-4 |
Masa de reacción de: 4-(3-etoxicarbonil-4-(5-(3-etoxicarbonil-5-hidroxi-1-(4-sulfonatofenil)pirazol-4-il)penta-2,4-dieniliden)-4,5-dihidro-5-oxopirazol-1-il)bencenosulfonato de disodio; 4-(3-etoxicarbonil-4-(5-(3-etoxicarbonil-5-oxido-1-(4-sulfonatofenil)pirazol-4-il)penta-2,4-dieniliden)-4,5-dihidro-5-oxopirazol-1-il)bencenosulfonato de trisodio |
402-660-9 |
— |
Repr. 1B Aquatic Chronic 3 |
H360D *** H412 |
GHS08 Dgr |
H360D *** H412 |
|
|
|
|
607-488-00-X |
(2-Acetilamino-5-fluoro-4-isotiocianatofenoxi)acetato de etilo |
414-210-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-489-00-5 |
Masa de reacción de: linolenato, linoleato y oleato de 2-etilhexilo; epoxioleato de 2-etilhexilo; diepoxilinoleato de 2-etilhexilo; triepoxilinolenato de 2-etilhexilo |
414-890-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-490-00-0 |
Glicinato de N-[2-hidroxi-3-(C12-16-alquiloxi)propil]-N-metilo |
415-060-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-491-00-6 |
Masa de reacción de: diéster de 4,4'-metilen-bis[2-(2-hidroxi-5-metilbencil)-3,6-dimetilfenol] y ácido 6-diazo-5,6-dihidro-5-oxonaftaleno-1-sulfónico (1:2); triéster de 4,4'-metilen-bis[2-(2-hidroxi-5-metilbencil)-3,6-dimetilfenol] y ácido 6-diazo-5,6-dihidro-5-oxonaftaleno-1-sulfónico (1:3) |
427-140-9 |
— |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
607-492-00-1 |
2-(1-(3',3'-Dimetil-1'-ciclohexil)etoxi)-2-metilpropanoato de propilo |
415-490-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-493-00-7 |
(3aR,4R,7aR)-2-Metil-4-(1S,2R,3-triacetoxipropil)-3a,7a-dihidro-4H-pirano[3,4-d]oxazol-6-carboxilato de metilo |
415-670-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-494-00-2 |
Bis(2-etilhexil)octilfosfonato |
417-170-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-495-00-8 |
4-Sulfofenil-6-((1-oxononil)amino)hexanoato de sodio |
417-550-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-496-00-3 |
Fosfito de 2,2'-metilenbis(4,6-di-terc-butil-fenil)-2-etilhexilo |
418-310-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-497-00-9 |
Isoestearato de óxido de cerio |
419-760-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-498-00-4 |
Hexadecanoato de (E)-3,7-dimetil-2,6-octadienilo |
421-370-3 |
Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Wng |
H315 H413 |
|
|
|
|
|
607-499-00-X |
1,2-Etanodiil-bis(2-hexadecenilsuccinato) de bis(dimetil-(2-hidroxietil)amonio) |
421-660-1 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
607-500-00-3 |
2,2,Bis[(5-tetrapropilen-2-hidroxi)fenil]etanoato de calcio |
421-670-4 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
607-501-00-9 |
Masa de reacción de: trifeniltiofosfato y derivados fenílicos terc-butilados |
421-820-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-502-00-4 |
4-Dodecilbencenosulfonato de (N-bencil-N, N,N-tributil)amonio |
422-200-0 |
Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H314 H302 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H411 |
|
|
|
|
|
607-503-00-X |
2,4,6-Tri-n-propil-2,4,6-trioxo-1,3,5,2,4,6-trioxatrifosforinano |
422-210-5 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
607-504-00-5 |
1-Hidroxi-2-(4-(4-carboxifenilazo)-2,5-dimetoxifenilazo)-7-amino-3-naftalenosulfonato de diamonio |
422-670-7 |
— |
Repr. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361f H301 H373** H410 |
|
|
|
|
607-505-00-0 |
7-(4-(4-(5-Amino-4-sulfonato-2-(4-((2-(sulfonato-etoxi)sulfonil)fenilazo)fenilamino)-6-cloro-1,3,5-triazin-2-il)amino-2-ureidofenilazo)naftaleno-1,3,6-trisulfonato de pentasodio |
422-930-1 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-506-00-6 |
Masa de reacción de: (4-cloro-2-((4,5-dihidro-3-metil-5-oxo-1-(3-sulfonatofenil)-1H-pirazol-4-il)azo)-5-metil)bencenosulfonato de estroncio; (4-cloro-2-((4,5-dihidro-3-metil-5-oxo-1-(3-sulfonatofenil)-1H-pirazol-4-il)azo)-5-metil)bencenosulfonato de disodio |
422-970-8 |
|
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-507-00-1 |
2,4-Diamino-3-[4-(2-sulfonatoetoxisulfonil)fenilazo]-5-[4-(2-sulfonatoetoxisulfonil)-2-sulfonatofenilazo]-bencenosulfonato de potasio y sodio |
422-980-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-508-00-7 |
3,3'-[Iminobis[sulfonil-4,1-fenilen-(5-hidroxi-3-metilpirazol-1,4-diil)azo-4,1-fenilensulfonilimino-(4-amino-6-hidroxipirimidina-2,5-diil)azo-4,1-fenilensulfonilimino(4-amino-6-hidroxipirimidina-2,5-diil)azo]bis(bencenosulfonato)] de disodio |
423-110-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-509-00-2 |
4-Aminobenzoato de 2-fenoxietilo |
430-880-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-510-00-8 |
4,4-Dióxido del ácido (2S,5R)-6,6-dibromo-3,3-dimetil-7-oxo-4-tia-1-azabiciclo[3.2.0]heptano-2-carboxílico |
427-200-4 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-511-00-3 |
Masa de reacción de: ácido 4-[(3-deciloxipropil)(3-isobutoxi-1-isobutoxicarbonil-3-oxopropil)amino]-4-oxobutírico; ácido 4-[(3-isobutoxi-1-isobutoxicarbonil-3-oxopropil)(3-octiloxipropil)amino]-4-oxobutírico |
423-750-4 |
— |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
607-512-00-9 |
2,4-Diamino-3,5-bis-[4-(2-sulfonatoetoxi)sulfonil)fenilazo]bencenosulfonato de trisodio |
423-970-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-513-00-4 |
Masa de reacción de: 4-benzoilamino-6-(6-etenosulfonil-1-sulfato-naftalen-2-ilazo)-5-hidroxinaftaleno-2,7-disulfonato de trisodio; ácido 5-(benzoilamino)-4-hidroxi-3-((1-sulfo-6-((2-(sulfooxi)etil)sulfonil)-2-naftil)azo)naftaleno-2,7-disulfónico, sal de sodio; ácido 5-(benzoilamino)-4-hidroxi-3-((1-sulfo-6-((2-(sulfooxi)etil)sulfonil)-2-naftil)azo)naftaleno-2,7-disulfónico |
423-200-3 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-514-00-X |
N-(1-Metoxi-1-oxobut-2-en-3-il)valinato de potasio |
427-240-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-515-00-5 |
Masa de reacción de: éter hexildifenílico de disulfonato de disodio; éter dihexildifenílico de disulfonato de disodio |
429-650-7 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
|
607-516-00-0 |
N, N'-Bis(trifluoroacetil)-S, S'-bis-L-homocisteína |
429-670-6 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
607-517-00-6 |
Ácido (S)-α-(acetiltio)bencenopropanoico |
430-300-0 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
|
607-518-00-1 |
Ácido 3-oxoandrost-4-eno-17-β-carboxílico |
414-990-0 |
Repr. 2 Aquatic Chronic 4 |
H361f H413 |
GHS08 Wng |
H361f H413 |
|
|
|
|
|
607-519-00-7 |
Poli[acetato de ((4-((4-etil-etilen)amino)fenil)-((4-(etil-(2-oxietilen)amino)fenil)metinil)ciclohexa-2,5-dieniliden)-N-etil-N-(2-hidroxietil)amonio] |
427-280-0 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H335 H315 H318 H410 |
|
|
|
|
|
607-520-00-2 |
Masa de reacción de: 4,5-dihidro-2-[(propionato)(C6-18)alquil]-3H-imidazolio-N-etilfosfato de sodio; 4,5-dihidro-2-[(dipropionato)(C6-18)alquil]-3H-imidazolio-N-etilfosfato de disodio |
427-740-0 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-521-00-8 |
N, N'-(Metilendiciclohexano-4,1-diil)bis-DL-aspartato de tetraetilo |
429-270-1 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-522-00-3 |
Sal de sodio del polímero de: 2-metilbuta-1,3-dien-1-sulfonato de sodio con ácido acrílico y 2-hidroxietil-2-metilacrilato |
429-720-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-523-00-9 |
Masa de reacción de 3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2-ilamino]-6-13-diclorobenzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a tetra(litio y/o sodio); 3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ilamino]-6-13-diclorobenzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a tetra(litio y/o sodio); 10,10'-diamino-6,6',13,13'-tetracloro-3,3'-[6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a penta(litio y/o sodio); 10-amino-6,6', 13,13'-tetracloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a hepta(litio y/o sodio); 10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenilendiiminobis[6-metil-(2-sulfonatoetil)amino]-1,3,5-triazina-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a hepta(litio y/o sodio) |
430-200-7 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-524-00-4 |
Ésteres de 2-[(tetrahidro-2H-piran-2-il) tio]etilo de tall oil |
430-310-5 |
— |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
607-525-00-X |
Ácido (Z)-2-metoximino-2-[2-(tritilamino)tiazol-4-il]acético |
431-520-1 |
Flam. Sol. 1**** Carc. 2 Aquatic Chronic 3 |
H228 H351 H412 |
GHS02 GHS08 Dgr |
H228 H351 H412 |
|
|
|
|
|
607-526-00-5 |
Cartap (ISO); 1,3-bis(carbamoiltio)-2-(dimetilamino)propano |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-527-00-0 |
Masa de reacción de: dodecanodioato de 1-(1'H,1'H,2'H,2'H-tridecafluorooctil)-12-(1''H,1''H,2''H,2''H-tridecafluorooctilo); dodecanodioato de 1-(1'H,1'H,2'H,2'H-tridecafluorooctil)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecilo); dodecanodioato de 1-(1'H,1'H,2'H,2'H-tridecafluorooctil)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecilo); dodecanodioato de 1-(1'H,1'H,2'H,2'H-tridecafluorooctil)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecilo); dodecanodioato de 1-(1'H,1'H,2'H,2'H-heptadecafluorodecil)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecilo); dodecanodioato de 1-(1'H,1'H,2'H,2'H-heptadecafluorodecil)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecilo |
423-180-6 |
— |
STOT RE 2 * |
H373 ** |
GHS08 Wng |
H373 ** |
|
|
|
|
607-528-00-6 |
Ácido (S)-3-metil-2-(2-oxotetrahidropirimidin-1-il)butírico |
430-900-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-529-00-1 |
cis-4-Amonio-4'-toluenosulfonato-1-ciclohexanocarboxilato de bencilo |
426-070-6 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-530-00-7 |
Masa de reacción de isómeros de: 3-(3,5-di-terc-butil-4-hidroxifenil)propionato de C7-9-alquilo |
406-040-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-531-00-2 |
3-Amino-4,6-dibromo-2-metil-benzoato de metilo |
425-190-6 |
STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
|
|
607-532-00-8 |
Ácido (S)-1-[2-terc-butoxicarbonil-3-(2-metoxietoxi)propil]-1-ciclopentanocarboxílico, sal de ciclohexilamina |
425-510-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-533-00-3 |
6-Cloro-3,10-bis[2-[4-cloro-6-(2,4-disulfofenilamino)-1,3,5-triazin-2-il-amino]etilamino]-13-etilbenzo[5.6][1.4]oxazino[2,3-b]fenoxazina-4,11-disulfonato de pentasodio y monohidrógeno |
414-910-4 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-534-00-9 |
2-(3-Benzoilfenil)propanoato de etilo |
414-920-9 |
Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 |
H301 H372** H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H372** H317 H411 |
|
|
|
|
|
607-535-00-4 |
Ácido 4-yodo-2-sulfonatobenzoico de potasio |
426-620-5 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-536-00-X |
Ácido (2,6-xililoxi)acético |
430-910-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
607-537-00-5 |
2-(3-Benzoilfenil)propionato de isopropilamonio |
417-970-1 |
— |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H372** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H301 H312 H372** H318 H410 |
|
|
|
|
607-539-00-6 |
((4-(5-Oxo-3-propilisoxazolidin-4-ilidenmetin)fenil)propoxicarbonilmetilenamino)acetato de propilo |
431-000-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-540-00-1 |
Ácido 1-(mercaptometil)ciclopropilacético |
420-240-3 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H312 H302 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H312 H302 H317 H411 |
|
|
|
|
|
607-541-00-7 |
[(1-metil-1,2-etanodiil)bis[nitrilobis(metilen)]]tetrakis(ácido fosfónico) |
421-940-1 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
|
607-542-00-2 |
2-(4-Butanosulfonamidofenoxi)tetradecanoato de metilo |
422-110-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-543-00-8 |
Poli[acetato de ((4-((4-(etil-etilen)amino)fenil)-(4-(etil-(2-oxietilen)amino)fenil)metinil)-3-metilciclohexa-2,5-dieniliden)-N-etil-N-(2-hidroxietil)amonio] |
427-480-8 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H335 H315 H318 H410 |
|
|
|
|
|
607-544-00-3 |
6,8-Difluoro-1-(formilmetilamino)-1,4-dihidro-7-(4-metil)piperazin-1-il)-4-oxo-quinolina-3-carboxilato de etilo |
427-490-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-545-00-9 |
Acetato de 1,2-dimetil-3-(1-metiletenil)ciclopentilo |
424-070-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
|||||||